pmid,e1,e2,label,sentence
18519692_2008.ann,K-Ras,colorectal cancer,1," Intriguingly, the ZKSCAN3 protein was also expressed in tumors wild-type for genes (APC, p53, K-Ras) commonly targeted in colorectal cancer."
18519692_2008.ann,p53,colorectal cancer,1," Intriguingly, the ZKSCAN3 protein was also expressed in tumors wild-type for genes (APC, p53, K-Ras) commonly targeted in colorectal cancer."
21679465_2011.ann,Notch-4,breast cancer,1, Notch-1 and Notch-4 are potent breast oncogenes that are overexpressed in triple-negative and other subtypes of breast cancer.
21679465_2011.ann,Notch-1,breast cancer,1, Notch-1 and Notch-4 are potent breast oncogenes that are overexpressed in triple-negative and other subtypes of breast cancer.
7478622_1995.ann,p53 gene,colorectal cancer,1," Surprisingly, given the proposed role for loss of function mutations of the p53 gene in the development of human colorectal cancer, we have found no evidence for either an increase in the rate of adenoma formation in APC +/-, p53 -/- animals,  or an increased rate of progression to malignancy compared with APC +/- p53 +/+ mice."
19005184_2009.ann,p53,adenomatous polyposis coli,1," Tumors were graded for histology and immunostained for p53, adenomatous polyposis coli, beta-catenin, cyclooxygenase-2 (Cox-2) and inducible nitric oxide synthase  (iNOS) and sequenced for p53 mutations."
17942462_2008.ann,COX-2 gene,prostate tumorigenesis,1,A TRAMP/COX-2 knockout mouse model was also generated to determine the effects of the loss of the COX-2 gene on prostate tumorigenesis in TRAMP mice.
25516351_2014.ann,SPARC gene promoter,gastric cancer,1,Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.
15958644_2005.ann,p53,colorectal cancer,1,Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
17597105_2007.ann,Aldo-keto reductase family 1 B10 gene,colorectal cancer,1,Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
17906616_2007.ann,CDX2,intestinal metaplasia,1,"Although incomplete intestinal metaplasia morphologically resembles  colon, its CDX2 expression was apparently lower than that in the normal colon."
21062980_2010.ann,HNF4alpha,colorectal cancer,1,Analysis of a colorectal cancer patient cohort establishes that HNF4alpha is significantly upregulated compared with adjacent normal epithelial resections.
19887544_2009.ann,15-PGDH gene,colon tumor,1,Animal breast and colon tumor therapy studies showed that 15-PGDH gene therapy produced a significant delay in 2LMP and LS174T tumor growth.
24931456_2014.ann,miR-222,colitis,1,Antagonism of miR-221 and miR-222 reduces growth of colon tumors in mice with colitis.
18852136_2008.ann,bcl-2,colorectal cancer,1,Antisense oligodeoxynucleotides to human superoxide dismutase 2 and/or ectopic bcl-2 overexpression avoided polyphenols and chemoradiotherapy-induced colorectal cancer elimination and showed that the mangano-type superoxide dismutase and Bcl-2 are key targets in the molecular mechanism activated by the combined application of t-PTER and QUER.
17906616_2007.ann,CDX2,intestinal metaplasia,1,"As incomplete intestinal metaplasia is associated with higher risk of gastric cancer, its lower CDX2 expression compared with that in complete intestinal metaplasia and normal colon epithelium resolved  the current contradiction between the tumor-suppressive role of CDX2 in the colon and the high prevalence of CDX2 in intestinal metaplasia."
17906616_2007.ann,CDX2,gastric cancer,1,"As incomplete intestinal metaplasia is associated with higher risk of gastric cancer, its lower CDX2 expression compared with that in complete intestinal metaplasia and normal colon epithelium resolved  the current contradiction between the tumor-suppressive role of CDX2 in the colon and the high prevalence of CDX2 in intestinal metaplasia."
21464044_2011.ann,HER2,gastrointestinal cancers,1,"As key molecules that drive progression and chemoresistance in gastrointestinal cancers, epidermal growth factor receptor (EGFR) and HER2 have become efficacious drug targets in this setting."
17404573_2007.ann,Bcl-2,colorectal cancers,1,"Beta-catenin/T-cell factor (Tcf) signaling is constitutively active in the majority of human colorectal cancers, and there are accompanying changes in Bcl-2 expression."
17906616_2007.ann,CDX2,gastric intestinal cancer,1,"CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer."
17906616_2007.ann,CDX2,Intestinal metaplasia,1,"CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer. Intestinal metaplasia is a key event in multistep gastric carcinogenesis."
17906616_2007.ann,CDX2,intestinal metaplasia,1,"CDX2 expression was significantly decreased in incomplete intestinal metaplasia, which expresses both gastric mucins (MUC5AC and MUC6) and intestinal mucin (MUC2), compared with complete intestinal metaplasia, which expresses intestinal mucin (MUC2) only."
11875002_2002.ann,Cdx2,intestinal metaplasia,1,"Cdx2 induces differentiation of intestinal epithelial cells in vitro; therefore, we sought to establish whether a causal relationship exists between Cdx2 activation and intestinal metaplasia."
9704932_1998.ann,CDX2,colorectal cancer,1,"CDX2, a human homologue of Drosophila caudal, is mutated in both alleles in a replication error positive colorectal cancer."
17906616_2007.ann,CDX2,colon cancer,1,"CDX2, a master regulator of intestinal phenotype, was shown to play a tumor-suppressive role in colon cancer."
11875002_2002.ann,Cdx2,intestinal metaplasia,1,CONCLUSIONS: Gastric expression of Cdx2 alone was sufficient to induce intestinal metaplasia in mice.
24931456_2014.ann,miR-221,CRC,1,"CONCLUSIONS: In human CRC cells, miR-221 and miR-222 act in a positive feedback loop to increase expression levels of RelA and STAT3."
24931456_2014.ann,miR-222,CRC,1,"CONCLUSIONS: In human CRC cells, miR-221 and miR-222 act in a positive feedback loop to increase expression levels of RelA and STAT3."
27639802_2017.ann,Hes1,colitis,1,"CONCLUSIONS: In mice, fucosylation deficiency leads to colitis and adenocarcinoma, loss of Notch activation, and down-regulation of Hes1."
22986531_2013.ann,HNF4alpha,colon cancer,1,"Correlated patterns were observed between HNF4alpha and Cdx2 in several experimental models of human colon cancer cell lines: xenografts in nude mice, wound healing and glucose starvation."
22986531_2013.ann,Cdx2,colon cancer,1,"Correlated patterns were observed between HNF4alpha and Cdx2 in several experimental models of human colon cancer cell lines: xenografts in nude mice, wound healing and glucose starvation."
28356122_2017.ann,miR-195-5p,CRC,1,CRC patients with a decreased  level of miR-195-5p in tumor tissues had significantly shortened survival as revealed by the TCGA colon adenocarcinoma (COAD) dataset and our CRC cohort.
22986531_2013.ann,Cdx2,intestinal cancers,1,Crossing Apc(Delta14/+) mice prone to spontaneous intestinal tumor development with pCdx2-9LacZ transgenic mice containing the LacZ reporter under the control of the 9.3-kb Cdx2 promoter showed that this promoter segment contains sequences recapitulating the decrease of Cdx2 expression in intestinal cancers.
25491321_2014.ann,miR-610,hepatocellular carcinoma,1,Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/beta-catenin signaling in human hepatocellular carcinoma.
24885920_2014.ann,miR-139-5p,colon cancer,1,Ectopic expression of miR-139-5p in colon cancer cell lines significantly suppressed cell growth as evidenced by cell viability assay (P < 0.001) and colony formation assay (P < 0.01) and in xenograft tumor growth in nude mice (P < 0.01).
11521200_2001.ann,CDX2,colon cancer,1,Expression of the gut-enriched Kruppel-like factor (Kruppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2.
18627302_2008.ann,KLK13 genes,non-small-cell lung cancer,1,Expression of the KLK13 and KLK14 genes was examined at the mRNA and protein levels in a cohort of 57 patients with non-small-cell lung cancer (NSCLC).
18627302_2008.ann,KLK14 genes,non-small-cell lung cancer,1,Expression of the KLK13 and KLK14 genes was examined at the mRNA and protein levels in a cohort of 57 patients with non-small-cell lung cancer (NSCLC).
17906616_2007.ann,CDX2,intestinal metaplasia,1,Further decrease of CDX2 expression in gastric dysplasia and cancer suggests that CDX2 plays a similar anticarcinogenic role in intestinal metaplasia as it does in colon.
15141379_2004.ann,CDX2,metastatic colorectal cancer,1,"Furthermore, as high and uniform expression of CDX2 was characteristic of metastatic colorectal cancer, weak and/or focal CDX2 expression should alert surgical pathologists to the possibility of primary lung adenocarcinoma, especially in the presence of goblet cell morphology."
22986531_2013.ann,HNF4alpha,colon cancer,1,"Furthermore, Cdx2 decreased by knocking down HNF4alpha in human colon cancer cells using siRNA and in the colon of mice conditionally knocked out for the Hnf4alpha gene in the adult intestine (Hnf4alpha(f/f);VilCre(ERT2) mice)."
25501825_2014.ann,mir-660,lung cancer,1,"Furthermore, stable overexpression using lentiviral vectors in NCI-H460 and A549 cells inhibited tumor xenograft growth in immunodeficient mice (95 and 50% reduction compared with control, respectively), whereas the effects of mir-660 overexpression were absent in H1299, a lung cancer cell line lacking p53 locus, both in in vitro and in vivo assays."
19147571_2009.ann,Notch-1,colon cancer,1,gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.
25030372_2014.ann,BER genes,colorectal cancer,1,"Germline and  somatic mutations in BER genes, such as MutY Homolog (MUTYH/MYH) and DNA-directed polymerase (POLB), are associated with increased risk of colorectal cancer."
25321483_2014.ann,BMF gene,colon cancer,1,HDAC8 and STAT3 repress BMF gene activity in colon cancer cells.
22986531_2013.ann,Cdx2,colon cancers,1,Here we have studied the role of HNF4alpha in the mechanism of deregulation of Cdx2 in colon cancers.
27132515_2016.ann,Bcl-3,colitis,1,"Here we investigated the role of Bcl-3 in azoxymethane/dextran sulfate sodium (AOM/DSS)-induced colon tumors, a mouse model for colitis-associated colorectal cancers in humans."
27132515_2016.ann,Bcl-3,colorectal cancers,1,"Here we investigated the role of Bcl-3 in azoxymethane/dextran sulfate sodium (AOM/DSS)-induced colon tumors, a mouse model for colitis-associated colorectal cancers in humans."
18790750_2008.ann,p53,prostate cancer,1,"Here, we investigated the cell death signaling mechanisms induced by PGG  in human prostate cancer cells of different p53 functional status."
23934188_2014.ann,miR-137,neuroblastoma,1,"Here, we report the inversely related expression of miR-137 and CAR in parental and doxorubicin-resistant neuroblastoma cells, wherein miR-137 is downregulated in resistant cells."
22851508_2012.ann,NANOG,colorectal cancers,1,"Herein, we show NANOG is expressed from both NANOG1 and NANOGP8 in human colorectal cancers (CRC)."
22851508_2012.ann,NANOG,CRC,1,"Herein, we show NANOG is expressed from both NANOG1 and NANOGP8 in human colorectal cancers (CRC)."
22851508_2012.ann,NANOG1,CRC,1,"Herein, we show NANOG is expressed from both NANOG1 and NANOGP8 in human colorectal cancers (CRC)."
22851508_2012.ann,NANOG1,colorectal cancers,1,"Herein, we show NANOG is expressed from both NANOG1 and NANOGP8 in human colorectal cancers (CRC)."
22851508_2012.ann,NANOGP8,colorectal cancers,1,"Herein, we show NANOG is expressed from both NANOG1 and NANOGP8 in human colorectal cancers (CRC)."
22851508_2012.ann,NANOGP8,CRC,1,"Herein, we show NANOG is expressed from both NANOG1 and NANOGP8 in human colorectal cancers (CRC)."
25608619_2015.ann,miR-146a,hepatocellular carcinoma (HCC),1,"However, the  molecular details underlying miR-146a mediated regulation of its target genes and its precise biological function in cancer, especially in hepatocellular carcinoma (HCC) remains unclear."
24931456_2014.ann,miR-221,CRC,1,Human CRC tissues had higher levels of miR-221 and miR-222 than nontumor colon tissues; increases correlated with increased levels of RelA and STAT3 mRNAs.
24931456_2014.ann,miR-222,CRC,1,Human CRC tissues had higher levels of miR-221 and miR-222 than nontumor colon tissues; increases correlated with increased levels of RelA and STAT3 mRNAs.
23934188_2014.ann,miR-137,neuroblastoma,1,Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.
23668310_2013.ann,c-myc,colorectal cancer,1,"Immunohistochemistry for beta-catenin, c-myc, Ki-67 and TUNEL-staining was performed to investigate TQ's effect on major colorectal cancer pathways."
24013097_2013.ann,miR-141,pancreatic cancer,1,"In a nude mouse xenograft model, both overexpression of miR-141 and knockdown of MAP4K4 significantly repressed pancreatic cancer cell growth."
27486174_2016.ann,MYC,prostate cancer,1,"In addition, PIM kinases activate MYC signaling and mRNA translation in prostate cancer and cooperate with MYC to accelerate tumorigenesis."
18794809_2008.ann,POX gene,colorectal cancer,1,"In our current report, we used DLD-1 colorectal cancer cells stably transfected with the POX gene under the control of a tetracycline-inducible promoter and found that three pathways which cross talk  with each other were downregulated by POX: the cyclooxygenase-2 (COX-2) pathway,  the epidermal growth factor receptor (EGFR) pathway and the Wnt/beta-catenin pathway."
17599044_2008.ann,Cdx2,invasive cancer,1,"In particular, the expression of the intestine-specific transcription factor Cdx2, a key gene for intestinal identity downregulated in invasive cancer cells, is reduced during wound healing in vitro."
19147571_2009.ann,Notch-1,colon cancer,1,"In summary, colon cancer cells may up-regulate Notch-1 as a protective mechanism in response to chemotherapy."
22901255_2012.ann,Cdx1,gastrointestinal cancers,1,"In the adult, Cdx1 and Cdx2, but not Cdx4, have been  intensively explored for their function in intestinal tissue homeostasis and the  pathogenesis of gastrointestinal cancers."
22901255_2012.ann,Cdx2,gastrointestinal cancers,1,"In the adult, Cdx1 and Cdx2, but not Cdx4, have been  intensively explored for their function in intestinal tissue homeostasis and the  pathogenesis of gastrointestinal cancers."
19384949_2009.ann,TS gene,colon cancer,1,"In this study, we demonstrate that the histone deacetylase inhibitors (HDACi) vorinostat and LBH589 significantly downregulate TS gene expression in a panel of colon cancer cell lines."
24013097_2013.ann,miR-141,pancreatic cancer,1,"In this study, we explored the role of miR-141 in pancreatic cancer."
17599044_2008.ann,Cdx2,colon cancer,1,"In vitro, forced expression of Cdx2 in human  colon cancer cell lines retarded wound repair and reduced migration, whereas inhibition of Cdx2 expression by RNA interference enhanced migration."
24931456_2014.ann,miR-221,CRC,1,Incubation of CRC cells with miR-221 and miR-222 inhibitors reduced their proliferation and colony formation compared with control cells.
24784840_2014.ann,p53,gastric adenocarcinoma,1,"Interestingly, gastric adenocarcinoma was significantly more frequent in Pdx-1-Cre;Smad4(F/F);Trp53(F/F);Cdh1(F) (/+) mice than in Pdx-1-Cre;Smad4(F/F);Trp53(F/F);Cdh1(+/+) mice, demonstrating that Cdh1 heterozygosity accelerates the development and progression of gastric adenocarcinoma, in combination with loss of Smad4 and p53."
17906616_2007.ann,CDX2,gastric cancer,1,Intestinal metaplasia or dysplasia with low expression of CDX2 may serve as predictive markers for gastric cancer.
17906616_2007.ann,CDX2,Intestinal metaplasia,1,Intestinal metaplasia or dysplasia with low expression of CDX2 may serve as predictive markers for gastric cancer.
22537901_2012.ann,HER2,Triple negative breast cancer,1,"INTRODUCTION: Triple negative breast cancer (TNBC) is very aggressive and currently has no specific therapeutic targets, such as hormone receptors or human epidermal growth factor receptor type 2 (HER2); therefore, prognosis is poor."
18676755_2008.ann,K-Ras,colorectal cancer,1,K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
22120154_2012.ann,LINE-1,intestinal metaplasia,1,LINE-1 methylation decreased during the transition from intestinal metaplasia to gastric adenoma and no further decrease occurred during the transition from gastric adenoma to GC.
22120154_2012.ann,LINE-1,gastric adenoma,1,LINE-1 methylation decreased during the transition from intestinal metaplasia to gastric adenoma and no further decrease occurred during the transition from gastric adenoma to GC.
26342199_2015.ann,c-fos proto-oncogene,bladder cancer,1,"Little is known about biological significance of ELK1, a transcriptional factor that activates downstream targets including c-fos proto-oncogene, in bladder cancer."
24931456_2014.ann,miR-221,CRC,1,METHODS: CRC cell lines (HCT116 and RKO) were transfected with miR-221 or miR-222 mimics or inhibitors.
24931456_2014.ann,miR-222,CRC,1,METHODS: CRC cell lines (HCT116 and RKO) were transfected with miR-221 or miR-222 mimics or inhibitors.
21205878_2011.ann,Hes1,colorectal cancer,1,METHODS: Notch status was analysed by studying expression of the Notch effector Hes1 and Notch ligands/receptors in human colorectal cancer (CRC) and mouse models of Apc mutation.
21205878_2011.ann,Hes1,CRC,1,METHODS: Notch status was analysed by studying expression of the Notch effector Hes1 and Notch ligands/receptors in human colorectal cancer (CRC) and mouse models of Apc mutation.
25516351_2014.ann,SPARC gene,gastric cancer,1,"Methylation rate of SPARC gene was 80% in ten gastric cancer cell lines and 74% (163 of 220) in primary tumors, while it was 5% in normal gastric mucosa (n = 40)."
10498885_1999.ann,Msh2,gastrointestinal cancer,1,"Mice with mutations in the mismatch repair genes, Msh2 and Mlh1, exhibit a mismatch repair  defect and are predisposed to developing gastrointestinal cancer, lymphomas and tumors of other organ systems."
10498885_1999.ann,Mlh1,gastrointestinal cancer,1,"Mice with mutations in the mismatch repair genes, Msh2 and Mlh1, exhibit a mismatch repair  defect and are predisposed to developing gastrointestinal cancer, lymphomas and tumors of other organ systems."
23934188_2014.ann,miR-137,neuroblastoma,1,"miR-137 overexpression resulted in downregulation of CAR protein and mRNA (via mRNA degradation); it sensitized doxorubicin-resistant cells to doxorubicin (as shown  by reduced proliferation, increased apoptosis and increased G2-phase cell cycle arrest) and reduced the in vivo growth rate of neuroblastoma xenografts."
23934188_2014.ann,miR-137,neuroblastoma,1,miR-137 regulates the constitutive androstane receptor and modulates doxorubicin  sensitivity in parental and doxorubicin-resistant neuroblastoma cells.
25503559_2015.ann,miR-490-3p,intestinal metaplasia,1,"miR-490-3p exhibited progressive downregulation in gastritis, intestinal metaplasia, and adenocarcinoma during H."
25501825_2014.ann,Mir-660,lung cancer,1,Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
24013097_2013.ann,miRNA-141,pancreatic cancer,1,"miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4."
24960159_2014.ann,c-MYC,intestinal cancers,1,"Moreover,  we identified Usp28 as a c-MYC target gene highly expressed in murine and human intestinal cancers, which indicates that USP28 and c-MYC form a positive feedback loop that maintains high c-MYC protein levels in tumors."
11875002_2002.ann,Cdx2,intestinal neoplasia,1,"Moreover, as gastric cancer in humans is often preceded by intestinal metaplasia, the phenotype described here strongly suggests involvement of Cdx2 in the initiation of the process leading to intestinal neoplasia of the gastric mucosa."
17906616_2007.ann,CDX2,gastric cancer,1,"Moreover, CDX2 expression was progressively reduced in gastric dysplasia and cancer."
8640784_1996.ann,secretory phospholipase A(2) gene,intestinal polyps,1,"Mutation of Pla2g2a, a secretory phospholipase A(2) gene, dramatically increases  the number of intestinal polyps that develop in the multiple intestinal neoplasia (Min) mouse, a murine model for adenomatous polyposis coli in humans."
8640784_1996.ann,secretory phospholipase A(2) gene,intestinal neoplasia,1,"Mutation of Pla2g2a, a secretory phospholipase A(2) gene, dramatically increases  the number of intestinal polyps that develop in the multiple intestinal neoplasia (Min) mouse, a murine model for adenomatous polyposis coli in humans."
8640784_1996.ann,secretory phospholipase A(2) gene,adenomatous polyposis coli,1,"Mutation of Pla2g2a, a secretory phospholipase A(2) gene, dramatically increases  the number of intestinal polyps that develop in the multiple intestinal neoplasia (Min) mouse, a murine model for adenomatous polyposis coli in humans."
27489358_2016.ann,Notch1,gastric cancers,1,Notch1 directly induced CD133 expression in human diffuse type gastric cancers.
21436051_2011.ann,adenomatous polyposis coli gene,CRC,1,One of  the most common rate-limiting mutations in human CRC occurs in the adenomatous polyposis coli (APC) gene.
18413743_2008.ann,SOX17 gene,CRC,1,Our recent global analysis of CpG island hypermethylation and gene expression in colorectal cancer (CRC) cell lines revealed that SOX17 gene silencing is associated with DNA hypermethylation of a CpG island in the promoter region.
18413743_2008.ann,SOX17 gene,colorectal cancer,1,Our recent global analysis of CpG island hypermethylation and gene expression in colorectal cancer (CRC) cell lines revealed that SOX17 gene silencing is associated with DNA hypermethylation of a CpG island in the promoter region.
24013097_2013.ann,miR-141,pancreatic cancer,1,"Overexpression of miR-141 in pancreatic cancer cells inhibited cell proliferation, clonogenicity, and invasion; induced G1 arrest and apoptosis; and enhanced chemosensitivity."
19652364_2009.ann,gastrin gene,colorectal cancer,1,"Overexpression of progastrin, a nonamidated and incompletely processed product of the gastrin gene, has been shown to induce colonic hyperproliferation and promote colorectal cancer in mice, but the mechanism of pathogenesis has not been defined."
24642471_2014.ann,p53,CRC,1,p53 activation in CRC cells interfered with IL-6-induced invasion and migration via miR-34a-dependent downregulation of IL6R expression.
18790750_2008.ann,p53,prostate cancer,1,"Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in  vivo."
15269146_2004.ann,p14ARF gene,non-small cell lung cancer,1,PURPOSE AND EXPERIMENTAL DESIGN: The molecular mechanisms by which the p14ARF gene is altered in non-small cell lung cancer (NSCLC) are complex and unclear.
21531817_2011.ann,IFITM3,colorectal cancer,1,"PURPOSE: IFITM3, an IFN-inducible gene, is overexpressed in human colorectal cancer."
27486174_2016.ann,MYC oncogene,prostate cancer,1,PURPOSE: The MYC oncogene is frequently overexpressed in prostate cancer.
22986531_2013.ann,HNF4alpha,intestinal cancer,1,Regulation of the tumor suppressor homeogene Cdx2 by HNF4alpha in intestinal cancer.
26210742_2015.ann,ISG15,colon tumorigenesis,1,"Results show KLF9 to be a haploinsufficient suppressor of colon tumorigenesis in Apc(Min/+) mice in part, by repression of ISG15 and the latter's antiapoptotic function."
21679465_2011.ann,Notch,breast cancer,1,RESULTS: Herein we provide new evidence for transcriptional regulation of Notch by PEA3 in breast cancer.
24931456_2014.ann,miR-221,CRC,1,"RESULTS: In CRC cell lines, mimics of miR-221 and miR-222  activated NF-kappaB and STAT3, further increasing expression of miR-221 and miR-222."
24931456_2014.ann,miR-222,CRC,1,"RESULTS: In CRC cell lines, mimics of miR-221 and miR-222  activated NF-kappaB and STAT3, further increasing expression of miR-221 and miR-222."
15107824_2004.ann,Sil  gene,lung cancer,1,Sil  gene expression in lung cancer correlated with the expression of several kinetochore check-point genes and with the histopathologic mitotic index.
25043185_2014.ann,MLH1,colorectal cancers,1,Silencing of MLH1 is frequently seen in sporadic colorectal cancers.
25939752_2015.ann,CDX1,colon cancer,1,"Similarly, the treatment of human colon cancer cell lines with a hypomethylating agent induces differentiation-related genes, including CDX1."
26716648_2016.ann,Bcl-2,colitis-associated cancer,1,"Sonic hedgehog inhibitors prevent colitis-associated cancer via orchestrated mechanisms of IL-6/gp130 inhibition, 15-PGDH induction, Bcl-2 abrogation, and tumorsphere inhibition."
23376423_2013.ann,beta-catenin-target genes,CRC,1,"SPDEF inhibited the expression of beta-catenin-target genes in mouse colon tumors, and interacted with beta-catenin to block its transcriptional activity in CRC cell lines, resulting in lower levels of cyclin D1 and c-MYC."
23376423_2013.ann,c-MYC,CRC,1,"SPDEF inhibited the expression of beta-catenin-target genes in mouse colon tumors, and interacted with beta-catenin to block its transcriptional activity in CRC cell lines, resulting in lower levels of cyclin D1 and c-MYC."
7769122_1995.ann,Ha-ras,colon cancer,1,Stable transfection of Ha-ras into the human colon cancer line CaCo2 results in the morphologic differentiation to a small bowel phenotype.
20010873_2010.ann,adenomatous polyposis coli gene,colorectal cancers,1,The adenomatous polyposis coli (APC) gene product is mutated in the vast majority of human colorectal cancers.
22349829_2013.ann,L1CAM,CRC,1,The adhesion molecule L1CAM mediates chemoresistance and migration of tumor cells and is elevated in CRC tissues being associated with metastatic spread and poor prognosis for the patients.
24013097_2013.ann,miR-141,pancreatic cancer,1,The analysis of clinical characteristics showed that miR-141 was significantly downregulated in tissues and cell lines of  pancreatic cancer.
17704804_2008.ann,IEX-1,colorectal cancer,1,The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.
17906616_2007.ann,CDX2,gastric cancer,1,The CDX2 expression in gastric cancer was also inversely correlated with  the expression of gastric mucins.
28231808_2017.ann,ITIH5,breast cancer,1,The ECM-modulator inter- alpha-trypsin inhibitor heavy chain family member five (ITIH5) was recently identified as tumor suppressor potentially involved in impairing breast cancer progression but molecular mechanisms underlying its function are still elusive.
15705887_2005.ann,folate transporter gene,colon carcinogenesis,1,The effect of folate transporter gene ablation on colon carcinogenesis was evaluated 8 and 38 weeks post-azoxymethane injection in wild-type and heterozygous mice.
24931456_2014.ann,miR-221,CRC,1,"The levels of miR-221 and miR-222 as well as RelA, STAT3, and PDLIM2 mRNAs were measured in 57 paired CRC and adjacent nontumor tissues from patients."
24931456_2014.ann,miR-222,CRC,1,"The levels of miR-221 and miR-222 as well as RelA, STAT3, and PDLIM2 mRNAs were measured in 57 paired CRC and adjacent nontumor tissues from patients."
23975432_2014.ann,KCNQ1,gastrointestinal cancers,1,The role of KCNQ1 in mouse and human gastrointestinal cancers.
17599044_2008.ann,Cdx2,colon cancer,1,"These data provide evidence that Cdx2 antagonizes the process of tumor cell dissemination, and they suggest that this homeobox gene might represent a new therapeutic target against metastatic spreading of colon cancer."
9816310_1996.ann,K-sam,stomach cancer,1,"These results suggest that K-sam overexpression is associated with the malignant phenotype of the undifferentiated type of stomach cancer, such as infiltrative growth and metastasis."
18372904_2008.ann,K-Ras,colon cancer,1,"This K-Ras tumor phenotype was associated with attenuated signaling through the MAPK pathway, and human colon cancer cells expressing mutant K-Ras were hypersensitive to inhibition of Raf, but not Mek."
12970743_2003.ann,C-CRK proto-oncogene,lung cancers,1,This study provides the first quantitative analysis of discrete CRKI and CRKII protein isoforms in human lung tumors and provides evidence that the C-CRK proto-oncogene may foment a more aggressive phenotype in lung cancers.
18171987_2007.ann,c-Myc,colorectal cancer,1,This study shows that c-Myc is critical for Apc-dependent intestinal tumorigenesis in mice and provides a potential therapeutic target in the treatment of colorectal cancer.
24013097_2013.ann,miR-141,pancreatic cancer,1,"To  understand how miR-141 mediates the phenotype of pancreatic cancer cells, a bioinformatics tool was used to identify MAP4K4 as a potential target of miR-141."
23975432_2014.ann,KCNQ1,CRC,1,"To investigate the role of KCNQ1 in human colorectal cancer (CRC), we measured protein levels of KCNQ1 by immunohistochemistry in tissue microarrays containing samples from CRC patients with liver metastases who had undergone hepatic resection."
25501825_2014.ann,mir-660,lung cancer,1,"Transient and stable overexpression of mir-660 using miRNA mimics  reduced migration, invasion, and proliferation properties and increased apoptosis in p53 wild-type lung cancer cells (NCI-H460, LT73, and A549)."
27489358_2016.ann,Notch1,gastric cancers,1,We aimed to investigate whether Notch1 signaling contributes to the carcinogenesis of gastric cancers and CD133 induction.
21319196_2011.ann,PAX5,hepatocellular carcinoma,1,We examined the biological functions and related molecular mechanisms of PAX5 in hepatocellular carcinoma (HCC).
21319196_2011.ann,PAX5,hepatocellular carcinoma (HCC),1,We examined the biological functions and related molecular mechanisms of PAX5 in hepatocellular carcinoma (HCC).
9797364_1998.ann,apobec-1 gene,colon cancer,1,We have examined apobec-1 gene expression in human gastrointestinal tumors and in colon cancer-derived cell lines.
17360473_2007.ann,gatekeeper gene,Adenomatous polyposis coli,1,We have investigated whether a rat model carrying a knockout allele in the gatekeeper gene Adenomatous polyposis coli (Apc) recapitulates familial colon cancer of the human more closely than existing murine models.
24931456_2014.ann,miR-222,CRC,1,We investigated whether microRNA miR-221 and miR-222 regulate NF-kappaB and signal transducer and activator of transcription 3 (STAT3) activation in human CRC cell lines.
20980345_2011.ann,p53,colorectal cancer,1,"We wanted to  determine whether genetic defects that are relevant for colorectal cancer, such as Msh2 or p53 deficiency, would influence the efficiency of sulindac chemoprevention or increase the side effects."
24013097_2013.ann,miR-141,pancreatic cancer,1,Western blot and quantitative real-time PCR (qRT-PCR) analyses revealed that MAP4K4 expression was inversely correlated with miR-141 expression both in pancreatic cancer samples and cell lines.
21081470_2011.ann,c-Myc,colon tumor,1,"Western blots revealed overexpression of beta-catenin, c-Myc, cyclin D1, inducible nitric oxide synthase and cyclooxygenase-2 in colon tumor samples."
24501326_2014.ann,CDX2,colorectal cancer,1,"Wnt/beta-catenin signaling is critical for intestinal cell proliferation, but a decreased CDX2 expression has influence  on the Wnt signaling-related genes and progression of colorectal cancer."
23208495_2013.ann,p53,colon cancer,1,YY1 promotes colon cancer growth through inhibiting p53 and promoting Wnt signaling pathways and serves as an independent  prognostic biomarker for CRC patients.
11809705_2002.ann,C/EBPalpha gene,lung cancer,2, Genetic analysis of the C/EBPalpha gene is in progress to fully evaluate its role as a novel tumor suppressor in lung cancer.
12029619_2002.ann,c-Myc,hepatocarcinogenesis,2," Preneoplastic and neoplastic hepatocytes undergo c-Myc up-regulation and overgrowth in rats genetically susceptible to hepatocarcinogenesis, but not in resistant rats."
17638894_2007.ann,HER2/neu,breast and other cancers,2, The HER2/neu oncogene is an important diagnostic and prognostic factor and therapeutic target in breast and other cancers.
25175341_2014.ann,Cby gene,laryngeal carcinoma,2,A better understanding of the mechanisms of Cby gene activation in LSCC could provide potential novel therapeutic targets for human laryngeal carcinoma.
17699796_2007.ann,putative oncogene,lung adenocarcinomas,2,A functional genomic approach integrating microarray and proteomic analyses done  in our laboratory has identified 14-3-3zeta as a putative oncogene whose activation was common and driven by its genomic amplification in lung adenocarcinomas.
11438465_2001.ann,balanced t(X;17)(p11.2;q25),ASPS,2,"A relationship between these renal tumors and ASPS was initially suggested by the cytogenetic finding of a balanced t(X;17)(p11.2;q25) in two of the cases, and the ASPL-TFE3 fusion transcripts were then confirmed by reverse transcriptase-polymerase chain reaction."
11731438_2001.ann,fragile histidine triad (FHIT) gene,idiopathic pulmonary fibrosis,2,Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis.
24114583_2014.ann,oncogenic driver genes,NSCLC,2,"Activating alterations in a variety of potential oncogenic driver genes have also been identified in NSCLC, including ROS1, RET, MET, HER2, and BRAF."
24114583_2014.ann,oncogenic driver genes,ROS1,2,"Activating alterations in a variety of potential oncogenic driver genes have also been identified in NSCLC, including ROS1, RET, MET, HER2, and BRAF."
24114583_2014.ann,oncogenic driver genes,RET,2,"Activating alterations in a variety of potential oncogenic driver genes have also been identified in NSCLC, including ROS1, RET, MET, HER2, and BRAF."
24114583_2014.ann,oncogenic driver genes,BRAF,2,"Activating alterations in a variety of potential oncogenic driver genes have also been identified in NSCLC, including ROS1, RET, MET, HER2, and BRAF."
24415871_2014.ann,anaplastic lymphoma kinase (ALK) gene,hepatocellular carcinoma (HCC),2,AIM: To examine the status and clinical significance of anaplastic lymphoma kinase (ALK) gene alterations in hepatocellular carcinoma (HCC) patients.
24415871_2014.ann,ALK gene,hepatocellular carcinoma,2,ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
24346100_2014.ann,NCOA4 genes,thyroid cancer,2,"All fusions identified were between RET and KIF5B genes, and no RET fusions to CCDC6  or NCOA4 genes, characteristic for thyroid cancer, were identified in the irradiated lung cells."
21317929_2011.ann,human enhancer of filamentation 1,melanoma,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,human enhancer of filamentation 1,breast,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,human enhancer of filamentation 1,CRC,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,HEF1,melanoma,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,HEF1,breast,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,HEF1,CRC,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,NEDD9,melanoma,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,NEDD9,breast,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,NEDD9,CRC,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,Cas-L,melanoma,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,Cas-L,breast,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,Cas-L,CRC,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC."
21317929_2011.ann,human enhancer of filamentation 1,CRC,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC. However, the regulation of HEF1 and the role of HEF1 in CRC tumorigenesis are not fully understood."
21317929_2011.ann,HEF1,CRC,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC. However, the regulation of HEF1 and the role of HEF1 in CRC tumorigenesis are not fully understood."
21317929_2011.ann,NEDD9,CRC,2,"Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC. However, the regulation of HEF1 and the role of HEF1 in CRC tumorigenesis are not fully understood."
18505920_2008.ann,HMGA2,lung cancer,2,"Although additional  studies with animal models are needed, these findings suggest that targeting HMGA2 could be therapeutically beneficial in lung cancer and other cancers characterized by increased HMGA2 expression."
24130125_2014.ann,significantly  mutated gene,endometrial cancer,2,"Although CTCF was described as a significantly  mutated gene by the endometrial cancer TCGA, the A(7) track variants leading to T204 frameshifts were not reported."
19277044_2009.ann,EphA1,CRC,2,"Although therapies targeting high EphA1 expression seem plausible in CRC, the loss of expression in advanced disease suggests a potential risk that targeted therapy, by selecting for loss of expression, might contribute to disease progression."
14569398_2004.ann,tumour suppressor genes,MM,2,"Among frequently deleted chromosomal sites, LOH at chromosome 3p has been detected in MM, suggesting the presence of one or several  tumour suppressor genes that have an important role in development of the disease."
24122835_2014.ann,MAP3K3 gene,breast cancer,2,Amplification and over-expression of MAP3K3 gene in human breast cancer promotes  formation and survival of breast cancer cells.
24122835_2014.ann,MAP3K3 gene,breast cancer,2,An integrative bioinformatics analysis of this region nominated the MAP3K3 gene as a potential therapeutic target in breast cancer.
24145651_2014.ann,EGFR and CCND1 gene,MASCs,2,Analysis of TP53 and CTNNB1 gene  mutations in the HG component of MASCs as well as detection of copy number aberration of EGFR and CCND1 gene did not harbor any abnormalities.
18770861_2008.ann,CDCA1,cancers,2,"As a result, CDCA1 is a novel cancer-testis antigen overexpressed in LC, cholangiocellular cancer, urinary bladder cancer and renal cell cancers, and CDCA1 may therefore be an ideal TAA useful for the diagnosis and immunotherapy of these cancers."
26084280_2015.ann,Her2,breast cancers,2,"As Bim expression is a critical biomarker for response to many targeted therapies, PTK6 inhibition may offer a therapeutic approach to treating patients with Her2 targeted therapy-resistant breast cancers."
11596032_2001.ann,tracheobronchial mucosa cDNA,lung carcinoma,2,"BACKGROUND: MUC4 has been cloned from tracheobronchial mucosa cDNA and reportedly is highly expressed in some human malignancies, including lung carcinoma."
24335643_2014.ann,PTCH1,Basal cell carcinosarcoma,2,Basal cell carcinosarcoma with PTCH1 mutations in both epithelial and sarcomatoid primary tumor components and in the sarcomatoid metastasis.
24335643_2014.ann,PTCH1,epithelial primary tumor,2,Basal cell carcinosarcoma with PTCH1 mutations in both epithelial and sarcomatoid primary tumor components and in the sarcomatoid metastasis.
24335643_2014.ann,PTCH1,sarcomatoid metastasis,2,Basal cell carcinosarcoma with PTCH1 mutations in both epithelial and sarcomatoid primary tumor components and in the sarcomatoid metastasis.
26271547_2015.ann,BCL2-like 11 intron 2 deletion polymorphism,small cell lung cancer,2,BCL2-like 11 intron 2 deletion polymorphism is not associated with non-small cell lung cancer risk and prognosis.
27489358_2016.ann,CD133,gastric  cancers,2,"CD133 is considered as a stem-like cell marker in some cancers including gastric  cancers, and Notch1 signaling is known to play an important role in the maintenance and differentiation of stem-like cells."
21084391_2011.ann,SOX6,esophageal squamous cell carcinoma,2,Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.
11598160_2001.ann,Chemokine gene,lymphoid interstitial pneumonitis,2,Chemokine gene expression and clonal analysis of B cells in tissues involved by lymphoid interstitial pneumonitis from HIV-infected pediatric patients.
12514793_2002.ann,Chromosomal,choriocarcinomatous tumor,2,"Chromosomal analysis revealed a close genetic relationship between the papillary urothelial and choriocarcinomatous tumor components, documenting for the first time that choriocarcinoma of the renal pelvis results from clonal evolution of urothelial carcinoma with acquisition of  trophoblastic differentiation."
19709125_2009.ann,kallistatin gene,hepatocellular carcinoma,2,Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice.
24121643_2014.ann,Pathogenesis-Related 1(P6) gene,CF,2,"Comparative analysis of the expression of the Pathogenesis-Related 1(P6) gene, a marker for induced resistance to pathogens, in various tissues of tomato plants treated with CF on their roots suggested that the B."
24121643_2014.ann,Pathogenesis-Related 1(P6) gene,thuringiensis,2,"Comparative analysis of the expression of the Pathogenesis-Related 1(P6) gene, a marker for induced resistance to pathogens, in various tissues of tomato plants treated with CF on their roots suggested that the B. thuringiensis-induced defense system was  activated in the leaf, stem, and main root tissues, but not in the lateral root tissue."
19445940_2009.ann,DCAMKL-1,colorectal cancer,2,CONCLUSIONS: DCAMKL-1 is a negative regulator of let-7a miRNA biogenesis in intestinal stem and colorectal cancer cells; it could represent a novel target for anti-cancer stem cell-based strategies.
12209756_2002.ann,codon 12 of K-ras gene,lung carcinoma,2,CONCLUSIONS: Expression of ras protein in type II alveolar pneumocytes and mutation in the codon 12 of K-ras gene in lung tissue may contribute to the induction of lung carcinoma in patients with IPF.
20589433_2010.ann,Jab1,HCCs,2,"CONCLUSIONS: Jab1 expression, as well as p27(Kip1) upregulation, is evident from the very early stages of hepatocarcinogenesis, suggesting that Jab1  could be a diagnostic marker and a treatment target for precancerous lesions and  early HCCs."
14581367_2003.ann,p21 and bax gene,NSCLCs,2,CONCLUSIONS: Reduction of ING1b gene expression was associated  with reduced p21 and bax gene expression in NSCLCs.
23374247_2013.ann,lung cancer-related gene,lung cancer,2,CONCLUSIONS: The two libraries of differentially expressed genes may provide the  basis for new insights or clues for finding novel lung cancer-related genes; several genes were newly found in lung cancer with ERGIC3 seeming a novel lung cancer-related gene.
24346090_2014.ann,ALK gene,EML4-ALK+ variants,2,"CONCLUSIONS: This panel of variant-specific, quantitative RT-PCR assays detects common EML4-ALK+ variants as well as ALK gene expression level in archival formalin-fixed paraffin-embedded NSCLC specimens."
24346090_2014.ann,ALK gene,NSCLC,2,"CONCLUSIONS: This panel of variant-specific, quantitative RT-PCR assays detects common EML4-ALK+ variants as well as ALK gene expression level in archival formalin-fixed paraffin-embedded NSCLC specimens."
21084391_2011.ann,SOX6,ESCC,2,CONCLUSIONS: We provided the first evidence that SOX6 is a novel tumor-suppressor gene in ESCC development and is a potential prognostic marker in ESCC.
19549529_2009.ann,Nr4A2,colorectal cancers,2,Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
26206333_2015.ann,TP53,lung adenocarcinomas,2,DDR2(L63V);TP53(L/L) mice developed poorly differentiated lung adenocarcinomas in all transgenic animals analyzed with a latency of 40 to 50 weeks and a median survival of 67.5 weeks.
28733537_2017.ann,DEPDC1,bladder cancer,2,DEP domain containing 1 (DEPDC1) is a newly identified cancer-related and cell cycle related gene and has been demonstrated as a novel therapeutic target for bladder cancer.
28733537_2017.ann,DEP domain containing 1 (DEPDC1),bladder cancer,2,DEP domain containing 1 (DEPDC1) is a newly identified cancer-related and cell cycle related gene and has been demonstrated as a novel therapeutic target for bladder cancer.
28733537_2017.ann,DEP domain containing 1,bladder cancer,2,DEP domain containing 1 (DEPDC1) is a newly identified cancer-related and cell cycle related gene and has been demonstrated as a novel therapeutic target for bladder cancer.
28733537_2017.ann,DEPDC1,nasopharyngeal carcinoma,2,DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma.
21917650_2012.ann,BCL6B,GC,2,Detection of methylated BCL6B may serve as an independent biomarker for the prognosis of GC.
22105368_2012.ann,methylated PAX5,GC,2,Detection of methylated PAX5 can be utilized as an independent prognostic factor in GC.
22105368_2012.ann,PAX5,GC,2,Detection of methylated PAX5 can be utilized as an independent prognostic factor in GC.
20802524_2010.ann,TBX5,malignancy,2,Detection of methylated TBX5 may serve as a potential biomarker for the prognosis of this malignancy.
19435926_2009.ann,TFPI2,CRCs,2,Detection of TFPI2 methylation in stool DNA may act as a useful adjunct to the noninvasive strategies for screening of CRCs in the future.
24324629_2013.ann,DLGAP5,HCC,2,"DLGAP5 overexpression was evident in 25% (22 of 88) of the HCC specimens without AFP expression, suggesting that DLGAP5 may be a novel biomarker for HCC pathogenesis."
18665156_2008.ann,interferon-alpha gene,hepatocellular carcinoma,2,Dual therapeutic effects of interferon-alpha gene therapy in a rat hepatocellular carcinoma model with liver cirrhosis.
24114583_2014.ann,ALK gene fusions,NSCLC,2,EGFR gene mutations and ALK gene fusions are well-characterized molecular targets in NSCLC.
24122813_2014.ann,leukaemic HOX code,MLL-rearranged leukaemia,2,Epigenetic dysregulation of leukaemic HOX code in MLL-rearranged leukaemia mouse  model.
17854601_2007.ann,RB,HCC,2,Evaluation of RB status may be a useful prognostic factor in human HCC.
27578530_2016.ann,DRD2,Pancreatic Ductal Adenocarcinoma,2,Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
11731438_2001.ann,FHIT gene,lung carcinoma,2,Fifty-four (73%)  of the 74 lesions of metaplasias and bronchiolar epithelia obtained from the IPF  patients with lung carcinoma and 8 (17%) of the 46 samples obtained from the IPF  patients without lung carcinoma showed LOH at the FHIT gene (P < 0.0001).
18829568_2008.ann,CD133,primary tumors,2,"Furthermore, the CD133 DNA methylation seems to constitute an abnormal promoter signature because it is not  found in normal brain and colon but only in cultured and primary tumors."
24122835_2014.ann,17q chromosomal region,breast cancers,2,Gene amplifications in the 17q chromosomal region are observed frequently in breast cancers.
26806338_2016.ann,ELF3,Ampullary Carcinoma,2,Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.
21317929_2011.ann,HEF1,CRC,2,HEF1 may represent an attractive candidate for drug targeting in CRC.
11753661_2001.ann,Ha-ras,hepatocarcinogenesis,2,"Here we have investigated the prevalence and patterns of mutations in two genes, Ha-ras and beta-catenin, both  known mutational targets in mouse hepatocarcinogenesis."
11753661_2001.ann,beta-catenin,hepatocarcinogenesis,2,"Here we have investigated the prevalence and patterns of mutations in two genes, Ha-ras and beta-catenin, both  known mutational targets in mouse hepatocarcinogenesis."
26206333_2015.ann,discoidin domain receptor 2 (DDR2) gene,lung adenocarcinoma,2,"Here, we generated a mouse model of lung adenocarcinoma driven by mutation of the discoidin domain receptor 2 (DDR2) gene combined with loss of TP53."
26206333_2015.ann,TP53,lung adenocarcinoma,2,"Here, we generated a mouse model of lung adenocarcinoma driven by mutation of the discoidin domain receptor 2 (DDR2) gene combined with loss of TP53."
16524972_2006.ann,TP53,tumours,2,Higher frequencies of inactive TP53 mutations were also seen in advanced  stage tumours (P = 0.0003) and in tumours with the poor prognostic features of vascular (P = 0.006) and lymphatic invasion (P = 0.002).
17693578_2008.ann,exon 3 of the beta-catenin gene,tumour,2,"However, mutation  of exon 3 of the beta-catenin gene was detected in only one tumour that expressed nuclear beta-catenin in lining and polygonal components."
24122813_2014.ann,HOX genes,leukaemia,2,HOX genes are frequently dysregulated in human leukaemia with the gene rearrangement between mixed lineage leukaemia (MLL) and partner genes.
24122813_2014.ann,lineage leukaemia (MLL) and partner genes,leukaemia,2,HOX genes are frequently dysregulated in human leukaemia with the gene rearrangement between mixed lineage leukaemia (MLL) and partner genes.
17254769_2007.ann,trophinin,lung cancer,2,Identification of trophinin as an enhancer for cell invasion and a prognostic factor for early stage lung cancer.
16831586_2006.ann,IHH,diffuse cancers,2,IHH and SMO may be useful biomarkers of diffuse cancers that may show growth inhibition with Hh antagonists such as cyclopamine.
24121643_2014.ann,salicylic acid (SA)-responsive defense-related genes,CF,2,"In CF-treated main roots, but not CF-treated lateral roots, the expression of several salicylic acid (SA)-responsive defense-related genes was specifically induced, whereas jasmonic  acid (JA)-related gene expression was either down-regulated or not induced in response to the CF."
24121643_2014.ann,salicylic acid (SA)-responsive defense-related genes,CF,2,"In CF-treated main roots, but not CF-treated lateral roots, the expression of several salicylic acid (SA)-responsive defense-related genes was specifically induced, whereas jasmonic  acid (JA)-related gene expression was either down-regulated or not induced in response to the CF."
24121643_2014.ann,salicylic acid (SA)-responsive defense-related genes,CF,2,"In CF-treated main roots, but not CF-treated lateral roots, the expression of several salicylic acid (SA)-responsive defense-related genes was specifically induced, whereas jasmonic  acid (JA)-related gene expression was either down-regulated or not induced in response to the CF."
24321521_2014.ann,Akt,bone tumors,2,"In conclusion, in a defined subset of bone and soft tissue tumors, including benign tumors, Akt was frequently overexpressed and activated, and AKT1/2 copy number was increased."
19822196_2009.ann,cdk4,HCC,2,"In conclusion, we suggest that changes in the level of cdk4 may be useful as a biomarker for detection of HCC."
19190340_2009.ann,WT1,HCC,2,"In conclusion, WT1 is expressed in a substantial proportion of HCC contributing to tumor progression and resistance to chemotherapy, suggesting that WT1 may be an important target for HCC treatment."
17854601_2007.ann,RB,HCC,2,In silico analyses were used to probe the association between gene expression signatures for RB loss and chromosomal instability and the ability of genes up-regulated by RB loss to predict the survival of human HCC patients.
22964644_2013.ann,KRAS,NSCLCs,2,"In the current study, we found that EREG is overexpressed in NSCLCs harboring KRAS, BRAF or EGFR mutations compared with NSCLCs with wild-type KRAS/BRAF/EGFR."
22964644_2013.ann,BRAF,NSCLCs,2,"In the current study, we found that EREG is overexpressed in NSCLCs harboring KRAS, BRAF or EGFR mutations compared with NSCLCs with wild-type KRAS/BRAF/EGFR."
22964644_2013.ann,EGFR,NSCLCs,2,"In the current study, we found that EREG is overexpressed in NSCLCs harboring KRAS, BRAF or EGFR mutations compared with NSCLCs with wild-type KRAS/BRAF/EGFR."
20112425_2010.ann,eukaryotic initiation factor 5A2 (EIF5A2),HCC,2,"In the present study a novel metastasis-related gene, eukaryotic initiation factor 5A2 (EIF5A2), was characterized for its role in HCC metastasis and underlying molecular mechanisms."
20112425_2010.ann,eukaryotic initiation factor 5A2,HCC,2,"In the present study a novel metastasis-related gene, eukaryotic initiation factor 5A2 (EIF5A2), was characterized for its role in HCC metastasis and underlying molecular mechanisms."
20112425_2010.ann,EIF5A2,HCC,2,"In the present study a novel metastasis-related gene, eukaryotic initiation factor 5A2 (EIF5A2), was characterized for its role in HCC metastasis and underlying molecular mechanisms."
11280771_2001.ann,p16,non-small cell lung cancer,2,Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
25980581_2015.ann,ING5,carcinogenesis,2,"ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression."
15386424_2005.ann,HER-2/neu gene,lung cancer,2,"Irrespective of protein overexpression, HER-2/neu gene amplification is rare in lung cancer and studies on its prevalence and clinicopathological implications in early stage non-small cell lung cancer (NCSLC) and neuroendocrine tumours (NET) of the lung are lacking."
10956413_2000.ann,microsatellite,gastric carcinomas,2,"It is likely that the major genotypes of gastric carcinomas can be placed into at least 4 microsatellite categories, thus allowing the construction  of a comprehensive genetic classification useful for the prediction of diverse clinical courses."
25980581_2015.ann,ING5,gastric carcinogenesis,2,"It was suggested that ING5 expression might be employed as a good marker for gastric carcinogenesis and subsequent progression by inhibiting proliferation, growth, migration, invasion and metastasis."
24122813_2014.ann,Hox,leukaemic,2,"Knock-down of Prmt1 was insufficient to reverse the active chromatin status and the hypomethylated Hox loci, suggesting that Prmt1-mediated  histone arginine methylation was only partially involved in the maintenance of Hox expression in leukaemic cells."
24116743_2014.ann,TnC gene,colitis,2,"Knock-down of TnC gene increased susceptibility to DSS-induced colitis, compared with TnC(+/+)  littermates."
14695323_2004.ann,K-ras gene,lung adenocarcinoma,2,K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma.
24688052_2014.ann,KRAS gene,non-small cell lung cancer (NSCLC),2,KRAS gene mutation is linked to poor prognosis and resistance to therapeutics in  non-small cell lung cancer (NSCLC).
24688052_2014.ann,KRAS gene,non-small cell lung cancer,2,KRAS gene mutation is linked to poor prognosis and resistance to therapeutics in  non-small cell lung cancer (NSCLC).
24688052_2014.ann,KRAS gene,NSCLC,2,KRAS gene mutation is linked to poor prognosis and resistance to therapeutics in  non-small cell lung cancer (NSCLC).
14990969_2004.ann,K-ras gene,pleomorphic carcinoma,2,K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung.
22964644_2013.ann,KRAS,non-small-cell lung cancer,2,KRAS mutations are one of the most common driver mutations in non-small-cell lung cancer (NSCLC) and finding druggable target molecules to inhibit oncogenic KRAS signaling is a significant challenge in NSCLC therapy.
22964644_2013.ann,KRAS,NSCLC,2,KRAS mutations are one of the most common driver mutations in non-small-cell lung cancer (NSCLC) and finding druggable target molecules to inhibit oncogenic KRAS signaling is a significant challenge in NSCLC therapy.
11731438_2001.ann,FHIT locus,IPF,2,LOH of the FHIT locus was frequently found among the lesions of metaplasias and bronchiolar epithelia in the patients with IPF [62 (52%) of 119 informative lesions].
24145651_2014.ann,ETV6-NTRK3 gene fusion,secretory carcinoma,2,"Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, beta-catenin, EGFR, and CCND1 genes."
24145651_2014.ann,"TP53, beta-catenin, EGFR, and CCND1 genes",secretory carcinoma,2,"Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, beta-catenin, EGFR, and CCND1 genes."
11801721_2002.ann,neuT genes,metastases,2,"Mammary tumours were not observed in the EphB4 transgenic animals; however, in double transgenic animals expressing both EphB4 and the neuT genes, tumour appearance was significantly accelerated and, in contrast to neuT-only animals, metastases were observed in the lung."
24123340_2014.ann,folate-related genes,neural tube defects,2,Maternal folate levels and polymorphisms in folate-related genes are known risk factors for neural tube defects (NTDs).
24123340_2014.ann,folate-related genes,neural tube defects (NTDs),2,Maternal folate levels and polymorphisms in folate-related genes are known risk factors for neural tube defects (NTDs).
24123340_2014.ann,folate-related genes,NTDs,2,Maternal folate levels and polymorphisms in folate-related genes are known risk factors for neural tube defects (NTDs).
15612080_2005.ann,9p21,peripheral-type lung adenocarcinoma,2,"METHODS: Aberrant methylation status of the p16 promoter region, the expression of its product, and loss of heterozygosity (LOH) on 9p21 were examined in surgically resected lung specimens from 57 patients (28 males and 29 females) with peripheral-type lung adenocarcinoma measuring </= 2 cm in diameter."
19435926_2009.ann,TFPI2,colorectal cancer,2,Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection  of colorectal cancer.
25066097_2015.ann,EGFR gene,pulmonary adenocarcinomas (ADCs),2,Mutations in the EGFR gene  are detected in pulmonary adenocarcinomas (ADCs).
25066097_2015.ann,EGFR gene,pulmonary adenocarcinomas,2,Mutations in the EGFR gene  are detected in pulmonary adenocarcinomas (ADCs).
25066097_2015.ann,EGFR gene,ADCs,2,Mutations in the EGFR gene  are detected in pulmonary adenocarcinomas (ADCs).
12023575_2002.ann,oncogene,pulmonary lymphoepithelioma-like carcinomas,2,New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas.
24077583_2014.ann,brain-targeted gene,MPS-I,2,OBJECTIVE: To test whether brain-targeted gene therapy with recombinant adeno-associated virus (rAAV5)-IDUA  vectors in an MPS-I transgenic mouse model would reverse the pathological hallmarks.
24931004_2014.ann,Odd-skipped related 1,gastric cancer,2,Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.
10426811_1999.ann,bcl-X(L),adenomas,2,"Of the acidophilic lesions, the majority of foci (28/32, 88%) and adenomas (47/50, 94%) expressed increased bcl-X(L), whereas increased bcl-2 was observed in only 12.5% of acidophilic preneoplastic foci (4/32) and 14% of acidophilic adenomas (7/50)."
10426811_1999.ann,bcl-X(L),adenomas,2,"Of the small-cell heterogeneous basophilic lesions, 86% of foci (31/36) and 85% of adenomas (35/41) exhibited increased bcl-2 protein levels compared with surrounding normal hepatocytes, whereas only 12.5% of foci (4/36) and 12% of adenomas (5/41) exhibited increased bcl-X(L) levels."
24335643_2014.ann,exons of 230 cancer-associated genes,metastatic tumor,2,"One year later, intra-abdominal metastatic tumor was detected and resected. It had sarcomatoid features by light microscopy and failed to stain for epithelial markers by immunohistochemistry. DNA was extracted separately from the epithelial and sarcomatoid component of the primary tumor, intra-abdominal metastasis, and normal tissue. All exons of 230 cancer-associated genes were sequenced to an average read depth of >500-fold."
17984115_2008.ann,DNp73,hepatocarcinogenesis,2,"Our data firmly establish the unique oncogenic capability of DNp73 to drive hepatocarcinogenesis in vivo, supporting its significance as a marker for disease severity in patients and as target for cancer prevention."
19277044_2009.ann,EphA1,CRC,2,Our findings identify EphA1 as a potential prognostic marker in CRC.
11731438_2001.ann,FHIT gene,IPF,2,Our findings suggest that allelic loss of the FHIT gene may be involved in carcinogenesis in the peripheral lung of patients with IPF.
23418309_2013.ann,KLLN,breast carcinomas,2,Our observations suggest that KLLN might be used as a potential prognostic marker and novel therapy target for breast carcinomas.
24123340_2014.ann,allele,NTDs,2,"Our results indicate that miR-9 and miR-197 specifically downregulate MTHFD1L levels in HEK293 and MCF-7 cells and that SNPrs7646 significantly affects miR-197 binding affinity to the MTHFD1L 3' UTR, causing more efficient posttranscriptional gene repression in the presence of the allele that is associated with increased risk of NTDs."
21464044_2011.ann,EGFR,CRC,2,Our results offer preclinical rationale warranting further clinical investigation combining HDACi with EGFR and HER2-targeted therapies for CRC treatment.
21464044_2011.ann,HER2,CRC,2,Our results offer preclinical rationale warranting further clinical investigation combining HDACi with EGFR and HER2-targeted therapies for CRC treatment.
25915847_2016.ann,beta-catenin-TCF target gene,CRC,2,"Overactivation of Wnt-beta-catenin signaling, including beta-catenin-TCF target gene expression, is a hallmark of colorectal cancer (CRC) development."
25915847_2016.ann,beta-catenin-TCF target gene,colorectal cancer (CRC),2,"Overactivation of Wnt-beta-catenin signaling, including beta-catenin-TCF target gene expression, is a hallmark of colorectal cancer (CRC) development."
25915847_2016.ann,beta-catenin-TCF target gene,colorectal cancer,2,"Overactivation of Wnt-beta-catenin signaling, including beta-catenin-TCF target gene expression, is a hallmark of colorectal cancer (CRC) development."
10395176_1999.ann,P53,malignant lymphoma,2,"P53 gene deficient mice (p53-/-) were found to spontaneously develop malignant lymphoma and hemangiosarcoma, whereas heterozygotes (p53+/-) mice display a high incidence of tumors of the urinary bladder when treated with N-butyl-N-(4-hydroxybutyl)nitrosamine."
10395176_1999.ann,P53,hemangiosarcoma,2,"P53 gene deficient mice (p53-/-) were found to spontaneously develop malignant lymphoma and hemangiosarcoma, whereas heterozygotes (p53+/-) mice display a high incidence of tumors of the urinary bladder when treated with N-butyl-N-(4-hydroxybutyl)nitrosamine."
18457901_2008.ann,gene Pdcd4 (programmed cell death 4),tumors,2,"Pdcd4 (programmed cell death 4) gene is tumor suppressor which expression is frequently down-regulated in tumors, which is considered as a diagnostic and prognostic marker as well as promising target for anti-cancer therapy."
14695323_2004.ann,K-ras gene,lung adenocarcinomas,2,"Point mutations of the K-ras gene, which are found in 10 to 30% of lung adenocarcinomas, are regarded as being an early event during the carcinogenesis."
11438465_2001.ann,ASPL-TFE3 gene,alveolar soft part sarcoma,2,Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
16467080_2006.ann,epidermal growth factor receptor (EGFR) gene,lung adenocarcinomas,2,PURPOSE: Activating somatic mutations in the epidermal growth factor receptor (EGFR) gene are present in a small subset of lung adenocarcinomas.
14581367_2003.ann,ING1b gene,non-small cell lung cancer,2,Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
16467080_2006.ann,EGFR gene mutations,primary tumors,2,RESULTS: EGFR gene mutations were identified in 13% of the primary tumors.
19427313_2009.ann,SMO,carcinomas,2,"SMO might be a good therapeutic target for patients with colorectal polyps and carcinomas, even in the absence of Hh signal activation."
25623055_2015.ann,SPOCK1,GBC,2,SPOCK1 acts as an oncogene and may be a prognostic factor or therapeutic target for patients with GBC.
27409347_2016.ann,ING5,lung cancer,2,"Taken together, our data suggested that ING5 downregulation might involved in carcinogenesis, growth, and invasion of lung cancer and could be considered as a promising marker to gauge the aggressiveness of lung cancer."
26908628_2016.ann,EZH2,lung adenocarcinoma,2,"Taken together, our findings indicated that PVT1/EZH2/LATS2 interactions might serve as new target for lung adenocarcinoma diagnosis and therapy."
26908628_2016.ann,LATS2,lung adenocarcinoma,2,"Taken together, our findings indicated that PVT1/EZH2/LATS2 interactions might serve as new target for lung adenocarcinoma diagnosis and therapy."
26673619_2016.ann,RhoC,EC,2,"Taken together, our results demonstrated for the first time that miR-372 suppresses tumorigenesis and the development of EC; RhoC  is a new and potentially important therapeutic target."
18972434_2009.ann,TIP30,gastric cancer,2,"Taken together, the present work revealed a novel function of TIP30, which can possibly be used as an independent prognostic factor and a potential therapeutic target for gastric cancer."
20663904_2010.ann,SRC-3,lung cancer,2,"Taken together, these data suggest that SRC-3 may be an important oncogene and therapeutic target for lung cancer."
24381140_2014.ann,rs16948627,osteosarcoma,2,"TaqMan PCR genotyping technology was used to detect the genotypes of ITGA3 gene SNPs (rs2230392, rs2285524 and rs16948627) in the peripheral blood. Then, associations of the SNP (rs2230392, rs2285524 and rs16948627) genotypes with the incidence risk and tumor characteristics of osteosarcoma were evaluated."
24369145_2014.ann,Testis-specific Fank1 gene,oligospermia,2,Testis-specific Fank1 gene in knockdown mice produces oligospermia via apoptosis.
19709125_2009.ann,kallistatin gene,HCC,2,The aim of this study was to determine whether combining kallistatin gene  therapy and meloxicam could offer a better therapeutic effect to combat HCC in mice.
24381142_2014.ann,spastic paraplegia-20 promoter,gastric  cancer,2,The aim of this study was to evaluate hypermethylation of the spastic paraplegia-20 promoter as a potential biomarker and prognostic factor in gastric  cancer.
16524972_2006.ann,TP53,CRC,2,The aim of this work was to evaluate whether TP53 mutations classified as functionally inactive (< or=20% of wildtype transactivation ability) had different prognostic and predictive values in CRC compared with mutations that retained significant activity.
20737421_2011.ann,oncogenes c-myc,gastric cancer,2,"The expression of gastric cancer markers MUC1, MUC2, and MUC5AC, and oncogenes c-myc, c-met, cyclin E1, and cancer stem cell marker CD44 was determined in MGCC3I cells."
14695323_2004.ann,K-ras gene,lung adenocarcinoma,2,"The lung adenocarcinoma cells bearing the K-ras gene mutation (A549 and H820) showed consistently higher levels of cell motilities than those without the mutation (TKB6 and TKB14), and the motility of A549 and H820 cells were significantly inhibited by dnAkt transfection."
11438465_2001.ann,ASPL-TFE3,renal tumors,2,"The morphology of these eight ASPL-TFE3 fusion-positive renal tumors, although overlapping in some aspects that of classic ASPS, more closely resembles renal cell carcinoma (RCC), which was the a priori diagnosis in all cases."
23461063_2012.ann,recombinant plasmids,lung cancer,2,The recombinant plasmids were transfected into human lung cancer A549 cells by liposome-mediated method.
24122813_2014.ann,target gene loci,leukaemia,2,The resultant MLL fusion proteins are known to mediate leukaemia through disruption of the normal epigenetic regulation at the target gene loci.
17157259_2006.ann,c-Myc,small cell lung cancer,2,The significant association of SNIP1 and c-Myc staining in a non-small cell lung cancer tissue array is further evidence that their activities might be linked and suggests that SNIP1 might be an important modulator of c-Myc activity in carcinogenesis.
11280771_2001.ann,p16 locus,lung cancer,2,The significant link between tobacco and loss of  the p16 locus identifies additional genetic targets of smoking in the pathogenesis of lung cancer.
28733537_2017.ann,DEPDC1,NPC,2,"The siRNA-mediated DEPDC1 depletion resulted in significant inhibition of proliferation and delay in cell cycle progression in both NPC cell lines, CNE-1 and HNE-1."
11438465_2001.ann,der(17)t(X;17)(p11.2;q25),alveolar soft part sarcoma,2,"The unbalanced translocation, der(17)t(X;17)(p11.2;q25), is characteristic of alveolar soft part sarcoma (ASPS)."
26923637_2016.ann,Per1,bile duct cancer,2,Therefore bile duct cancer patients may be treated with miR-34a inhibitor or Per1 stimulator in the future.
18391202_2008.ann,MYH11,intestinal neoplasia,2,These data challenge our view on MYH11 as a passive differentiation marker functioning in muscle contraction and add to our understanding of intestinal neoplasia.
17599044_2008.ann,homeobox gene,colon cancer,2,"These data provide evidence that Cdx2 antagonizes the process of tumor cell dissemination, and they suggest that this homeobox gene might represent a new therapeutic target against metastatic spreading of colon cancer."
26271547_2015.ann,BIM deletion polymorphism,Korean NSCLC,2,These findings indicate that the BIM deletion polymorphism is common in Korean NSCLC patients but does not significantly affect the intrinsic biologic function of BH3-only protein.
27489358_2016.ann,CD133,diffuse type gastric cancers,2,These findings suggested that Notch1 signaling plays an important role in  the maintenance of the cancer stem-like phenotype in diffuse type gastric cancer  through an RBP-Jkappa dependent pathway and that inhibiting Notch1 signaling could be an effective therapy against CD133 positive diffuse type gastric cancers.
12571641_2003.ann,intravenous gene,disseminated cancers,2,"These findings suggested that the endostatin gene therapy, using cationic vector-mediated intravenous gene transfer, might be  a feasible strategy for organ-targeted prevention and regulation of possible disseminated cancers."
22735679_2012.ann,ALK-gene,lung cancer,2,"These results favour non-invasive, ALK-gene status pre-screening on a routine basis on CTCs isolated from patients with lung cancer and open new avenues for real-time monitoring for adapted targeted therapy."
25516351_2014.ann,SPARC,human gastric cancers,2,These results implicate SPARC promoter methylation as an important factor in the tumorigenesis of gastric carcinomas and provide new insights into the potential use of SPARC as a novel biomarker and the potential clinical importance in human gastric cancers.
18413810_2008.ann,NAG-1,prostate cancer,2,These results indicate that  VES-induced expression of NAG-1 mRNA/protein is regulated by transcriptional/post-transcriptional mechanism in a p38 kinase-dependent manner and NAG-1 can be chemopreventive/therapeutic target in prostate cancer.
24123340_2014.ann,SNP rs7646,NTD,2,"These results reveal that the association of SNP rs7646 and NTD risk involves differences in microRNA regulation and, highlights the importance of genotype-dependent differential microRNA regulation in relation to human disease risk."
25916654_2015.ann,ERBB4,CRC,2,These results suggest ERBB4 as a novel therapeutic target in a subset  of CRC.
18665156_2008.ann,IFN-alpha gene,HCC,2,These results suggest that IFN-alpha gene therapy is a promising strategy to treat HCC  patients who have concomitant liver cirrhosis.
28165654_2017.ann,PSMA6,lung cancer,2,These results suggested that PSMA6 serves as an attractive target with a high therapeutic index for lung cancer.
19925653_2009.ann,TLR4,lung tumorigenesis,2,This study  was designed to identify TLR4-mediated gene expression pathways that may be used  as prognostic indicators of susceptibility to lung tumorigenesis in mice and provide insight into the mechanism.
18171987_2007.ann,c-Myc,colorectal cancer,2,This study shows that c-Myc is critical for Apc-dependent intestinal tumorigenesis in mice and provides a potential therapeutic target in the treatment of colorectal cancer.
20214788_2010.ann,c-Jun,liver cancer,2,This suggests that c-Jun inhibition may serve as a therapeutic target for liver cancer.
17254769_2007.ann,trophinin,lung cancer,2,"Through a combination of data mining and  biochemical assays, we identified trophinin, which could enhance cell invasion, as a novel prognostic factor for early stage lung cancer."
11280771_2001.ann,p16 gene,non-small cell lung cancer,2,"Thus, inactivation of the p16 gene is a common event in all non-small cell lung cancer, but the mechanism of gene alteration differs between smokers and nonsmokers."
15634757_2004.ann,DAP kinase promoter,NSCLC,2,"To determine whether DAP  kinase promoter methylation contributes to TRAIL resistance in NSCLC cells, we measured DAP kinase promoter methylation and its gene expression status in 11 NSCLC cell lines and correlated the methylation/expression status with the sensitivity of cells to TRAIL."
24122813_2014.ann,HOX,leukaemia,2,"To elucidate the pathogenic role of MLL fusion proteins in HOX dysregulation in leukaemia, we generated a novel haematopoietic lineage-specific Mll-Een knock-in mouse model using a Cre-mediated inversion strategy."
16467080_2006.ann,EGFR  gene,lung adenocarcinomas,2,"To further determine the genetic and molecular  characteristics of tumors carrying EGFR gene mutations, we investigated the EGFR  gene status in lung adenocarcinomas and evaluated its association with specific characteristics of the patients and tumors, such as mutations at KRAS and p53, EGFR and ErbB2 gene amplification, levels of EGFR and HER2 proteins, and levels of downstream effectors of EGFR, such as phospho-extracellular signal-regulated kinase and phospho-S6 proteins."
25888808_2015.ann,lncRNA,lung cancer,2,"To our knowledge, this is the first study to report the changes in an lncRNA expression profile induced by resveratrol in lung cancer."
24092381_2014.ann,netrin-1 gene,Tubular atrophy,2,Tubular atrophy and low netrin-1 gene expression are associated with delayed kidney allograft function.
24122813_2014.ann,Hox genes,leukaemic,2,"Using Mll-Een-expressing leukaemic cell lines derived from bone marrow of Mll(Een) (/+) mutant mice, we showed that induction of Hox genes in leukaemic cells was associated with hypomethylated promoter regions and an aberrant active chromatin  state at the Hox loci."
26658681_2016.ann,HAO2,HCC,2,We also demonstrate that dysregulation of HAO2 is a very early event in the development of HCC and it may represent a useful diagnostic and prognostic marker for human HCC.
11731438_2001.ann,FHIT gene,IPF,2,We confirmed allelic loss in the metaplasias and bronchiolar epithelia of IPF by FISH analysis of the FHIT gene.
11438465_2001.ann,t(X;17),renal tumors,2,"We confirmed the balanced nature of the t(X;17) translocation by fluorescence in situ hybridization in all seven renal tumors thus analyzed, which contrasts sharply with the unbalanced nature of the translocation in ASPS."
11438465_2001.ann,t(X;17),renal tumors,2,"We describe herein eight morphologically distinctive renal tumors occurring in young people that bear the identical ASPL-TFE3 fusion transcript as  ASPS, with the distinction that the t(X;17) translocation is cytogenetically balanced in these renal tumors."
19435926_2009.ann,TFPI2,CRC,2,We further explored the potential of TFPI2 as a biomarker for the early detection of CRC using stool DNA-based assays in patients with nonmetastatic CRC and average-risk  noncancer controls who were candidates for screening.
19709125_2009.ann,kallistatin gene,HCC,2,"We have previously reported that kallistatin gene therapy suppressed the growth of HCC tumors by its anti-angiogenic activity, and meloxicam, a selective COX-2 inhibitor, inhibited proliferation and induced apoptosis of human HCC cells in vitro."
26271547_2015.ann,BIM intron 2,lung cancer,2,We hypothesized that a BIM intron 2 deletion polymorphism increases lung cancer risk and predicts poor prognosis in non-small lung cancer (NSCLC) patients.
26271547_2015.ann,BIM intron 2,non-small lung cancer (NSCLC),2,We hypothesized that a BIM intron 2 deletion polymorphism increases lung cancer risk and predicts poor prognosis in non-small lung cancer (NSCLC) patients.
26271547_2015.ann,BIM intron 2,non-small lung cancer,2,We hypothesized that a BIM intron 2 deletion polymorphism increases lung cancer risk and predicts poor prognosis in non-small lung cancer (NSCLC) patients.
26271547_2015.ann,BIM intron 2,NSCLC,2,We hypothesized that a BIM intron 2 deletion polymorphism increases lung cancer risk and predicts poor prognosis in non-small lung cancer (NSCLC) patients.
24155122_2014.ann,MET proto-oncogene,CCPRCC,2,"We identified multiple  somatic mutations in CCPRCC cases, including a recurrent [3/14 cases (21%)] non-synonymous T992I mutation in the MET proto-oncogene, a gene associated with epithelial-to-mesenchymal transition (EMT)."
21743489_2012.ann,NAC1,ovarian cancer,2,"We report here that autophagy was involved in NAC1-mediated resistance to cisplatin, a commonly used  chemotherapeutic drug in the treatment of ovarian cancer."
24130121_2014.ann,genetic disease,cutaneous malignancies,2,"Xeroderma pigmentosum variant (XP-V) is a rare genetic disease, characterized by  some sunlight sensitivity and predisposition to cutaneous malignancies."
20506153_2011.ann,p53,hepatocellular carcinoma (HCC),3," A genetic basis of hepatocellular carcinoma (HCC) has been well-established and major signaling pathways, such as p53, Wnt-signaling, transforming growth factor-beta (TGF-beta) and Ras pathways, have been identified to be essential to  HCC development."
19919837_2010.ann,p53,hepatocellular carcinoma,3," BACKGROUND & AIMS: p53 Mutations are very common in human hepatocellular carcinoma, and induction of hepatic p53 expression causes lysis of implanted hepatoblastoma cells in a chimeric mouse."
24177224_2013.ann,Myc,hepatocellular carcinoma,3," Instead, data revealed that Skp2 regulated Myc activity, which has oncogenic potential in the generation of hepatocellular carcinoma."
24113455_2013.ann,miR-122,hepatocellular carcinoma,3, Loss of miR-122 causes chronic steatohepatitis and spontaneous hepatocellular carcinoma.
12060674_2002.ann,MAT1A,nonalcoholic steatohepatitis,3, Mice lacking MAT1A have reduced hepatic S-adenosylmethionine content and hyperplasia and spontaneously develop nonalcoholic steatohepatitis.
24531873_2014.ann,MicroRNA-122,hepatocellular carcinoma (HCC),3," MicroRNA-122 (miR-122), a highly abundant and liver-specific miRNA, acts as a tumor suppressor against hepatocellular carcinoma (HCC)."
24531873_2014.ann,MicroRNA-122,hepatocellular carcinoma,3," MicroRNA-122 (miR-122), a highly abundant and liver-specific miRNA, acts as a tumor suppressor against hepatocellular carcinoma (HCC)."
24531873_2014.ann,miR-122,hepatocellular carcinoma (HCC),3," MicroRNA-122 (miR-122), a highly abundant and liver-specific miRNA, acts as a tumor suppressor against hepatocellular carcinoma (HCC)."
24531873_2014.ann,miR-122,hepatocellular carcinoma,3," MicroRNA-122 (miR-122), a highly abundant and liver-specific miRNA, acts as a tumor suppressor against hepatocellular carcinoma (HCC)."
18302511_2008.ann,PPARgamma1,atherosclerosis,3, Peroxisome proliferator-activated receptor-gamma1 (PPARgamma1) is an important transcription factor involved in atherosclerosis progression.
7478622_1995.ann,p53 gene,colorectal cancer,3," Surprisingly, given the proposed role for loss of function mutations of the p53 gene in the development of human colorectal cancer, we have found no evidence for either an increase in the rate of adenoma formation in APC +/-, p53 -/- animals,  or an increased rate of progression to malignancy compared with APC +/- p53 +/+ mice."
9362446_1997.ann,Tg737 gene,liver tumors,3, The Tg737 gene was investigated for gross alterations in a series of rodent/human liver tumors and human tumorigenic cell lines.
21531817_2011.ann,IFITM3,colon cancer,3,A Cox proportional hazards model showed that IFITM3 expression was  an independent prognostic factor for disease-free survival in patients with colon cancer.
21038412_2010.ann,miR-122,hepatocellular carcinoma,3,A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
26068969_2015.ann,HER2,breast cancer,3,A previous investigation indicated that ATA is more effective in inhibiting the growth of breast cancer especially cells with HER2 overexpression.
21035526_2011.ann,let-7a,hepatocarcinogenesis,3,"Additional qRT-PCR analysis revealed gradual elevation of some circulating miRNAs (i.e., let-7a, let-7f, miR-34a, miR-98, miR-331, miR-338 and miR-652) with progress of hepatocarcinogenesis."
21035526_2011.ann,miR-34a,hepatocarcinogenesis,3,"Additional qRT-PCR analysis revealed gradual elevation of some circulating miRNAs (i.e., let-7a, let-7f, miR-34a, miR-98, miR-331, miR-338 and miR-652) with progress of hepatocarcinogenesis."
21035526_2011.ann,miR-98,hepatocarcinogenesis,3,"Additional qRT-PCR analysis revealed gradual elevation of some circulating miRNAs (i.e., let-7a, let-7f, miR-34a, miR-98, miR-331, miR-338 and miR-652) with progress of hepatocarcinogenesis."
21035526_2011.ann,miR-331,hepatocarcinogenesis,3,"Additional qRT-PCR analysis revealed gradual elevation of some circulating miRNAs (i.e., let-7a, let-7f, miR-34a, miR-98, miR-331, miR-338 and miR-652) with progress of hepatocarcinogenesis."
21035526_2011.ann,miR-338,hepatocarcinogenesis,3,"Additional qRT-PCR analysis revealed gradual elevation of some circulating miRNAs (i.e., let-7a, let-7f, miR-34a, miR-98, miR-331, miR-338 and miR-652) with progress of hepatocarcinogenesis."
21035526_2011.ann,miR-652,hepatocarcinogenesis,3,"Additional qRT-PCR analysis revealed gradual elevation of some circulating miRNAs (i.e., let-7a, let-7f, miR-34a, miR-98, miR-331, miR-338 and miR-652) with progress of hepatocarcinogenesis."
22093452_2011.ann,Hras,hepatocarcinogenesis,3,"AIM: To define the biological contributions of Hras to mouse hepatocarcinogenesis, we quantified in vivo interactions between mutant Hras and other genetic alterations frequently associated with liver cancer, including overexpression of the transcription factor c-myc and the epidermal growth factor receptor ligand transforming growth factor alpha (TGFalpha)."
22093452_2011.ann,Hras,liver cancer,3,"AIM: To define the biological contributions of Hras to mouse hepatocarcinogenesis, we quantified in vivo interactions between mutant Hras and other genetic alterations frequently associated with liver cancer, including overexpression of the transcription factor c-myc and the epidermal growth factor receptor ligand transforming growth factor alpha (TGFalpha)."
22093452_2011.ann,c-myc,liver cancer,3,"AIM: To define the biological contributions of Hras to mouse hepatocarcinogenesis, we quantified in vivo interactions between mutant Hras and other genetic alterations frequently associated with liver cancer, including overexpression of the transcription factor c-myc and the epidermal growth factor receptor ligand transforming growth factor alpha (TGFalpha)."
7846077_1995.ann,Apc gene,colon carcinogenesis,3,Alteration of the Apc gene was shown to play a more important role in PhIP-induced than in IQ-induced rat colon carcinogenesis.
7585562_1995.ann,hMSH2 gene,hereditary nonpolyposis colon cancer,3,Alterations of the hMSH2 gene has been linked to approximately 60% of hereditary nonpolyposis colon cancer cases.
23714159_2013.ann,p53,hepatocarcinogenesis,3,"Although induced cell death is regarded as the major component of p53 tumor-suppressive activity, we recently found that sustained p53 activation subsequent to DNA damage promotes inflammation-associated hepatocarcinogenesis."
17699716_2007.ann,HER2,breast cancer,3,"Amplification of the HER2 (ErbB2, c-Neu) proto-oncogene in breast cancer is associated with poor prognosis and high relapse rates."
23418309_2013.ann,KLLN,breast cancer,3,"Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas."
24531873_2014.ann,microRNA-122,hepatocellular carcinoma,3,Antitumor function of microRNA-122 against hepatocellular carcinoma.
25065684_2015.ann,c-Myc,hepatocarcinogenesis,3,Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in  mice.
25065684_2015.ann,Astrocyte elevated gene-1,hepatocarcinogenesis,3,Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in  mice.
8831610_1996.ann,APC gene,intestinal neoplasia,3,"BACKGROUND & AIMS: Mutations in the APC gene result in an increased propensity to develop intestinal neoplasia; however, a complete understanding of the mechanisms resulting in tumor formation has remained elusive."
19147571_2009.ann,Notch,colon cancer,3,"Because Notch signaling is implicated in colon cancer tumorigenesis and protects  cells from apoptosis by inducing prosurvival targets, it was hypothesized that inhibition of Notch signaling with gamma-secretase inhibitors (GSI) may enhance the chemosensitivity of colon cancer cells."
9816310_1996.ann,K-sam,stomach cancer,3,"By immunohistochemical analysis, 20 of 38 cases of the undifferentiated type of advanced stomach cancer  were K-sam positive, whereas none of 11 cases of the differentiated or intestinal type revealed K-sam staining."
24113455_2013.ann,miR-122,hepatocarcinogenesis,3,"Collectively, miR-122 depletion facilitates cystogenesis and hepatocarcinogenesis in mice on DEN challenge by up-regulating several genes involved in proliferation, growth factor signaling, neovascularization, and metastasis."
19726678_2009.ann,miR-122,liver cancer,3,"Collectively, these results suggest that the loss of multifunctional miR-122 contributes to the malignant phenotype of HCC cells, and miR-122 mimetic alone or in combination with anticancer drugs can be a promising therapeutic regimen against liver cancer."
24124108_2014.ann,quercetin,liver cancer,3,"CONCLUSION: The outcomes of this study represent a significant contribution to the current understanding on the preventive mechanisms of quercetin during the early stages of liver cancer development, demonstrating that in addition to its known proapoptotic characteristics, the flavonoid modulates the expression of critical cell cycle regulators and peroxisome proliferator activated receptor-alpha activity."
21531817_2011.ann,IFITM3,colon cancer,3,"CONCLUSION: These clinical and mechanistic findings indicate that IFITM3 is a direct transcriptional target of KLF4 and that dysregulated KLF4 expression leads to aberrant IFITM3 expression, thus contributing to colon cancer progression and metastasis."
15958644_2005.ann,p53,colorectal cancer,3,CONCLUSIONS: Acute ablation of GSK3beta in colorectal cancer cells activates p53-dependent apoptosis and antagonizes tumor growth.
24694019_2014.ann,Chrm3,intestinal neoplasia,3,"CONCLUSIONS: Our results identify a novel candidate mouse gene, Zfp277, whose expression pattern is compatible with a role in mediating divergent effects of Chrm3 and Chrm1 gene ablation on murine intestinal neoplasia."
24694019_2014.ann,Chrm1 gene,intestinal neoplasia,3,"CONCLUSIONS: Our results identify a novel candidate mouse gene, Zfp277, whose expression pattern is compatible with a role in mediating divergent effects of Chrm3 and Chrm1 gene ablation on murine intestinal neoplasia."
21291235_2011.ann,beta-catenin gene,CRC,3,"CRC is initiated by mutations of the tumor suppressor gene, adenomatous polyposis coli (APC), or beta-catenin gene."
10732766_2000.ann,p53,CRC,3,CRC xenografts differed in their p53 status (wt or muf) and in their microsatellite instability phenotype (MSI+ when altered).
10732766_2000.ann,microsatellite,CRC,3,CRC xenografts differed in their p53 status (wt or muf) and in their microsatellite instability phenotype (MSI+ when altered).
10732766_2000.ann,MSI,CRC,3,CRC xenografts differed in their p53 status (wt or muf) and in their microsatellite instability phenotype (MSI+ when altered).
18372904_2008.ann,K-Ras,colon tumor,3,"Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon."
18925631_2008.ann,hepatocyte nuclear factor-4alpha gene,hepatocellular carcinoma,3,Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.
19711427_2009.ann,miR-155,hepatocellular carcinoma (HCC),3,"Ectopic expression of miR-155 promoted growth of hepatocellular carcinoma (HCC) cells, whereas its depletion inhibited cell growth."
19711427_2009.ann,miR-155,hepatocellular carcinoma,3,"Ectopic expression of miR-155 promoted growth of hepatocellular carcinoma (HCC) cells, whereas its depletion inhibited cell growth."
26070602_2015.ann,miR-184,triple negative breast cancer,3,Ectopic reactivation of miR-184 inhibited the proliferation and self-renewal of triple negative breast cancer (TNBC) cell lines in vitro and delayed primary tumour formation and reduced metastatic burden in vivo.
22105368_2012.ann,p53,gastric cancer,3,"Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients."
25916654_2015.ann,ERBB4,colorectal cancer,3,"ERBB4 alterations in a The Cancer Genome Atlas colorectal cancer (CRC) data set stratified survival, and in a combined Moffitt Cancer Center and Vanderbilt Medical Center CRC expression data set, ERBB4 message levels were increased at all tumor stages."
25916654_2015.ann,ERBB4,CRC,3,"ERBB4 alterations in a The Cancer Genome Atlas colorectal cancer (CRC) data set stratified survival, and in a combined Moffitt Cancer Center and Vanderbilt Medical Center CRC expression data set, ERBB4 message levels were increased at all tumor stages."
22796152_2012.ann,FHL2,hepatocarcinogenesis,3,"Finally, while Apo-FHL2 mice developed no tumors, the FHL2 transgene enhanced hepatocarcinogenesis induced by liver-specific deletion of the adenomatous polyposis coli gene and aberrant Wnt/beta-catenin signaling in Apc(lox/lox) animals."
22796152_2012.ann,adenomatous polyposis coli gene,hepatocarcinogenesis,3,"Finally, while Apo-FHL2 mice developed no tumors, the FHL2 transgene enhanced hepatocarcinogenesis induced by liver-specific deletion of the adenomatous polyposis coli gene and aberrant Wnt/beta-catenin signaling in Apc(lox/lox) animals."
24113161_2013.ann,ADCY3,gastric cancer,3,Further study on the mechanism of ADCY3 in tumorigenesis will provide  the basis as a new molecular target of gastric cancer.
25550771_2014.ann,PTEN,hepatocarcinogenesis,3,Furthermore strategies designed to restore the expression of PTEN may  be promising therapies for preventing HCV dependent hepatocarcinogenesis.
9809998_1998.ann,APC gene,adenomatous polyposis coli,3,"Germ-line mutations in the APC gene cause adenomatous polyposis coli (APC), a syndrome in which patients develop hundreds to thousands of precancerous adenomatous colorectal polyps."
12189186_2002.ann,c-myc,colon cancer,3,"Hence, agents that prevented colon cancer decreased the mitotic index and altered the expression of c-myc, p16 and p27 suggesting that modulation in the expression of these genes are potential biomarkers for chemopreventive activity."
24113455_2013.ann,miR-122,hepatocellular carcinoma,3,Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.
22610915_2012.ann,microRNA-155,hepatocarcinogenesis,3,Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.
26627606_2016.ann,PTEN,Hepatocarcinogenesis,3,Hepatocarcinogenesis was induced by diethylnitrosamine or hepatic deletion of PTEN.
22986531_2013.ann,HNF4alpha,colon cancers,3,Here we have studied the role of HNF4alpha in the mechanism of deregulation of Cdx2 in colon cancers.
18722373_2008.ann,c-Myc,liver cancer,3,"Here, we investigated the molecular mechanisms underlying oncogenic cooperation between c-Myc and E2F1 in relationship to human  liver cancer."
17693663_2007.ann,PTEN,intestinal neoplasia,3,Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin.
22986531_2013.ann,HNF4alpha,CRC,3,HNF4alpha and Cdx2 also exhibited a comparable deregulated pattern in human CRC.
18925631_2008.ann,HNF4alpha,hepatocellular carcinoma,3,"However, the effect of HNF4alpha on cancer stem cells (CSCs)  and the treatment of hepatocellular carcinoma (HCC) with HNF4alpha have not been  reported."
18925631_2008.ann,HNF4alpha,hepatocellular carcinoma (HCC),3,"However, the effect of HNF4alpha on cancer stem cells (CSCs)  and the treatment of hepatocellular carcinoma (HCC) with HNF4alpha have not been  reported."
24324629_2013.ann,DLGAP5,hepatocarcinogenesis,3,"However, whether the up-regulation of DLGAP5 contributes to hepatocarcinogenesis remains unclear."
26244988_2015.ann,Let-7,intestinal cancer,3,"In aggregate, we conclude that Let-7 depletion drives a stem cell phenotype and the development of intestinal cancer, primarily via Hmga2."
18586688_2008.ann,PTEN,hepatocarcinogenesis,3,"In conclusion, loss of PTEN and dysregulation of transforming growth factor beta signaling can be considered to be involved in rat hepatocarcinogenesis from early stages."
23208495_2013.ann,MiR-7,colon cancer,3,"In conclusion, MiR-7 is a novel miRNA with tumor suppressive function in colon cancer by targeting oncogenic YY1."
22056881_2012.ann,miR-375,liver cancer,3,"In conclusion, our findings indicate that miR-375 targets AEG-1 in HCC and suppresses liver cancer cell growth in vitro and in vivo, and highlight the therapeutic potential of miR-375 in HCC treatment."
18302511_2008.ann,PPARgamma1 gene,atherosclerosis,3,"In conclusion, overexpression of the PPARgamma1 gene exerts beneficial effects in attenuating atherosclerosis progression and stabilizes vulnerable plaques."
21965270_2011.ann,LHX4,hepatocarcinogenesis,3,"In conclusion, these data indicate that LHX4 may act as a potential tumor suppressor in hepatocarcinogenesis, suggesting that targeting LHX4 to downregulate AFP might have therapeutic implications."
15538739_2004.ann,TS gene,rectal cancer,3,"In conclusion, this study shows that TS gene expression in a pretreatment biopsy predicts the response of local rectal cancer  to neo-adjuvant 5-FU-based chemoradiotherapy in a high percentage."
21704587_2011.ann,p53,hepatocellular carcinoma,3,"In damaged tissue, combined loss of RB and p53 resulted in early lesion formation, aggressive tumor progression, and gene expression signatures and histologic characteristics of advanced human hepatocellular carcinoma."
12839936_2003.ann,K-ras,colon cancer,3,"In the azoxymethane (AOM) model of colon cancer, in addition to K-ras mutations, we have shown that wild-type (WT) Ras can be activated by upstream pathways, including, e.g., signaling by ErbB receptors."
24264057_2014.ann,p53,obesity,3,"In this context, the study of p53 therefore has obvious implications for both human health and performance, given that impaired mitochondrial content and function is associated with the pathology of many metabolic disorders such as ageing, type 2 diabetes, obesity and cancer, as well as reduced exercise performance."
24130815_2013.ann,p53,hepatocellular carcinoma (HCC),3,"In this report, we show that the synergistic action of HBx and p53 mutation triggers progressive hepatocellular carcinoma (HCC) formation via src activation in zebrafish."
17387143_2007.ann,APC gene,colorectal cancer,3,Inactivation of the APC gene is considered the initiating event in human colorectal cancer.
19919837_2010.ann,p53,hepatocarcinogenesis,3,Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
26752646_2016.ann,cMYC,colon cancers,3,Integrated transcriptomic and genomic analyses defined a distinct superenhancer in CIMP+ colon cancers that regulates cMYC transcription.
27119498_2016.ann,PTEN,CRC,3,"Intestinal cancer driven purely by PTEN-deficiency in transgenic mice developed CM and in human CRC, CM associated with PTEN and PRKCZ readouts."
27119498_2016.ann,PTEN,Intestinal cancer,3,"Intestinal cancer driven purely by PTEN-deficiency in transgenic mice developed CM and in human CRC, CM associated with PTEN and PRKCZ readouts."
22353783_2012.ann,LKB1,breast cancer,3,Isogenic LKB1-knockdown breast cancer cell line pairs were developed.
19394332_2009.ann,ITF-2B,adenoma-carcinoma,3,"ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition."
19394332_2009.ann,ITF-2,adenoma-carcinoma,3,"ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition."
12839936_2003.ann,K-ras,colon cancer,3,K-ras mutations occur frequently in colon cancer and contribute to autonomous growth.
24130815_2013.ann,p53,hepatocarcinogenesis,3,"Many etiological factors, including hepatitis B virus X antigen (HBx) and p53 mutations, have been implicated in hepatocarcinogenesis."
7585622_1995.ann,Apc gene,intestinal neoplasia,3,Mice heterozygous for the dominant Min mutation in their Apc gene develop multiple intestinal neoplasia.
7585622_1995.ann,Min,intestinal neoplasia,3,Mice heterozygous for the dominant Min mutation in their Apc gene develop multiple intestinal neoplasia.
20890892_2010.ann,MAT1A,hepatocellular carcinoma (HCC),3,"Mice lacking methionine adenosyltransferase 1A (MAT1A) have reduced PHB1 expression, impaired mitochondrial function, and spontaneously develop hepatocellular carcinoma (HCC)."
28193514_2017.ann,MicroRNA 301A,Colitis-Associated Cancer,3,MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
19726678_2009.ann,MicroRNA-122,hepatocellular carcinoma,3,MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.
25608619_2015.ann,microRNA-146a,hepatocellular carcinoma,3,microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
26282675_2016.ann,MicroRNA-21,non-alcoholic fatty liver disease,3,MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.
26282675_2016.ann,MicroRNA-21,hepatocellular carcinoma,3,MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.
25817558_2015.ann,MicroRNA-221,liver cancer,3,MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer.
22056881_2012.ann,AEG-1,hepatocellular carcinoma,3,MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
22056881_2012.ann,MicroRNA-375,liver cancer,3,MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
22056881_2012.ann,MicroRNA-375,hepatocellular carcinoma,3,MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
28549468_2017.ann,MicroRNA-608,bladder cancer,3,MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
22234835_2012.ann,MicroRNA-7,hepatocellular carcinoma,3,MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
11286759_2001.ann,Microsatellite,gastric cancer,3,Microsatellite instability as a tool for the classification of gastric cancer.
21986945_2012.ann,Microsomal prostaglandin E synthase-1,colon carcinogenesis,3,Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis.
21743491_2012.ann,Microsomal prostaglandin E synthase-1,hepatocarcinogenesis,3,Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/beta-catenin signaling axis.
23056576_2012.ann,MiR-122,breast cancer,3,MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R.
22431718_2012.ann,MiR-145,hepatocellular carcinoma,3,MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
24911372_2014.ann,miR-185,hepatocellular carcinoma,3,miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt  pathway.
27501171_2016.ann,miR-221,Esophageal Adenocarcinoma,3,miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression.
25503559_2015.ann,miR-490-3p,gastric cancer,3,"miR-490-3p exerted growth- and metastasis-suppressive effects on gastric cancer cells through directly targeting SMARCD1, a SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeling complex subunit."
26583881_2016.ann,miRNA-548p,hepatocellular carcinoma,3,miRNA-548p suppresses hepatitis B virus X protein associated hepatocellular carcinoma by downregulating oncoprotein hepatitis B x-interacting protein.
15958644_2005.ann,p53,colorectal cancer,3,"Molecular targeting of GSK3beta by overexpression of a GSK3beta dominant-negative mutant, or acute-silencing of GSK3beta by RNA interference, reproduced the induction of transcriptionally active p53 in colorectal cancer cells."
8634090_1996.ann,Ki-ras,colorectal cancers,3,"Most human colorectal cancers arise through the accumulation of a series of genetic alterations such as point mutations within the Ki-ras and p53 genes, but  the chemical carcinogens that may be implicated in these events are still unidentified."
8634090_1996.ann,p53 genes,colorectal cancers,3,"Most human colorectal cancers arise through the accumulation of a series of genetic alterations such as point mutations within the Ki-ras and p53 genes, but  the chemical carcinogens that may be implicated in these events are still unidentified."
10657948_2000.ann,sPLA(2) gene,intestinal polyps,3,"Mouse strains with a disrupted sPLA(2) gene are susceptible to the Min phenotype and develop numerous intestinal polyps, whereas  mice with normal sPLA(2) develop only a limited number of polyps."
11516998_2001.ann,APC gene,colorectal cancers,3,Mutations in the APC gene are responsible for familial adenomatous polyposis (FAP) and for the majority of sporadic colorectal cancers.
18337503_2008.ann,MLH1,hereditary nonpolyposis colorectal cancer,3,"Mutations in the human DNA mismatch repair (MMR) gene MLH1 are associated with hereditary nonpolyposis colorectal cancer (Lynch syndrome, HNPCC) and a significant proportion of sporadic colorectal cancer."
18337503_2008.ann,MLH1,colorectal cancer,3,"Mutations in the human DNA mismatch repair (MMR) gene MLH1 are associated with hereditary nonpolyposis colorectal cancer (Lynch syndrome, HNPCC) and a significant proportion of sporadic colorectal cancer."
7606712_1995.ann,APC gene,colorectal cancer,3,Mutations of the APC gene play a critical role in both sporadic and familial forms of colorectal cancer.
21743489_2012.ann,NAC1,ovarian cancer,3,NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
17693663_2007.ann,PTEN,adenomatous polyposis coli,3,Number and size of intestinal tumors were significantly increased in mice bearing both adenomatous polyposis coli (APC) and PTEN mutations.
16959882_2006.ann,K-ras gene,colorectal cancers,3,Oncogenic mutations in the K-ras gene occur in approximately 50% of human colorectal cancers.
21436051_2011.ann,APC gene,CRC,3,One of  the most common rate-limiting mutations in human CRC occurs in the adenomatous polyposis coli (APC) gene.
27512943_2016.ann,miR-373,gastric cancer,3,Our data suggest an  important role of beta2-AR/STAT3/miR-373 signaling on the transformation of gastric cancer cells.
25501825_2014.ann,mir-660,lung cancer,3,Our finding supports that mir-660 acts as a tumor suppressor miRNA and we suggest the replacement of mir-660 as a new therapeutic approach for p53 wild-type lung cancer treatment.
17699782_2007.ann,PTEN,colon carcinogenesis,3,Our findings suggest that the JNK/PTEN and NF-kappaB/PTEN pathways play a critical role in normal intestinal homeostasis and colon carcinogenesis.
28356122_2017.ann,miR-195-5p,CRC,3,Our integrated microRNA profiling approach identified miR-195-5p independently associated with prognosis in CRC.
22679558_2012.ann,LSF,Hepatocellular carcinoma (HCC),3,Our recent studies establish an oncogenic role of LSF in Hepatocellular carcinoma (HCC).
22679558_2012.ann,LSF,Hepatocellular carcinoma,3,Our recent studies establish an oncogenic role of LSF in Hepatocellular carcinoma (HCC).
23418309_2013.ann,PTEN,breast cancer,3,Our recent study indicates that AR upregulates expression of tumor suppressor gene PTEN by promoter activation in breast cancer.
22679558_2012.ann,LSF,hepatocarcinogenesis,3,"Our studies identify a network of proteins, including osteopontin (OPN), Matrix metalloproteinase-9 (MMP-9), c-Met and complement factor H (CFH), that are directly regulated by LSF and play important role in LSF-induced hepatocarcinogenesis."
22056881_2012.ann,miR-375,liver cancer,3,"Overexpression of miR-375 in liver cancer cells decreased cell proliferation, clonogenicity, migration/invasion and also induced G1 arrest and apoptosis."
23714159_2013.ann,p53,hepatocarcinogenesis,3,p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release.
21319196_2011.ann,Paired box gene 5,hepatocellular carcinoma,3,Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway.
18574468_2008.ann,Parkin,hepatocellular carcinoma,3,Parkin as a tumor suppressor gene for hepatocellular carcinoma.
25257656_2015.ann,Apc gene,colorectal cancer,3,PIRC rats (F344/NTac-Apc (am1137) ) mutated in the Apc gene spontaneously develop colon tumors thus mimicking familial adenomatous polyposis (FAP) and sporadic colorectal cancer (CRC) more closely than Apc-based rodent models developing tumors mostly in the small intestine.
19711427_2009.ann,miR-122,hepatocarcinogenesis,3,"Real-time reverse transcription polymerase chain reaction (RT-PCR) analysis demonstrated up-regulation of oncogenic miR-155, miR-221/222, and miR-21 and down-regulation of the most abundant liver-specific miR-122 at early stages of hepatocarcinogenesis."
19711427_2009.ann,miR-155,hepatocarcinogenesis,3,"Real-time reverse transcription polymerase chain reaction (RT-PCR) analysis demonstrated up-regulation of oncogenic miR-155, miR-221/222, and miR-21 and down-regulation of the most abundant liver-specific miR-122 at early stages of hepatocarcinogenesis."
19711427_2009.ann,miR-21,hepatocarcinogenesis,3,"Real-time reverse transcription polymerase chain reaction (RT-PCR) analysis demonstrated up-regulation of oncogenic miR-155, miR-221/222, and miR-21 and down-regulation of the most abundant liver-specific miR-122 at early stages of hepatocarcinogenesis."
23056576_2012.ann,microRNA-122,hepatocellular carcinoma,3,"Recently, microRNA-122 (miR-122) has been proved to play an important role in hepatocellular carcinoma, but its functions in the context of breast cancer (BC) remain unknown."
23056576_2012.ann,miR-122,hepatocellular carcinoma,3,"Recently, microRNA-122 (miR-122) has been proved to play an important role in hepatocellular carcinoma, but its functions in the context of breast cancer (BC) remain unknown."
22234835_2012.ann,microRNA-7,breast cancer,3,"Recently, microRNA-7 (miR-7) has been proven to play a substantial role in glioblastoma and breast cancer, but its functions in the context of HCC remain unknown."
22234835_2012.ann,miR-7,breast cancer,3,"Recently, microRNA-7 (miR-7) has been proven to play a substantial role in glioblastoma and breast cancer, but its functions in the context of HCC remain unknown."
19711427_2009.ann,microRNA-155,hepatocarcinogenesis,3,Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
26068969_2015.ann,HER2,breast cancers,3,"Taken together, our data suggest that ATA may have broad utility in the treatment of HER2-overexpressed breast cancers."
19687802_2009.ann,BYSL,hepatocarcinogenesis,3,"Taken together, our studies indicate that upregulated BYSL expression plays a role in hepatocarcinogenesis."
22710713_2013.ann,miR-497,CRC,3,"Taken together, these results identify downregulation of miR-497 as an important mechanism of upregulation of IGF1-R in CRC cells that contributes to malignancy of CRC."
20010873_2010.ann,APC gene,colorectal cancers,3,The adenomatous polyposis coli (APC) gene product is mutated in the vast majority of human colorectal cancers.
7846077_1995.ann,APC gene,colon carcinogenesis,3,The APC gene plays a major role in human colon carcinogenesis.
27132515_2016.ann,Bcl-3,colon tumorigenesis,3,The B-cell tumor promoter Bcl-3 suppresses inflammation-associated colon tumorigenesis in epithelial cells.
18171987_2007.ann,c-myc oncogene,gastrointestinal cancers,3,"The c-myc oncogene plays an important role in tumorigenesis and is frequently deregulated in many human cancers, including gastrointestinal cancers."
28231808_2017.ann,ITIH5,breast cancer,3,The ECM-modulator inter- alpha-trypsin inhibitor heavy chain family member five (ITIH5) was recently identified as tumor suppressor potentially involved in impairing breast cancer progression but molecular mechanisms underlying its function are still elusive.
18574468_2008.ann,parkin,hepatocarcinogenesis,3,The finding that parkin-deficient mice are susceptible to hepatocarcinogenesis provided the first evidence showing that parkin is indeed a tumor suppressor gene.
10359802_1999.ann,Mlh1,intestinal cancer,3,The findings may provide a basis for understanding the greater predisposition to intestinal cancer of Mlh1(-/-) mice.
19394332_2009.ann,ITF-2 gene,colorectal cancers,3,The ITF-2 gene is located in  the chromosomal region 18q21; allelic loss of this locus occurs in 70% of colorectal cancers.
9816310_1996.ann,K-sam gene,stomach cancer,3,"The K-sam gene, originally isolated as an amplified gene from the stomach cancer  cell line KATO-III, is characterized by its preferential amplification in the undifferentiated type (diffuse type) of stomach cancer and encodes one of the receptors for heparin-binding growth factors or fibroblast growth factors."
21038412_2010.ann,miR-122,hepatocarcinogenesis,3,"The miR-122 regulatory circuitry and its implication  in hepatocarcinogenesis were identified using livers of different development stages, human hepatocellular carcinoma (HCC) tissues and cell lines, and aflatoxin B(1) (AFB(1))-transformed cells."
15090606_2004.ann,SLC5A8 gene,colon cancers,3,"The orphan cotransport protein expressed by the SLC5A8 gene has been shown to play a role in controlling the growth of colon cancers, and the silencing of this gene is a common and early event in human colon neoplasia."
26068969_2015.ann,HER2,breast cancer,3,The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways.
20622894_2010.ann,HER2,breast cancer,3,"The proliferation of certain human HER2-positive breast cancer lines also requires HSF1, as its knockdown led to upregulation of p21 and/or decrease in survivin, precipitating growth arrest."
15608557_2004.ann,MTHFR,colorectal cancer,3,The results suggest that MTHFR genotypes are relevant and independent factors of patient outcome in 5FU-based treatment of advanced colorectal cancer.
9362446_1997.ann,Tg737 gene,liver tumors,3,"The Tg737 gene was found to be altered in approximately 40% of the rodent chemically-induced liver tumors, 40% of the human liver tumors, and in liver, kidney and pancreatic human tumor cell lines."
22679558_2012.ann,LSF,hepatocellular carcinoma,3,The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.
26923637_2016.ann,miR-34a,bile duct cancer,3,Therefore bile duct cancer patients may be treated with miR-34a inhibitor or Per1 stimulator in the future.
24013097_2013.ann,miR-141,pancreatic cancer,3,"Therefore, we conclude that miR-141 targets MAP4K4, acts as a tumor suppressor in pancreatic cancer cells, and may serve as a novel therapeutic agent for miRNA-based pancreatic cancer therapy."
22241473_2012.ann,HNF4alpha,hepatocellular carcinoma,3,"These data suggest that HNF4alpha maintains hepatocyte differentiation in the adult healthy liver, and its loss may directly contribute  to hepatocellular carcinoma development, thus indicating this factor as a possible liver tumor suppressor gene."
27489358_2016.ann,Notch1,gastric cancer,3,These findings suggested that Notch1 signaling plays an important role in  the maintenance of the cancer stem-like phenotype in diffuse type gastric cancer  through an RBP-Jkappa dependent pathway and that inhibiting Notch1 signaling could be an effective therapy against CD133 positive diffuse type gastric cancers.
22679558_2012.ann,LSF,hepatocarcinogenesis,3,"These studies establish a key role of LSF in hepatocarcinogenesis and usher in a novel therapeutic avenue for HCC, an invariably fatal disease."
21330408_2011.ann,miR-205,renal cancer,3,"This is the first study showing that miR-205 inhibits proto-oncogenic SFKs, indicating a therapeutic potential of miR-205 in the treatment of renal cancer."
21639868_2011.ann,p53,breast cancers,3,This led us to investigate the antitumor growth and antimetastatic activities of alpha-mangostin in an immunocompetent xenograft model of mouse metastatic mammary cancer having a p53 mutation that induces a metastatic spectrum similar to that seen in human breast cancers.
23604118_2014.ann,PTEN,intestinal cancer,3,"Thus, inactivation of TGF-beta signaling and loss of PTEN cooperate to drive intestinal cancer formation and progression by suppressing cell cycle inhibitors."
18391202_2008.ann,MYH11,intestinal neoplasia,3,"Thus, MYH11 mutations appear to contribute also to human intestinal neoplasia."
18302511_2008.ann,PPARgamma1,atherosclerosis,3,"Thus, PPARgamma1 might offer a promising gene therapeutic target against atherosclerosis."
12800193_2003.ann,ki-ras,colon carcinogenesis,3,"To characterize the CC531 model at the molecular level, we screened for mutations in genes covering important signal-transduction  pathways that are known to play major roles during colon carcinogenesis, the wnt  and the ki-ras signaling pathways."
8608549_1996.ann,APC gene,colon carcinogenesis,3,"To investigate the roles of the APC gene and microsatellite instability (MI) in PhIP-induced colon carcinogenesis, mutations of the APC gene and alterations of microsatellites were examined."
16240453_2005.ann,microsatellites,colorectal cancer,3,Tumors lacking DNA mismatch repair activity (MMR) from patients with Hereditary Nonpolyposis Colorectal Cancer (HNPCC) or those with sporadic colorectal cancer can be identified by the presence of high levels of instability in repetitive sequences known as microsatellites (MSI).
16240453_2005.ann,MSI,colorectal cancer,3,Tumors lacking DNA mismatch repair activity (MMR) from patients with Hereditary Nonpolyposis Colorectal Cancer (HNPCC) or those with sporadic colorectal cancer can be identified by the presence of high levels of instability in repetitive sequences known as microsatellites (MSI).
24784840_2014.ann,p53,breast cancer,3,"UNLABELLED: Loss of E-cadherin (CDH1), Smad4, and p53 has been shown to play an integral role in gastric, intestinal, and breast cancer formation."
18593903_2008.ann,miR-1,hepatocarcinogenesis,3,"Up-regulation of several miR-1 targets including FoxP1, MET, and HDAC4 in primary human HCCs and down-regulation of their expression in 5-AzaC-treated HCC cells suggest their role in hepatocarcinogenesis."
21704587_2011.ann,p53,hepatocellular carcinoma,3,We analyzed the cooperation of RB  and p53 in liver development and pathogenesis of hepatocellular carcinoma.
18574468_2008.ann,parkin,hepatocellular carcinoma,3,We demonstrated here that parkin-/- mice had enhanced hepatocyte proliferation and developed macroscopic hepatic tumors with the characteristics of hepatocellular carcinoma.
19147571_2009.ann,Notch-1,colon cancer,3,"We first show that the Notch-1 receptor, as well as its downstream target Hes-1, is up-regulated with colon cancer progression, similar to other genes involved in chemoresistance."
23774401_2013.ann,Pol III gene,hepatocellular carcinoma (HCC),3,We have demonstrated that enhancement of Brf1 and Pol III gene expression is associated with the occurrences of hepatocellular carcinoma (HCC) in mice.
23774401_2013.ann,Pol III gene,hepatocellular carcinoma,3,We have demonstrated that enhancement of Brf1 and Pol III gene expression is associated with the occurrences of hepatocellular carcinoma (HCC) in mice.
25065684_2015.ann,AEG-1,hepatocarcinogenesis,3,"We now document the cooperation of AEG-1 and c-Myc in promoting hepatocarcinogenesis by analyzing hepatocyte-specific transgenic mice expressing either AEG-1 (albumin [Alb]/AEG-1), c-Myc (Alb/c-Myc), or both (Alb/AEG-1/c-Myc)."
25065684_2015.ann,c-Myc,hepatocarcinogenesis,3,"We now document the cooperation of AEG-1 and c-Myc in promoting hepatocarcinogenesis by analyzing hepatocyte-specific transgenic mice expressing either AEG-1 (albumin [Alb]/AEG-1), c-Myc (Alb/c-Myc), or both (Alb/AEG-1/c-Myc)."
18722373_2008.ann,c-Myc,hepatocellular carcinoma,3,"We previously reported that hepatic coexpression of c-Myc and E2F1, 2 key regulators of proliferation and apoptosis, enhanced hepatocellular carcinoma (HCC) development in transgenic mice."
18722373_2008.ann,c-Myc,hepatocellular carcinoma (HCC),3,"We previously reported that hepatic coexpression of c-Myc and E2F1, 2 key regulators of proliferation and apoptosis, enhanced hepatocellular carcinoma (HCC) development in transgenic mice."
12189188_2002.ann,Apc gene,intestinal polyps,3,"When Apc gene knockout mice (APC1309 mice) were given 600 or 1200 p.p.m. mofezolac in their diet for 8 weeks, the numbers of intestinal polyps were also dose-dependently decreased, with reduction to 59% of that in the control diet group at the higher dose."
17045692_2007.ann,interferon alpha,hepatocellular carcinoma (HCC),4, BACKGROUND/AIMS: Several studies have reported the efficacy of combination therapy of interferon (IFN) alpha and 5-fluorouracil (5-FU) for hepatocellular carcinoma (HCC).
17045692_2007.ann,interferon alpha,hepatocellular carcinoma,4, BACKGROUND/AIMS: Several studies have reported the efficacy of combination therapy of interferon (IFN) alpha and 5-fluorouracil (5-FU) for hepatocellular carcinoma (HCC).
17045692_2007.ann,5-fluorouracil,hepatocellular carcinoma (HCC),4, BACKGROUND/AIMS: Several studies have reported the efficacy of combination therapy of interferon (IFN) alpha and 5-fluorouracil (5-FU) for hepatocellular carcinoma (HCC).
17045692_2007.ann,5-fluorouracil,hepatocellular carcinoma,4, BACKGROUND/AIMS: Several studies have reported the efficacy of combination therapy of interferon (IFN) alpha and 5-fluorouracil (5-FU) for hepatocellular carcinoma (HCC).
17045692_2007.ann,5-FU,hepatocellular carcinoma (HCC),4, BACKGROUND/AIMS: Several studies have reported the efficacy of combination therapy of interferon (IFN) alpha and 5-fluorouracil (5-FU) for hepatocellular carcinoma (HCC).
19665249_2009.ann,sorafenib,hepatocellular carcinoma (HCC),4, BACKGROUND/AIMS: The success of sorafenib in the treatment of advanced hepatocellular carcinoma (HCC) has focused interest on the role of Ras signaling  in this malignancy.
19665249_2009.ann,sorafenib,hepatocellular carcinoma,4, BACKGROUND/AIMS: The success of sorafenib in the treatment of advanced hepatocellular carcinoma (HCC) has focused interest on the role of Ras signaling  in this malignancy.
22014088_2011.ann,Magnolol,skin cancer,4," BACKGROUND: Magnolol, a plant lignan isolated from the bark and seed cones of Magnolia officinalis, has been shown to have chemopreventive effects on chemically-induced skin cancer development."
23933019_2013.ann,Brucine,hepatocellular carcinoma (HCC),4, Brucine is an alkaloid derived from the seeds of Strychnos nux-vomica Linn. which have long been used as a traditional medicine for the treatment of hepatocellular carcinoma (HCC) in China.
23933019_2013.ann,Brucine,hepatocellular carcinoma,4, Brucine is an alkaloid derived from the seeds of Strychnos nux-vomica Linn. which have long been used as a traditional medicine for the treatment of hepatocellular carcinoma (HCC) in China.
18397917_2008.ann,Caffeic acid phenethyl ester,hepatocarcinogenesis,4," Caffeic acid phenethyl ester (CAPE), a natural component of propolis, shows anticarcinogenic properties in the modified resistant hepatocyte model when administered before initiation or promotion of hepatocarcinogenesis process; however, information about the mechanism underlying this chemoprotection is limited."
18524889_2008.ann,erlotinib,non-small-cell lung cancer,4, Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib shows potent antitumor activity in some non-small-cell lung cancer (NSCLC) cell lines and is approved by the Food and Drug Administration as second and third line treatment for NSCLC.
18691550_2008.ann,I kappaB kinase beta,hepatocarcinogenesis,4," Hepatocyte I kappaB kinase beta (IKK beta) inhibits hepatocarcinogenesis by suppressing accumulation of reactive oxygen species (ROS) and liver damage, whereas JNK1 activation promotes ROS accumulation, liver damage, and carcinogenesis."
18691550_2008.ann,I kappaB kinase beta,liver damage,4," Hepatocyte I kappaB kinase beta (IKK beta) inhibits hepatocarcinogenesis by suppressing accumulation of reactive oxygen species (ROS) and liver damage, whereas JNK1 activation promotes ROS accumulation, liver damage, and carcinogenesis."
24223741_2013.ann,branched-chain amino acids,hepatocellular carcinoma (HCC),4, PURPOSE: Recent studies have revealed that branched-chain amino acids (BCAA) reduce the development of hepatocellular carcinoma (HCC) in patients with obesity and hepatitis C virus infection by improving insulin resistance (IR).
24223741_2013.ann,branched-chain amino acids,hepatocellular carcinoma,4, PURPOSE: Recent studies have revealed that branched-chain amino acids (BCAA) reduce the development of hepatocellular carcinoma (HCC) in patients with obesity and hepatitis C virus infection by improving insulin resistance (IR).
25123088_2014.ann,Tamoxifen,breast cancer,4," Tamoxifen is a non-steroidal anti-estrogenic drug widely used for the treatment and prevention of breast cancer in women; however, there is evidence that tamoxifen is hepatocarcinogenic in rats, but not in mice."
19509257_2009.ann,inflexinol,colon cancer,4, These results suggest that inflexinol inhibits colon cancer cell growth via induction of apoptotic cell death through inactivation of NF-kappaB by a direct modification of cysteine residue in the p50 subunit of NF-kappaB.
12584176_2003.ann,sulindac,intestinal neoplasia,4," This research provides evidence that teas, particularly when administered in combination with sulindac, are highly effective at inhibiting intestinal neoplasia in male Apc(min) mice via direct or indirect effects on the beta-catenin/APC pathway."
21038411_2010.ann,coffee,chronic liver disease,4," UNLABELLED: Epidemiological data associate coffee consumption with a lower prevalence of chronic liver disease and a reduced risk of elevated liver enzyme levels (gamma glutamyl transpeptidase and alanine aminotransferase), advanced liver disease and its complications, and hepatocellular carcinoma."
21038411_2010.ann,coffee,hepatocellular carcinoma,4," UNLABELLED: Epidemiological data associate coffee consumption with a lower prevalence of chronic liver disease and a reduced risk of elevated liver enzyme levels (gamma glutamyl transpeptidase and alanine aminotransferase), advanced liver disease and its complications, and hepatocellular carcinoma."
25251587_2014.ann,5-aza-dC,atherosclerosis,4,"5-aza-dC treatment markedly decreased atherosclerosis development in Ldlr(-/-) mice without changes in body weight, plasma lipid profile, macrophage cholesterol levels and plaque lipid content."
24007863_2014.ann,5-Fluorouracil,hepatocellular carcinoma (HCC),4,5-Fluorouracil (5-FU) is one of the most common chemotherapeutic agents used for  the treatment of hepatocellular carcinoma (HCC).
24007863_2014.ann,5-Fluorouracil,hepatocellular carcinoma,4,5-Fluorouracil (5-FU) is one of the most common chemotherapeutic agents used for  the treatment of hepatocellular carcinoma (HCC).
24007863_2014.ann,5-FU,hepatocellular carcinoma (HCC),4,5-Fluorouracil (5-FU) is one of the most common chemotherapeutic agents used for  the treatment of hepatocellular carcinoma (HCC).
27865009_2017.ann,5-Fluorouracil,colon cancer,4,"5-Fluorouracil (5-FU) is one of the most commonly used chemotherapeutic agents in colon cancer treatment, but has a narrow therapeutic index limited by its toxicity."
27865009_2017.ann,5-FU,colon cancer,4,"5-Fluorouracil (5-FU) is one of the most commonly used chemotherapeutic agents in colon cancer treatment, but has a narrow therapeutic index limited by its toxicity."
26310874_2015.ann,5-Fluorouracil,CRC,4,"5-Fluorouracil (5-FU), a common chemotherapeutic agent used for the treatment of  colorectal cancer (CRC), by itself has inadequate response rates; highlighting the need for novel and improved treatment regimens for these patients."
26310874_2015.ann,5-Fluorouracil,colorectal cancer,4,"5-Fluorouracil (5-FU), a common chemotherapeutic agent used for the treatment of  colorectal cancer (CRC), by itself has inadequate response rates; highlighting the need for novel and improved treatment regimens for these patients."
26310874_2015.ann,5-FU,CRC,4,"5-Fluorouracil (5-FU), a common chemotherapeutic agent used for the treatment of  colorectal cancer (CRC), by itself has inadequate response rates; highlighting the need for novel and improved treatment regimens for these patients."
26310874_2015.ann,5-FU,colorectal cancer,4,"5-Fluorouracil (5-FU), a common chemotherapeutic agent used for the treatment of  colorectal cancer (CRC), by itself has inadequate response rates; highlighting the need for novel and improved treatment regimens for these patients."
26708719_2016.ann,acetaminophen,liver injury,4,Administration of SP600125 before or with acetaminophen protected Jnk(Deltahepa) and control mice from liver injury.
23714159_2013.ann,ethyl pyruvate,cirrhosis,4,"Administration of the HMGB1 release inhibitor ethyl pyruvate, which does not affect p53-mediated hepatic apoptosis, substantially prevented carcinogen-induced cirrhosis and tumorigenesis in rat livers."
24204981_2013.ann,Aliskiren,steatohepatitis,4,Aliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet.
20681671_2010.ann,pterostilbene,colon tumorigenesis,4,"All of these results revealed that pterostilbene is an effective antitumor agent as well as its inhibitory effect through the down-regulation of inflammatory iNOS and COX-2  gene expression and up-regulation of apoptosis in mouse colon, suggesting that pterostilbene is a novel functional agent capable of preventing inflammation-associated colon tumorigenesis."
27624867_2017.ann,Alternol,osteosarcoma,4,"Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways."
26383537_2015.ann,Anthocyanin,colon tumorigenesis,4,Anthocyanin-containing purple-fleshed potatoes suppress colon tumorigenesis via elimination of colon cancer stem cells.
18292937_2008.ann,pegylated interferon,hepatocarcinogenesis,4,Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model.
17957784_2008.ann,wogonin,breast cancers,4,"As wogonin was effective both in vitro and in vivo, our novel findings open the possibility of wogonin as an effective therapeutic and/or chemopreventive agent against both ER-positive and -negative breast cancers, particularly against the more aggressive and hormonal therapy-resistant ER-negative types."
27207670_2016.ann,Aspirin,CRC,4,"Aspirin [acetylsalicylic acid (ASA)] has been shown to prevent CRC; however, the epigenetic mechanisms of its action remain unknown."
27207670_2016.ann,acetylsalicylic acid,CRC,4,"Aspirin [acetylsalicylic acid (ASA)] has been shown to prevent CRC; however, the epigenetic mechanisms of its action remain unknown."
17876044_2007.ann,doxorubicin,hepatocellular carcinoma,4,AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma.
18202021_2008.ann,Beta-ionone,colon cancer,4,"Beta-ionone, an end-ring analogue of beta-carotenoid, which is a constituent of vegetables and fruits, has been analyzed for colon cancer chemoprevention and treatment."
23011081_2013.ann,Bortezomib,liver fibrosis,4,Bortezomib also prevented the activation of hepatic stellate cells and inhibited the liver fibrosis of the DEN/CDAA model.
23011081_2013.ann,Bortezomib,liver fibrosis,4,Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosis.
19906067_2010.ann,Branched-chain amino acids,hepatocellular carcinoma,4,"Branched-chain amino acids (BCAA), which improve insulin resistance, inhibited obesity-related colon carcinogenesis in a rodent model, and also reduced the incidence of hepatocellular carcinoma in obese patients with liver cirrhosis."
24123777_2014.ann,bromelain,colorectal cancer,4,Bromelain-containing foods and/or bromelain itself may represent good candidates for colorectal cancer chemoprevention.
23933019_2013.ann,Brucine,hepatocellular carcinoma,4,"Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: the role of hypoxia inducible factor 1 pathway."
16353145_2006.ann,Celecoxib,colon cancer,4,"Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is effective as chemopreventive against colon cancer and it is the only nonsteoroidal antiinflammatory drug approved by the FDA for adjuvant therapy in patients with familial adenomatous polyposis."
21038411_2010.ann,polyphenols,liver damage,4,Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.
21038411_2010.ann,melanoidins,liver damage,4,Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.
21038411_2010.ann,Coffee,liver damage,4,Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.
22581840_2012.ann,SDs,Colon cancer,4,"Colon cancer cells treated with SDs exhibited reduced Wnt transcriptional activity, as well as reduced nuclear beta-catenin localization and subsequent reduction in active-beta-catenin levels."
26918349_2016.ann,aspirin,colon cancer,4,Combination of aspirin and sorafenib may be an effective regimen to treat HCC and colon cancer.
26918349_2016.ann,sorafenib,colon cancer,4,Combination of aspirin and sorafenib may be an effective regimen to treat HCC and colon cancer.
25600769_2015.ann,EPLE,CRC,4,"Combined treatments of EPLE and 5-fluorouracil, the first-line chemotherapy for CRC patients, achieved a synergistic effect."
25600769_2015.ann,5-fluorouracil,CRC,4,"Combined treatments of EPLE and 5-fluorouracil, the first-line chemotherapy for CRC patients, achieved a synergistic effect."
19709125_2009.ann,meloxicam,hepatocellular carcinoma,4,Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice.
24247078_2014.ann,Compound Astragalus and Salvia miltiorrhiza extract,hepatocellular carcinoma,4,Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
18381954_2008.ann,curcumin,colorectal cancer,4,"CONCLUSION: Collectively, our results suggest that curcumin potentiates the antitumor effects of radiation therapy in colorectal cancer by suppressing NF-kappaB and NF-kappaB-regulated gene products, leading to inhibition of proliferation and angiogenesis."
23590467_2013.ann,gemcitabine,pancreatic cancer,4,"CONCLUSION: In summary, these findings provide preclinical evidence supporting further evaluation of agents such as DMAPT and gemcitabine for the prevention and treatment of pancreatic cancer."
21038411_2010.ann,coffee,liver damage,4,CONCLUSION: Our data demonstrate that coffee consumption protects the liver from damage caused by a high-fat diet.
19671906_2009.ann,aspirin,colorectal cancer,4,"CONCLUSION: Regular aspirin use after the diagnosis of colorectal cancer is associated with lower risk of colorectal cancer-specific and overall mortality, especially among individuals with tumors that overexpress COX-2."
28255652_2017.ann,glycerol,liver cancer,4,CONCLUSION: The present work provides novel data concerning the preventive actions of glycerol during the development of liver cancer and represents an economically feasible intervention to treat high-risk individuals.
23422335_2013.ann,TFA,liver injury,4,CONCLUSION: These results suggested that TFA protected mice against CCl4-induced liver injury through antioxidant stress and antiinflammatory effects.
21607999_2011.ann,saffron,liver cancer,4,CONCLUSION: This study provides evidence that saffron exerts a significant chemopreventive effect against liver cancer through inhibition of cell proliferation and induction of apoptosis.
24204981_2013.ann,Aliskiren,steatohepatitis,4,CONCLUSIONS: Aliskiren attenuates steatohepatitis and fibrosis in mice fed with a MCD diet.
22014088_2011.ann,Magnolol,skin cancer,4,"CONCLUSIONS: Magnolol pretreatments prevent UVB-induced skin cancer development by enhancing apoptosis, causing cell cycle arrest at G2/M phase, and affecting various signaling pathways."
20823143_2010.ann,Silibinin,colon carcinogenesis,4,CONCLUSIONS: Silibinin targets beta-catenin and IGF-1Rbeta pathways for its chemopreventive efficacy against azoxymethane-induced colon carcinogenesis in A/J mice.
21639868_2011.ann,alpha-mangostin,breast cancer,4,"CONCLUSIONS: Since lymph node involvement is the most important prognostic factor in breast cancer patients, the antimetastatic activity of alpha-mangostin as detected in mammary cancers carrying a p53 mutation in the present study may have specific clinical applications."
21639868_2011.ann,alpha-mangostin,mammary cancers,4,"CONCLUSIONS: Since lymph node involvement is the most important prognostic factor in breast cancer patients, the antimetastatic activity of alpha-mangostin as detected in mammary cancers carrying a p53 mutation in the present study may have specific clinical applications."
15930366_2005.ann,ABT-100,hepatocellular carcinoma,4,"CONCLUSIONS: Taken together, these findings identify  a mechanism of ABT-100 function and show the efficacy of ABT-100 as a chemopreventive agent of hepatocellular carcinoma."
24520095_2014.ann,sorafenib,hepatocellular carcinoma,4,"CONCLUSIONS: These findings  suggest that MPT0E028 in combination with sorafenib has significant anti-hepatocellular carcinoma activity in preclinical models, potentially suggesting a novel therapeutic strategy for patients with advanced hepatocellular carcinoma."
24495750_2014.ann,dovitinib,colon cancer,4,CONCLUSIONS: This study demonstrates the synergistic antitumor activity of combination of dovitinib and oxaliplatin against colon cancer with different RAS-RAF status.
24495750_2014.ann,oxaliplatin,colon cancer,4,CONCLUSIONS: This study demonstrates the synergistic antitumor activity of combination of dovitinib and oxaliplatin against colon cancer with different RAS-RAF status.
26494227_2015.ann,luteolin,non-alcoholic steatohepatitis,4,Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.
26494227_2015.ann,Connexin 32,non-alcoholic steatohepatitis,4,Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.
26494227_2015.ann,luteolin,hepatocarcinogenesis,4,Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.
26494227_2015.ann,Connexin 32,hepatocarcinogenesis,4,Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.
19549529_2009.ann,osteopontin,colorectal cancers,4,Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
27093553_2016.ann,Cytochrome P450 1A2,Hepatocellular Carcinoma,4,Cytochrome P450 1A2 Metabolizes 17beta-Estradiol to Suppress Hepatocellular Carcinoma.
27696512_2017.ann,melatonin,hepatocarcinogenesis,4,Data obtained suggest a contribution of the SphK/S1P system and related signaling pathways to the protective effects of melatonin in hepatocarcinogenesis.
22159220_2012.ann,Decorin,colorectal cancer,4,Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice.
19384949_2009.ann,fluoropyrimidine,colon cancer,4,"Despite recent therapeutic advances, the response rates to chemotherapy for patients with metastatic colon cancer remain at approximately 50% with the fluoropyrimidine, 5-fluorouracil (5-FU), continuing to serve as the foundation chemotherapeutic agent for the treatment of this disease."
19384949_2009.ann,5-fluorouracil,colon cancer,4,"Despite recent therapeutic advances, the response rates to chemotherapy for patients with metastatic colon cancer remain at approximately 50% with the fluoropyrimidine, 5-fluorouracil (5-FU), continuing to serve as the foundation chemotherapeutic agent for the treatment of this disease."
19384949_2009.ann,5-FU,colon cancer,4,"Despite recent therapeutic advances, the response rates to chemotherapy for patients with metastatic colon cancer remain at approximately 50% with the fluoropyrimidine, 5-fluorouracil (5-FU), continuing to serve as the foundation chemotherapeutic agent for the treatment of this disease."
20061362_2010.ann,pterostilbene,colon carcinogenesis,4,"Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats."
19551842_2010.ann,lycopene,hepatocarcinogenesis,4,Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats.
22116467_2012.ann,lecithin,hepatocarcinogenesis,4,Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.
14970324_2004.ann,5-fluorouracil,colorectal cancer,4,Digital karyotyping identifies thymidylate synthase amplification as a mechanism  of resistance to 5-fluorouracil in metastatic colorectal cancer patients.
23665045_2013.ann,Diosmin,hepatocarcinogenesis,4,"Diosmin abrogates chemically induced hepatocarcinogenesis via alleviation of oxidative stress, hyperproliferative and inflammatory markers in murine model."
16510598_2006.ann,5-fluorouracil,colorectal cancer,4,DNA microarray analysis was used to analyze the transcriptional profile of HCT116 colorectal cancer cells that were treated with 5-fluorouracil (5-FU) or oxaliplatin and selected for resistance to these agents.
16510598_2006.ann,5-FU,colorectal cancer,4,DNA microarray analysis was used to analyze the transcriptional profile of HCT116 colorectal cancer cells that were treated with 5-fluorouracil (5-FU) or oxaliplatin and selected for resistance to these agents.
16510598_2006.ann,oxaliplatin,colorectal cancer,4,DNA microarray analysis was used to analyze the transcriptional profile of HCT116 colorectal cancer cells that were treated with 5-fluorouracil (5-FU) or oxaliplatin and selected for resistance to these agents.
19458067_2009.ann,Embelin,colon carcinogenesis,4,"Embelin inhibits chemical carcinogen-induced colon carcinogenesis, but this effect is partially dependent on the presence of functional PPARgamma, indicating that PPARgamma is a necessary signaling pathway involved in the antitumor activity of normal organisms."
10389917_1999.ann,vitamin D,colon cancer,4,Epidemiological evidence suggests that vitamin D may play a  role in inhibiting the development of colon and prostate cancer.
16963246_2007.ann,folate,colon cancer,4,"Epidemiological studies indicate that adequate dietary folate is protective against colon cancer, although mechanisms remain largely elusive."
24677197_2014.ann,Erlotinib,liver injury,4,Erlotinib also decreased hepatocyte proliferation and liver injury.
19074849_2008.ann,tolfenamic acid,colorectal cancer,4,ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells.
22840450_2012.ann,Fumaria indica,hepatocellular carcinoma,4,Evaluation of chemopreventive effect of Fumaria indica against N-nitrosodiethylamine and CCl4-induced hepatocellular carcinoma in Wistar rats.
28319060_2017.ann,Exenatide,non-alcoholic fatty liver disease,4,"Exenatide (Ex-4), a potent diabetes drug targeting glucagon-like peptide-1 receptor (GLP-1R), is protective against non-alcoholic fatty liver disease (NAFLD)."
15731169_2005.ann,5-fluorouracil,colorectal cancer,4,"Furthermore, exposure of colorectal cancer cells to anti-periostin antibodies activates apoptosis and potentiates the effects of 5-fluorouracil chemotherapy."
24981158_2014.ann,Garcinol,colon carcinogenesis,4,Garcinol suppresses inflammation-associated colon carcinogenesis in mice.
23494807_2013.ann,Garlic oil,hepatocarcinogenesis,4,Garlic oil attenuated nitrosodiethylamine-induced hepatocarcinogenesis by modulating the metabolic activation and detoxification enzymes.
23590467_2013.ann,Gemcitabine,pancreatic cancer,4,"Gemcitabine, the current standard-of-care chemotherapy for pancreatic cancer, has limited clinical benefit."
22187166_2012.ann,Glucans,colon carcinogenesis,4,Glucans from the edible mushroom Pleurotus pulmonarius inhibit colitis-associated colon carcinogenesis in mice.
17613133_2007.ann,Glycyrrhizic Acid,chronic hepatitis,4,"Glycyrrhizic Acid has been used to treat chronic hepatitis, inhibiting the penetration of the  hepatitis A virus into hepatocytes."
10025872_1998.ann,ursodeoxycholic acid,colon cancer,4,Great interest has been focused on the chemoprevention of colonic carcinogenesis  by oral administration of ursodeoxycholic acid (UDCA) because its administration  reportedly reduces the incidence of colon cancer in animal experiments.
20126370_2008.ann,vitamin E,hepatocellular carcinoma,4,"Here we aimed to determine the mechanism of actions  of DHEA, in comparison to vitamin E, in a chemically-induced hepatocellular carcinoma model in rats."
20823143_2010.ann,silibinin,colon tumorigenesis,4,"Herein, for the first time, we investigate in vivo the efficacy of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice."
19642983_2009.ann,betaine,hepatocarcinogenesis,4,"However, there are few investigations on the protective effect of betaine in hepatocarcinogenesis."
10503899_1999.ann,"1,2-dimethylhydrazine",colon carcinogenesis,4,"HTHQ also inhibited 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced colon carcinogenesis in a two stage colon carcinogenesis model using 1,2-dimethylhydrazine (DMH) as an initiator."
21909139_2012.ann,cisplatin,ovarian cancer,4,Hyperactive EGFR signaling through Stat3 and the Jak-Stat3 activity together promote ovarian  cancer progression to cisplatin resistance and therefore represent targets for preventing the development of cisplatin resistance and the recurrent disease during cisplatin therapy in ovarian cancer.
20502879_2011.ann,oxfendazole,hepatocarcinogenesis,4,Immunohistochemical analyses at the late stage of tumor promotion by oxfendazole  in a rat hepatocarcinogenesis model.
19934284_2009.ann,oligoamines,colon tumor,4,"Importantly, cotreatment with low doses of oligoamines and a DNA methyltransferase inhibitor highly induces the reexpression of the aberrantly silenced SFRP2 gene and results in significant inhibition of the growth of established tumors in a human colon tumor model in vivo."
25886177_2015.ann,thalidomide,liver tumors,4,"In a 2012 case report, we described our breakthrough finding in two advanced HCC patients, of whom one achieved complete remission of  liver tumors and the other a normalized alpha-fetoprotein level, along with complete remission of their lung metastases, after the concomitant use of thalidomide and cyproheptadine."
25886177_2015.ann,cyproheptadine,liver tumors,4,"In a 2012 case report, we described our breakthrough finding in two advanced HCC patients, of whom one achieved complete remission of  liver tumors and the other a normalized alpha-fetoprotein level, along with complete remission of their lung metastases, after the concomitant use of thalidomide and cyproheptadine."
21639868_2011.ann,alpha-mangostin,breast cancer,4,"In addition, alpha-mangostin may have chemopreventive benefits and/or prove useful as an adjuvant therapy, or as a complementary alternative medicine in the treatment of breast cancer."
24146112_2014.ann,dioscin,liver injury,4,"In conclusion, dioscin shows excellent protective effect against ethanol-induced liver injury through ameliorating ethanol-induced oxidative stress, mitochondrial function, inflammatory cytokine production, apoptosis and liver steatosis, which should be developed as a new drug for the treatment of ethanol-induced liver injury in the future."
24146112_2014.ann,dioscin,liver injury,4,"In conclusion, dioscin shows excellent protective effect against ethanol-induced liver injury through ameliorating ethanol-induced oxidative stress, mitochondrial function, inflammatory cytokine production, apoptosis and liver steatosis, which should be developed as a new drug for the treatment of ethanol-induced liver injury in the future."
18521906_2008.ann,simvastatin,colon cancer,4,"In conclusion, simvastatin inhibited colon cancer development by induction of apoptosis and suppression of angiogenesis."
17438113_2007.ann,ursodeoxycholic acid,colitis,4,"In the current study, we investigated whether ursodeoxycholic acid (UDCA) can inhibit colitis-related mouse colon carcinogenesis and compared it with the effects of sulfasalazine."
17438113_2007.ann,ursodeoxycholic acid,colon carcinogenesis,4,"In the current study, we investigated whether ursodeoxycholic acid (UDCA) can inhibit colitis-related mouse colon carcinogenesis and compared it with the effects of sulfasalazine."
19074849_2008.ann,tolfenamic acid,colorectal cancer,4,"In the present study,  we investigated the anticancer activity of tolfenamic acid in human colorectal cancer cells."
22763672_2012.ann,myrtenal,hepatocellular carcinoma,4,"In the present study, it is shown that myrtenal, a natural monoterpene, which acts as an antineoplastic agent against diethylnitrosamine induced phenobarbital promoted experimental hepatocellular carcinoma."
25434800_2015.ann,alantolactone,triple-negative breast cancer,4,"In the present study, we demonstrated that alantolactone, which is a sesquiterpene lactone, has potential activity against triple-negative breast cancer MDA-MB-231 cells by suppressing the signal transducer and activator of transcription 3 (STAT3) signaling pathway."
21711565_2011.ann,pitavastatin,hyperlipidemia,4,"In the present study, we examined the effects of pitavastatin - a drug used for the treatment of hyperlipidemia - on the development of diethylnitrosamine (DEN)-induced liver preneoplastic lesions in C57BL/KsJ-db/db (db/db) obese mice."
23665045_2013.ann,diosmin,hepatocarcinogenesis,4,"In the present study, we have shown that diosmin attenuates 2-AAF induced hepatic toxicity and early tumor promotion markers (ODC, PCNA and Ki67),  its chemopreventive efficacy against DEN initiated and 2-AAF promoted hyper-proliferation and hepatocarcinogenesis in Wistar rats."
21850372_2011.ann,resveratrol,hepatocarcinogenesis,4,"In this study, we report the effects of resveratrol in the early and advanced stages of hepatocarcinogenesis in a model of N-nitrosodiethylamine (DEN)-induced hepatocellular carcinoma (HCC) of male Wistar rats."
19509257_2009.ann,Inflexinol,colon cancer,4,Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-kappaB activity via direct interaction with p50.
1917145_1991.ann,retinoic acid,hepatocarcinogenesis,4,Inhibition by retinoic acid of hepatocarcinogenesis induced by N-nitrosomorpholine and of expression of myc oncogene protein in Sprague-Dawley rats.
19418558_2009.ann,c-Jun NH2-terminal kinase,hepatocellular carcinoma,4,Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.
23404993_2013.ann,oleanolic acid,hepatocellular carcinoma,4,Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
20823143_2010.ann,silibinin,colon tumorigenesis,4,Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice.
18676755_2008.ann,fluoropyrimidine,colorectal cancer,4,K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
26210742_2015.ann,Kruppel-like factor 9,colorectal cancer,4,Kruppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.
24399246_2014.ann,Latexin,hepatocellular carcinoma,4,Latexin exhibits tumor suppressor potential in hepatocellular carcinoma.
10959800_2000.ann,tamoxifen,liver tumors,4,Liver cell proliferation increased significantly only in the liver tumors of tamoxifen-treated rats after  12 months of treatment and during the recovery period.
20890892_2010.ann,prohibitin 1,liver fibrosis,4,"Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice."
20890892_2010.ann,prohibitin 1,liver injury,4,"Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice."
20890892_2010.ann,prohibitin 1,hepatocellular carcinoma,4,"Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice."
19272382_2009.ann,Dicer,hepatocarcinogenesis,4,Loss of Dicer primarily impairs hepatocyte survival but can promote hepatocarcinogenesis in cooperation with additional oncogenic stimuli.
21159647_2010.ann,metallothionein,hepatocarcinogenesis,4,Loss of metallothionein predisposes mice to diethylnitrosamine-induced hepatocarcinogenesis by activating NF-kappaB target genes.
24660901_2014.ann,Lycopene,hepatocarcinogenesis,4,Lycopene is an active chemopreventive agent that offers protection against DEN-induced hepatocarcinogenesis by inhibiting NF-kappaB and mTOR pathways.
22014088_2011.ann,Magnolol,skin cancer,4,Magnolol could be a potentially safe and potent anticarcinogenic agent against skin cancer.
26656265_2015.ann,Melatonin,liver injury,4,"Melatonin improved survival rates and successfully attenuated liver injury, as shown by histopathology, decreased levels of serum transaminases and reduced expression of placental glutathione S-transferase."
26548419_2016.ann,Metformin,hepatocarcinogenesis,4,Metformin inhibits early stage diethylnitrosamineinduced hepatocarcinogenesis in  rats.
21980390_2011.ann,resveratrol,Pancreatic cancer,4,METHODOLOGY/PRINCIPAL FINDINGS: Pancreatic cancer cell lines were treated with resveratrol.
22014088_2011.ann,magnolol,skin cancer,4,METHODS: UVB-induced skin carcinogenesis model in SKH-1 mice was used for determining the preventive effects of magnolol on skin cancer development.
20557081_2010.ann,Methyl antcinate A,liver cancer,4,Methyl antcinate A from Antrodia camphorata induces apoptosis in human liver cancer cells through oxidant-mediated cofilin- and Bax-triggered mitochondrial pathway.
19850985_2008.ann,Huqi San,hepatocarcinogenesis,4,"Modulation of energy metabolic enzyme expression in N-nitrosodiethylamine-mediated hepatocarcinogenesis by Chinese herbs, Huqi San."
25600769_2015.ann,EPLE,CRC,4,"More importantly, EPLE hampered tumor development in a CRC xenograft model."
25944804_2015.ann,acifluorfen,colon cancer,4,"Moreover, using a mouse xenograft model, we show that treatment with the specific PPOX inhibitor acifluorfen significantly reduced the growth of  three of the seven (42.8%) colon cancer lines investigated."
22763672_2012.ann,Myrtenal,hepatocellular carcinoma,4,"Myrtenal, a natural monoterpene, down-regulates TNF-alpha expression and suppresses carcinogen-induced hepatocellular carcinoma in rats."
17942915_2007.ann,N-acetyl-L-cysteine,hepatocarcinogenesis,4,N-acetyl-L-cysteine blocked the EGFR activation  and reduced the N-nitrosodiethylamine-initiated hepatocarcinogenesis to the levels of Cre-Ctrl mice.
18852136_2008.ann,polyphenols,colorectal cancer,4,Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts  by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism.
27735939_2016.ann,pectolinarigenin,osteosarcoma,4,Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via  SHP-1-mediated STAT3 signaling inhibition.
23613111_2013.ann,Nitidine chloride,hepatocellular carcinoma,4,Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
16818512_2006.ann,indomethacin,colon cancer,4,Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.
20627873_2010.ann,sulindac,colon cancer,4,"Non-steroidal anti-inflammatory drugs such as sulindac are promising chemoprevention agents against colon cancer, but their weak potency and side effects limit their use for both chemoprevention and chemotherapy."
19358264_2009.ann,adeno-XAF1,gastric cancer,4,"Notably, adeno-XAF1 treatment significantly inhibited tumor growth,  strongly enhanced the antitumor activity of TRAIL in a gastric cancer xenograft model in vivo, and significantly prolonged the survival time of animals bearing tumor xenografts."
25503930_2015.ann,sulindac,colon tumor,4,"Notably, colon tumor prevention activity by sulindac was accompanied by  a marked induction of lymphoid aggregates and proximal colonic inflammatory mass  lesions, a side effect seen to a lesser degree with celecoxib, but not with aspirin."
16331619_2006.ann,5-FU,colon cancer,4,Nuclear Maspin expression is highly predictive of 5-FU chemotherapy response in patients  with advanced stage colon cancer.
25766325_2015.ann,2-aryl benzimidazole derivative,breast cancer,4,"On the basis of our findings, further development of this 2-aryl benzimidazole derivative, a new class of multitarget anticancer agents, is warranted and represents a novel strategy for improving breast cancer treatment."
25766325_2015.ann,2-aryl benzimidazole,breast cancer,4,"On the basis of our findings, further development of this 2-aryl benzimidazole derivative, a new class of multitarget anticancer agents, is warranted and represents a novel strategy for improving breast cancer treatment."
24660901_2014.ann,lycopene,hepatocarcinogenesis,4,Orally administered lycopene attenuates diethylnitrosamine-induced hepatocarcinogenesis in rats by modulating Nrf-2/HO-1 and Akt/mTOR pathways.
25811798_2015.ann,nifuroxazide,breast cancer,4,Our data indicated that nifuroxazide may potentially be a therapeutic agent for growth and metastasis of  breast cancer.
18339886_2008.ann,silymarin,liver damage,4,"Our data indicated that silymarin has therapeutic effects on the early stages of liver damage, reversing fatty changes and recovering liver histopathology in a dose-dependent manner."
25600769_2015.ann,EPLE,CRC,4,Our data thus establish EPLE as a novel inhibitor of Wnt signaling that holds great promise as a potential candidate for further preclinical evaluation for CRC treatments.
20061362_2010.ann,pterostilbene,colon cancer,4,"Our data with pterostilbene in suppressing colon tumorigenesis, cell proliferation as well as key inflammatory markers in vivo and in vitro suggest the potential use of pterostilbene for colon cancer prevention."
20061362_2010.ann,pterostilbene,colon tumorigenesis,4,"Our data with pterostilbene in suppressing colon tumorigenesis, cell proliferation as well as key inflammatory markers in vivo and in vitro suggest the potential use of pterostilbene for colon cancer prevention."
22763672_2012.ann,myrtenal,liver cancer,4,Our findings also showed that myrtenal restrains the liver cancer by preventing the DEN-PB induced up-regulation of TNF-alpha protein expression by immunoblot.
19479993_2009.ann,rimonabant,colorectal cancer,4,Our findings suggest that rimonabant is able to inhibit colorectal cancer cell growth at different stages of colon cancer pathogenesis inducing mitotic catastrophe in vitro.
19479993_2009.ann,rimonabant,colon cancer,4,Our findings suggest that rimonabant is able to inhibit colorectal cancer cell growth at different stages of colon cancer pathogenesis inducing mitotic catastrophe in vitro.
20061362_2010.ann,pterostilbene,colon carcinogenesis,4,Our present study was to identify the chemopreventive potential of pterostilbene with colonic tumor formation as an end point and further to evaluate the mechanistic action of pterostilbene during colon carcinogenesis.
23494807_2013.ann,garlic oil,hepatocarcinogenesis,4,"Our previous study has demonstrated that garlic oil (GO) could prevent NDEA-induced hepatocarcinogenesis in rats, but the underlying mechanisms  are not fully understood."
26130745_2015.ann,sulfated polysaccharides,hepatocarcinogenesis,4,Our results clearly indicate that sulfated polysaccharides of U. lactuca exert a marked chemoprevention of DENA-initiated hepatocarcinogenesis through inhibition of abnormal cell proliferation and induction of apoptosis.
25893854_2015.ann,elaiophylin,ovarian cancer,4,"Our results demonstrate, for the first time, that elaiophylin is a novel autophagy inhibitor, with significant antitumor efficacy as a single agent or in combination in human ovarian cancer cells, establishing the potential treatment of ovarian cancer by this compound."
22116467_2012.ann,DEN-activating enzymes,liver tumor,4,"Our results indicate that Lrat KO mice are less susceptible to DEN-induced hepatocarcinogenesis due to increased retinoid signaling and higher expression of p21, which is accompanied by altered hepatic levels of DEN-activating enzymes and MGMT in Lrat KO mice also contribute to decreased cancer initiation and suppressed liver tumor development."
21850372_2011.ann,resveratrol,hepatocarcinogenesis,4,Our results indicate that the administration of resveratrol either at the early or advanced stages of hepatocarcinogenesis is equally effective and involves the activation of the apoptotic pathway in male Wistar rats.
19221092_2009.ann,enzastaurin,colon cancer,4,Our results show that enzastaurin is an effective chemopreventive agent in a mouse model of sporadic colon cancer that significantly reduces both tumor initiation and progression by inhibiting expression of proproliferative genes.
18202782_2008.ann,cimetidine,hepatocarcinogenesis,4,Our results showed that cimetidine has an inhibiting effect on hepatocarcinogenesis.
23665045_2013.ann,diosmin,liver tumor,4,"Our study demonstrates that the inhibition of cell proliferation and down regulation of inflammatory markers  may be, at least in part, the underlying mechanisms related to the liver tumor inhibition by diosmin."
27470341_2016.ann,artesunate,hepatocellular carcinoma,4,"Overall all these findings substantiate that artesunate promotes anti-tumour, anti-proliferation and apoptosis against nitrosodiethylamine mediated hepatocellular carcinoma."
20061362_2010.ann,pterostilbene,colon tumor,4,"Overall analyses indicated that pterostilbene reduced colon tumor multiplicity of non-invasive adenocarcinomas, lowered proliferating cell nuclear  antigen and downregulated the expression of beta-catenin and cyclin D1."
20823143_2010.ann,silibinin,colorectal cancer,4,"Overall,  these results support the translational potential of silibinin in colorectal cancer chemoprevention."
26499380_2015.ann,Klotho,liver cancer,4,Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/beta-catenin signaling pathway.
19458067_2009.ann,Embelin,colon carcinogenesis,4,Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.
18448328_2008.ann,5-fluorouracil,colorectal cancer,4,Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer.
18448328_2008.ann,capecitabine,colorectal cancer,4,Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer.
18157836_2008.ann,Phyllanthus urinaria,steatohepatitis,4,Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo.
19398233_2009.ann,Polyenephosphatidylcholine,alcoholic liver disease,4,Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress.
18166357_2008.ann,Polyinosinic-polycytidylic acid (Poly I:C),liver fibrosis,4,Polyinosinic-polycytidylic acid (Poly I:C) or IFN-gamma treatment inhibited liver fibrosis in pair-fed but not in ethanol-fed mice.
18166357_2008.ann,Polyinosinic-polycytidylic acid,liver fibrosis,4,Polyinosinic-polycytidylic acid (Poly I:C) or IFN-gamma treatment inhibited liver fibrosis in pair-fed but not in ethanol-fed mice.
19458067_2009.ann,embelin,colon cancer,4,"PPARgamma(+/-) mice were more susceptible to DMH-induced colon carcinogenesis than PPARgamma(+/+) mice, and embelin significantly reduced the incidence of colon cancer in PPARgamma(+/+) mice but not in PPARgamma(+/-) mice."
16935385_2007.ann,Pravastatin,hepatocellular carcinoma,4,Pravastatin reduces lung metastasis of rat hepatocellular carcinoma via a coordinated decrease of MMP expression and activity.
26918349_2016.ann,aspirin,colorectal adenomas,4,Preclinical and clinical investigations demonstrate that aspirin can inhibit several types of cancer such as colorectal adenomas and hepatocellular carcinoma (HCC).
26918349_2016.ann,aspirin,hepatocellular carcinoma,4,Preclinical and clinical investigations demonstrate that aspirin can inhibit several types of cancer such as colorectal adenomas and hepatocellular carcinoma (HCC).
26918349_2016.ann,aspirin,hepatocellular carcinoma (HCC),4,Preclinical and clinical investigations demonstrate that aspirin can inhibit several types of cancer such as colorectal adenomas and hepatocellular carcinoma (HCC).
15538739_2004.ann,5-FU,rectal cancer,4,Pre-operative 5-fluorouracil (5-FU)-based chemoradiotherapy in locally advanced rectal cancer (UICC-II/III) may significantly reduce local tumour mass.
15538739_2004.ann,5-fluorouracil,rectal cancer,4,Pre-operative 5-fluorouracil (5-FU)-based chemoradiotherapy in locally advanced rectal cancer (UICC-II/III) may significantly reduce local tumour mass.
24275088_2014.ann,coffee,liver fibrosis,4,Prevention of rat liver fibrosis and carcinogenesis by coffee and caffeine.
24275088_2014.ann,caffeine,liver fibrosis,4,Prevention of rat liver fibrosis and carcinogenesis by coffee and caffeine.
22159220_2012.ann,decorin,colorectal cancer,4,"Previous studies have shown that decorin expression is significantly reduced in colorectal cancer tissues and cancer cells, and genetic deletion of the decorin gene is sufficient to cause intestinal tumor formation in mice, resulting from a  downregulation of p21, p27(kip1) and E-cadherin and an upregulation of beta-catenin signaling [Bi,X."
16799960_2006.ann,CC3,hepatocellular carcinoma,4,"Previous works showed that loss of TIP30, also called CC3, a putative tumor suppressor, increased the incidence of hepatocellular carcinoma in mice, and some clinical samples of human HCC tissues had aberrant expression of TIP30."
17920061_2007.ann,Progastrin,colorectal cancer,4,Progastrin targeting strategies should provide an exciting prospect for the differentiation therapy of colorectal cancer.
24146112_2014.ann,dioscin,liver injury,4,Protective effects of dioscin against alcohol-induced liver injury.
24634417_2014.ann,Protein kinase d,colorectal cancer,4,Protein kinase d as a potential chemotherapeutic target for colorectal cancer.
20681671_2010.ann,Pterostilbene,colon carcinogenesis,4,Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice.
17401013_2007.ann,oxaliplatin,colorectal cancer,4,"PURPOSE: The objective is to investigate whether polymorphisms with putative influence on fluorouracil/oxaliplatin activity are associated with clinical outcomes of patients with advanced colorectal cancer treated with first-line oxaliplatin, folinic acid, and fluorouracil palliative chemotherapy."
17401013_2007.ann,folinic acid,colorectal cancer,4,"PURPOSE: The objective is to investigate whether polymorphisms with putative influence on fluorouracil/oxaliplatin activity are associated with clinical outcomes of patients with advanced colorectal cancer treated with first-line oxaliplatin, folinic acid, and fluorouracil palliative chemotherapy."
17401013_2007.ann,fluorouracil,colorectal cancer,4,"PURPOSE: The objective is to investigate whether polymorphisms with putative influence on fluorouracil/oxaliplatin activity are associated with clinical outcomes of patients with advanced colorectal cancer treated with first-line oxaliplatin, folinic acid, and fluorouracil palliative chemotherapy."
19665249_2009.ann,sorafenib,hepatocellular carcinoma,4,Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
19665249_2009.ann,rapamycin,hepatocellular carcinoma,4,Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
19671906_2009.ann,aspirin,colorectal cancer,4,"Regular aspirin use after diagnosis was associated with a lower risk of colorectal cancer-specific mortality among participants in whom primary tumors overexpressed COX-2 (multivariate HR, 0.39; 95% CI, 0.20-0.76), whereas aspirin use was not associated with lower risk among those with primary tumors with weak or absent expression (multivariate HR, 1.22; 95% CI, 0.36-4.18)."
18202021_2008.ann,beta-ionone,colon cancer,4,Results from in vitro and in vivo bioassay clearly suggest that  beta-ionone could be further developed for prevention and treatment of colon cancer.
16935385_2007.ann,pravastatin,Liver tumor,4,"RESULTS: Liver tumor mass was lower in pravastatin group (PG) than control group (CG), as estimated from the number of liver tumors  (p<0.004) and the liver weight/body weight ratio (p<0.04)."
20823143_2010.ann,Silibinin,colon tumorigenesis,4,RESULTS: Silibinin feeding showed a dose-dependent decrease in azoxymethane-induced colon tumorigenesis with stronger efficacy in pretreatment versus posttreatment regimen.
21850372_2011.ann,Resveratrol,hepatocellular carcinoma,4,Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
19479993_2009.ann,Rimonabant,colon cancer,4,Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon.
17045692_2007.ann,interferon-alpha,hepatocellular carcinoma,4,Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
17045692_2007.ann,fluorouracil,hepatocellular carcinoma,4,Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
21607999_2011.ann,Saffron,hepatocellular carcinoma,4,Saffron: a potential candidate for a novel anticancer drug against hepatocellular carcinoma.
20460401_2010.ann,Sesamin,hyperlipidemia,4,"Sesamin, a lipid-soluble lignan, is one such agent that belongs to a class of phytoestrogens, isolated from sesame (Sesamum indicum), and has been linked with prevention of hyperlipidemia, hypertension, and carcinogenesis through an unknown mechanism."
24736071_2014.ann,Signal transducer and activator of transcription 3,non-small-cell lung cancer,4,Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer.
18521906_2008.ann,Simvastatin,colon cancer,4,"Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice."
26871288_2016.ann,Sodium alginate,non-alcoholic steatohepatitis,4,Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.
12663524_2003.ann,Sulindac,colon cancer,4,Sulindac and other NSAIDs have been widely studied as potential chemopreventive agents for colon cancer.
19366832_2009.ann,branched-chain amino acids,liver cancer,4,"Supplementation with branched-chain amino acids (BCAA) reduces the risk of liver cancer in cirrhotic patients who are obese, and this has been associated with an improvement of insulin resistance."
18001218_2007.ann,vanadium,hepatocarcinogenesis,4,"Suppression of early stages of neoplastic transformation in a two-stage chemical  hepatocarcinogenesis model: supplementation of vanadium, a dietary micronutrient, limits cell proliferation and inhibits the formations of 8-hydroxy-2'-deoxyguanosines and DNA strand-breaks in the liver of sprague-dawley rats."
28055016_2017.ann,nifuroxazide,CRC,4,"Taken together, our results indicated that nifuroxazide could effectively inhibit tumor metastasis by mediating Stat3 pathway and it might have a therapeutic potential for the treatment of CRC."
19037088_2009.ann,flavonoid fisetin,colon cancer,4,"Taken together, we  provide evidence that the plant flavonoid fisetin can induce apoptosis and suppress the growth of colon cancer cells by inhibition of COX2- and Wnt/EGFR/NF-kappaB-signaling pathways."
20512928_2010.ann,Nemo-like kinase,hepatocellular carcinoma,4,Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.
24302446_2014.ann,folic acid,hepatocarcinogenesis,4,The aim of this study was to investigate molecular mechanisms for the chemopreventive effects of folic acid and tributyrin alone or in combination on rat hepatocarcinogenesis.
24302446_2014.ann,tributyrin,hepatocarcinogenesis,4,The aim of this study was to investigate molecular mechanisms for the chemopreventive effects of folic acid and tributyrin alone or in combination on rat hepatocarcinogenesis.
17145853_2006.ann,celecoxib,colon cancer,4,The cyclooxygenase-2 (COX-2) inhibitor celecoxib is an approved drug in the clinic for colon cancer chemoprevention and has been tested for its chemopreventive and therapeutic efficacy in various clinical trials.
16061884_2005.ann,roxithromycin,hepatocellular carcinoma,4,The data provide additional evidence for the potential use  of roxithromycin in treatment of hepatocellular carcinoma prevention.
27486174_2016.ann,PIM Kinase,Prostate Cancer,4,The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.
20799354_2010.ann,sorafenib,hepatocellular carcinoma (HCC),4,"The oncogenic kinase inhibitor sorafenib can significantly prolong median survival of patients with advanced hepatocellular carcinoma (HCC), although the response is disease-stabilizing and cytostatic rather than one of tumor regression."
20799354_2010.ann,sorafenib,hepatocellular carcinoma,4,"The oncogenic kinase inhibitor sorafenib can significantly prolong median survival of patients with advanced hepatocellular carcinoma (HCC), although the response is disease-stabilizing and cytostatic rather than one of tumor regression."
23665045_2013.ann,diosmin,hepatocarcinogenesis,4,"The present study allows us to conclude that diosmin being a dietary supplement, could be used as chemopreventive agent to prevent hepatocarcinogenesis."
27895800_2016.ann,"(1E,4E)-1,5-bis(2-bromophenyl)penta-1,4-dien-3-one",hepatocellular carcinoma (HCC),4,"The present study offers an strategy for a novel CUR analogue, (1E,4E)-1,5-bis(2-bromophenyl)penta-1,4-dien-3-one (GL63), to be used as a potential therapeutic agent for hepatocellular carcinoma (HCC) in vitro and in vivo."
27895800_2016.ann,"(1E,4E)-1,5-bis(2-bromophenyl)penta-1,4-dien-3-one",hepatocellular carcinoma,4,"The present study offers an strategy for a novel CUR analogue, (1E,4E)-1,5-bis(2-bromophenyl)penta-1,4-dien-3-one (GL63), to be used as a potential therapeutic agent for hepatocellular carcinoma (HCC) in vitro and in vivo."
21607999_2011.ann,saffron,liver cancer,4,The purpose of this investigation was to investigate the chemopreventive action and the possible mechanisms of saffron against diethylnitrosamine (DEN)-induced liver cancer in rats.
20442315_2010.ann,HO-3867,ovarian cancer,4,The purpose of this study was to evaluate the anticancer potency and mechanism of a novel difluorodiarylidenyl piperidone (H-4073) and its N-hydroxypyrroline modification (HO-3867) in human ovarian cancer.
19074836_2008.ann,dibenzazepine,colon cancer,4,The rate of proliferation of  HT29 human colon cancer cells was reduced when treated with the gamma-secretase inhibitor dibenzazepine to inhibit Notch signaling or small interfering RNA directed against Notch.
22966293_2010.ann,6-MSITC,colon carcinogenesis,4,"The results indicated that 6-MSITC exerted chemopreventive effects in the present short-term colon carcinogenesis bioassay, through alterations in cell proliferation activity and drug metabolizing enzyme levels."
27669229_2016.ann,Gefitinib,hepatocarcinogenesis,4,The selective EGFR inhibitor Gefitinib was found to prevent hepatocarcinogenesis in rat cirrhotic livers.
20442315_2010.ann,HO-3867,ovarian cancer,4,The study suggested that HO-3867 may be useful as a safe and effective anticancer agent for ovarian cancer therapy.
26130745_2015.ann,sulfated polysaccharides,hepatocarcinogenesis,4,The sulfated polysaccharides from U. lactuca may have unique properties of providing protection against DENA-induced oxidative stress which could contribute to chemoprevention of experimental hepatocarcinogenesis.
21968689_2012.ann,"3,5,7,3',4'-pentahydroxy flavone",hepatocarcinogenesis,4,"The theme of the study was to evaluate the therapeutic efficacy of nanoencapsulated flavonoidal quercetin (3,5,7,3',4'-pentahydroxy flavone, QC) in combating DEN-induced hepatocarcinogenesis in rats."
24912819_2014.ann,imidazolium compound,hepatocellular carcinoma,4,Therapeutic effect of a multi-targeted imidazolium compound in hepatocellular carcinoma.
23566222_2013.ann,docetaxel,prostate cancer,4,Therapy targeting Vav3 in combination with docetaxel may have practical implications for managing castration-resistant prostate cancer.
14970324_2004.ann,5-FU,colorectal cancer,4,These data suggest that genetic amplification of TYMS is a major mechanism of 5-FU resistance in vivo and have important implications for the management of colorectal cancer patients with recurrent disease.
12810952_2003.ann,aspirin,colon cancer,4,"These findings confirm the hypothesis that the ODC polymorphism is a genetic marker for colon cancer risk, and support the use of ODC inhibitors and aspirin, or other nonsteroidal antiinflammatory drugs (NSAIDs), in combination as a strategy for colon cancer prevention."
25503930_2015.ann,sulindac,colon cancer,4,"These findings suggest that sulindac may be the most effective agent for colon cancer prevention in humans with low 15-PGDH, but its use may also be associated with inflammatory lesions in the colon."
19826045_2009.ann,celecoxib,colon cancer,4,"These observations show, for  the first time, that CP-31398 possesses significant dose-dependent chemopreventive activity in a well-established colon cancer model and that a combination of low-dose CP-31398 and celecoxib significantly enhanced colon cancer chemopreventive efficacy."
26065336_2015.ann,cisplatin,lung cancer,4,These results also support the role of BMX as a potential drug candidate for use in combination with cisplatin in the treatment of human lung cancer.
18547703_2008.ann,chitin,hepatocarcinogenesis,4,"These results indicate that chitin, chitosan and related compounds do not exert unequivocal chemopreventive effects on heterocyclic amine-induced hepatocarcinogenesis, and that effects in other organs may be tissue specific with possible inhibitory action in the mammary gland being offset by promotion of colon lesion development."
18547703_2008.ann,chitosan,hepatocarcinogenesis,4,"These results indicate that chitin, chitosan and related compounds do not exert unequivocal chemopreventive effects on heterocyclic amine-induced hepatocarcinogenesis, and that effects in other organs may be tissue specific with possible inhibitory action in the mammary gland being offset by promotion of colon lesion development."
25419570_2014.ann,Valerian,hepatocarcinogenesis,4,"These results indicate that Valerian exhibits inhibitory effects on rat hepatocarcinogenesis by inhibiting oxidative DNA damage, suppressing cell proliferation and inducing apoptosis in GST-P(+) foci by activating GABA(A)R-mediated signaling."
25434800_2015.ann,alantolactone,breast cancer,4,These results provide preclinical evidence to continue the development of alantolactone as a STAT3 inhibitor and as a potential therapeutic agent against breast cancer.
26494227_2015.ann,luteolin,hepatocarcinogenesis,4,"These results show that Cx32 and luteolin have suppressive roles in inflammation, fibrosis and hepatocarcinogenesis during NASH progression, suggesting a potential therapeutic application for NASH."
18521906_2008.ann,simvastatin,colon cancer,4,These results suggest that simvastatin could be a potential chemopreventive and therapeutic agent of CAC as well as de novo colon cancer.
20683949_2010.ann,Thiazolidinediones,hepatocarcinogenesis,4,Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin.
22791808_2012.ann,Thioredoxin reductase 1,hepatocarcinogenesis,4,Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis  via control of cellular redox homeostasis.
24361483_2014.ann,decorin,liver cancer,4,"Thus, our results support future utilization of decorin as an antitumor agent in liver cancer."
19221092_2009.ann,enzastaurin,colon cancer,4,"Thus, PKCbetaII is an important target for colon cancer chemoprevention and the PKCbeta-selective inhibitor enzastaurin may represent an effective chemopreventive agent in patients at high risk for colon cancer."
20377131_2010.ann,As2O3,hepatocellular carcinoma,4,"Thus, the combination of As2O3 and Ad-PML has synergistic inhibitory effects on hepatocellular carcinoma (HCC), possibly resulting from regulation of apoptotic gene expression enhanced HCC apoptosis."
20377131_2010.ann,As2O3,hepatocellular carcinoma (HCC),4,"Thus, the combination of As2O3 and Ad-PML has synergistic inhibitory effects on hepatocellular carcinoma (HCC), possibly resulting from regulation of apoptotic gene expression enhanced HCC apoptosis."
22763672_2012.ann,myrtenal,hepatocellular carcinoma,4,"Thus, this study shows that myrtenal has the ability to suppress the hepatocellular carcinoma in rats."
15538739_2004.ann,5-FU,rectal cancer,4,"Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer."
18366456_2008.ann,Thymoquinone,colon cancer,4,Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models.
11139434_2000.ann,Levamisole,colon cancer,4,"To better understand the anticancer activity of Levamisole (LMS), which serves as an adjuvant in colon cancer therapy in combination with 5-Fluorouracil, this study analyses LMS' ability to induce apoptosis and growth arrest in cultured human micro- and macrovascular endothelial cells (ECs) and fibroblasts."
23055533_2012.ann,bortezomib,thyroid cancer,4,"To improve the clinical  outcome, further investigation into the potential of bortezomib therapy of thyroid cancer is clearly warranted."
20454513_2010.ann,silibinin,CRC,4,"Together, these findings suggest that silibinin inhibits the growth of SW480 tumors carrying the mutant APC gene by down-regulating CDK8 and beta-catenin signaling and, therefore, could be an effective agent against CRC."
17985342_2008.ann,celecoxib,Tongue cancer,4,"Tongue cancer prevention studies were conducted in zinc-deficient rats previously exposed to a tongue carcinogen by celecoxib treatment with or without zinc replenishment, or by zinc replenishment alone."
28123000_2017.ann,Canertinib,liver injury,4,"Treatment of mice with an EGFR-inhibitor (EGFRi), Canertinib, 1h post-APAP resulted in robust inhibition of EGFR-activation and a striking reduction in APAP-induced liver injury."
16374840_2006.ann,Troglitazone,hepatocellular carcinoma,4,Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
20683949_2010.ann,thiazolidinediones,hepatocellular carcinoma,4,"UNLABELLED: Antidiabetic thiazolidinediones (TZD) have in vitro antiproliferative effect in epithelial cancers, including hepatocellular carcinoma (HCC)."
20683949_2010.ann,thiazolidinediones,hepatocellular carcinoma (HCC),4,"UNLABELLED: Antidiabetic thiazolidinediones (TZD) have in vitro antiproliferative effect in epithelial cancers, including hepatocellular carcinoma (HCC)."
21362627_2011.ann,Ursodeoxycholic acid,colorectal cancer,4,Ursodeoxycholic acid (UDCA) is known as a suppressor of cholestatic liver diseases and colorectal cancer development.
25419570_2014.ann,Valerian,hepatocarcinogenesis,4,Valerian inhibits rat hepatocarcinogenesis by activating GABA(A) receptor-mediated signaling.
18001218_2007.ann,Vanadium,hepatocarcinogenesis,4,Vanadium is chemopreventive against the early stages of 2-AAF-induced hepatocarcinogenesis in rats.
16298452_2006.ann,pamidronate,hepatocellular carcinoma (HCC),4,We demonstrated a possible beneficial use of pamidronate in the treatment of hepatocellular carcinoma (HCC).
19221092_2009.ann,enzastaurin,colon tumor,4,We find that enzastaurin potently reduces azoxymethane-induced colon tumor initiation and progression by inhibiting PKCbetaII-mediated tumor cell proliferation and beta-catenin accumulation.
25526090_2015.ann,N-acetylcysteine,hepatocarcinogenesis,4,"We found that impairing autophagy in hepatocytes would induce oxidative stress and DNA damage, followed by the initiation of hepatocarcinogenesis, which could be suppressed by the antioxidant N-acetylcysteine."
19384947_2009.ann,Astragalus saponins,colon cancer,4,We had recently demonstrated that total Astragalus saponins (AST) possess anticarcinogenic and proapoptotic properties in human colon cancer cells and tumor xenograft.
12839936_2003.ann,ursodeoxycholic acid,colon cancer,4,We have also  shown that ursodeoxycholic acid (UDCA) prevented AOM-induced colon cancer and suppressed Cox-2 induction.
18024478_2008.ann,pectin,colon cancer,4,We have shown that dietary fish oil and pectin (FP) protects against radiation-enhanced colon cancer by upregulating apoptosis in colonic mucosa.
18024478_2008.ann,fish oil,colon cancer,4,We have shown that dietary fish oil and pectin (FP) protects against radiation-enhanced colon cancer by upregulating apoptosis in colonic mucosa.
23590467_2013.ann,gemcitabine,pancreatic cancer,4,We hypothesize that NF-kappaB suppression by the novel inhibitor dimethylaminoparthenolide (DMAPT) may enhance  the effect of gemcitabine in pancreatic cancer.
17909047_2007.ann,erlotinib,intestinal polyps,4,"We observed a significant reduction in the number and size of small intestinal polyps in APC(min+/-) mice treated with either celecoxib (a selective COX-2 inhibitor) or erlotinib (Tarceva, an EGFR inhibitor)."
17909047_2007.ann,celecoxib,intestinal polyps,4,"We observed a significant reduction in the number and size of small intestinal polyps in APC(min+/-) mice treated with either celecoxib (a selective COX-2 inhibitor) or erlotinib (Tarceva, an EGFR inhibitor)."
24651526_2014.ann,embelin,colon carcinogenesis,4,"We previously showed that embelin inhibits the growth of colon cancer cells in vitro, and effectively suppresses 1,2-dimethylhydrazine dihydrochloride-induced colon carcinogenesis in mice."
17615358_2007.ann,estrogen,liver cancer,4,"We propose that estrogen-mediated inhibition of IL-6 production by KCs reduces liver cancer risk  in females, and these findings may be used to prevent HCC in males."
18093689_2008.ann,estrogen,liver cancer,4,"We propose that estrogen-mediated inhibition of IL-6 production by KCs reduces liver cancer risk  in females, and these findings may be used to prevent HCC in males."
21743489_2012.ann,cisplatin,ovarian cancer,4,"We report here that autophagy was involved in NAC1-mediated resistance to cisplatin, a commonly used  chemotherapeutic drug in the treatment of ovarian cancer."
24660901_2014.ann,lycopene,hepatocarcinogenesis,4,We studied  the mechanisms underlying the inhibition of diethylnitrosamine (DEN)-induced hepatocarcinogenesis by lycopene in rats.
19037088_2009.ann,fisetin,colon cancer,4,We suggest that fisetin could be a useful  agent for prevention and treatment of colon cancer.
19003968_2009.ann,Zerumbone,colon carcinogenesis,4,"Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice."
18639551_2008.ann,Androgen,hepatocellular carcinoma (HCC),5, BACKGROUND & AIMS: Androgen effects on hepatocellular carcinoma (HCC) remain controversial and androgen ablation therapy to treat HCC also leads to inconsistent results.
18639551_2008.ann,Androgen,hepatocellular carcinoma,5, BACKGROUND & AIMS: Androgen effects on hepatocellular carcinoma (HCC) remain controversial and androgen ablation therapy to treat HCC also leads to inconsistent results.
23022495_2013.ann,Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like,hepatocellular carcinoma (HCC),5, BACKGROUND & AIMS: Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1L) is an SNF2-like transcription factor involved in the development of human hepatocellular carcinoma (HCC).
23022495_2013.ann,Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like,hepatocellular carcinoma,5, BACKGROUND & AIMS: Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1L) is an SNF2-like transcription factor involved in the development of human hepatocellular carcinoma (HCC).
23022495_2013.ann,CHD1L,hepatocellular carcinoma (HCC),5, BACKGROUND & AIMS: Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1L) is an SNF2-like transcription factor involved in the development of human hepatocellular carcinoma (HCC).
23022495_2013.ann,CHD1L,hepatocellular carcinoma,5, BACKGROUND & AIMS: Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1L) is an SNF2-like transcription factor involved in the development of human hepatocellular carcinoma (HCC).
19061943_2009.ann,iron,liver tumors,5," BACKGROUND: It has been suggested that the altered iron metabolism in liver tumors, characterized by the iron-deficient phenotype, is of importance for tumor growth."
19754954_2009.ann,ErbB2/Her2/Neu receptor tyrosine kinase,breast cancers,5, BACKGROUND: The ErbB2/Her2/Neu receptor tyrosine kinase is amplified in approximately 30% of human breast cancers.
17591676_2007.ann,Dehydroepiandrosterone,obesity,5," Dehydroepiandrosterone (DHEA), the major precursor of androgens and estrogens, has several beneficial effects on the immune system, on memory function, and in modulating the effects of diabetes, obesity, and chemical carcinogenesis."
12115560_2002.ann,Dimethylarsinic acid,liver cancer,5," Dimethylarsinic acid (DMA) is a major metabolite of inorganic arsenicals, which are epidemiologically significant chemicals in relation to liver cancer in mammals."
23707493_2013.ann,Ethanol,liver injury,5, Ethanol consumption causes serious liver injury including cirrhosis and hepatocellular carcinoma.
23707493_2013.ann,Ethanol,cirrhosis,5, Ethanol consumption causes serious liver injury including cirrhosis and hepatocellular carcinoma.
23707493_2013.ann,Ethanol,hepatocellular carcinoma,5, Ethanol consumption causes serious liver injury including cirrhosis and hepatocellular carcinoma.
11872629_2002.ann,choline,cirrhosis,5," Expression of cyclooxygenase (COX)-2 protein during rat hepatocarcinogenesis associated with fatty change, fibrosis, cirrhosis and oxidative DNA damage, caused by a choline-deficient, L-amino acid-defined (CDAA) diet were investigated in F344 male rats, along with the chemopreventive efficacy of the specific COX-2  inhibitor, nimesulide (NIM)."
11872629_2002.ann,L-amino acid,cirrhosis,5," Expression of cyclooxygenase (COX)-2 protein during rat hepatocarcinogenesis associated with fatty change, fibrosis, cirrhosis and oxidative DNA damage, caused by a choline-deficient, L-amino acid-defined (CDAA) diet were investigated in F344 male rats, along with the chemopreventive efficacy of the specific COX-2  inhibitor, nimesulide (NIM)."
20484730_2010.ann,androgen,hepatocellular carcinoma (HCC),5, Hepatitis B virus (HBV)-induced hepatitis and carcinogen-induced hepatocellular carcinoma (HCC) are associated with serum androgen concentration.
20484730_2010.ann,androgen,hepatocellular carcinoma,5, Hepatitis B virus (HBV)-induced hepatitis and carcinogen-induced hepatocellular carcinoma (HCC) are associated with serum androgen concentration.
26844701_2016.ann,Caspase-3,CRC,5," In line with this observation, lower serum levels of active Caspase-3 were found  in patients with metastasised CRC who revealed stable disease or tumour regression compared with those with disease progression."
2399535_1990.ann,peroxisomal hydrogen peroxide,hepatocarcinogenesis,5," In order to clarify whether peroxisomal hydrogen peroxide (H2O2) plays an important role in peroxisome proliferator-induced hepatocarcinogenesis, we examined the change in metabolism of peroxisomal H2O2 in vivo and in vitro using  male Fischer-344 rats fed clofibrate, bezafibrate and di(2-ethylhexyl)phthalate (DEHP) for up to 78 weeks."
2399535_1990.ann,H2O2,hepatocarcinogenesis,5," In order to clarify whether peroxisomal hydrogen peroxide (H2O2) plays an important role in peroxisome proliferator-induced hepatocarcinogenesis, we examined the change in metabolism of peroxisomal H2O2 in vivo and in vitro using  male Fischer-344 rats fed clofibrate, bezafibrate and di(2-ethylhexyl)phthalate (DEHP) for up to 78 weeks."
18579559_2008.ann,inducible nitric oxide synthase,hepatocellular carcinoma (HCC),5," Mounting evidence underlines the role of inducible nitric oxide synthase (iNOS) in hepatocellular carcinoma (HCC) development, but its functional interactions with pathways involved in HCC progression remain uninvestigated."
18579559_2008.ann,inducible nitric oxide synthase,hepatocellular carcinoma,5," Mounting evidence underlines the role of inducible nitric oxide synthase (iNOS) in hepatocellular carcinoma (HCC) development, but its functional interactions with pathways involved in HCC progression remain uninvestigated."
21604268_2012.ann,Sorafenib,hepatocellular carcinoma (HCC),5, Sorafenib increases survival rate of patients with advanced hepatocellular carcinoma (HCC).
16230393_2005.ann,ADAM9,prostate cancer,5," Taken together, these results suggest that ADAM9 contributes to the pathogenesis  of prostate cancer and potentially also other carcinomas, raising the possibility that ADAM9 might be a good target for antitumor drugs."
19126423_2009.ann,pesticides,hepatocarcinogenesis,5, The purpose of this investigation was to evaluate the possible influence of a mixture of pesticides on medium-term carcinogenesis using improved hepatocarcinogenesis protocols.
21092749_2011.ann,phytoestrogens,breast cancer,5, There is increasing interest in phytoestrogens as potential alternatives to synthetic selective estrogen receptor modulators (SERMs) in the prevention and therapy of breast cancer.
22272000_2009.ann,N-Acetyl-L-Cysteine,hepatocarcinogenesis,5," To clarify the modifying effect of N-Acetyl-L-Cysteine (NAC), which has antioxidative ability, on hepatocarcinogenesis promoted by fenofibrate (FF), a peroxisome proliferator-activated receptor (PPAR) alpha agonist , male F344/N rats were administered a single intraperitoneal injection of N-diethylnitrosamine (DEN) as an initiator followed by administration of a diet containing 3,000 ppm of FF for 16 weeks."
20583210_2010.ann,beta-catenin,hepatocellular carcinoma,5," UNLABELLED: Activation of beta-catenin, the central effector of the canonical Wnt pathway and a recognized oncogene, has been implicated in hepatocellular carcinoma."
20683949_2010.ann,thiazolidinediones,hepatocellular carcinoma (HCC),5," UNLABELLED: Antidiabetic thiazolidinediones (TZD) have in vitro antiproliferative effect in epithelial cancers, including hepatocellular carcinoma (HCC)."
20683949_2010.ann,thiazolidinediones,hepatocellular carcinoma,5," UNLABELLED: Antidiabetic thiazolidinediones (TZD) have in vitro antiproliferative effect in epithelial cancers, including hepatocellular carcinoma (HCC)."
20432254_2010.ann,beta-catenin,hepatocellular cancer,5, UNLABELLED: The Wnt/beta-catenin pathway is implicated in the pathogenesis of hepatocellular cancer (HCC).
15993848_2005.ann,17-Allylamino-17-demethoxygeldanamycin,colon cancer,5,17-Allylamino-17-demethoxygeldanamycin overcomes TRAIL resistance in colon cancer cell lines.
21833474_2011.ann,5-Lipoxygenase,hepatocellular carcinoma,5,5-Lipoxygenase contributes to the progression of hepatocellular carcinoma.
15592521_2005.ann,CYR61-alphavbeta3 integrin,breast cancer,5,A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
22177475_2011.ann,fatty acid synthase,breast cancer,5,A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.
15958644_2005.ann,glycogen synthase kinase-3beta,colorectal  cancer,5,"A pivotal signaling network in colorectal  cancer cells involves glycogen synthase kinase-3beta (GSK3beta), a multifunctional kinase whose role in tumor cell survival is not defined."
16230393_2005.ann,ADAM9,prostate cancer,5,"A potential underlying mechanism for the role of ADAM9 in prostate cancer emerged from cell-based assays: ADAM9 can cleave and release epidermal growth factor and FGFR2iiib from cells, both of which have pivotal functions in the pathogenesis of this disease."
15896469_2005.ann,beta-catenin,gastric cancer,5,"Aberrant beta-catenin intracellular distribution has been found in gastric cancer, but the pattern of Wnt expression in stepwise gastrocarcinogenesis and its potential influence in beta-catenin distribution are still lesser known."
11774276_2002.ann,cyclooxygenase 2,gastric cancer,5,Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer.
11774276_2002.ann,cyclooxygenase 2,gastric cancer,5,"About 80% of the gastric cancer showed a high level of expression of cyclooxygenase 2, but a subset of cases do not express without unknown reason."
20432254_2010.ann,beta-catenin,hepatocarcinogenesis,5,Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin.
24886245_2014.ann,Acylglycerol kinase,breast cancer,5,Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
21480218_2011.ann,diethylnitrosamine,hepatocarcinogenesis,5,"After a 2-week treatment, animals were subjected to the ""resistant hepatocyte"" model of hepatocarcinogenesis (initiation with diethylnitrosamine, selection/promotion with 2-acetylaminofluorene and partial hepatectomy) and euthanized after 8 weeks  of treatment."
21480218_2011.ann,2-acetylaminofluorene,hepatocarcinogenesis,5,"After a 2-week treatment, animals were subjected to the ""resistant hepatocyte"" model of hepatocarcinogenesis (initiation with diethylnitrosamine, selection/promotion with 2-acetylaminofluorene and partial hepatectomy) and euthanized after 8 weeks  of treatment."
17597105_2007.ann,Aldo-keto reductase family 1 B10,hepatocellular carcinoma,5,"Aldo-keto reductase family 1 B10 (AKR1B10), a member of aldo-keto reductase superfamily, is overexpressed in human hepatocellular carcinoma, lung squamous cell carcinoma and lung adenocarcinoma."
24508477_2014.ann,acrylamide,hepatocellular carcinoma,5,All these results suggest that low concentration of acrylamide may contribute to progression of hepatocellular carcinoma (HCC).
24508477_2014.ann,acrylamide,hepatocellular carcinoma (HCC),5,All these results suggest that low concentration of acrylamide may contribute to progression of hepatocellular carcinoma (HCC).
21465510_2011.ann,diethylnitrosamine,liver cancer,5,"Although they did not spontaneously develop liver tumors, IL-22TG mice were more  susceptible to diethylnitrosamine-induced liver cancer."
20512928_2010.ann,beta-catenin,colon cancer,5,"Although, NLK is known to be a tumor suppressor in Wnt/beta-catenin signaling pathway of colon cancer, the other events occurring downstream of NLK pathways in other types of cancer remain unclear."
17671175_2007.ann,4-ABP,breast cancers,5,"Among others, bladder, lung, colon, and breast cancers have been associated with 4-ABP."
22105228_2012.ann,lipid peroxides,hepatocellular carcinoma,5,Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.
22105228_2012.ann,selenium,hepatocellular carcinoma,5,Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.
17957784_2008.ann,wogonin,breast cancer,5,Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts.
14604892_2004.ann,matrilysin,gastric cancer,5,Antisense E1AF-transfected MKN45 gastric cancer cells expressed reduced levels of matrilysin and were less invasive in vitro than mock-transfected MKN45 cells.
21488081_2011.ann,Apoptosis signal-regulating kinase 1,hepatocarcinogenesis,5,Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase.
19671906_2009.ann,Aspirin,colorectal cancer,5,Aspirin use and survival after diagnosis of colorectal cancer.
26065336_2015.ann,cisplatin,lung cancer,5,BACKGROUND: Drug combination therapies using cisplatin and natural products are common practice in the treatment of human lung cancer.
25925741_2015.ann,Epidermal growth factor receptor-tyrosine kinase inhibitors,small cell lung cancer,5,BACKGROUND: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are approved for patients with recurrent non-small cell lung cancer (NSCLC).
22159228_2012.ann,dextran sulfate sodium,colon cancer,5,Balb/c mice were treated with azoxymethane (AOM) and dextran sulfate sodium to induce colon cancer.
17404573_2007.ann,Beta-catenin,colorectal cancers,5,"Beta-catenin/T-cell factor (Tcf) signaling is constitutively active in the majority of human colorectal cancers, and there are accompanying changes in Bcl-2 expression."
18202021_2008.ann,Beta-ionone,colon cancer,5,"Beta-ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-alpha in human colon cancer cells."
28245338_2017.ann,azoxymethane,colon tumorigenesis,5,Boswellia serrata resin extract alleviates azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colon tumorigenesis.
28245338_2017.ann,dextran sodium sulfate,colon tumorigenesis,5,Boswellia serrata resin extract alleviates azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colon tumorigenesis.
23027617_2012.ann,Branched-chain amino acids,liver cirrhosis,5,"Branched-chain amino acids (BCAA), which improve protein malnutrition in patients with liver cirrhosis, reduce the risk of hepatocellular carcinoma in these patients with obesity."
23027617_2012.ann,Branched-chain amino acids,hepatocellular carcinoma,5,"Branched-chain amino acids (BCAA), which improve protein malnutrition in patients with liver cirrhosis, reduce the risk of hepatocellular carcinoma in these patients with obesity."
17638894_2007.ann,gefitinib,Breast cancer,5,Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.
19221000_2009.ann,genistein,renal cancer,5,"BTG3 tumor suppressor gene promoter demethylation, histone modification and cell  cycle arrest by genistein in renal cancer."
19321006_2009.ann,resveratrol,hepatocellular carcinoma,5,Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model.
17145853_2006.ann,celecoxib,lung cancer,5,Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells.
25092647_2014.ann,pronamide,hepatocarcinogenesis,5,Characterization of nuclear receptor-mediated murine hepatocarcinogenesis of the  herbicide pronamide and its human relevance.
22056877_2012.ann,Chitinase 3-like 1,colorectal cancer,5,Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer.
22640941_2012.ann,Chlorophyllin,liver cancer,5,"Chlorophyllin has been shown to significantly reduce genotoxic AFB biomarkers in humans, and it therefore holds promise as a practical means of reducing the incidence of AFB-induced liver cancer."
24997475_2014.ann,Claudin-1,colon tumorigenesis,5,Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis.
21038411_2010.ann,polyphenols,steatohepatitis,5,Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.
21038411_2010.ann,melanoidins,steatohepatitis,5,Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.
22539621_2012.ann,oxyfluorfen,liver tumors,5,"Collectively, these data along with the negative genotoxicity demonstrate that oxyfluorfen (> 98% purity) has the potential to induce mouse liver tumors through a nongenotoxic, mitogenic MOA with a clear threshold and is not predicted to be carcinogenic in humans at relevant exposure  levels."
21464044_2011.ann,lapatinib,CRC,5,Combined lapatinib and panobinostat treatment interacted synergistically to inhibit the proliferation and colony formation in all CRC cell lines tested.
21464044_2011.ann,panobinostat,CRC,5,Combined lapatinib and panobinostat treatment interacted synergistically to inhibit the proliferation and colony formation in all CRC cell lines tested.
20803560_2010.ann,endotoxin,cirrhosis,5,CONCLUSION:  Our data indicate that sustained LPS accumulation represents a pathological mediator of inflammation-associated hepatocellular carcinoma (HCC) and manipulation of the gut flora to prevent pathogenic bacterial translocation and endotoxin absorption may favorably influence liver function in patients with cirrhosis who are at risk of developing HCC.
24123777_2014.ann,Bromelain,colon carcinogenesis,5,CONCLUSION: Bromelain exerts antiproliferative and proapoptotic effects in colorectal carcinoma cells and chemopreventive actions in colon carcinogenesis in vivo.
18312651_2008.ann,estrogen,breast cancer,5,CONCLUSION: Functional interaction between FOXO3a and ER plays a critical role in suppressing estrogen-dependent breast cancer cell growth and tumorigenesis in vivo.
24644001_2014.ann,Metformin,non-small cell lung cancer,5,"CONCLUSION: Metformin, generally considered nontoxic and remarkably inexpensive, might be used in combination with TKIs in patients with non-small cell lung cancer, harboring EGFR mutations to overcome TKI resistance and prolong survival."
24981158_2014.ann,garcinol,colon cancer,5,CONCLUSION: Our results suggest that garcinol may merit further clinical investigation as a chemoprophylactic food that helps prevent colitis-associated colon cancer.
23258740_2013.ann,chloroquine,prostate cancer,5,"CONCLUSION: Taken together, these data show that the Akt inhibitor AZD5363 synergizes with the lysosomotropic inhibitor of autophagy chloroquine to induce apoptosis and delay tumor progression in prostate cancer models that are resistant to monotherapy AZD5363, providing a new therapeutic approach potentially translatable to patients."
21278145_2011.ann,retinoid,hepatocarcinogenesis,5,CONCLUSIONS:  The absence of retinoid-containing HSC lipid droplets does not promote HSC activation but reduces hepatocarcinogenesis.
28430601_2017.ann,Raloxifene,liver cancer,5,CONCLUSIONS: Our results suggest that Raloxifene is a potent IL-6/GP130 inhibitor and may be a chemoprevention agent for liver cancer by targeting persistent STAT3 signaling.
21711565_2011.ann,Pitavastatin,liver cancer,5,"CONCLUSIONS: Pitavastatin is effective in inhibiting the early phase  of obesity-related liver tumorigenesis and, therefore, may be useful in the chemoprevention of liver cancer in obese individuals."
22353783_2012.ann,honokiol,breast cancer,5,"CONCLUSIONS: Taken together, these data provide the first in vitro and in vivo evidence of the integral role of the LKB1-AMPK axis in honokiol-mediated inhibition of the invasion and migration of breast cancer cells."
18927292_2008.ann,5-LOX,adenomatous colon cancer,5,CONCLUSIONS: This study showed that 5-LOX is up-regulated in adenomatous colon polyps and cancer compared with normal colonic mucosa.
20583210_2010.ann,beta-catenin,hepatocarcinogenesis,5,Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.
21652540_2011.ann,5-FU,colorectal cancer,5,"Consistent with this finding, the ABCB5-expressing tumor cell population was also treatment refractory and exhibited resistance to 5-FU-induced apoptosis in a colorectal cancer xenograft model of 5-FU monotherapy."
19920184_2009.ann,phosphoinositide 3-kinase,prostate cancer,5,"Constitutive activation of phosphoinositide 3-kinase (PI3K)-Akt pathway transmits growth-regulatory signals that play a central role in promoting survival, proliferation, and angiogenesis in human prostate cancer cells."
19749792_2009.ann,Wnt/beta-catenin,colon cancer,5,Constitutive activation of the Wnt/beta-catenin pathway has been implicated as the primary cause of colon cancer.
25302369_2014.ann,A20,liver damage,5,"Conversely, partial loss of A20, as in A20 heterozygote mice, significantly impairs liver regeneration and damage, which confers high lethality to an otherwise safe procedure i.e., 2/3 partial hepatectomy."
24784840_2014.ann,E-cadherin,gastric adenocarcinoma,5,Cooperativity of E-cadherin and Smad4 loss to promote diffuse-type gastric adenocarcinoma and metastasis.
15896469_2005.ann,beta-catenin,gastric cancers,5,Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination.
16230393_2005.ann,ADAM9,prostate cancer,5,Critical function for ADAM9 in mouse prostate cancer.
18708364_2008.ann,mitogen-activated protein kinase,liver cancer,5,Cross-talk between aryl hydrocarbon receptor and mitogen-activated protein kinase signaling pathway in liver cancer through c-raf transcriptional regulation.
19118003_2009.ann,Cryptotanshinone,prostate cancer,5,Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
19118003_2009.ann,Cryptotanshinone,prostate cancer,5,Cryptotanshinone rapidly inhibited STAT3 Tyr705 phosphorylation in DU145 prostate cancer cells and the growth of the cells through 96 hours of the treatment.
18381954_2008.ann,Curcumin,colorectal cancer,5,Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
11774276_2002.ann,Cyclooxygenase 2,gastrointestinal cancers,5,Cyclooxygenase 2 plays a critical role in the development of gastrointestinal cancers in both human and animal models.
21730361_2011.ann,Cyclooxygenase-2,colorectal cancer,5,Cyclooxygenase-2 (COX-2) is constitutively  expressed in a variety of tumors including colorectal cancer.
21214675_2011.ann,clofibrate,hepatocarcinogenesis,5,Decrease of hepatic stellate cells in rats with enhanced sensitivity to clofibrate-induced hepatocarcinogenesis.
17724725_2008.ann,folate,colon cancer,5,"Deficiency of folate, which plays a role in the synthesis of SAM leads to increased risk for colon cancer."
22791817_2012.ann,Desmoplakin,lung cancer,5,Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/beta-catenin signaling pathway in human lung cancer.
22806512_2013.ann,ethanol,hepatocellular carcinoma,5,Diet-induced obesity and ethanol impair progression of hepatocellular carcinoma in a mouse mesenteric vein injection model.
14970324_2004.ann,thymidylate synthase,colorectal cancer,5,Digital karyotyping identifies thymidylate synthase amplification as a mechanism  of resistance to 5-fluorouracil in metastatic colorectal cancer patients.
21741923_2011.ann,azoxymethane,colon tumorigenesis,5,Disruption of Ptk6 decreases azoxymethane-induced colon tumorigenesis in mice.
21205313_2011.ann,"7, 12-dimethylbenz(a)anthracene",liver tumors,5,"DNA methylation alterations were detected in zebrafish liver tumors induced by the environmental carcinogen 7, 12-dimethylbenz(a)anthracene."
22027573_2012.ann,Dovitinib,retinoblastoma,5,"Dovitinib also caused dephosphorylation of retinoblastoma, upregulation of p-histone H2A-X and p27, and downregulation of p-cdk-2 and cyclin B1, which resulted in a reduction in cellular proliferation and the induction of tumor cell apoptosis."
22027573_2012.ann,Dovitinib,hepatocellular carcinoma,5,Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma.
22583478_2012.ann,progestin,breast cancer,5,Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
20979053_2010.ann,A kinase anchor protein 12,hepatocarcinogenesis,5,Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
22677193_2012.ann,Kruppel-like factor 4,hepatocellular carcinoma,5,Dysregulated Kruppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.
22014088_2011.ann,magnolol,skin cancer,5,Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action.
22159228_2012.ann,methylthioadenosine,colon cancer,5,Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice.
22159228_2012.ann,S-adenosylmethionine,colon cancer,5,Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice.
23912631_2013.ann,coactivator-associated arginine methyltransferase 1,hepatocarcinogenesis,5,Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis.
23038005_2012.ann,omeprazole,liver tumor,5,Enhanced liver tumor promotion but not liver initiation activity in rats subjected to combined administration of omeprazole and beta-naphthoflavone.
23038005_2012.ann,beta-naphthoflavone,liver tumor,5,Enhanced liver tumor promotion but not liver initiation activity in rats subjected to combined administration of omeprazole and beta-naphthoflavone.
18666234_2008.ann,ubiquitin carboxyl-terminal hydrolase L1,hepatocellular carcinoma,5,Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other  digestive tumors.
15741050_2005.ann,ErbB2 receptor tyrosine kinases,colon cancer,5,"ErbB2 and ErbB3 receptor tyrosine kinases have been associated with  the development of human colon cancer, and the expressions of both receptors are  high in HT-29 cells."
15741050_2005.ann,ErbB3 receptor tyrosine kinases,colon cancer,5,"ErbB2 and ErbB3 receptor tyrosine kinases have been associated with  the development of human colon cancer, and the expressions of both receptors are  high in HT-29 cells."
16284949_2006.ann,CCL3,hepatocellular carcinoma,5,"Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression."
15930366_2005.ann,ABT-100,liver cancer,5,"EXPERIMENTAL DESIGN: In the present study, we investigated the effects of a novel farnesyltransferase inhibitor, ABT-100, on human liver cancer cell lines, HepG2 and Huh7, and on an animal model of hepatocarcinogenesis."
15930366_2005.ann,ABT-100,hepatocarcinogenesis,5,"EXPERIMENTAL DESIGN: In the present study, we investigated the effects of a novel farnesyltransferase inhibitor, ABT-100, on human liver cancer cell lines, HepG2 and Huh7, and on an animal model of hepatocarcinogenesis."
14604892_2004.ann,matrilysin,gastric cancer,5,Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
23867582_2013.ann,glutathione peroxidase 2,hepatocarcinogenesis,5,Expression of glutathione peroxidase 2 is associated with not only early hepatocarcinogenesis but also late stage metastasis.
7705931_1995.ann,protein kinase C isoenzymes,colorectal cancer,5,Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids.
15930366_2005.ann,ABT-100,liver cancer,5,"Farnesyltransferase inhibitor, ABT-100, is a potent liver cancer chemopreventive  agent."
22796152_2012.ann,beta-catenin,hepatocarcinogenesis,5,"Finally, while Apo-FHL2 mice developed no tumors, the FHL2 transgene enhanced hepatocarcinogenesis induced by liver-specific deletion of the adenomatous polyposis coli gene and aberrant Wnt/beta-catenin signaling in Apc(lox/lox) animals."
15705887_2005.ann,Folate,colon carcinogenesis,5,Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis.
15059925_2004.ann,matrix proteases,colon cancers,5,"For example, genes involved in inflammation and matrix proteases and a cell cycle regulator gene, cyclin D2, were highly expressed in colon cancers."
18312651_2008.ann,estrogen,breast cancer,5,Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
15660382_2005.ann,Gefitinib,hepatocellular carcinoma,5,"Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis."
15660382_2005.ann,Gefitinib,cirrhosis,5,"Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis."
19363144_2009.ann,conazoles,hepatocellular cancer,5,Genes expressed by PB or the two conazoles were also compared with those genes associated with human hepatocellular cancer.
15374632_2004.ann,5-fluorouracil,colon tumor,5,"Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts."
15374632_2004.ann,Geraniol,colon tumor,5,"Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts."
21092749_2011.ann,tamoxifen,hepatocarcinogenesis,5,"Glycine soya diet synergistically enhances the suppressive effect of tamoxifen and inhibits tamoxifen-promoted hepatocarcinogenesis in 7,12-dimethylbenz[alpha]anthracene-induced rat mammary tumor model."
23038002_2012.ann,tamoxifen,non-alcoholic steatohepatitis,5,Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models.
21652540_2011.ann,5-FU,colorectal cancer,5,Here we show that ATP-binding cassette member B5 (ABCB5) identifies therapy-refractory tumor cells in colorectal cancer patients following fluorouracil (5-FU)-based chemoradiation therapy and provide evidence for a functional role of ABCB5 in colorectal cancer 5-FU resistance.
21652540_2011.ann,fluorouracil,colorectal cancer,5,Here we show that ATP-binding cassette member B5 (ABCB5) identifies therapy-refractory tumor cells in colorectal cancer patients following fluorouracil (5-FU)-based chemoradiation therapy and provide evidence for a functional role of ABCB5 in colorectal cancer 5-FU resistance.
21652540_2011.ann,5-FU,colorectal cancer,5,Here we show that ATP-binding cassette member B5 (ABCB5) identifies therapy-refractory tumor cells in colorectal cancer patients following fluorouracil (5-FU)-based chemoradiation therapy and provide evidence for a functional role of ABCB5 in colorectal cancer 5-FU resistance.
15731169_2005.ann,periostin,colorectal cancers,5,"Here, we provide evidence that periostin, a protein with structural and sequence  homology with a TGF-beta-inducible gene, beta ig-h3, is upregulated in colorectal cancers and their liver metastasis, and it may play a role in promoting growth in these tumors."
19711427_2009.ann,choline,nonalcoholic steatohepatitis,5,"Here, we report identification of hepatic microRNAs that are dysregulated at early stages of feeding C57BL/6 mice choline-deficient and amino acid-defined (CDAA) diet that is known to promote nonalcoholic steatohepatitis (NASH)-induced hepatocarcinogenesis after 84 weeks."
19711427_2009.ann,amino acid,nonalcoholic steatohepatitis,5,"Here, we report identification of hepatic microRNAs that are dysregulated at early stages of feeding C57BL/6 mice choline-deficient and amino acid-defined (CDAA) diet that is known to promote nonalcoholic steatohepatitis (NASH)-induced hepatocarcinogenesis after 84 weeks."
16356827_2006.ann,androgen,prostate cancer,5,"Here, we report that MPA also induces such a differentiation in the androgen-independent prostate cancer derived cell line DU145."
25600769_2015.ann,EPLE,CRC,5,"Herein, we found that whereas sparing normal human colon mucosal epithelial cells, EPLE selectively inhibited the proliferation of CRC cell lines as well as primary tumor cells."
17893235_2008.ann,alpha-LA,hepatocarcinogenesis,5,"Herein, we investigated the effect of alpha-LA on the  development of rat pre-neoplastic lesions generated by a model of hepatocarcinogenesis, which has similarities in its histopathological sequence to human hepatocellular carcinoma development with cirrhosis."
17957784_2008.ann,wogonin,breast cancer,5,"Herein, we investigated the in vitro and in vivo anticancer effects and associated mechanisms of wogonin in human breast cancer."
22392728_2012.ann,Histone deacetylase 6,liver cancer,5,Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer.
22353783_2012.ann,Honokiol,breast cancer,5,Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
22353783_2012.ann,AMP-activated protein kinase,breast cancer,5,Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
22583478_2012.ann,progesterone,breast cancer,5,"However, the molecular mechanisms of progesterone action in  breast cancer still remain elusive."
24408928_2014.ann,Hypoxia-inducible factors,colorectal cancer,5,"Hypoxia-inducible factors (HIFs) accumulate in both neoplastic and inflammatory cells within the tumor microenvironment and impact the progression of a variety of diseases, including colorectal cancer."
16160472_2005.ann,thymidylate synthase,rectal cancer,5,"Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation  with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy."
16160472_2005.ann,thymidine phosphorylase,rectal cancer,5,"Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation  with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy."
16160472_2005.ann,dihydropyrimidine dehydrogenase,rectal cancer,5,"Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation  with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy."
15705887_2005.ann,folate,colon cancer,5,"In conclusion, Folbp1 and RFC1 genetically modified mice exhibit distinct changes in colonocyte phenotype and therefore have utility as models to examine the role of folate homeostasis in colon cancer development."
19775285_2010.ann,insulin,diabetic,5,"In conclusion, our results indicate that insulin-independent liver tumor promotion occurred in diabetic mice."
9458096_1998.ann,arachidonic acid,colorectal cancer,5,"In contrast, the high level of sPLA2 expression is more likely contributing to the elevated levels of arachidonic acid found in colorectal cancer and, in conjunction with the elevated expression of cyclooxygenase-2, could be another factor in tumor formation."
20197465_2010.ann,alpha-fetoprotein,hepatocarcinogenesis,5,"In HepG2 cells, transfection of RARgamma enhanced, whereas downregulation of RARgamma expression  by siRNA approach impaired, the effect of RA on inducing the expression of alpha-fetoprotein, a protein marker of hepatocarcinogenesis."
9458096_1998.ann,arachidonic acid,colorectal cancer,5,"In human colorectal cancer, both arachidonic acid and eicosanoid levels are elevated."
9458096_1998.ann,eicosanoid,colorectal cancer,5,"In human colorectal cancer, both arachidonic acid and eicosanoid levels are elevated."
14523586_2004.ann,iodine-124-labeled iodo-azomycin-galactoside,MCa breast tumors,5,"In the current study, serial microPET imaging was used to evaluate iodine-124-labeled iodo-azomycin-galactoside ((124)I-IAZG) (4.2-day physical half-life) as a hypoxia imaging agent in 17 MCa breast tumors and six FSaII fibrosarcomas implanted in mice."
14523586_2004.ann,(124)I-IAZG,MCa breast tumors,5,"In the current study, serial microPET imaging was used to evaluate iodine-124-labeled iodo-azomycin-galactoside ((124)I-IAZG) (4.2-day physical half-life) as a hypoxia imaging agent in 17 MCa breast tumors and six FSaII fibrosarcomas implanted in mice."
14523586_2004.ann,iodine-124-labeled iodo-azomycin-galactoside,FSaII fibrosarcomas,5,"In the current study, serial microPET imaging was used to evaluate iodine-124-labeled iodo-azomycin-galactoside ((124)I-IAZG) (4.2-day physical half-life) as a hypoxia imaging agent in 17 MCa breast tumors and six FSaII fibrosarcomas implanted in mice."
14523586_2004.ann,(124)I-IAZG,FSaII fibrosarcomas,5,"In the current study, serial microPET imaging was used to evaluate iodine-124-labeled iodo-azomycin-galactoside ((124)I-IAZG) (4.2-day physical half-life) as a hypoxia imaging agent in 17 MCa breast tumors and six FSaII fibrosarcomas implanted in mice."
22353783_2012.ann,honokiol,breast cancer,5,"In the present study, we sought to examine the effectiveness of honokiol in inhibiting migration and invasion of  breast cancer cells and to elucidate the underlying molecular mechanisms."
17908994_2007.ann,celecoxib,prostate cancer,5,"In this study, we determined the combined effect of celecoxib, a COX-2 inhibitor, along with exisulind (sulindac sulfone/Aptosyn) at low doses in  prostate cancer."
27197176_2016.ann,progastrin,colorectal cancer,5,"In this study, we investigated the role of progastrin in regulating CSC phenotype in advanced colorectal cancer."
17909072_2007.ann,estrogen,breast cancer,5,"In view of the strong association between estrogen, progesterone, prolactin, and breast cancer, the PhIP repertoire of hormone-like activities provides further mechanistic support for the tissue-specific carcinogenicity of the chemical."
17909072_2007.ann,progesterone,breast cancer,5,"In view of the strong association between estrogen, progesterone, prolactin, and breast cancer, the PhIP repertoire of hormone-like activities provides further mechanistic support for the tissue-specific carcinogenicity of the chemical."
17909072_2007.ann,prolactin,breast cancer,5,"In view of the strong association between estrogen, progesterone, prolactin, and breast cancer, the PhIP repertoire of hormone-like activities provides further mechanistic support for the tissue-specific carcinogenicity of the chemical."
23766363_2013.ann,nimbolide,colorectal cancer,5,"In vivo, nimbolide (at 5 and 20 mg/kg body weight), injected intraperitoneally after tumor inoculation, significantly decreased the volume of colorectal cancer xenografts."
11872629_2002.ann,choline,hepatocarcinogenesis,5,"Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis  caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide."
11872629_2002.ann,L-amino acid,hepatocarcinogenesis,5,"Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis  caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide."
11872629_2002.ann,nimesulide,hepatocarcinogenesis,5,"Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis  caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide."
20116663_2010.ann,licorice flavonoid oil,hepatocarcinogenesis,5,Inhibition by licorice flavonoid oil of glutathione S-transferase-positive foci in the medium-term rat hepatocarcinogenesis bioassay.
21858812_2012.ann,sorafenib,hepatocellular carcinoma,5,Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
24408928_2014.ann,hypoxia-inducible factors,colorectal cancer,5,Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer.
22203730_2012.ann,nitidine chloride,gastric cancer,5,Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.
17498859_2007.ann,N-diethylnitrosamine,hepatocarcinogenesis,5,injection of N-diethylnitrosamine (DEN) to initiate hepatocarcinogenesis.
19775285_2010.ann,Insulin,diabetic,5,Insulin-independent promotion of chemically induced hepatocellular tumor development in genetically diabetic mice.
14656947_2004.ann,isoflavones,prostate cancer,5,Intake of isoflavones derived from soybean products may impact on prostate cancer risk.
15765122_2005.ann,diethylnitrosamine,hepatocarcinogenesis,5,Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.
12885482_2003.ann,TCF/beta catenin,colorectal cancer,5,"INTERPRETATION: Stimulation of survivin expression by TCF/beta catenin might impose a stem cell-like phenotype to colonic crypt epithelium coupling enhanced cell proliferation with resistance to apoptosis, and contribute to the molecular pathogenesis of colorectal cancer."
26084280_2015.ann,non-receptor tyrosine kinase,breast cancers,5,INTRODUCTION: Protein tyrosine kinase 6 (PTK6) is a non-receptor tyrosine kinase  that is highly expressed in Human Epidermal Growth Factor 2(+) (Her2(+)) breast cancers.
22854281_2012.ann,furanodiene,breast cancer,5,"Ling extract, which has a high furanodiene content, showed anti-cancer effects in breast cancer cells in vitro."
21878202_2011.ann,caspase-8,hepatocarcinogenesis,5,Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury.
21878202_2011.ann,caspase-8,liver injury,5,Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury.
21159647_2010.ann,diethylnitrosamine,hepatocarcinogenesis,5,Loss of metallothionein predisposes mice to diethylnitrosamine-induced hepatocarcinogenesis by activating NF-kappaB target genes.
26844701_2016.ann,Caspase-3,colorectal cancer,5,Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in  advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach.
20979057_2011.ann,phosphatase,liver tumor,5,Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation.
20979057_2011.ann,Lupeol,liver tumor,5,Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation.
24144777_2013.ann,Lycopene,hepatocarcinogenesis,5,"Lycopene modulates initiation of N-nitrosodiethylamine induced hepatocarcinogenesis: studies on chromosomal abnormalities, membrane fluidity and antioxidant defense system."
19850985_2008.ann,6-glucosephosphatase (G-6-Pase),hepatocarcinogenesis,5,"METHODS: A Solt-Farber two-step test model of hepatocarcino genesis was established by diethylnitrosamine (DEN) and 2-acetylaminofluorene (AAF) in rats to investigate the modifying effects of expression of 6-glucosephosphatase (G-6-Pase), succinodehydrogenase (SDH), adenosine triphosphatase (ATPase) in N-nitrosodiethylamine-mediated hepatocarcinogenesis."
19850985_2008.ann,6-glucosephosphatase,hepatocarcinogenesis,5,"METHODS: A Solt-Farber two-step test model of hepatocarcino genesis was established by diethylnitrosamine (DEN) and 2-acetylaminofluorene (AAF) in rats to investigate the modifying effects of expression of 6-glucosephosphatase (G-6-Pase), succinodehydrogenase (SDH), adenosine triphosphatase (ATPase) in N-nitrosodiethylamine-mediated hepatocarcinogenesis."
19850985_2008.ann,G-6-Pase,hepatocarcinogenesis,5,"METHODS: A Solt-Farber two-step test model of hepatocarcino genesis was established by diethylnitrosamine (DEN) and 2-acetylaminofluorene (AAF) in rats to investigate the modifying effects of expression of 6-glucosephosphatase (G-6-Pase), succinodehydrogenase (SDH), adenosine triphosphatase (ATPase) in N-nitrosodiethylamine-mediated hepatocarcinogenesis."
19850985_2008.ann,succinodehydrogenase,hepatocarcinogenesis,5,"METHODS: A Solt-Farber two-step test model of hepatocarcino genesis was established by diethylnitrosamine (DEN) and 2-acetylaminofluorene (AAF) in rats to investigate the modifying effects of expression of 6-glucosephosphatase (G-6-Pase), succinodehydrogenase (SDH), adenosine triphosphatase (ATPase) in N-nitrosodiethylamine-mediated hepatocarcinogenesis."
19850985_2008.ann,adenosine triphosphatase,hepatocarcinogenesis,5,"METHODS: A Solt-Farber two-step test model of hepatocarcino genesis was established by diethylnitrosamine (DEN) and 2-acetylaminofluorene (AAF) in rats to investigate the modifying effects of expression of 6-glucosephosphatase (G-6-Pase), succinodehydrogenase (SDH), adenosine triphosphatase (ATPase) in N-nitrosodiethylamine-mediated hepatocarcinogenesis."
24204981_2013.ann,methionine,steatohepatitis,5,METHODS: Male C57BL/6 mice were fed with a methionine and choline-deficient (MCD) diet to induce steatohepatitis.
24204981_2013.ann,choline,steatohepatitis,5,METHODS: Male C57BL/6 mice were fed with a methionine and choline-deficient (MCD) diet to induce steatohepatitis.
15608557_2004.ann,fluorouracil,colorectal cancer,5,Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients.
15608557_2004.ann,Methylenetetrahydrofolate reductase,colorectal cancer,5,Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients.
20890892_2010.ann,methionine adenosyltransferase 1A,hepatocellular carcinoma (HCC),5,"Mice lacking methionine adenosyltransferase 1A (MAT1A) have reduced PHB1 expression, impaired mitochondrial function, and spontaneously develop hepatocellular carcinoma (HCC)."
18547703_2008.ann,chitin,hepatocarcinogenesis,5,"Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model."
18547703_2008.ann,chitosan,hepatocarcinogenesis,5,"Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model."
18547703_2008.ann,"2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline",hepatocarcinogenesis,5,"Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model."
24418717_2014.ann,indole-3-carbinol,liver tumor,5,Modifying effects of liver tumor promotion in rats subjected to co-administration of indole-3-carbinol and phenobarbital.
24418717_2014.ann,phenobarbital,liver tumor,5,Modifying effects of liver tumor promotion in rats subjected to co-administration of indole-3-carbinol and phenobarbital.
24552772_2014.ann,Monensin,multiple intestinal neoplasia,5,Monensin inhibits canonical Wnt signaling in human colorectal cancer cells and suppresses tumor growth in multiple intestinal neoplasia mice.
16356827_2006.ann,Mycophenolic acid,prostate cancer,5,"Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145."
16356827_2006.ann,androgen,prostate cancer,5,"Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145."
25056574_2014.ann,Nestin,adenomatous polyposis coli,5,"Nestin silencing also upregulated Axin, glycogen synthase kinase-3 beta (GSK-3beta), adenomatous polyposis coli (APC), and peroxisome proliferator-activated receptor alpha (PPARa), and downregulated beta-catenin, c-Myc, cyclin D and MMP-7 expression in CSC."
21630261_2012.ann,Neurotensin receptor-1,colon cancers,5,Neurotensin receptor-1 (NTR-1) is overexpressed in colon cancers and colon cancer cell lines.
25811798_2015.ann,Nifuroxazide,breast cancer,5,Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer  model.
16818512_2006.ann,azoxymethane,colon cancer,5,Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.
22272000_2009.ann,Fenofibrate,Hepatocarcinogenesis,5,No Modifying Effect of Antioxidant N-Acetyl-L-Cysteine on Fenofibrate-induced Hepatocarcinogenesis in Rats.
16331619_2006.ann,Maspin,colon cancer,5,Nuclear Maspin expression is highly predictive of 5-FU chemotherapy response in patients  with advanced stage colon cancer.
21917648_2012.ann,Vitamin D(3) upregulated protein 1,gastric cancer,5,"OBJECTIVE: Vitamin D(3) upregulated protein 1 (VDUP1) is a potent tumour suppressor whose expression is dramatically reduced in various types of human cancers, including gastric cancer."
20112253_2010.ann,polo-like kinases,hepatocellular carcinoma,5,Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma.
19775285_2010.ann,insulin,hyperinsulinemia,5,One reasonable possibility is that this is attributable to hyperinsulinemia compensatory for obesity-related insulin resistance.
23824743_2013.ann,isorhamnetin,colon cancer,5,"Our observations suggest the chemoprotective effects of isorhamnetin in colon cancer are linked to its anti-inflammatory activities and its inhibition of oncogenic Src activity and consequential loss of nuclear beta-catenin, activities that are dependent on CSK  expression."
22613095_2012.ann,panobinostat,triple-negative breast cancer,5,Our results demonstrate a potential therapeutic role of panobinostat in targeting aggressive  triple-negative breast cancer cell types.
26310874_2015.ann,resveratrol,CRC,5,"Our results demonstrate that resveratrol can potentiate the anti-tumor effects of 5-FU on CRC cells by chemosensitizing them, inhibiting an EMT phenotype via up-regulation of intercellular junctions and by down-regulation of NF-kappaB pathway."
26310874_2015.ann,5-FU,CRC,5,"Our results demonstrate that resveratrol can potentiate the anti-tumor effects of 5-FU on CRC cells by chemosensitizing them, inhibiting an EMT phenotype via up-regulation of intercellular junctions and by down-regulation of NF-kappaB pathway."
21565489_2011.ann,2-SeCD,breast cancer,5,"Overall, 2-SeCD sensitises resistant breast cancer cells to TRAIL-based apoptosis in vitro and in vivo."
18927292_2008.ann,5-lipoxygenase,colon cancer,5,Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
19037088_2009.ann,cyclooxygenase 2,colorectal cancer,5,Overexpression of cyclooxygenase 2 (COX2) and uncontrolled wingless and Int (Wnt)-signaling pathway have long been suggested to play crucial roles in colorectal cancer.
19037088_2009.ann,COX2,colorectal cancer,5,Overexpression of cyclooxygenase 2 (COX2) and uncontrolled wingless and Int (Wnt)-signaling pathway have long been suggested to play crucial roles in colorectal cancer.
27450326_2016.ann,cyclooxygenase 2,lung cancers,5,Overexpression of cyclooxygenase 2 (COX-2) is frequently found in early and advanced lung cancers.
12384525_2002.ann,phenobarbital,liver tumors,5,Overexpression of glutamine synthetase is associated with beta-catenin-mutations  in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
16298452_2006.ann,Pamidronate,hepatocellular carcinoma,5,"Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in  hepatocellular carcinoma."
22710713_2013.ann,insulin-like growth factor 1,CRC,5,"Past studies have shown that amplified insulin-like growth factor 1 (IGF1)/IGF1 receptor (IGF1-R) signalling has an important role in colorectal cancer (CRC) development, progression and resistance to treatment."
15341023_2004.ann,estrogen,hepatocellular carcinoma,5,Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females.
17985342_2008.ann,zinc,upper aerodigestive tract cancer,5,Prevention of upper aerodigestive tract cancer in zinc-deficient rodents: inefficacy of genetic or pharmacological disruption of COX-2.
24164383_2014.ann,alcohol,hepatocarcinogenesis,5,"Previously,  we showed that habitual heavy alcohol ingestion amplified age-related hepatocarcinogenesis in P rats, with over 80% of alcohol-consuming P rats developing HCCs after 18 months of alcohol exposure, compared with only 5% of water-drinking controls."
12060633_2002.ann,metallothionein,gastrointestinal cancer,5,Prognostic significance of metallothionein in human gastrointestinal cancer.
21984479_2012.ann,perfluoroalkyl acids,hepatocarcinogenesis,5,Promotion of hepatocarcinogenesis by perfluoroalkyl acids in rainbow trout.
19221092_2009.ann,Protein kinase Cbeta,colon cancer,5,Protein kinase Cbeta is an effective target for chemoprevention of colon cancer.
19221092_2009.ann,Protein kinase CbetaII,colon carcinogenesis,5,Protein kinase CbetaII (PKCbetaII) plays a requisite role in the initiation of colon carcinogenesis in a preclinical mouse model by promoting proliferation and increased beta-catenin accumulation.
25149539_2014.ann,Protein kinase D1,colon cancer,5,Protein kinase D1 attenuates tumorigenesis in colon cancer by modulating beta-catenin/T cell factor activity.
18413838_2008.ann,Fatty acid synthase (FAS),lung cancer,5,"PURPOSE: Fatty acid synthase (FAS) is overexpressed in lung cancer, and we have investigated the potential use of FAS inhibitors for chemoprevention of lung cancer."
18413838_2008.ann,Fatty acid synthase,lung cancer,5,"PURPOSE: Fatty acid synthase (FAS) is overexpressed in lung cancer, and we have investigated the potential use of FAS inhibitors for chemoprevention of lung cancer."
19366832_2009.ann,insulin-like growth factor (IGF,colon cancer,5,"PURPOSE: Obesity and related metabolic abnormalities, including insulin resistance and activation of the insulin-like growth factor (IGF)/IGF-I receptor  (IGF-IR) axis, are risk factors for colon cancer."
19366832_2009.ann,insulin-like growth factor,colon cancer,5,"PURPOSE: Obesity and related metabolic abnormalities, including insulin resistance and activation of the insulin-like growth factor (IGF)/IGF-I receptor  (IGF-IR) axis, are risk factors for colon cancer."
19861436_2009.ann,Signal transducer and activator of transcription-3,non-small cell lung cancer,5,"PURPOSE: Signal transducer and activator of transcription-3 (STAT3) is downstream of growth factor and cytokine receptors, and regulates key oncogenic pathways in  non-small cell lung cancer (NSCLC)."
9743297_1998.ann,basic fibroblast growth factor,colorectal cancer,5,Quantitative analysis of basic fibroblast growth factor and vascular endothelial  growth factor in human colorectal cancer.
10419916_1999.ann,cyclooxygenase 2 proteins,hereditary nonpolyposis colorectal cancers,5,Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers.
10866311_2000.ann,interferon gamma,colon cancer,5,"Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate."
10866311_2000.ann,indomethacin,colon cancer,5,"Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate."
10866311_2000.ann,phenylbutyrate,colon cancer,5,"Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate."
10866311_2000.ann,5-fluorouracil,colon cancer,5,"Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate."
18927292_2008.ann,5-LOX,adenomatous polyps,5,RESULTS: 5-LOX is overexpressed in adenomatous polyps and cancer compared with that of normal colonic mucosa.
19549529_2009.ann,osteopontin,colon cancer,5,"RESULTS: Microarray analysis revealed that osteopontin, a marker of colon cancer progression, was down-regulated in polyps from Apc(Delta14/+) mice given parecoxib compared with controls."
25056574_2014.ann,Nestin,triple-negative breast cancer,5,RESULTS: Nestin expression was significantly associated with poor survival in patients with triple-negative breast cancer (P = 0.01).
26310874_2015.ann,Resveratrol,colorectal cancer,5,"Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer."
27578530_2016.ann,pimozide,pancreatic cancer,5,"RNA interference knockdown of DRD2 or inhibition with pharmacologic antagonists (pimozide and haloperidol) reduced proliferation of pancreatic cancer cells, induced endoplasmic reticulum stress and apoptosis, and  reduced cell migration."
27578530_2016.ann,haloperidol,pancreatic cancer,5,"RNA interference knockdown of DRD2 or inhibition with pharmacologic antagonists (pimozide and haloperidol) reduced proliferation of pancreatic cancer cells, induced endoplasmic reticulum stress and apoptosis, and  reduced cell migration."
19711427_2009.ann,choline,hepatocarcinogenesis,5,Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
19711427_2009.ann,amino acid,hepatocarcinogenesis,5,Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
22318685_2012.ann,methionine adenosyltransferases,liver cancer,5,Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
16061884_2005.ann,Roxithromycin,hepatocellular carcinoma,5,Roxithromycin inhibits constitutive activation of nuclear factor {kappa}B by diminishing oxidative stress in a rat model of hepatocellular carcinoma.
21565489_2011.ann,Seleno-cyclodextrin,breast cancer,5,Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappaB suppression.
16170372_2005.ann,Selenoprotein,hepatocarcinogenesis,5,Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice.
21741923_2011.ann,Signal transducer and activator of transcription 3,colon cancer,5,Signal transducer and activator of transcription 3 (STAT3) mediates pathogenesis of colon cancer and is a substrate of PTK6.
18521906_2008.ann,Simvastatin,colitis,5,"Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice."
12902981_2003.ann,Sodium butyrate,colon cancer,5,"Sodium butyrate (NaB) inhibits proliferation, stimulates apoptosis, and promotes  differentiation of human colon cancer cells along the absorptive phenotype."
21604268_2012.ann,Sorafenib,hepatocellular carcinoma,5,Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.
26940565_2016.ann,"3,19-(2-bromobenzylidene)andrographolide",breast cancer,5,"SRJ09 (3,19-(2-bromobenzylidene)andrographolide), a semisynthetic andrographolide (AGP) derivative, was shown to induce G1 cell cycle arrest and eventually apoptosis in breast and colon cancer cell lines."
26940565_2016.ann,"3,19-(2-bromobenzylidene)andrographolide",colon cancer,5,"SRJ09 (3,19-(2-bromobenzylidene)andrographolide), a semisynthetic andrographolide (AGP) derivative, was shown to induce G1 cell cycle arrest and eventually apoptosis in breast and colon cancer cell lines."
25503930_2015.ann,15-PGDH,colon tumor,5,Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
25503930_2015.ann,Sulindac,colon tumor,5,Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
21445586_2011.ann,phenobarbital,liver tumor,5,Suppressive effect of enzymatically modified isoquercitrin on phenobarbital-induced liver tumor promotion in rats.
21445586_2011.ann,enzymatically modified isoquercitrin,liver tumor,5,Suppressive effect of enzymatically modified isoquercitrin on phenobarbital-induced liver tumor promotion in rats.
24025784_2013.ann,phenobarbital,liver tumor,5,Suppressive effect of liver tumor-promoting activities in rats subjected to combined administration of phenobarbital and piperonyl butoxide.
24025784_2013.ann,piperonyl butoxide,liver tumor,5,Suppressive effect of liver tumor-promoting activities in rats subjected to combined administration of phenobarbital and piperonyl butoxide.
26771139_2016.ann,Survivin,gastric cancer,5,"Survivin overexpression is associated with poor prognosis of human gastric cancer, and is a target for gastric cancer therapy."
12907637_2003.ann,aflatoxin B1,hepatocellular carcinoma,5,Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.
28207072_2017.ann,atorvastatin,colon carcinogenesis,5,Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.
27735939_2016.ann,pectolinarigenin,osteosarcoma,5,"Taken together, our findings demonstrate that pectolinarigenin may be a candidate for osteosarcoma intervention linked to its STAT3 signaling inhibitory activity."
22159220_2012.ann,decorin,colorectal cancer,5,"Taken together, our results provide direct evidence that decorin-mediated inhibition of colorectal cancer growth and migration are through the interaction with and stabilization of E-cadherin."
23427297_2013.ann,Tandutinib,colon cancer,5,Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growth.
17909047_2007.ann,cyclooxygenase-2,intestinal cancer,5,Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer.
18397917_2008.ann,cytochrome P450,hepatocarcinogenesis,5,"The aim of this work was to characterize the effect of CAPE on cytochrome P450 (CYP), which is involved in diethylnitrosamine (DEN) metabolism during the initiation stage of chemical hepatocarcinogenesis."
15592521_2005.ann,Heregulin,metastatic breast cancer,5,"The angiogenic inducer CYR61 is differentially overexpressed in breast cancer cells exhibiting high levels of Heregulin (HRG), a growth factor closely associated with a metastatic breast cancer phenotype."
22005518_2012.ann,thymoquinone,colon cancer,5,"The anti-tumor effects of thymoquinone have also been investigated in tumor xenograft mice models for colon, prostate, pancreatic and lung cancer."
22005518_2012.ann,thymoquinone,prostate cancer,5,"The anti-tumor effects of thymoquinone have also been investigated in tumor xenograft mice models for colon, prostate, pancreatic and lung cancer."
22005518_2012.ann,thymoquinone,lung cancer,5,"The anti-tumor effects of thymoquinone have also been investigated in tumor xenograft mice models for colon, prostate, pancreatic and lung cancer."
18927292_2008.ann,5-LOX,colon cancer,5,The blockade of 5-LOX inhibits colon cancer cell proliferation both in vitro and in vivo and may prove  a beneficial chemopreventive therapy in colon cancer.
17909072_2007.ann,"2-amino-3-methylimidazo[4,5-b]pyridine",breast cancer,5,"The cooked meat derived genotoxic carcinogen 2-amino-3-methylimidazo[4,5-b]pyridine has potent hormone-like activity: mechanistic support for a role in breast cancer."
12432545_2002.ann,copper chelator trientine,hepatocellular carcinoma,5,"The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production."
15059925_2004.ann,defensins,colon cancers,5,"the defensins and matrilysin,  were highly overexpressed in colon cancers."
15059925_2004.ann,matrilysin,colon cancers,5,"the defensins and matrilysin,  were highly overexpressed in colon cancers."
15705887_2005.ann,azoxymethane,colon carcinogenesis,5,The effect of folate transporter gene ablation on colon carcinogenesis was evaluated 8 and 38 weeks post-azoxymethane injection in wild-type and heterozygous mice.
22353783_2012.ann,honokiol,breast cancer,5,"The effect of honokiol on invasion and migration of breast cancer cells was evaluated by using Matrigel  invasion, scratch-migration, spheroid-migration, and electric cell-substrate impedance sensing (ECIS)-based migration assays."
24007863_2014.ann,5-fluorouracil,hepatocellular carcinoma,5,The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
10657948_2000.ann,secretory phospholipase,multiple intestinal neoplasia,5,The murine non-pancreatic secretory phospholipase A(2) (sPLA(2)) has been proposed as a tumor modifier of multiple intestinal neoplasia (Min).
21630261_2012.ann,neurotensin receptor-1,colon cancer,5,The neurotensin receptor-1 promotes tumor development in a sporadic but not an inflammation-associated mouse model of colon cancer.
24718703_2014.ann,dioxin,liver tumor,5,The observation that TKO mice were resistant to the tumor promoting effects of dioxin in liver suggests that inflammatory cytokines play an important step in dioxin mediated liver tumor promotion in the mouse.
25811798_2015.ann,nifuroxazide,breast cancer,5,The potency of nifuroxazide on breast cancer was assessed in vitro and in vivo.
26068969_2015.ann,acetyltanshinone IIA,breast cancer,5,The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways.
16364925_2006.ann,thymosin beta-4,colon cancer,5,The present work was conducted to further examine the effects of thymosin beta-4  (Tbeta4) upregulation on the apoptosis of SW480 colon cancer cells induced by T cells and various chemotherapeutic agents because reduced susceptibility to the cytotoxicity of an anti-Fas IgM (CH-11) in Tbeta4-overexpressing cells has previously been reported by us.
15731169_2005.ann,periostin,colorectal cancers,5,"The results demonstrate the growth-promoting properties of periostin, and a possible role of targeting this protein as a therapeutic option in colorectal cancers."
15896469_2005.ann,beta-catenin,gastric cancers,5,"The results demonstrated (1) that Wnt2 expression and cytoplasmic/nuclear beta-catenin accumulations appeared in most gastric cancers irrespective to their morphological phenotypes, (2) that over-expressed Wnt and nuclear translocalisation of beta-catenin were found in 68 and 58% of i-GCs and in 47 and 47% of d-GCs in a closely related pattern (P<0.01) and (3) that co-existence of Wnt2 up-regulation/beta-catenin nuclear translocalisation were positively associated with lymph node metastasis (P<0.05) as well as T-stage."
14604892_2004.ann,matrilysin,gastric cancer,5,"The results of this study suggest that E1AF, the expression of which is closely correlated with the expression of matrilysin, plays a key role in the progression of gastric cancer."
9515794_1998.ann,beta-catenin,colon carcinogenesis,5,The results provide evidence for a major role of the beta-catenin/Apc pathway in the development of heterocyclic amine-induced colon tumors and give further weight to the view that regulation of beta-catenin is critical to the tumor suppressive effects of Apc during colon carcinogenesis.
15608557_2004.ann,5FU,colorectal cancer,5,The results suggest that MTHFR genotypes are relevant and independent factors of patient outcome in 5FU-based treatment of advanced colorectal cancer.
19452510_2009.ann,Ron receptor tyrosine kinase,colon cancers,5,The Ron receptor tyrosine kinase is overexpressed in approximately half of all human colon cancers.
15896469_2005.ann,beta-catenin,gastric cancers,5,"These data indicate that Wnt/beta-catenin signalling pathway is activated in most of gastric cancers, which may play pivotal roles either in gastric cancer formation or in tumour invasion and dissemination."
22115830_2012.ann,BMP,CRC,5,"These findings provide important information about the interaction among transforming growth factor beta, BMP, and Wnt signaling pathways in progression of CRC."
15341023_2004.ann,estrogen,hepatocarcinogenesis,5,These findings strongly suggest that estrogen play a critical role in female hepatocarcinogenesis.
23912631_2013.ann,CARM1,hepatocarcinogenesis,5,These findings suggest that aberrantly expressed CARM1 in tumor marker-positive cells promotes tumorigenesis in the early stages of hepatocarcinogenesis.
23804703_2013.ann,sulindac,colorectal cancer,5,These observations suggest that safer and more efficacious sulindac derivatives can be developed for colorectal cancer chemoprevention by targeting PDE5 and possibly other cGMP-degrading isozymes.
20683949_2010.ann,nucleophosmin,hepatocarcinogenesis,5,Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin.
26844701_2016.ann,Caspase-3,CRC,5,"This indicates that low levels of active Caspase-3 may represent a new predictor of CT responsiveness, and inhibition of Caspase-3, or antagonising downstream effectors of Caspase-3 paracrine signalling, such as COX-2 may improve patient outcomes following CT in  advanced CRC."
21639868_2011.ann,alpha-mangostin,metastatic mammary cancer,5,This led us to investigate the antitumor growth and antimetastatic activities of alpha-mangostin in an immunocompetent xenograft model of mouse metastatic mammary cancer having a p53 mutation that induces a metastatic spectrum similar to that seen in human breast cancers.
21743489_2012.ann,cisplatin,ovarian cancer,5,"Thus, the NAC1-mediated autophagy may be exploited as a new target for enhancing the efficacy of cisplatin against ovarian cancer and other types of malignancies."
15538739_2004.ann,dihydropyrimidine dehydrogenase,rectal cancer,5,"Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer."
15538739_2004.ann,thymidine phosphorylase,rectal cancer,5,"Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer."
15538739_2004.ann,Thymidylate synthase,rectal cancer,5,"Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer."
19074849_2008.ann,Tolfenamic acid,colorectal cancer,5,"Tolfenamic acid also facilitated translocation of endogenous and exogenous ESE-1 to the nucleus in colorectal cancer cells, and gene silencing using ESE-1 small interfering RNA attenuated tolfenamic acid-induced EGR-1 expression and apoptosis."
20007298_2010.ann,diethylnitrosamine,hepatocarcinogenesis,5,Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse.
21520178_2011.ann,cyclin dependent kinase 4,hepatocellular cancer,5,"Transforming growth factor-beta adaptor, beta2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer."
21356386_2011.ann,cyclooxygenase-2,hepatocarcinogenesis,5,Transgenic mice expressing cyclooxygenase-2 in hepatocytes reveal a minor contribution of this enzyme to chemical hepatocarcinogenesis.
24784840_2014.ann,E-cadherin,breast cancer,5,"UNLABELLED: Loss of E-cadherin (CDH1), Smad4, and p53 has been shown to play an integral role in gastric, intestinal, and breast cancer formation."
25503930_2015.ann,sulindac,colon tumor,5,"Unlike celecoxib, sulindac proved highly effective in colon tumor prevention of 15-PGDH  KO mice."
18593903_2008.ann,5-AzaC,hepatocarcinogenesis,5,"Up-regulation of several miR-1 targets including FoxP1, MET, and HDAC4 in primary human HCCs and down-regulation of their expression in 5-AzaC-treated HCC cells suggest their role in hepatocarcinogenesis."
12839936_2003.ann,Ursodeoxycholic acid,colon cancer,5,"Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer."
22832932_2012.ann,Ursolic acid,colorectal cancer,5,Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.
18926688_2009.ann,folate,colitis,5,Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancer.
18926688_2009.ann,folate,colon cancer,5,Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancer.
18312651_2008.ann,estrogen,breast cancer,5,"Using protein-protein interaction screening, we found that FOXO3a interacted with ER-alpha and ER-beta proteins in the human breast carcinoma cell line MCF-7, suggesting that there exists a crosstalk between the FOXO3a and ER signaling pathways in estrogen-dependent breast cancer cells."
15993848_2005.ann,17-AAG,colon cancer,5,We  have shown that the Hsp90 inhibitor 17-AAG enhances the cytotoxicity of oxaliplatin in colon cancer cell lines through inhibition of NF-kappaB.
15993848_2005.ann,oxaliplatin,colon cancer,5,We  have shown that the Hsp90 inhibitor 17-AAG enhances the cytotoxicity of oxaliplatin in colon cancer cell lines through inhibition of NF-kappaB.
16105666_2005.ann,nitric oxide synthase,colon carcinogenesis,5,"We examined in HT-29 human colon adenocarcinoma cells the effect of NO-ASA on the inducible form of nitric oxide synthase (NOS2), an enzyme implicated in colon carcinogenesis."
12432545_2002.ann,copper chelator trientine,hepatocellular carcinoma (HCC),5,"We examined the antiangiogenic effect against hepatocellular carcinoma (HCC) of the copper chelator trientine, especially focusing on the relationship between copper and interleukin-8 (IL-8), a potent angiogenic factor  produced by hepatoma cells."
12432545_2002.ann,copper chelator trientine,hepatocellular carcinoma,5,"We examined the antiangiogenic effect against hepatocellular carcinoma (HCC) of the copper chelator trientine, especially focusing on the relationship between copper and interleukin-8 (IL-8), a potent angiogenic factor  produced by hepatoma cells."
21045137_2010.ann,pioglitazone,lung cancer,5,We examined the effect of pioglitazone  on lung cancer development in carcinogen-induced lung adenocarcinoma and squamous cell carcinoma (SCC).
16170372_2005.ann,selenoproteins,liver tumor,5,"We examined the role of Se and selenoproteins in liver tumor formation in TGFalpha/c-Myc transgenic mice, which are characterized by disrupted redox homeostasis and develop liver cancer by 6 months of age."
27865009_2017.ann,5-FU,colon cancer,5,"We found that melatonin significantly enhanced the 5-FU-mediated inhibition of cell proliferation, colony formation, cell migration  and invasion in colon cancer cells."
27865009_2017.ann,melatonin,colon cancer,5,"We found that melatonin significantly enhanced the 5-FU-mediated inhibition of cell proliferation, colony formation, cell migration  and invasion in colon cancer cells."
19037088_2009.ann,COX2,colon cancer,5,"We found that the treatment of COX2-overexpressing HT29 human colon cancer cells with fisetin (30-120 microM) resulted in induction  of apoptosis, downregulation of COX2 protein expression without affecting COX1 and inhibited the secretion of prostaglandin E2."
26956619_2016.ann,diaminothiazole 4-Amino-5-benzoyl-2-(4-methoxy phenylamino)thiazole,colon cancer,5,We have  also examined the toxicity and in vivo efficacy of a lead diaminothiazole 4-Amino-5-benzoyl-2-(4-methoxy phenylamino)thiazole (DAT1) in colon cancer xenografts.
21435243_2011.ann,gamma-cyclodextrin,breast cancer,5,We have recently shown that I3C cyclic tetrameric derivative CTet formulated in gamma-cyclodextrin (gamma-CD) efficiently inhibited cellular proliferation in breast cancer cell lines.
26084280_2015.ann,Lapatinib,breast cancer,5,"We hypothesized that PTK6 inhibition is an effective strategy to inhibit growth and survival of Her2(+) breast cancer cells, including those that are relatively resistant to Lapatinib,  a targeted therapy for Her2(+) breast cancer, either intrinsically or acquired after continuous drug exposure."
15374632_2004.ann,geraniol,colon cancer,5,"We investigated on colon cancer cells the effect of geraniol on thymidylate synthase and thymidine kinase expression, two enzymes related to 5-fluorouracil cytotoxicity."
19010916_2008.ann,leptin,CRC,5,We investigated the expression of leptin and its receptor in 171 consecutive patients (78 female and 93 male; 71 years) with CRC.
16061884_2005.ann,roxithromycin,hepatocellular carcinoma,5,We investigated the suppressive effect of roxithromycin on accelerated hepatocellular carcinoma growth in a rat hepatocarcinogenetic model and compared  results with effects from TNP-470.
27639802_2017.ann,GDP-fucose,colon carcinogenesis,5,We investigated whether a lack of fucosylation consequent to loss of GDP-fucose synthesis contributes to colon carcinogenesis.
18521906_2008.ann,simvastatin,colitis,5,We previously demonstrated that simvastatin inhibits NF-kappaB signaling in human intestinal epithelial cells and ameliorates acute murine colitis.
26383537_2015.ann,anthocyanin,colon cancer,5,"We previously showed that anthocyanin-containing baked purple-fleshed potato (PP) extracts (PA) suppressed  early and advanced human colon cancer cell proliferation and induced apoptosis, but their effect on colon CSCs is not known."
24651526_2014.ann,"1,2-dimethylhydrazine dihydrochloride",colon carcinogenesis,5,"We previously showed that embelin inhibits the growth of colon cancer cells in vitro, and effectively suppresses 1,2-dimethylhydrazine dihydrochloride-induced colon carcinogenesis in mice."
16356827_2006.ann,inosine 5'-monophosphate dehydrogenase,prostate cancer,5,"We suggest that inosine 5'-monophosphate dehydrogenase inhibitors, which are already used for the treatment of other diseases, may be used as potential differentiation therapy drugs to control prostate cancer."
9743297_1998.ann,basic fibroblast growth factor,colorectal cancer,5,We tested the role of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in the switch  to the angiogenic phenotype in 35 patients with colorectal cancer at different stages of disease.
9743297_1998.ann,basic fibroblast growth factor (bFGF),colorectal cancer,5,We tested the role of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in the switch  to the angiogenic phenotype in 35 patients with colorectal cancer at different stages of disease.
10753194_2000.ann,beta-catenin,intestinal polyps,5,"While the exact mechanism(s) for this antitumor activity of p-XSC remains to be elucidated, it appears that modulation of beta-catenin expression and COX-2 activity is associated with inhibition of intestinal polyps."
22370639_2013.ann,Zinc-finger protein 331,gastric cancer,5,"Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer."
19850985_2008.ann,N-nitrosodiethylamine,hepatocarcinogenesis,6," AIM: To elucidate the anticancer mechanism of Huqi San by assessing the expression of G-6-Pase, SDH, ATPase and AFP in N-nitrosodiethylamine-mediated hepatocarcinogenesis in rats."
26190035_2016.ann,free fatty acid (FFA),fatty liver,6, AIM: To investigate the therapeutic effect and potential mechanisms of the natural flavonoid quercetin-3-O-beta-D-glucuronide (Q3GA) against lipid metabolism disorder in free fatty acid (FFA)-induced fatty liver in vivo and in vitro.
26190035_2016.ann,free fatty acid,fatty liver,6, AIM: To investigate the therapeutic effect and potential mechanisms of the natural flavonoid quercetin-3-O-beta-D-glucuronide (Q3GA) against lipid metabolism disorder in free fatty acid (FFA)-induced fatty liver in vivo and in vitro.
25427908_2015.ann,Alcohol,hepatocellular carcinoma,6," Alcohol is a well-established risk factor for hepatocellular carcinoma, and the mechanisms by which alcohol liver cancer is complex."
12841865_2003.ann,tamoxifen,hepatocarcinogenesis,6, Altered gene expression of the DNA repair- and cell proliferation-associated proteins/enzymes was examined during the process of tamoxifen-induced hepatocarcinogenesis in female Sprague-Dawley rats.
18166357_2008.ann,alcohol,liver fibrosis,6, BACKGROUND & AIMS: Chronic alcohol drinking accelerates liver fibrosis in patients with viral hepatitis that cannot be fully explained by ethanol-enhanced  liver damage.
24164383_2014.ann,Alcohol,hepatocellular carcinoma,6, BACKGROUND: Alcohol consumption promotes hepatocellular carcinoma (HCC).
24164383_2014.ann,Alcohol,hepatocellular carcinoma (HCC),6, BACKGROUND: Alcohol consumption promotes hepatocellular carcinoma (HCC).
20434301_2010.ann,diethylnitrosamine,hepatocarcinogenesis,6, BACKGROUND: Chemopreventive effect of a selective cyclooxygenase-2 (COX-2) inhibitor JTE-522 on diethylnitrosamine (DEN)-induced hepatocarcinogenesis was evaluated in Wistar rats.
22017344_2012.ann,ethanol,hepatocellular carcinoma (HCC),6, BACKGROUND: Chronic ethanol consumption increases the risk of hepatic cirrhosis and hepatocellular carcinoma (HCC).
22806512_2013.ann,ethanol,Hepatocellular carcinoma (HCC),6," BACKGROUND: Hepatocellular carcinoma (HCC) is a rapidly increasing cancer whose known risk factors are chronic ethanol abuse, viral hepatitis infection, and aflatoxin exposure."
27466604_2016.ann,selenium,hyperinsulinemia,6, BACKGROUND: Prolonged high intakes of dietary selenium have been shown to induce  gestational diabetes in rats and hyperinsulinemia in pigs.
18350280_2008.ann,copper gluconate,liver tumor,6," Carcinogenic risk and molecular mechanisms underlying the liver tumor-promoting activity of copper gluconate, an additive of functional foods, were investigated  using a rat medium-term liver carcinogenicity bioassay protocol (Ito test) and a  2-week short-term administration experiment."
25592162_2015.ann,alcohol,alcoholic liver disease (ALD),6, Chronic and excessive alcohol consumption leads to the development of alcoholic liver disease (ALD) and greatly increases the risk of liver cancer.
25592162_2015.ann,alcohol,liver cancer,6, Chronic and excessive alcohol consumption leads to the development of alcoholic liver disease (ALD) and greatly increases the risk of liver cancer.
26187448_2015.ann,toxaphene,liver tumors,6, Chronic exposure to toxaphene resulted in an increase in liver tumors in B6C3F1 mice.
17997003_2008.ann,hepatotoxins,Hepatocellular carcinoma (HCC),6," Hepatocellular carcinoma (HCC) is one of the common cancers worldwide, caused by  Hepatitis C virus (HCV) and hepatotoxins."
20403969_2010.ann,chlordane,hepatomegaly,6, Mouse nongenotoxic hepatocarcinogens phenobarbital (PB) and chlordane induce hepatomegaly characterized by hypertrophy and hyperplasia.
22775223_2012.ann,N-nitrosodiethylamine,hepatocellular carcinoma,6, OBJECTIVES: The chemopreventive potential of Tephrosia purpurea extract (TPE) on  N-nitrosodiethylamine (NDEA)-induced hepatocellular carcinoma (HCC) in Wistar rats was assessed.
22775223_2012.ann,N-nitrosodiethylamine,hepatocellular carcinoma (HCC),6, OBJECTIVES: The chemopreventive potential of Tephrosia purpurea extract (TPE) on  N-nitrosodiethylamine (NDEA)-induced hepatocellular carcinoma (HCC) in Wistar rats was assessed.
17451858_2007.ann,arsenic,hepatocellular carcinoma (HCC),6, Our prior work showed that brief exposure of pregnant C3H mice to inorganic arsenic-induced hepatocellular carcinoma (HCC) formation in adult male offspring.
17451858_2007.ann,arsenic,hepatocellular carcinoma,6, Our prior work showed that brief exposure of pregnant C3H mice to inorganic arsenic-induced hepatocellular carcinoma (HCC) formation in adult male offspring.
23665940_2013.ann,orphenadrine,liver tumor,6, Phenobarbital (PB) and orphenadrine (ORPH) are cytochrome P450 (CYP) 2B inducers  and have liver tumor-promoting effects in rats.
8001232_1994.ann,N-nitrosodiethylamine,liver tumors,6," Rat liver tumors initiated with N-nitrosodiethylamine (DEN) followed by promotion with phenobarbital (PB) were examined for expression of transforming growth factor-beta (TGF beta) type I, II and III receptors."
8001232_1994.ann,phenobarbital,liver tumors,6," Rat liver tumors initiated with N-nitrosodiethylamine (DEN) followed by promotion with phenobarbital (PB) were examined for expression of transforming growth factor-beta (TGF beta) type I, II and III receptors."
25092647_2014.ann,pronamide,liver tumors,6," The key events responsible for mouse liver tumors induced by a pesticide (viz., pronamide) were investigated in a series of studies employing molecular, biochemical, cellular, and apical endpoints."
25553083_2015.ann,diethylnitrosamine,hepatocarcinogenesis,6, The objective of this study was to determine a chemopreventive activity of Korean red ginseng extract (KRG) in diethylnitrosamine (DEN) induced hepatocarcinogenesis in rats.
17786350_2007.ann,3'-methyl-4-dimethylaminoazobenzene,hepatocarcinogenesis,6, The present study was designed to determine whether alterations in the expression of RXRalpha and the other retinoid receptors RARalpha and RARbeta are involved in hepatocarcinogenesis using a 3'-methyl-4-dimethylaminoazobenzene (3'-MeDAB)-induced rat liver carcinogenesis model.
17786350_2007.ann,3'-MeDAB,hepatocarcinogenesis,6, The present study was designed to determine whether alterations in the expression of RXRalpha and the other retinoid receptors RARalpha and RARbeta are involved in hepatocarcinogenesis using a 3'-methyl-4-dimethylaminoazobenzene (3'-MeDAB)-induced rat liver carcinogenesis model.
22272001_2009.ann,N-nitrosodiethylamine,hepatocarcinogenesis,6, The present study was undertaken to investigate the effect of dietary supplementation with nimesulide or eugenol on N-nitrosodiethylamine (DEN)-initiated early hepatocarcinogenesis in F344 male rats.
27697726_2016.ann,azoxymethane,colon carcinogenesis,6, The preventive effect of a processed Aloe vera gel (PAG) on colon carcinogenesis  was examined using an azoxymethane (AOM)-initiated and dextran sodium sulfate (DSS)-promoted mouse colon carcinogenesis model.
27697726_2016.ann,dextran sodium sulfate,colon carcinogenesis,6, The preventive effect of a processed Aloe vera gel (PAG) on colon carcinogenesis  was examined using an azoxymethane (AOM)-initiated and dextran sodium sulfate (DSS)-promoted mouse colon carcinogenesis model.
24535843_2014.ann,diethylnitrosamine,hepatocarcinogenesis,6," The process of hepatocarcinogenesis in the diethylnitrosamine (DEN) initiation/phenobarbital (PB) promotion mouse model involves the selective clonal outgrowth of cells harboring oncogene mutations in Ctnnb1, while spontaneous or DEN-only-induced tumors are often Ha-ras- or B-raf-mutated."
18164116_2008.ann,beta-naphthoflavone,hepatocarcinogenesis,6," The tumour-promoting effects of beta-naphthoflavone (BNF), a novel aryl hydrocarbon receptor (AhR) agonist, were investigated using a medium-term hepatocarcinogenesis model in rats."
26655499_2016.ann,alcohol,hepatocellular carcinoma (HCC),6, There is abundant epidemiological evidence that heavy alcohol intake contributes  to hepatocellular carcinoma (HCC) development.
26655499_2016.ann,alcohol,hepatocellular carcinoma,6, There is abundant epidemiological evidence that heavy alcohol intake contributes  to hepatocellular carcinoma (HCC) development.
27533849_2016.ann,diethylnitrosamine,hepatocellular carcinoma,6," This study validates the utility of Gum Arabic-conjugated gold nanoparticles (GA-AuNPs) and laser to induce photothermal inhibition of hepatocarcinogenesis, via employing a diethylnitrosamine (DEN)-mediated hepatocellular carcinoma model."
22272000_2009.ann,fenofibrate,hepatocarcinogenesis,6," To clarify the modifying effect of N-Acetyl-L-Cysteine (NAC), which has antioxidative ability, on hepatocarcinogenesis promoted by fenofibrate (FF), a peroxisome proliferator-activated receptor (PPAR) alpha agonist , male F344/N rats were administered a single intraperitoneal injection of N-diethylnitrosamine (DEN) as an initiator followed by administration of a diet containing 3,000 ppm of FF for 16 weeks."
17498859_2007.ann,piperonyl butoxide,hepatocarcinogenesis,6," To clarify the possible mechanism of non-genotoxic hepatocarcinogenesis induced by piperonyl butoxide (PBO), male F344 rats were administered an i.p."
24680176_2014.ann,N-diethylnitrosamine,hepatocarcinogenesis,6," To investigate the protective effect of bilberry extracts (BBE) and enzymatically modified isoquercitrin (EMIQ) on the hepatocarcinogenic process involving oxidative stress responses, we used a two-stage hepatocarcinogenesis model in N-diethylnitrosamine-initiated and piperonyl butoxide (PBO)-promoted rats."
24793618_2014.ann,flutamide,liver damage,6, We investigated the effects of the liver damage induced by flutamide in primary rat hepatocytes using liver microfluidic biochips.
9163695_1997.ann,"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",multiple intestinal neoplasia,6,"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors,  cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice."
10656603_1999.ann,2-Nitrobenzo[a]pyrene,liver tumors,6,"2-Nitrobenzo[a]pyrene and 6-nitrochrysene induced a high incidence of liver tumors (91-100%), while the remaining test compounds did not induce tumors at a rate significantly higher than the solvent control."
10656603_1999.ann,6-nitrochrysene,liver tumors,6,"2-Nitrobenzo[a]pyrene and 6-nitrochrysene induced a high incidence of liver tumors (91-100%), while the remaining test compounds did not induce tumors at a rate significantly higher than the solvent control."
24096051_2014.ann,diethylnitrosamine,liver cancer,6,A diethylnitrosamine-induced liver cancer model was used to evaluate the role of Myc in hepatocarcinogenesis.
25123088_2014.ann,tamoxifen,non-alcoholic fatty liver disease,6,"Additionally, it has been reported that tamoxifen may cause non-alcoholic fatty liver disease (NAFLD)  in humans and experimental animals."
26708719_2016.ann,acetaminophen,liver injury,6,"Administration of acetaminophen to Jnk(Deltahepa) mice produced a greater level of liver injury than that observed in Jnk1(Deltahepa) or control mice, based on levels of serum markers and microscopic and histologic analysis of liver tissues."
10959800_2000.ann,tamoxifen,liver tumors,6,After the 3-month recovery period all tamoxifen-treated rats had large liver tumors (diameter up to 3 cm).
16774945_2006.ann,"1,2-dimethylhydrazine",colon cancer,6,"AIRmax were also more susceptible than AIRmin to colon cancer induced by 2 or 7 weekly doses of 1,2-dimethylhydrazine (DMH), showing significantly higher numbers of colonic aberrant crypt foci (ACF)  at 150 days after DMH treatment (P = 0.01) and significantly higher numbers of tumors affecting larger intestinal areas at 300-475 days."
26190035_2016.ann,free fatty acid,fatty liver,6,Amelioration of free fatty acid-induced fatty liver by quercetin-3-O-beta-D-glucuronide through modulation of peroxisome proliferator-activated receptor-alpha/sterol regulatory element-binding protein-1c signaling.
20937726_2011.ann,Arsenic,hepatocellular carcinoma,6,"Arsenic induced dose-related increases in lung adenocarcinoma (both sexes), hepatocellular carcinoma (both sexes), gallbladder tumors (males), and uterine carcinomas."
18164116_2008.ann,beta-Naphthoflavone,hepatocarcinogenesis,6,beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats.
18164116_2008.ann,diethylnitrosamine,hepatocarcinogenesis,6,beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats.
25447507_2015.ann,N-diethylnitrosamine,hepatocellular carcinoma,6,Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
17651763_2007.ann,diethylnitrosamine,hepatocarcinogenesis,6,Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
26130745_2015.ann,Diethylnitrosamine,Hepatocarcinogenesis,6,Chemoprevention of Diethylnitrosamine-Initiated and Phenobarbital-Promoted Hepatocarcinogenesis in Rats by Sulfated Polysaccharides and Aqueous Extract of Ulva lactuca.
22775223_2012.ann,N-nitrosodiethylamine,hepatocarcinogenesis,6,Chemopreventive evaluation of Tephrosia purpurea against N-nitrosodiethylamine-induced hepatocarcinogenesis in Wistar rats.
22017344_2012.ann,ethanol,hepatocellular carcinoma,6,Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis.
15073043_2004.ann,arsenic inorganic,hepatocarcinogenesis,6,Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis.
28193514_2017.ann,dextran sulfate sodium,Colitis,6,"Colitis was induced in knockout, transgenic, and control (C57BL/B6) mice by administration of dextran sulfate sodium (DSS), and mice were  given azoxymethane to induce colorectal carcinogenesis."
23422335_2013.ann,CCl4,liver injury,6,CONCLUSION: These results suggested that TFA protected mice against CCl4-induced liver injury through antioxidant stress and antiinflammatory effects.
26708719_2016.ann,CCl4,liver injury,6,"CONCLUSIONS: In hepatocytes, JNK1 and JNK2 appear to have combined effects in protecting mice from CCl4- and acetaminophen-induced liver injury."
26708719_2016.ann,acetaminophen,liver injury,6,"CONCLUSIONS: In hepatocytes, JNK1 and JNK2 appear to have combined effects in protecting mice from CCl4- and acetaminophen-induced liver injury."
26122096_2015.ann,fibrate,hepatocarcinogenesis,6,CONCLUSIONS: Our data suggest that the truncated PPARalpha splice variant functions as an endogenous inhibitor of proliferative and pro-inflammatory genes in human cells and that its absence in mouse may explain species-specific differences in fibrate-induced hepatocarcinogenesis.
20823143_2010.ann,azoxymethane,colon carcinogenesis,6,CONCLUSIONS: Silibinin targets beta-catenin and IGF-1Rbeta pathways for its chemopreventive efficacy against azoxymethane-induced colon carcinogenesis in A/J mice.
18544905_2008.ann,kojic acid,liver tumor,6,Concurrent administration of ascorbic acid enhances liver tumor-promoting activity of kojic acid in rats.
19176532_2009.ann,fibrates,cholestasis,6,"Considerable attention has focused on peroxisome proliferator-induced hepatocellular carcinoma, a phenomenon not noted in man, whereas limited studies examine fibrates and other therapeutic drugs that induce cholestasis, a common finding in humans."
22272001_2009.ann,N-Nitrosodiethylamine,Hepatocarcinogenesis,6,Cyclooxygenase 2 and Prostaglandin E2 are not Involved in N-Nitrosodiethylamine-Initiated Early Rat Hepatocarcinogenesis.
21278145_2011.ann,diethylnitrosamine,hepatocarcinogenesis,6,DESIGN: Spontaneous and experimental fibrogenesis as well as a diethylnitrosamine-induced hepatocarcinogenesis were investigated in lecithin-retinol acyltransferase (LRAT)-deficient mice which lack retinoid-containing lipids droplets in their HSCs.
27864128_2017.ann,Dextran sodium sulfate,colitis,6,"Dextran sodium sulfate (DSS) was given to induce colitis in C57/BL6 (control) mice, as well as in mice with disruption of the hydroxyprostaglandin dehydrogenase 15 gene (15-PGDH-knockout mice), Yap1 gene (YAP-knockout mice), and double-knockout mice."
27864128_2017.ann,Dextran sodium sulfate,colitis,6,"Dextran sodium sulfate (DSS) was given to induce colitis in C57/BL6 (control) mice, as well as in mice with disruption of the hydroxyprostaglandin dehydrogenase 15 gene (15-PGDH-knockout mice), Yap1 gene (YAP-knockout mice), and double-knockout mice."
17602206_2007.ann,clofibric acid,hepatocarcinogenesis,6,Diethylnitrosamine initiation does not alter clofibric acid-induced hepatocarcinogenesis in the rat.
28207963_2017.ann,Diethylnitrosamine,hepatocarcinogenesis,6,Diethylnitrosamine-induced hepatocarcinogenesis was suppressed in heterozygous NRDC-deficient mice compared to their wild-type littermates.
26383537_2015.ann,azoxymethane,colon tumorigenesis,6,Effects of baked PP (20% wt/wt) against colon CSCs were also tested in vivo in mice with azoxymethane-induced colon tumorigenesis.
23665940_2013.ann,orphenadrine,liver tumor,6,Enhanced liver tumor promotion activity in rats subjected to combined administration of phenobarbital and orphenadrine.
22017344_2012.ann,Ethanol,liver damage,6,"Ethanol diminished hepatic function and increased liver damage, but ethanol alone did not induce hepatic foci/HCC formation."
22840450_2012.ann,N-nitrosodiethylamine,hepatocellular carcinoma,6,Evaluation of chemopreventive effect of Fumaria indica against N-nitrosodiethylamine and CCl4-induced hepatocellular carcinoma in Wistar rats.
22840450_2012.ann,CCl4,hepatocellular carcinoma,6,Evaluation of chemopreventive effect of Fumaria indica against N-nitrosodiethylamine and CCl4-induced hepatocellular carcinoma in Wistar rats.
21374661_2011.ann,diethylnitrosamine,hepatocarcinogenesis,6,Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice.
10657948_2000.ann,azoxymethane,colon tumorigenesis,6,Expression analysis of the group IIA secretory phospholipase A(2) in mice with differential susceptibility to azoxymethane-induced colon tumorigenesis.
17786350_2007.ann,3'-methyl-4-dimethylaminoazobenzene,hepatocellular carcinoma,6,Expression of retinoid X receptor alpha is decreased in 3'-methyl-4-dimethylaminoazobenzene-induced hepatocellular carcinoma in rats.
26187448_2015.ann,toxaphene,liver tumors,6,"Following an initial 14 day dietary dose range-finding study in male mice, a mechanistic study (0, 3, 32, and 320 ppm toxaphene in diet for 7, 14, and 28 days of treatment) was performed to examine the potential mechanisms of toxaphene induced mouse liver tumors."
19458067_2009.ann,"1,2-dimethylhydrazine dihydrochloride",colon cancer,6,"For in vivo studies, 1,2-dimethylhydrazine dihydrochloride (DMH) was s.c. injected to induce colon cancer in PPARgamma(+/+)  and PPARgamma(+/-) mice."
23494807_2013.ann,nitrosodiethylamine,hepatocarcinogenesis,6,Garlic oil attenuated nitrosodiethylamine-induced hepatocarcinogenesis by modulating the metabolic activation and detoxification enzymes.
15509519_2004.ann,N-nitrosodiethylamine,hepatocellular carcinoma (HCC),6,"Glutathione S-transferase placental (GST-P)-negative hepatocellular altered foci (HAF), hepatocellular adenoma (HCA), and hepatocellular carcinoma (HCC) were generated by two initiation-promotion models  with N-nitrosodiethylamine (NDEN) and peroxisome proliferators, Wy-14,643 and clofibrate."
15509519_2004.ann,clofibrate,hepatocellular carcinoma (HCC),6,"Glutathione S-transferase placental (GST-P)-negative hepatocellular altered foci (HAF), hepatocellular adenoma (HCA), and hepatocellular carcinoma (HCC) were generated by two initiation-promotion models  with N-nitrosodiethylamine (NDEN) and peroxisome proliferators, Wy-14,643 and clofibrate."
15509519_2004.ann,clofibrate,hepatocellular carcinoma,6,"Glutathione S-transferase placental (GST-P)-negative hepatocellular altered foci (HAF), hepatocellular adenoma (HCA), and hepatocellular carcinoma (HCC) were generated by two initiation-promotion models  with N-nitrosodiethylamine (NDEN) and peroxisome proliferators, Wy-14,643 and clofibrate."
25980751_2015.ann,diethylnitrosamine,liver injury,6,"GP73(-/-), GP73(+/-), and GP73(+/+) mice were given injections of diethylnitrosamine to induce liver injury."
17699720_2007.ann,azoxymethane,colorectal cancer,6,GT-094 is the first nitrate  reported to reduce aberrant crypt foci (by 45%) when administered after carcinogen in the standard azoxymethane rat model of colorectal cancer.
11532874_2001.ann,chloroform,liver tumors,6,"Hence, chloroform prevented the hypomethylation and increased mRNA expression of the c-myc gene and the promotion of liver tumors by DCA, while enhancing DCA-promotion of kidney tumors."
26627606_2016.ann,diethylnitrosamine,Hepatocarcinogenesis,6,Hepatocarcinogenesis was induced by diethylnitrosamine or hepatic deletion of PTEN.
22728872_2012.ann,diethylnitrosamine,Hepatocarcinogenesis,6,Hepatocarcinogenesis was induced by diethylnitrosamine/phenobarbital (DEN/PB).
18001218_2007.ann,2-acetylaminofluorene,Hepatocarcinogenesis,6,Hepatocarcinogenesis was induced in  male Sprague-Dawley rats by chronic feeding of 2-acetylaminofluorene (2-AAF) at a dose of 0.05% in basal diet daily for 5 days a week.
18001218_2007.ann,2-AAF,Hepatocarcinogenesis,6,Hepatocarcinogenesis was induced in  male Sprague-Dawley rats by chronic feeding of 2-acetylaminofluorene (2-AAF) at a dose of 0.05% in basal diet daily for 5 days a week.
18978307_2008.ann,fenofibrate,hepatocarcinogenesis,6,Hepatocarcinogenic susceptibility of fenofibrate and its possible mechanism of carcinogenicity in a two-stage hepatocarcinogenesis model of rasH2 mice.
10959800_2000.ann,tamoxifen,Hepatocellular carcinoma,6,Hepatocellular carcinoma was found in four out of five rats after 12 months of tamoxifen treatment.
23315968_2013.ann,diethylnitrosamine,hepatocellular carcinoma,6,Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents.
25242409_2014.ann,nitrosodiethylamine,hepatocarcinogenesis,6,"Here, we conducted a two stage hepatocarcinogenesis study in rats exposed to the initiating agent nitrosodiethylamine (DEN), and hepatotoxic compounds thioacetamide (TAA), methapyrilene (MP) and acetaminophen (APAP) for 1-2 weeks followed by the liver tumor promoter phenobarbital (PB)."
25242409_2014.ann,thioacetamide,hepatocarcinogenesis,6,"Here, we conducted a two stage hepatocarcinogenesis study in rats exposed to the initiating agent nitrosodiethylamine (DEN), and hepatotoxic compounds thioacetamide (TAA), methapyrilene (MP) and acetaminophen (APAP) for 1-2 weeks followed by the liver tumor promoter phenobarbital (PB)."
25242409_2014.ann,methapyrilene,hepatocarcinogenesis,6,"Here, we conducted a two stage hepatocarcinogenesis study in rats exposed to the initiating agent nitrosodiethylamine (DEN), and hepatotoxic compounds thioacetamide (TAA), methapyrilene (MP) and acetaminophen (APAP) for 1-2 weeks followed by the liver tumor promoter phenobarbital (PB)."
25242409_2014.ann,acetaminophen,hepatocarcinogenesis,6,"Here, we conducted a two stage hepatocarcinogenesis study in rats exposed to the initiating agent nitrosodiethylamine (DEN), and hepatotoxic compounds thioacetamide (TAA), methapyrilene (MP) and acetaminophen (APAP) for 1-2 weeks followed by the liver tumor promoter phenobarbital (PB)."
26990576_2016.ann,diethylnitrosamine,hepatocarcinogenesis,6,"Here, we examined chemopreventive potential of Acteoside (ACT), a plant derived phenylethanoid glycoside against an environmental and dietary carcinogen, diethylnitrosamine (DEN)-induced rat hepatocarcinogenesis."
18166357_2008.ann,alcohol,liver fibrosis,6,"Here, we identified a novel mechanism by which alcohol accelerates  liver fibrosis: inhibition of the antifibrotic effects of natural killer (NK) cells and interferon-gamma (IFN-gamma)."
17363595_2007.ann,diethylnitrosamine,liver tumors,6,"Here, we report that the levels of MT-1 and MT-2A are drastically reduced in primary human hepatocellular carcinomas (HCCs) and in diethylnitrosamine-induced  liver tumors in mice, which is primarily due to transcriptional repression."
22898879_2012.ann,diethylnitrosamine,hepatocarcinogenesis,6,Herein we report the concurrent increase of liver progenitor cells (LPCs) and transforming growth factor-beta (TGF-beta) in diethylnitrosamine (DEN)-induced rat hepatocarcinogenesis and cirrhotic livers of HCC patients.
24127579_2013.ann,diethylnitrosamine,hepatocellular carcinoma,6,Herein we show that global loss of ERRalpha accelerates the development of diethylnitrosamine (DEN)-induced hepatocellular carcinoma.
20823143_2010.ann,azoxymethane,colon tumorigenesis,6,"Herein, for the first time, we investigate in vivo the efficacy of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice."
25808184_2015.ann,diethylnitrosamine,hepatocarcinogenesis,6,"Herein, we investigated MMP10 expression and function in human hepatocellular carcinoma (HCC) and diethylnitrosamine (DEN)-induced mouse hepatocarcinogenesis."
25410681_2014.ann,diethylnitrosamine,hepatocellular carcinoma,6,High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
26983689_2016.ann,azoxymethane,colon tumorigenesis,6,"However, Ptk6-null mice were also resistant to azoxymethane-induced colon tumorigenesis."
24481444_2014.ann,Sorafenib,liver injury,6,"However, Sorafenib treatment transiently inhibited cell cycle progression and resulted in  mitotic catastrophe and enhanced non-apoptotic liver injury during regeneration."
24146112_2014.ann,ethanol,liver injury,6,"However, the action of the compound against ethanol-induced liver injury  is still unknown."
10503899_1999.ann,"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",colon carcinogenesis,6,"HTHQ also inhibited 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced colon carcinogenesis in a two stage colon carcinogenesis model using 1,2-dimethylhydrazine (DMH) as an initiator."
26910375_2016.ann,azoxymethane,colon carcinogenesis,6,"Importantly, GEN-27 protected mice from azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colon carcinogenesis, with reduced mortality, tumor  number and tumor volume."
26910375_2016.ann,dextran sodium sulfate,colon carcinogenesis,6,"Importantly, GEN-27 protected mice from azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colon carcinogenesis, with reduced mortality, tumor  number and tumor volume."
21778049_2012.ann,Diethylnitrosamine,hepatocarcinogenesis,6,"In addition, in the mouse Diethylnitrosamine model of hepatocarcinogenesis we observed a very strong induction of CXCR7 and CXCL11 transcripts, confirming that CXCR7/CXCL11 up-regulation is conserved between human and mice liver cancer."
23813475_2013.ann,diethylnitrosamine,hepatocarcinogenesis,6,"In an experimental mouse model of hepatocarcinogenesis (diethylnitrosamine-induced), tumors showed increased activation of the TGF-beta pathway and enhanced CXCR4 levels."
24146112_2014.ann,ethanol,liver injury,6,"In conclusion, dioscin shows excellent protective effect against ethanol-induced liver injury through ameliorating ethanol-induced oxidative stress, mitochondrial function, inflammatory cytokine production, apoptosis and liver steatosis, which should be developed as a new drug for the treatment of ethanol-induced liver injury in the future."
24146112_2014.ann,ethanol,liver injury,6,"In conclusion, dioscin shows excellent protective effect against ethanol-induced liver injury through ameliorating ethanol-induced oxidative stress, mitochondrial function, inflammatory cytokine production, apoptosis and liver steatosis, which should be developed as a new drug for the treatment of ethanol-induced liver injury in the future."
10467420_1999.ann,vinyl carbamate,liver tumors,6,"In contrast, only three of 18 vinyl carbamate-induced liver tumors, one of 18 TCDD-induced liver tumors, and two of 22 spontaneous liver neoplasms had mutations in beta-catenin."
17538239_2007.ann,phenobarbital,hepatocarcinogenesis,6,"In medium-term carcinogenesis test in rats, 2.0% KA was orally given to F344/DuCrj rats for 4 weeks of the initiation period, followed by the combination of partial hepatectomy and treatment with a hepatocarcinogenesis promoter, phenobarbital (PB)."
15447978_2005.ann,bezafibrate,hepatocellular carcinoma,6,"In mice fed bezafibrate for 1 year, preneoplastic foci, adenomas and a hepatocellular carcinoma were found in (+/+) mice, while only a single microscopic adenoma was found in one (-/-) mouse."
17893236_2008.ann,azoxymethane,colon cancer,6,"In order to prepare for a human trial on the inhibition of colon carcinogenesis, we conducted a study with green tea polyphenols as the preventive agent in an azoxymethane (AOM)-induced rat colon cancer model using aberrant crypt foci (ACF) as an end point."
12839936_2003.ann,azoxymethane,colon cancer,6,"In the azoxymethane (AOM) model of colon cancer, in addition to K-ras mutations, we have shown that wild-type (WT) Ras can be activated by upstream pathways, including, e.g., signaling by ErbB receptors."
18644992_2008.ann,azoxymethane,colon carcinogenesis,6,"In the azoxymethane-treated rat model of experimental colon carcinogenesis, sulindac treatment markedly induced Csk with a corresponding increase in inhibitory phosphorylation of Src (Tyr(527))."
24146112_2014.ann,ethanol,chronic liver damage,6,"In the present paper, ethanol-induced acute and chronic liver damage rat models were used, and the results showed that dioscin significantly alleviated liver steatosis, reduced the levels of alanine aminotransferase, aspartate aminotransferase, total triglyceride (TG), total cholesterol and malondialdehyde, and increased the levels of high-density lipoprotein, superoxide dismutase, glutathione and glutathione peroxidase."
22763672_2012.ann,diethylnitrosamine,hepatocellular carcinoma,6,"In the present study, it is shown that myrtenal, a natural monoterpene, which acts as an antineoplastic agent against diethylnitrosamine induced phenobarbital promoted experimental hepatocellular carcinoma."
21785164_2011.ann,2-acetylaminofluorene,hepatocarcinogenesis,6,"In the present study, using an in vivo model of rat hepatocarcinogenesis induced by 2-acetylaminofluorene, we found extensive alterations in cellular iron metabolism at preneoplastic stages of liver carcinogenesis."
12841865_2003.ann,tamoxifen,hepatocarcinogenesis,6,"In the present study, we demonstrate the altered gene expression of various proteins/enzymes involved in DNA repair, cell growth and the cell cycle during the process of tamoxifen-induced hepatocarcinogenesis."
23665045_2013.ann,2-AAF,hepatocarcinogenesis,6,"In the present study, we have shown that diosmin attenuates 2-AAF induced hepatic toxicity and early tumor promotion markers (ODC, PCNA and Ki67),  its chemopreventive efficacy against DEN initiated and 2-AAF promoted hyper-proliferation and hepatocarcinogenesis in Wistar rats."
26727596_2016.ann,diethylnitrosamine,hepatocarcinogenesis,6,"In the present study, we investigated the role of IDO in diethylnitrosamine (DEN)-induced hepatocarcinogenesis by using IDO-knockout (KO) mice."
19959557_2010.ann,azoxymethane,colon cancer,6,"In this study, we  investigated the chemopreventive efficacy of PEITC and DBM in the azoxymethane (AOM)-initiated and dextran sodium sulfate (DSS)-promoted colon cancer mouse model and to compare their potential in vivo mechanisms leading to chemoprevention."
19959557_2010.ann,azoxymethane,colon cancer,6,"In this study, we  investigated the chemopreventive efficacy of PEITC and DBM in the azoxymethane (AOM)-initiated and dextran sodium sulfate (DSS)-promoted colon cancer mouse model and to compare their potential in vivo mechanisms leading to chemoprevention."
24361483_2014.ann,thioacetamide,hepatocarcinogenesis,6,"In this study, we characterized cell signaling events evoked by decorin deficiency in two experimental models of hepatocarcinogenesis using thioacetamide or diethyl nitrosamine as carcinogens."
24361483_2014.ann,diethyl nitrosamine,hepatocarcinogenesis,6,"In this study, we characterized cell signaling events evoked by decorin deficiency in two experimental models of hepatocarcinogenesis using thioacetamide or diethyl nitrosamine as carcinogens."
16204055_2005.ann,dimethylhydrazine,colon tumorigenesis,6,"In this study, we evaluated the susceptibility of Vparp-/- and Tep1-/- mice to dimethylhydrazine-induced colon tumorigenesis and urethane-induced lung tumorigenesis."
17557908_2007.ann,cyproconazole,liver hypertrophy,6,"In wild-type mice, 200 ppm cyproconazole caused liver hypertrophy, increased liver weight and cell proliferation, single-cell necrosis and fat vacuolation, effects generally similar to those caused by 850 ppm phenobarbital."
22840450_2012.ann,N-nitrosodiethylamine,hepatocarcinogenesis,6,indica) extract (FIE) on N-nitrosodiethylamine and CCl(4)-induced hepatocarcinogenesis in Wistar rats.
1917145_1991.ann,N-nitrosomorpholine,hepatocarcinogenesis,6,Inhibition by retinoic acid of hepatocarcinogenesis induced by N-nitrosomorpholine and of expression of myc oncogene protein in Sprague-Dawley rats.
19826045_2009.ann,azoxymethane,colorectal cancer,6,"Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats."
20823143_2010.ann,azoxymethane,colon tumorigenesis,6,Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice.
23710613_2014.ann,diethylnitrosamine,hepatocellular carcinoma,6,injected with diethylnitrosamine  (DEN) to induce hepatocellular carcinoma.
23901063_2014.ann,diethylnitrosamine,liver tumors,6,"Injection of the carcinogen, diethylnitrosamine, induced significantly more and larger liver tumors in HCV transgenic mice that overexpress PP2Ac compared with control mice."
26928356_2016.ann,Acifluorfen,Liver Injury,6,Involvement of Mouse Constitutive Androstane Receptor in Acifluorfen-Induced Liver Injury and Subsequent Tumor Development.
18056438_2007.ann,diethylnitrosamine,hepatocarcinogenesis,6,"It is suggested that CYP2E1 completely participates in diethylnitrosamine-induced hepatocarcinogenesis, and high frequency of tumors in wild-type mice could be associated with the increased apoptosis."
18784768_2007.ann,haloacetic acids,liver tumors,6,It was also nominated because dichloroacetic acid is the most studied representative of the class of haloacetic acids and has been shown to cause liver tumors in both rats and mice.
26708719_2016.ann,carbon tetrachloride (CCl4),liver damage,6,JNK proteins are activated via phosphorylation in response to acetaminophen- or carbon tetrachloride (CCl4)-induced liver damage; the level of activation correlates with the degree of injury.
26708719_2016.ann,acetaminophen,liver damage,6,JNK proteins are activated via phosphorylation in response to acetaminophen- or carbon tetrachloride (CCl4)-induced liver damage; the level of activation correlates with the degree of injury.
26708719_2016.ann,carbon tetrachloride,liver damage,6,JNK proteins are activated via phosphorylation in response to acetaminophen- or carbon tetrachloride (CCl4)-induced liver damage; the level of activation correlates with the degree of injury.
26708719_2016.ann,CCl4,liver damage,6,JNK proteins are activated via phosphorylation in response to acetaminophen- or carbon tetrachloride (CCl4)-induced liver damage; the level of activation correlates with the degree of injury.
26627606_2016.ann,carbon tetrachloride,Liver fibrosis,6,"Liver fibrosis was induced by carbon tetrachloride, bile duct ligation, or disruption of the multidrug-resistance transporter 2 gene (Mdr2)."
25305127_2014.ann,fluopyram,Liver tumor,6,Liver tumor formation in female rat induced by fluopyram is mediated by CAR/PXR nuclear receptor activation.
22467020_2012.ann,etofenprox,Liver tumor,6,Liver tumor promoting effect of etofenprox in rats and its possible mechanism of  action.
23665939_2013.ann,orphenadrine,Liver tumor,6,Liver tumor promoting effect of orphenadrine in rats and its possible mechanism of action including CAR activation and oxidative stress.
8565130_1996.ann,diethylnitrosamine,Liver tumors,6,Liver tumors were induced in male Fischer F344 rats by diethylnitrosamine (DEN).
17942915_2007.ann,N-nitrosodiethylamine,hepatocarcinogenesis,6,Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.
15705887_2005.ann,folate,colon cancer,6,"Low dietary folate intake is associated with an increased risk for colon cancer;  however, relevant genetic animal models are lacking."
24144777_2013.ann,N-nitrosodiethylamine,hepatocarcinogenesis,6,"Lycopene modulates initiation of N-nitrosodiethylamine induced hepatocarcinogenesis: studies on chromosomal abnormalities, membrane fluidity and antioxidant defense system."
25419570_2014.ann,diethylnitrosamine,hepatocarcinogenesis,6,"Male F344 rats were treated with one of the most  powerful Valerian species (Valeriana sitchensis) at doses of 0, 50, 500 and 5000  ppm in their drinking water after initiation of hepatocarcinogenesis with diethylnitrosamine (DEN)."
28260109_2017.ann,diethylnitrosamine,liver cancer,6,"Male Malat1-/- mice and their wild-type (WT) littermates were studied one year after treatment with the genotoxic agent diethylnitrosamine (DEN), a potent inducer of liver cancer."
26187448_2015.ann,Toxaphene,Liver Tumors,6,Mechanistic Investigation of Toxaphene Induced Mouse Liver Tumors.
22076107_2012.ann,flutamide,liver tumor,6,Mechanistic study on liver tumor promoting effects of flutamide in rats.
26656265_2015.ann,Diethylnitrosamine,Hepatocarcinogenesis,6,Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis.
27696512_2017.ann,diethylnitrosamine,hepatocellular carcinoma,6,Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma.
26548419_2016.ann,diethylnitrosamine,hepatocarcinogenesis,6,Metformin inhibits early stage diethylnitrosamineinduced hepatocarcinogenesis in  rats.
19850985_2008.ann,N-nitrosodiethylamine,hepatocarcinogenesis,6,"METHODS: A Solt-Farber two-step test model of hepatocarcino genesis was established by diethylnitrosamine (DEN) and 2-acetylaminofluorene (AAF) in rats to investigate the modifying effects of expression of 6-glucosephosphatase (G-6-Pase), succinodehydrogenase (SDH), adenosine triphosphatase (ATPase) in N-nitrosodiethylamine-mediated hepatocarcinogenesis."
19913322_2010.ann,carbon tetrachloride,Liver fibrosis,6,METHODS: Liver fibrosis was induced in mice receiving bile duct ligation (BDL) or carbon tetrachloride (CCl(4)) administration.
24725680_2014.ann,diethylnitrosamine,hepatocellular carcinoma,6,METHODS: Twenty-four Sprague-Dawley rats were treated with diethylnitrosamine and phenobarbital to induce hepatocellular carcinoma.
26161998_2015.ann,diethylnitrosamine,hepatocellular carcinoma,6,Mice developing diethylnitrosamine-induced hepatocellular carcinoma were subjected to hydrodynamic gene delivery to overexpress Gas1 in liver.
19176366_2009.ann,metofluthrin,liver tumors,6,Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation.
19850985_2008.ann,N-nitrosodiethylamine,hepatocarcinogenesis,6,"Modulation of energy metabolic enzyme expression in N-nitrosodiethylamine-mediated hepatocarcinogenesis by Chinese herbs, Huqi San."
19479993_2009.ann,azoxymethane,colon carcinogenesis,6,"Moreover, in the mouse model of azoxymethane-induced colon carcinogenesis, rimonabant significantly decreased aberrant crypt foci (ACF) formation, which precedes colorectal cancer."
19176532_2009.ann,fibrates,cholestasis,6,"Moreover, the mechanisms by which fibrates induce hepatocyte proliferation and cholestasis are still not fully understood."
17942915_2007.ann,N-nitrosodiethylamine,hepatocarcinogenesis,6,N-acetyl-L-cysteine blocked the EGFR activation  and reduced the N-nitrosodiethylamine-initiated hepatocarcinogenesis to the levels of Cre-Ctrl mice.
19004024_2009.ann,diethylnitrosamine,hepatocarcinogenesis,6,Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats.
24660901_2014.ann,diethylnitrosamine,hepatocarcinogenesis,6,Orally administered lycopene attenuates diethylnitrosamine-induced hepatocarcinogenesis in rats by modulating Nrf-2/HO-1 and Akt/mTOR pathways.
26219504_2015.ann,HCB,hepatocarcinogenesis,6,Our results provide a clue to the molecular events involved in the mechanism of action of HCB-induced hepatocarcinogenesis.
12771043_2003.ann,ciprofibrate,liver tumors,6,Our results show that HCCs developing in AOX-/- mice share a number of deregulated (up- or down-regulated) genes with ciprofibrate-induced liver tumors.
27470341_2016.ann,nitrosodiethylamine,hepatocellular carcinoma,6,"Overall all these findings substantiate that artesunate promotes anti-tumour, anti-proliferation and apoptosis against nitrosodiethylamine mediated hepatocellular carcinoma."
26714183_2015.ann,acetaminophen,liver injury,6,Overdose of acetaminophen (APAP) causes liver injury in humans and animals.
22687991_2012.ann,N-diethylnitrosamine,hepatocarcinogenesis,6,"Partial hepatectomized rats (n = 11 to 12) were fed diets containing 0, 0.03, 0.06, 0.125 or 0.25% BNF for 6 weeks after an intraperitoneal injection of N-diethylnitrosamine (DEN) to initiate hepatocarcinogenesis."
11753661_2001.ann,Phenobarbital,hepatocarcinogenesis,6,Phenobarbital (PB) is an antiepileptic drug which promotes hepatocarcinogenesis in rodents when administered subsequent to an initiating carcinogen like diethylnitrosamine (DEN).
18253720_2008.ann,fenofibrate,hepatocarcinogenesis,6,Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats.
17498859_2007.ann,piperonyl butoxide,hepatocarcinogenesis,6,Possible involvement of oxidative stress in piperonyl butoxide induced hepatocarcinogenesis in rats.
27697726_2016.ann,dextran sodium sulfate,colon carcinogenesis,6,Prevention of azoxymethane/dextran sodium sulfate-induced mouse colon carcinogenesis by processed Aloe vera gel.
27697726_2016.ann,azoxymethane,colon carcinogenesis,6,Prevention of azoxymethane/dextran sodium sulfate-induced mouse colon carcinogenesis by processed Aloe vera gel.
24146112_2014.ann,alcohol,liver injury,6,Protective effects of dioscin against alcohol-induced liver injury.
7955063_1994.ann,tetrachloroethylene,liver tumors,6,"ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice."
7955063_1994.ann,trichloroethylene,liver tumors,6,"ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice."
7955063_1994.ann,dichloroacetic acid,liver tumors,6,"ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice."
15660382_2005.ann,diethylnitrosamine,cirrhosis,6,Rats received weekly intraperitoneal injections of diethylnitrosamine (DEN) followed by a 2-week wash-out period that caused cirrhosis in 14 weeks and multifocal HCC in 18 weeks.
19406679_2009.ann,azoxymethane,colon cancer,6,Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and  colon cancer in growth hormone deficient rats.
19061943_2009.ann,diethylnitrosamine,liver tumors,6,Regulation of iron metabolism-related genes in diethylnitrosamine-induced mouse liver tumors.
27825961_2017.ann,azoxymethane,colitis,6,Reporter mice were given azoxymethane followed by dextran sulfate sodium to induce colitis and colon tumors; some mice were given the ROCK inhibitor fasudil along with these agents (ROCK inhibitors increase miRNA function).
27825961_2017.ann,azoxymethane,colitis,6,Reporter mice were given azoxymethane followed by dextran sulfate sodium to induce colitis and colon tumors; some mice were given the ROCK inhibitor fasudil along with these agents (ROCK inhibitors increase miRNA function).
15447978_2005.ann,bezafibrate,hepatocarcinogenesis,6,"Results from these studies demonstrate  that the PPARalpha is required to mediate hepatocarcinogenesis induced by bezafibrate, and that PPARalpha protects against potential cholestasis."
26627606_2016.ann,diethylnitrosamine,hepatocarcinogenesis,6,"RESULTS: Deletion of Tgfbr2 from liver epithelial cells did not alter liver injury, toxin-induced or biliary fibrosis, or diethylnitrosamine-induced hepatocarcinogenesis."
20823143_2010.ann,azoxymethane,colon tumorigenesis,6,RESULTS: Silibinin feeding showed a dose-dependent decrease in azoxymethane-induced colon tumorigenesis with stronger efficacy in pretreatment versus posttreatment regimen.
27154061_2016.ann,adrenaline,hepatocarcinogenesis,6,"RESULTS: We uncovered that adrenaline promoted DEN-induced hepatocarcinogenesis, which was reversed by the ADRB2 antagonist ICI118,551."
18056438_2007.ann,diethylnitrosamine,hepatocarcinogenesis,6,Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo.
18775883_2008.ann,fenofibrate,hepatocarcinogenesis,6,Role of Nrf2 and oxidative stress on fenofibrate-induced hepatocarcinogenesis in  rats.
15447978_2005.ann,bezafibrate,hepatocarcinogenesis,6,Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
15447978_2005.ann,bezafibrate,cholestasis,6,Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
18490896_2008.ann,ethanol,liver damage,6,Role of the life span determinant P66(shcA) in ethanol-induced liver damage.
23288052_2013.ann,carbon tetrachloride,liver fibrosis,6,"Second, carbon tetrachloride (CCl(4); 0.2ml/kg, 2/week ip starting at 8 weeks of age) was administered for 9 or 14 weeks to develop advanced liver fibrosis."
11753661_2001.ann,phenobarbital,liver tumors,6,Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
26708719_2016.ann,acetaminophen,liver injury,6,"SP600125, a JNK inhibitor, has been reported to block  acetaminophen-induced liver injury."
19176366_2009.ann,Metofluthrin,liver tumors,6,The above parameters related to the key events in Metofluthrin-induced liver tumors were observed at or below tumorigenic dose levels.
24223741_2013.ann,diethylnitrosamine,liver cirrhosis,6,The aim of  this study was to examine the anti-cancer and anti-fibrotic effects of BCAA on the development of diethylnitrosamine (DEN)-induced HCC and liver cirrhosis in a  rat model.
18397917_2008.ann,diethylnitrosamine,hepatocarcinogenesis,6,"The aim of this work was to characterize the effect of CAPE on cytochrome P450 (CYP), which is involved in diethylnitrosamine (DEN) metabolism during the initiation stage of chemical hepatocarcinogenesis."
25092647_2014.ann,pronamide,liver tumors,6,The conclusion from this evaluation is that pronamide-induced mouse liver tumors occur via an NR-mediated MoA involving CAR and PPAR-alpha activation and this MoA is not relevant to humans based on qualitative/quantitative differences between mice and humans.
1995187_1991.ann,diethylnitrosamine,hepatocarcinogenesis,6,The correlation of body growth with diethylnitrosamine-induced hepatocarcinogenesis in relation to serum insulin and somatomedin-C.
18558347_2008.ann,diethyl nitrosamine,hepatocarcinogenesis,6,The effects of D-allose on diethyl nitrosamine (DEN)-induced hepatocarcinogenesis were examined in male F344 rats by a rat medium-term bioassay based on the two-step model of hepatocarcinogenesis (experiment 1).
12841865_2003.ann,tamoxifen,hepatocarcinogenesis,6,The gene expression of hepatic proteins responsible for DNA repair and cell proliferation in tamoxifen-induced hepatocarcinogenesis.
25123088_2014.ann,tamoxifen,hepatocarcinogenesis,6,"The goals of the present study were to (i) investigate the mechanisms of the resistance of mice to tamoxifen-induced hepatocarcinogenesis, and (ii) clarify effects of tamoxifen on NAFLD-associated liver injury."
17557908_2007.ann,cyproconazole,liver damage,6,"The higher dose (450 ppm) of cyproconazole caused similar changes, but greater evidence of liver damage was observed, including a large increase in plasma transaminases."
12060674_2002.ann,CCl4,liver damage,6,"The knockout animals have increased lipid peroxidation and enhanced sensitivity to CCl4-induced liver damage, which was largely due to increased CYP2E1 expression because diallyl sulfide, an inhibitor of CYP2E1, prevented CCl4-induced liver injury."
12060674_2002.ann,CCl4,liver injury,6,"The knockout animals have increased lipid peroxidation and enhanced sensitivity to CCl4-induced liver damage, which was largely due to increased CYP2E1 expression because diallyl sulfide, an inhibitor of CYP2E1, prevented CCl4-induced liver injury."
20034026_2010.ann,diethyl-nitrosamine,hepatocarcinogenesis,6,The objective of this study was to examine the effect of pharmacology PARP-1 inhibition on the reduction of tumor volume of HCC xenograft and on the hepatocarcinogenesis induced by diethyl-nitrosamine (DEN).
15492232_2004.ann,phenobarbital,liver tumor,6,The orphan nuclear receptor constitutive active/androstane receptor is essential  for liver tumor promotion by phenobarbital in mice.
12771043_2003.ann,ciprofibrate,liver tumors,6,"The overall commonality of expression between  AOX-/- and ciprofibrate-induced liver tumors but not with DENA-induced tumors strongly implicates the activation of PPARalpha and PPARalpha-regulated genes in  liver, including those participating in lipid catabolism, as key factors in the development of HCC in AOX-/- and in ciprofibrate-treated mice."
24012840_2013.ann,N-nitrosodiethylamine,hepatocarcinogenesis,6,"The present study was aimed to investigate the efficacy of thymoquinone (TQ), an active compound derived from the medicinal plant Nigella sativa, on N-nitrosodiethylamine (NDEA) [0.01% in drinking water for 16 weeks]-induced hepatocarcinogenesis in experimental rats."
23422335_2013.ann,carbon tetrachloride,liver injury,6,The present study was designed to investigate the hepatoprotective effect of the plant extracts against carbon tetrachloride (CCl4) induced hepatocyte damage in vitro and liver injury in vivo.
23422335_2013.ann,carbon tetrachloride (CCl4),liver injury,6,The present study was designed to investigate the hepatoprotective effect of the plant extracts against carbon tetrachloride (CCl4) induced hepatocyte damage in vitro and liver injury in vivo.
23422335_2013.ann,CCl4,liver injury,6,The present study was designed to investigate the hepatoprotective effect of the plant extracts against carbon tetrachloride (CCl4) induced hepatocyte damage in vitro and liver injury in vivo.
21607999_2011.ann,diethylnitrosamine,liver cancer,6,The purpose of this investigation was to investigate the chemopreventive action and the possible mechanisms of saffron against diethylnitrosamine (DEN)-induced liver cancer in rats.
10959800_2000.ann,tamoxifen,hepatocarcinogenesis,6,"The results show that tamoxifen, but not toremifene, has the potential to induce and promote the development of rat hepatocarcinogenesis in this experimental model."
26443840_2016.ann,carbon  tetrachloride,liver cirrhosis,6,"Therefore, the effects of the orally bioavailable synthetic triterpenoid 2-cyano-3,12-dioxooleana- 1,9(11)-dien-28-oate-ethyl amide (CDDO-EA, RTA 405), which has potent antioxidative and antiinflammatory properties, was evaluated in a chronic carbon  tetrachloride (CCl(4))-induced model of liver cirrhosis and hepatocellular carcinoma (HCC)."
26443840_2016.ann,carbon  tetrachloride,hepatocellular carcinoma,6,"Therefore, the effects of the orally bioavailable synthetic triterpenoid 2-cyano-3,12-dioxooleana- 1,9(11)-dien-28-oate-ethyl amide (CDDO-EA, RTA 405), which has potent antioxidative and antiinflammatory properties, was evaluated in a chronic carbon  tetrachloride (CCl(4))-induced model of liver cirrhosis and hepatocellular carcinoma (HCC)."
26443840_2016.ann,carbon  tetrachloride,hepatocellular carcinoma (HCC),6,"Therefore, the effects of the orally bioavailable synthetic triterpenoid 2-cyano-3,12-dioxooleana- 1,9(11)-dien-28-oate-ethyl amide (CDDO-EA, RTA 405), which has potent antioxidative and antiinflammatory properties, was evaluated in a chronic carbon  tetrachloride (CCl(4))-induced model of liver cirrhosis and hepatocellular carcinoma (HCC)."
20972371_2010.ann,diethylnitrosamine,hepatocarcinogenesis,6,"Therefore, this study has been initiated to investigate whether thymoquinone (TQ), Nigella sativa derived-compound with strong antioxidant properties, supplementation could prevent initiation of hepatocarcinogenesis-induced by diethylnitrosamine (DENA),  a potent initiator and hepatocarcinogen, in rats."
14688030_2004.ann,o-nitrotoluene,colon cancer,6,"These alterations, which are hallmarks of human colon cancer, probably contributed to the pathogenesis of the large intestinal carcinomas in mice following o-nitrotoluene exposure."
26187448_2015.ann,toxaphene,liver tumors,6,"These findings, taken together with previously reported studies, support the mode of action of toxaphene induced mouse liver tumors is through a nongenotoxic mechanism involving primarily a CAR-mediated processes that results in an increase in cell proliferation in the liver, promotes the clonal expansion of preneoplastic lesions leading to adenoma formation."
17942915_2007.ann,N-nitrosodiethylamine,hepatocarcinogenesis,6,These results argue that intact HGF/c-Met signaling is essential for maintaining normal redox homeostasis in the liver and has tumor suppressor effect(s) during the early stages of N-nitrosodiethylamine-induced hepatocarcinogenesis.
17997003_2008.ann,Thioacetamide,steatohepatitis,6,"Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio."
24275088_2014.ann,carbon tetrachloride (CCl4),liver fibrosis,6,This study evaluated the beneficial effects of coffee or caffeine in a medium-term bioassay for rat liver fibrosis/carcinogenesis induced by diethylnitrosamine (DEN) and carbon tetrachloride (CCl4).
24275088_2014.ann,diethylnitrosamine,liver fibrosis,6,This study evaluated the beneficial effects of coffee or caffeine in a medium-term bioassay for rat liver fibrosis/carcinogenesis induced by diethylnitrosamine (DEN) and carbon tetrachloride (CCl4).
24275088_2014.ann,carbon tetrachloride,liver fibrosis,6,This study evaluated the beneficial effects of coffee or caffeine in a medium-term bioassay for rat liver fibrosis/carcinogenesis induced by diethylnitrosamine (DEN) and carbon tetrachloride (CCl4).
24275088_2014.ann,CCl4,liver fibrosis,6,This study evaluated the beneficial effects of coffee or caffeine in a medium-term bioassay for rat liver fibrosis/carcinogenesis induced by diethylnitrosamine (DEN) and carbon tetrachloride (CCl4).
17724725_2008.ann,azoxymethane,colon carcinogenesis,6,This study tested the effectiveness of SAM supplementation in protecting against azoxymethane (AOM)-induced colon carcinogenesis in male F344 rats.
26187448_2015.ann,toxaphene,liver tumors,6,This study was performed to investigate the mode of action of toxaphene induced mouse liver tumors.
19176366_2009.ann,Metofluthrin,liver tumors,6,"Thus, it is highly likely that the MOA  for Metofluthrin-induced liver tumors in rats is through CYP induction and increased hepatocyte proliferation, similar to that seen for phenobarbital."
24012840_2013.ann,N-nitrosodiethylamine,hepatocellular carcinoma,6,Thymoquinone inhibits cell proliferation through regulation of G1/S phase cell cycle transition in N-nitrosodiethylamine-induced experimental rat hepatocellular carcinoma.
15765122_2005.ann,diethylnitrosamine,liver tumors,6,"To  approach this question, molecular and cellular responses were monitored during the development of liver tumors in mice exposed to a chemical hepatocarcinogen, diethylnitrosamine (DEN), in drinking water (50 microg/l)."
14633663_2004.ann,diethylnitrosamine,hepatocarcinogenesis,6,"To clarify the mechanism by which IFN-alpha prevents hepatocarcinogenesis, we examined the effect of IFN-alpha in a chemically induced hepatocarcinogenesis model initiated by diethylnitrosamine (DEN) and promoted by  2-acetylaminofluorene (2-AAF) and partial hepatectomy, in which hepatocellular carcinoma (HCC) arises through pre-neoplastic foci without inflammation or fibrosis."
14633663_2004.ann,2-acetylaminofluorene,hepatocarcinogenesis,6,"To clarify the mechanism by which IFN-alpha prevents hepatocarcinogenesis, we examined the effect of IFN-alpha in a chemically induced hepatocarcinogenesis model initiated by diethylnitrosamine (DEN) and promoted by  2-acetylaminofluorene (2-AAF) and partial hepatectomy, in which hepatocellular carcinoma (HCC) arises through pre-neoplastic foci without inflammation or fibrosis."
14633663_2004.ann,2-AAF,hepatocarcinogenesis,6,"To clarify the mechanism by which IFN-alpha prevents hepatocarcinogenesis, we examined the effect of IFN-alpha in a chemically induced hepatocarcinogenesis model initiated by diethylnitrosamine (DEN) and promoted by  2-acetylaminofluorene (2-AAF) and partial hepatectomy, in which hepatocellular carcinoma (HCC) arises through pre-neoplastic foci without inflammation or fibrosis."
18056438_2007.ann,diethylnitrosamine,hepatocarcinogenesis,6,"To clarify this, we carried out a diethylnitrosamine-induced hepatocarcinogenesis experiment using Cyp2e1-null mice."
10025872_1998.ann,azoxymethane,colon carcinogenesis,6,"To elucidate the precise role of UDCA in the chemoprevention of azoxymethane-induced colon carcinogenesis, we examined the expression levels of group II phospholipase A2 in the colonic tissue of UDCA-treated and untreated rats and correlated the levels with the findings of aberrant crypt foci, putative preneoplastic lesions."
24339898_2013.ann,N-diethylnitrosamine,hepatocellular carcinoma,6,"To explore the role of CHOP in hepatocarcinogenesis, we induced hepatocellular carcinoma (HCC) in wild type (wt) and CHOP knockout (KO) mice using the carcinogen N-diethylnitrosamine (DEN)."
24339898_2013.ann,N-diethylnitrosamine,hepatocellular carcinoma (HCC),6,"To explore the role of CHOP in hepatocarcinogenesis, we induced hepatocellular carcinoma (HCC) in wild type (wt) and CHOP knockout (KO) mice using the carcinogen N-diethylnitrosamine (DEN)."
24247078_2014.ann,diethylinitrosamine,hepatocarcinogenesis,6,To investigate the effects of Compound Astragalus and Salvia miltiorrhiza Extract (CASE) on diethylinitrosamine (DEN)-induced hepatocarcinogenesis in rats.
15059925_2004.ann,"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",colon cancer,6,"To shed light on global changes in gene expression of colon cancers and to gain further insight into the molecular mechanisms underlying colon carcinogenesis, we have conducted a comprehensive microarray analysis of mRNA using a rat colon cancer model with the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)."
17703865_2007.ann,"2,2',4,4',5,5'-hexachlorobiphenyl",hepatocarcinogenesis,6,"To test our hypothesis, we studied the effects of Kupffer cell inhibition by dietary glycine (an inhibitor of Kupffer cell secretory activity) in a rat two-stage hepatocarcinogenesis model using 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153, a non-dioxin-like PCB) or 3,3',4,4'-tetrachlorobiphenyl (PCB-77, a dioxin-like PCB) as promoters."
17703865_2007.ann,"3,3',4,4'-tetrachlorobiphenyl",hepatocarcinogenesis,6,"To test our hypothesis, we studied the effects of Kupffer cell inhibition by dietary glycine (an inhibitor of Kupffer cell secretory activity) in a rat two-stage hepatocarcinogenesis model using 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153, a non-dioxin-like PCB) or 3,3',4,4'-tetrachlorobiphenyl (PCB-77, a dioxin-like PCB) as promoters."
18434113_2008.ann,diethylnitrosamine,hepatocarcinogenesis,6,Tomato oleoresin inhibits DNA damage but not diethylnitrosamine-induced rat hepatocarcinogenesis.
8001232_1994.ann,phenobarbital,liver tumors,6,"Transforming growth factor-beta receptors type I, II and III in phenobarbital-promoted rat liver tumors."
26918349_2016.ann,sorafenib,colon cancer,6,Treatment of HCC and colon cancer xenografts with both aspirin and sorafenib results in more significant tumor suppression than single agent.
18001218_2007.ann,2-AAF,hepatocarcinogenesis,6,Vanadium is chemopreventive against the early stages of 2-AAF-induced hepatocarcinogenesis in rats.
12771043_2003.ann,ciprofibrate,liver tumors,6,"We  found a panel of 12 genes upregulated in all three classes of liver tumors, namely AOX-/-, ciprofibrate-induced and DENA-induced."
16818512_2006.ann,azoxymethane,colon cancer,6,We assessed the chemopreventive properties of NO-indomethacin (NCX 530) and NO-aspirin (NCX 4016) against azoxymethane-induced  colon cancer.
19363144_2009.ann,conazoles,liver tumors,6,"We conclude that although PB and these 2 conazoles induce mouse liver tumors and exhibit similar toxicological responses, their transcriptional profiles are significantly different and thus their mechanisms of tumorigenic action are likely to differ."
18056438_2007.ann,diethylnitrosamine,hepatocarcinogenesis,6,We conclude that Cyp2e1-null mice show lower tumor incidence and multiplicity compared with wild-type mice in  diethylnitrosamine-induced hepatocarcinogenesis.
19221092_2009.ann,azoxymethane,colon tumor,6,We find that enzastaurin potently reduces azoxymethane-induced colon tumor initiation and progression by inhibiting PKCbetaII-mediated tumor cell proliferation and beta-catenin accumulation.
23479080_2013.ann,N-nitrosodiethylamine,liver tumors,6,We have induced liver tumors in mice by treatment with the liver carcinogen N-nitrosodiethylamine followed by chronic treatment with the tumor promoter phenobarbital.
14691202_2004.ann,arsenite,hepatocellular carcinoma (HCC),6,We have reported that brief exposure of pregnant C3H mice to arsenite in their drinking water during gestation induced hepatocellular carcinoma (HCC) in male offspring after they became adults.
14691202_2004.ann,arsenite,hepatocellular carcinoma,6,We have reported that brief exposure of pregnant C3H mice to arsenite in their drinking water during gestation induced hepatocellular carcinoma (HCC) in male offspring after they became adults.
17582756_2007.ann,diethylnitrosamine,hepatocarcinogenesis,6,"We monitored pre-neoplastic foci induced by a two-stage initiation/promotion model of hepatocarcinogenesis in rats, using diethylnitrosamine and acetylaminofluorene."
17582756_2007.ann,acetylaminofluorene,hepatocarcinogenesis,6,"We monitored pre-neoplastic foci induced by a two-stage initiation/promotion model of hepatocarcinogenesis in rats, using diethylnitrosamine and acetylaminofluorene."
20007298_2010.ann,diethylnitrosamine,hepatocarcinogenesis,6,We now examined the role of PBP/MED1 in genotoxic chemical  carcinogen diethylnitrosamine (DEN)-induced and phenobarbital-promoted hepatocarcinogenesis.
17417780_2007.ann,dextran sodium sulfate,colon carcinogenesis,6,We previously reported that dextran sodium sulfate (DSS) strongly enhances colon carcinogenesis in the Apc(Min/+) mice and the over-expression of inducible nitric oxide synthase (iNOS) contributes to this enhancement.
19551842_2010.ann,diethylnitrosamine,hepatocarcinogenesis,6,We recently showed that high-fat diet (HFD)-induced nonalcoholic steatohepatitis (NASH) promoted diethylnitrosamine (DEN)-initiated hepatocarcinogenesis in a rat model.
24660901_2014.ann,diethylnitrosamine,hepatocarcinogenesis,6,We studied  the mechanisms underlying the inhibition of diethylnitrosamine (DEN)-induced hepatocarcinogenesis by lycopene in rats.
9163695_1997.ann,"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",intestinal neoplasia,6,"We studied whether the most abundant mutagenic heterocyclic amine isolated from cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), could influence early intestinal neoplasia in C57BL/6J-Min/+ and C57BL/6J- +/+ (wild-type) mice of both sexes."
12771043_2003.ann,ciprofibrate,liver tumor,6,"We then compared the AOX-/- liver tumor expression profiles with those induced by ciprofibrate, a non-genotoxic peroxisome proliferator, or by the genotoxic carcinogen diethylnitrosamine (DENA) to discern differences in gene expression patterns that may predict or distinguish PPARalpha-mediated liver tumors from genotoxically derived tumors."
25687406_2015.ann,dextran sodium sulfate,ulcerative colitis,6,We thus treated simple Tgfbr2(DeltaIEC) mice with dextran sodium sulfate (DSS) that causes ulcerative colitis.
20214788_2010.ann,diethylnitrosamine,liver cancer,6,We used diethylnitrosamine (DEN) injection to initiate liver cancer in mice and assessed the extent of liver cancer in JDP2-transgenic and wild type  control mice by biochemical and molecular biology techniques.
23747414_2013.ann,goldenseal,liver tumors,6,"When goldenseal was evaluated  by the National Toxicology Program (NTP) in the standard 2-year bioassay, goldenseal induced an increase in liver tumors in rats and mice; however, the mechanism of goldenseal-associated liver carcinogenicity remains unknown."
18202802_2008.ann,PTX-2,growth response-1 (Egr-1) gene,7," Additionally, the transcription factor early growth response-1 (Egr-1) gene was transcriptionally activated and the levels of non-steroidal anti-inflammatory drugs (NSAID)-activated gene-1 (NAG-1) protein were also elevated in PTX-2-treated Hep3B cells."
18202802_2008.ann,PTX-2,NAG-1,7," Additionally, the transcription factor early growth response-1 (Egr-1) gene was transcriptionally activated and the levels of non-steroidal anti-inflammatory drugs (NSAID)-activated gene-1 (NAG-1) protein were also elevated in PTX-2-treated Hep3B cells."
18202802_2008.ann,non-steroidal anti-inflammatory drugs (NSAID),NAG-1,7," Additionally, the transcription factor early growth response-1 (Egr-1) gene was transcriptionally activated and the levels of non-steroidal anti-inflammatory drugs (NSAID)-activated gene-1 (NAG-1) protein were also elevated in PTX-2-treated Hep3B cells."
18202802_2008.ann,non-steroidal anti-inflammatory drugs,NAG-1,7," Additionally, the transcription factor early growth response-1 (Egr-1) gene was transcriptionally activated and the levels of non-steroidal anti-inflammatory drugs (NSAID)-activated gene-1 (NAG-1) protein were also elevated in PTX-2-treated Hep3B cells."
18202802_2008.ann,NSAID,NAG-1,7," Additionally, the transcription factor early growth response-1 (Egr-1) gene was transcriptionally activated and the levels of non-steroidal anti-inflammatory drugs (NSAID)-activated gene-1 (NAG-1) protein were also elevated in PTX-2-treated Hep3B cells."
18202802_2008.ann,PTX-2,Egr-1 gene,7," Additionally, the transcription factor early growth response-1 (Egr-1) gene was transcriptionally activated and the levels of non-steroidal anti-inflammatory drugs (NSAID)-activated gene-1 (NAG-1) protein were also elevated in PTX-2-treated Hep3B cells."
18202802_2008.ann,PTX-2,growth response-1 gene,7," Additionally, the transcription factor early growth response-1 (Egr-1) gene was transcriptionally activated and the levels of non-steroidal anti-inflammatory drugs (NSAID)-activated gene-1 (NAG-1) protein were also elevated in PTX-2-treated Hep3B cells."
18524889_2008.ann,erlotinib,Epidermal growth factor receptor (EGFR),7, Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib shows potent antitumor activity in some non-small-cell lung cancer (NSCLC) cell lines and is approved by the Food and Drug Administration as second and third line treatment for NSCLC.
18524889_2008.ann,erlotinib,Epidermal growth factor receptor,7, Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib shows potent antitumor activity in some non-small-cell lung cancer (NSCLC) cell lines and is approved by the Food and Drug Administration as second and third line treatment for NSCLC.
18524889_2008.ann,erlotinib,EGFR,7, Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib shows potent antitumor activity in some non-small-cell lung cancer (NSCLC) cell lines and is approved by the Food and Drug Administration as second and third line treatment for NSCLC.
22579649_2012.ann,ACR,FXR-regulated genes,7," Our results suggest that ACR and GW4064 cooperatively inhibit RXRalpha phosphorylation, modulate the expression of FXR-regulated genes, thus resulting in the induction of apoptosis and the inhibition of growth in HCC cells."
12717389_2003.ann,troglitazone,Skp2,7, Quantitative real-time RT-PCR analysis showed that troglitazone down-regulated Skp2 at the mRNA levels.
12584176_2003.ann,sulindac,APC,7," This research provides evidence that teas, particularly when administered in combination with sulindac, are highly effective at inhibiting intestinal neoplasia in male Apc(min) mice via direct or indirect effects on the beta-catenin/APC pathway."
26383537_2015.ann,PA,p53,7," Thus, isolated colon CSCs (positive for CD44, CD133 and ALDH1b1 markers) with functioning p53 and shRNA-attenuated p53 were treated with PA at 5.0 mug/ml."
15347726_2004.ann,iodine,hNIS gene,7," UNLABELLED: To evaluate the possibility of radionuclide gene therapy and imaging  in hepatocellular carcinoma cancer, we investigated the iodine accumulation of a  human hepatocellular carcinoma cell line, SK-Hep1, by transfer of human sodium iodide symporter (hNIS) gene."
15347726_2004.ann,iodine,human sodium iodide symporter (hNIS) gene,7," UNLABELLED: To evaluate the possibility of radionuclide gene therapy and imaging  in hepatocellular carcinoma cancer, we investigated the iodine accumulation of a  human hepatocellular carcinoma cell line, SK-Hep1, by transfer of human sodium iodide symporter (hNIS) gene."
15347726_2004.ann,iodine,human sodium iodide symporter gene,7," UNLABELLED: To evaluate the possibility of radionuclide gene therapy and imaging  in hepatocellular carcinoma cancer, we investigated the iodine accumulation of a  human hepatocellular carcinoma cell line, SK-Hep1, by transfer of human sodium iodide symporter (hNIS) gene."
11895860_2002.ann,DEN,glutathione S-transferase P1-1,7," Whether single cells immunohistochemically positive for glutathione S-transferase P1-1 (GSTP1-1) induced in the female mouse liver by DEN (Hatayama et al., Carcinogenesis, 14, 537-538, 1993) are precursor initiated cells of preneoplastic foci, is of importance in chemical hepatocarcinogenesis."
11895860_2002.ann,DEN,glutathione S-transferase P1-1 (GSTP1-1),7," Whether single cells immunohistochemically positive for glutathione S-transferase P1-1 (GSTP1-1) induced in the female mouse liver by DEN (Hatayama et al., Carcinogenesis, 14, 537-538, 1993) are precursor initiated cells of preneoplastic foci, is of importance in chemical hepatocarcinogenesis."
11895860_2002.ann,DEN,GSTP1-1,7," Whether single cells immunohistochemically positive for glutathione S-transferase P1-1 (GSTP1-1) induced in the female mouse liver by DEN (Hatayama et al., Carcinogenesis, 14, 537-538, 1993) are precursor initiated cells of preneoplastic foci, is of importance in chemical hepatocarcinogenesis."
23112173_2012.ann,"1,25D",MYC gene,7,"1,25D inhibited MYC gene expression and accelerated its protein turnover."
23112173_2012.ann,"1,25D",c-MYC,7,"1,25D inhibited transcription of c-MYC-regulated genes in vitro, and topical 1,25D suppressed expression of c-MYC and its target setd8 in mouse skin,  whereas MXD1 levels increased."
25766325_2015.ann,benzimidazole,HER2,7,A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells.
26528816_2015.ann,beta-catenin,Ctnnb1 gene,7,"A critical threshold for beta-catenin levels in TCF-regulated transcription was uncovered for Apc mutation-induced effects in colon epithelium, along with evidence of a feed-forward role for beta-catenin in Ctnnb1 gene expression and CTNNB1 transcription."
24104199_2014.ann,APAP,DAX-1,7,A decreased protein level of DAX-1 by APAP treatment was also enhanced by miR-561 mimic transfection in HepG2 cells and primary human hepatocytes.
20035057_2010.ann,retinoic acid,cyclin E1 gene,7,Activation of RXRalpha by retinoic acids increased the cyclin E1 promoter activity indicating retinoic acid-mediated signaling positively controls cyclin E1 gene expression.
10426811_1999.ann,phenobarbital,bcl-2,7,"Acute treatment of B6C3F1 mice with phenobarbital resulted  in increased levels of bcl-2 and decreased levels of bax protein, while acute treatment with WY-14,643 resulted in increased bcl-2 and BAG-1 protein in the liver."
10426811_1999.ann,"WY-14,643",bcl-2,7,"Acute treatment of B6C3F1 mice with phenobarbital resulted  in increased levels of bcl-2 and decreased levels of bax protein, while acute treatment with WY-14,643 resulted in increased bcl-2 and BAG-1 protein in the liver."
22008536_2011.ann,CF,CCNB1,7,"Additionally, DNA microarray data indicated that cell cycle-related genes such as cyclins CCNB1 and CCNA2 and cyclin-dependent kinase inhibitor CDKN3 were also down-regulated by treatment with either PB or CF at 13 weeks."
22008536_2011.ann,CF,CCNA2,7,"Additionally, DNA microarray data indicated that cell cycle-related genes such as cyclins CCNB1 and CCNA2 and cyclin-dependent kinase inhibitor CDKN3 were also down-regulated by treatment with either PB or CF at 13 weeks."
22008536_2011.ann,CF,CDKN3,7,"Additionally, DNA microarray data indicated that cell cycle-related genes such as cyclins CCNB1 and CCNA2 and cyclin-dependent kinase inhibitor CDKN3 were also down-regulated by treatment with either PB or CF at 13 weeks."
19427195_2009.ann,"S-trans, trans-farnesylthiosalicyclic acid (FTS)",Ras,7,"AIMS/METHODS: We evaluated in vivo the  effect of intraperitoneal injections of the Ras inhibitor S-trans, trans-farnesylthiosalicyclic acid (FTS) on Ras activation and the development of  preneoplastic liver lesions in rats receiving weekly diethylnitrosamine (DEN) injections for 16weeks."
19427195_2009.ann,"S-trans, trans-farnesylthiosalicyclic acid",Ras,7,"AIMS/METHODS: We evaluated in vivo the  effect of intraperitoneal injections of the Ras inhibitor S-trans, trans-farnesylthiosalicyclic acid (FTS) on Ras activation and the development of  preneoplastic liver lesions in rats receiving weekly diethylnitrosamine (DEN) injections for 16weeks."
19427195_2009.ann,FTS,Ras,7,"AIMS/METHODS: We evaluated in vivo the  effect of intraperitoneal injections of the Ras inhibitor S-trans, trans-farnesylthiosalicyclic acid (FTS) on Ras activation and the development of  preneoplastic liver lesions in rats receiving weekly diethylnitrosamine (DEN) injections for 16weeks."
11076880_2000.ann,NSAIDs,tumour suppressor adenomatous polyposis coli (APC) gene,7,AIMS: The aim of this study was to examine the effects of NSAIDs on mRNA expression of tumour suppressor adenomatous polyposis coli (APC) gene in rat colon mucosa.
20681671_2010.ann,pterostilbene,COX-2  gene,7,"All of these results revealed that pterostilbene is an effective antitumor agent as well as its inhibitory effect through the down-regulation of inflammatory iNOS and COX-2  gene expression and up-regulation of apoptosis in mouse colon, suggesting that pterostilbene is a novel functional agent capable of preventing inflammation-associated colon tumorigenesis."
23108405_2013.ann,trig,proteasomal genes,7,"Along with Nrf2 inhibition, trig blocked the Nrf2-dependent expression of proteasomal genes (for example, s5a/psmd4 and alpha5/psma5) and reduced proteasome activity in all cell lines tested."
18202802_2008.ann,PTX-2,Egr-1,7,"Although further studies are needed to prove that an increased expression of Egr-1 by PTX-2 directly leads to NAG-1 induction and then apoptosis induction in p53-deficient Hep3B cells, the results of this study suggest that PTX-2 may be a good candidate for the development of a potential anti-tumorigenic agent in p53-deficient tumors."
18202802_2008.ann,PTX-2,NAG-1,7,"Although further studies are needed to prove that an increased expression of Egr-1 by PTX-2 directly leads to NAG-1 induction and then apoptosis induction in p53-deficient Hep3B cells, the results of this study suggest that PTX-2 may be a good candidate for the development of a potential anti-tumorigenic agent in p53-deficient tumors."
18337503_2008.ann,cisplatin,Mlh1,7,"Although the Mlh1(G67R) mutation resulted in DNA repair deficiency in homozygous mutant mice, it did not affect the MMR-mediated cellular response to DNA damage, including the apoptotic response of epithelial cells in the intestinal mucosa to cisplatin, which was defective in Mlh1(-/-) mice but remained normal in Mlh1(G67R/G67R) mice."
19190340_2009.ann,topoisomerase 2 inhibitors,WT1,7,"Among different chemotherapeutics, induction of WT1 transcription was restricted to topoisomerase 2 inhibitors."
20943371_2011.ann,grifolin,death-associated protein kinase 1,7,An apoptosis-related gene expression profiling analysis provided a clue that death-associated protein kinase 1 (dapk1) gene was upregulated at least twofold in response to grifolin treatment in nasopharyngeal carcinoma cell CNE1.
20943371_2011.ann,grifolin,death-associated protein kinase 1 (dapk1) gene,7,An apoptosis-related gene expression profiling analysis provided a clue that death-associated protein kinase 1 (dapk1) gene was upregulated at least twofold in response to grifolin treatment in nasopharyngeal carcinoma cell CNE1.
20943371_2011.ann,grifolin,dapk1,7,An apoptosis-related gene expression profiling analysis provided a clue that death-associated protein kinase 1 (dapk1) gene was upregulated at least twofold in response to grifolin treatment in nasopharyngeal carcinoma cell CNE1.
25232488_2014.ann,Androgen,GATA3 mRNA,7,"Androgen (R1881, dihydrotestosterone) treatment in SVHUC immortalized normal urothelial cells stably expressing AR (SVHUC-AR) decreased GATA3 expression at both mRNA and protein levels, which was  abolished by anti-androgens."
25232488_2014.ann,dihydrotestosterone,GATA3 mRNA,7,"Androgen (R1881, dihydrotestosterone) treatment in SVHUC immortalized normal urothelial cells stably expressing AR (SVHUC-AR) decreased GATA3 expression at both mRNA and protein levels, which was  abolished by anti-androgens."
18852136_2008.ann,t-PTER,Bcl-2,7,Antisense oligodeoxynucleotides to human superoxide dismutase 2 and/or ectopic bcl-2 overexpression avoided polyphenols and chemoradiotherapy-induced colorectal cancer elimination and showed that the mangano-type superoxide dismutase and Bcl-2 are key targets in the molecular mechanism activated by the combined application of t-PTER and QUER.
18852136_2008.ann,polyphenols,bcl-2,7,Antisense oligodeoxynucleotides to human superoxide dismutase 2 and/or ectopic bcl-2 overexpression avoided polyphenols and chemoradiotherapy-induced colorectal cancer elimination and showed that the mangano-type superoxide dismutase and Bcl-2 are key targets in the molecular mechanism activated by the combined application of t-PTER and QUER.
18852136_2008.ann,human superoxide dismutase 2,bcl-2,7,Antisense oligodeoxynucleotides to human superoxide dismutase 2 and/or ectopic bcl-2 overexpression avoided polyphenols and chemoradiotherapy-induced colorectal cancer elimination and showed that the mangano-type superoxide dismutase and Bcl-2 are key targets in the molecular mechanism activated by the combined application of t-PTER and QUER.
18852136_2008.ann,Antisense oligodeoxynucleotides,bcl-2,7,Antisense oligodeoxynucleotides to human superoxide dismutase 2 and/or ectopic bcl-2 overexpression avoided polyphenols and chemoradiotherapy-induced colorectal cancer elimination and showed that the mangano-type superoxide dismutase and Bcl-2 are key targets in the molecular mechanism activated by the combined application of t-PTER and QUER.
15073043_2004.ann,Arsenic,ER-alpha gene,7,"Arsenic also markedly reduced  the methylation within the ER-alpha gene promoter region, as assessed by methylation-specific PCR, and this reduction was statistically significant in 8 of 13 CpG sites within the promoter region."
19384947_2009.ann,LY294002,NAG-1,7,AST-induced NAG-1 activation was intensified when PI3K inhibitor LY294002 or Akt inhibitor was co-treated and reversed by NAG-1 siRNA transfection.
17916909_2007.ann,silibinin,Bcl-2,7,"At molecular level, silibinin increased IGFBP-3, Cip1/p21, Kip1/p27 levels and ERK1/2 activation and decreased Bcl-2, survivin and VEGF levels in tumors."
17916909_2007.ann,survivin,Bcl-2,7,"At molecular level, silibinin increased IGFBP-3, Cip1/p21, Kip1/p27 levels and ERK1/2 activation and decreased Bcl-2, survivin and VEGF levels in tumors."
19394332_2009.ann,beta-catenin,ITF-2B,7,"BACKGROUND & AIMS: The ubiquitously expressed basic helix-loop-helix transcription factor ITF-2B has an important role in differentiation processes, and its transcription is regulated by beta-catenin."
9037065_1997.ann,matrilysin,Min,7,"Based on these findings, we conclude that matrilysin is a suppressor of the Min phenotype, possibly by functioning in a capacity independent of matrix degradation."
19147571_2009.ann,gamma-secretase inhibitors (GSI),Notch,7,"Because Notch signaling is implicated in colon cancer tumorigenesis and protects  cells from apoptosis by inducing prosurvival targets, it was hypothesized that inhibition of Notch signaling with gamma-secretase inhibitors (GSI) may enhance the chemosensitivity of colon cancer cells."
19147571_2009.ann,gamma-secretase inhibitors,Notch,7,"Because Notch signaling is implicated in colon cancer tumorigenesis and protects  cells from apoptosis by inducing prosurvival targets, it was hypothesized that inhibition of Notch signaling with gamma-secretase inhibitors (GSI) may enhance the chemosensitivity of colon cancer cells."
19147571_2009.ann,GSI,Notch,7,"Because Notch signaling is implicated in colon cancer tumorigenesis and protects  cells from apoptosis by inducing prosurvival targets, it was hypothesized that inhibition of Notch signaling with gamma-secretase inhibitors (GSI) may enhance the chemosensitivity of colon cancer cells."
19642983_2009.ann,DEN,c-myc,7,Betaine supplementation attenuated the down-regulation of p16 and inhibited the up-regulation of c-myc induced by DEN in a dose-dependent manner (P < 0.01).
19642983_2009.ann,Betaine,c-myc,7,Betaine supplementation attenuated the down-regulation of p16 and inhibited the up-regulation of c-myc induced by DEN in a dose-dependent manner (P < 0.01).
19642983_2009.ann,Betaine,p16,7,Betaine supplementation attenuated the down-regulation of p16 and inhibited the up-regulation of c-myc induced by DEN in a dose-dependent manner (P < 0.01).
18490896_2008.ann,alcohol,p66,7,"Biochemical analysis of liver tissues revealed induction of the p66 protein by ethanol, whereas p66-deficient livers responded to alcohol  with a significant upregulation of the mitochondrial antioxidant enzyme MnSOD, nearly absent in control mice."
19147571_2009.ann,GSI34,Notch,7,"Blocking the activation of Notch signaling with GSI34 sensitized cells to chemotherapy and was synergistic with oxaliplatin, 5-FU, and SN-38."
19221000_2009.ann,genistein,BTG3 tumor suppressor gene promoter,7,"BTG3 tumor suppressor gene promoter demethylation, histone modification and cell  cycle arrest by genistein in renal cancer."
11753661_2001.ann,DEN/PB,Ha-ras,7,"By contrast, Ha-ras mutations were undetectable in tumors from mice treated with DEN/PB (0/32), while approximately 80% (37/46) of tumors from this group showed beta-catenin mutations."
12189186_2002.ann,sulindac,p27,7,"Calcium chloride, DFMO and piroxicam increased the protein and mRNA levels of p16 and along with sulindac increased the protein level of p27, but not its mRNA."
12189186_2002.ann,piroxicam,p16,7,"Calcium chloride, DFMO and piroxicam increased the protein and mRNA levels of p16 and along with sulindac increased the protein level of p27, but not its mRNA."
12189186_2002.ann,DFMO,p16,7,"Calcium chloride, DFMO and piroxicam increased the protein and mRNA levels of p16 and along with sulindac increased the protein level of p27, but not its mRNA."
12189186_2002.ann,Calcium chloride,p16,7,"Calcium chloride, DFMO and piroxicam increased the protein and mRNA levels of p16 and along with sulindac increased the protein level of p27, but not its mRNA."
12189186_2002.ann,Calcium chloride,c-myc,7,"Calcium chloride, DFMO, piroxicam and sulindac administered for 7 days decreased the mitotic index  and reduced the protein and mRNA levels of c-myc in colon tumors."
12189186_2002.ann,DFMO,c-myc,7,"Calcium chloride, DFMO, piroxicam and sulindac administered for 7 days decreased the mitotic index  and reduced the protein and mRNA levels of c-myc in colon tumors."
12189186_2002.ann,piroxicam,c-myc,7,"Calcium chloride, DFMO, piroxicam and sulindac administered for 7 days decreased the mitotic index  and reduced the protein and mRNA levels of c-myc in colon tumors."
12189186_2002.ann,sulindac,c-myc,7,"Calcium chloride, DFMO, piroxicam and sulindac administered for 7 days decreased the mitotic index  and reduced the protein and mRNA levels of c-myc in colon tumors."
23807222_2013.ann,salinomycin,Skp2,7,"Cdh1 knockdown by siRNA reversed salinomycin-induced Skp2 downregulation and p27Kip1 upregulation, indicating that salinomycin activates the APC(Cdh1)-Skp2-p27Kip1 pathway."
19706164_2009.ann,Celecoxib,p53,7,"Celecoxib did not induce significant autophagy in U87MG-PFT, U87MG-E6 and U373MG cells, which lack functional p53."
19706164_2009.ann,Celecoxib,p21,7,"Celecoxib induced G1-phase cell cycle arrest, accompanied with p21 activation in U87MG cells."
19706164_2009.ann,Celecoxib,p53,7,"Celecoxib inhibits glioblastoma cell viability by induction of DNA  damage, leading to p53-dependent G1 cell cycle arrest and p53-dependent autophagy, but not apoptosis."
24112473_2013.ann,MK-801,p27,7,"Cell cycle analysis showed that MK-801 induced G1 cell cycle arrest by down-regulating cyclin D1 and up-regulating p27. MK-801 dephosphorylated Thr24 in FOXO1 and induced its nuclear translocation, thus increasing transcription of TXNIP, a tumor suppressor gene."
25419570_2014.ann,Valerian,c-myc,7,"Cell proliferation was significantly inhibited, while apoptosis was induced in areas of GST-P(+) foci of Valerian groups associated with suppression of c-myc, Mafb, cyclin D1 and induction of p21(Waf1/Cip1), p53 and Bax mRNA expression."
25419570_2014.ann,Valerian,Mafb,7,"Cell proliferation was significantly inhibited, while apoptosis was induced in areas of GST-P(+) foci of Valerian groups associated with suppression of c-myc, Mafb, cyclin D1 and induction of p21(Waf1/Cip1), p53 and Bax mRNA expression."
25419570_2014.ann,Valerian,cyclin D1,7,"Cell proliferation was significantly inhibited, while apoptosis was induced in areas of GST-P(+) foci of Valerian groups associated with suppression of c-myc, Mafb, cyclin D1 and induction of p21(Waf1/Cip1), p53 and Bax mRNA expression."
21158707_2011.ann,micronutrients,epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit."
21158707_2011.ann,butyrate,epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit. E), butyrate, polyphenols (from green tea, apples, coffee, and other dietary sources), genistein and soy isoflavones, parthenolide, curcumin, ellagitannin, indol-3-carbinol (I3C) and diindolylmethane (DIM), mahanine, nordihydroguaiaretic acid (NDGA), lycopene, sulfur-containing compounds from Allium and cruciferous vegetables (sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS), allyl mercaptan (AM)), antibiotics (mithramycin A, apicidin), pharmacological agents (celecoxib, DFMO, 5-aza-2'-deoxycytidine and zebularine), compounds affecting sirtuin activity (resveratrol, dihydrocoumarin, cambinol), inhibitors of histone acetyl transferases (anacardic acid, garcinol, ursodeoxycholic acid), and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogues, n-3 polyunsaturated fatty acids)."
21158707_2011.ann,genistein,epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit. E), butyrate, polyphenols (from green tea, apples, coffee, and other dietary sources), genistein and soy isoflavones, parthenolide, curcumin, ellagitannin, indol-3-carbinol (I3C) and diindolylmethane (DIM), mahanine, nordihydroguaiaretic acid (NDGA), lycopene, sulfur-containing compounds from Allium and cruciferous vegetables (sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS), allyl mercaptan (AM)), antibiotics (mithramycin A, apicidin), pharmacological agents (celecoxib, DFMO, 5-aza-2'-deoxycytidine and zebularine), compounds affecting sirtuin activity (resveratrol, dihydrocoumarin, cambinol), inhibitors of histone acetyl transferases (anacardic acid, garcinol, ursodeoxycholic acid), and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogues, n-3 polyunsaturated fatty acids)."
21158707_2011.ann,soy isoflavones,epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit. E), butyrate, polyphenols (from green tea, apples, coffee, and other dietary sources), genistein and soy isoflavones, parthenolide, curcumin, ellagitannin, indol-3-carbinol (I3C) and diindolylmethane (DIM), mahanine, nordihydroguaiaretic acid (NDGA), lycopene, sulfur-containing compounds from Allium and cruciferous vegetables (sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS), allyl mercaptan (AM)), antibiotics (mithramycin A, apicidin), pharmacological agents (celecoxib, DFMO, 5-aza-2'-deoxycytidine and zebularine), compounds affecting sirtuin activity (resveratrol, dihydrocoumarin, cambinol), inhibitors of histone acetyl transferases (anacardic acid, garcinol, ursodeoxycholic acid), and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogues, n-3 polyunsaturated fatty acids)."
21158707_2011.ann,parthenolide,epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit. E), butyrate, polyphenols (from green tea, apples, coffee, and other dietary sources), genistein and soy isoflavones, parthenolide, curcumin, ellagitannin, indol-3-carbinol (I3C) and diindolylmethane (DIM), mahanine, nordihydroguaiaretic acid (NDGA), lycopene, sulfur-containing compounds from Allium and cruciferous vegetables (sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS), allyl mercaptan (AM)), antibiotics (mithramycin A, apicidin), pharmacological agents (celecoxib, DFMO, 5-aza-2'-deoxycytidine and zebularine), compounds affecting sirtuin activity (resveratrol, dihydrocoumarin, cambinol), inhibitors of histone acetyl transferases (anacardic acid, garcinol, ursodeoxycholic acid), and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogues, n-3 polyunsaturated fatty acids)."
21158707_2011.ann,curcumin,epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit. E), butyrate, polyphenols (from green tea, apples, coffee, and other dietary sources), genistein and soy isoflavones, parthenolide, curcumin, ellagitannin, indol-3-carbinol (I3C) and diindolylmethane (DIM), mahanine, nordihydroguaiaretic acid (NDGA), lycopene, sulfur-containing compounds from Allium and cruciferous vegetables (sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS), allyl mercaptan (AM)), antibiotics (mithramycin A, apicidin), pharmacological agents (celecoxib, DFMO, 5-aza-2'-deoxycytidine and zebularine), compounds affecting sirtuin activity (resveratrol, dihydrocoumarin, cambinol), inhibitors of histone acetyl transferases (anacardic acid, garcinol, ursodeoxycholic acid), and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogues, n-3 polyunsaturated fatty acids)."
21158707_2011.ann,ellagitannin,epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit. E), butyrate, polyphenols (from green tea, apples, coffee, and other dietary sources), genistein and soy isoflavones, parthenolide, curcumin, ellagitannin, indol-3-carbinol (I3C) and diindolylmethane (DIM), mahanine, nordihydroguaiaretic acid (NDGA), lycopene, sulfur-containing compounds from Allium and cruciferous vegetables (sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS), allyl mercaptan (AM)), antibiotics (mithramycin A, apicidin), pharmacological agents (celecoxib, DFMO, 5-aza-2'-deoxycytidine and zebularine), compounds affecting sirtuin activity (resveratrol, dihydrocoumarin, cambinol), inhibitors of histone acetyl transferases (anacardic acid, garcinol, ursodeoxycholic acid), and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogues, n-3 polyunsaturated fatty acids)."
21158707_2011.ann,indol-3-carbinol (I3C),epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit. E), butyrate, polyphenols (from green tea, apples, coffee, and other dietary sources), genistein and soy isoflavones, parthenolide, curcumin, ellagitannin, indol-3-carbinol (I3C) and diindolylmethane (DIM), mahanine, nordihydroguaiaretic acid (NDGA), lycopene, sulfur-containing compounds from Allium and cruciferous vegetables (sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS), allyl mercaptan (AM)), antibiotics (mithramycin A, apicidin), pharmacological agents (celecoxib, DFMO, 5-aza-2'-deoxycytidine and zebularine), compounds affecting sirtuin activity (resveratrol, dihydrocoumarin, cambinol), inhibitors of histone acetyl transferases (anacardic acid, garcinol, ursodeoxycholic acid), and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogues, n-3 polyunsaturated fatty acids)."
21158707_2011.ann,diindolylmethane (DIM),epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit. E), butyrate, polyphenols (from green tea, apples, coffee, and other dietary sources), genistein and soy isoflavones, parthenolide, curcumin, ellagitannin, indol-3-carbinol (I3C) and diindolylmethane (DIM), mahanine, nordihydroguaiaretic acid (NDGA), lycopene, sulfur-containing compounds from Allium and cruciferous vegetables (sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS), allyl mercaptan (AM)), antibiotics (mithramycin A, apicidin), pharmacological agents (celecoxib, DFMO, 5-aza-2'-deoxycytidine and zebularine), compounds affecting sirtuin activity (resveratrol, dihydrocoumarin, cambinol), inhibitors of histone acetyl transferases (anacardic acid, garcinol, ursodeoxycholic acid), and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogues, n-3 polyunsaturated fatty acids)."
21158707_2011.ann,nordihydroguaiaretic acid (NDGA),epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit. E), butyrate, polyphenols (from green tea, apples, coffee, and other dietary sources), genistein and soy isoflavones, parthenolide, curcumin, ellagitannin, indol-3-carbinol (I3C) and diindolylmethane (DIM), mahanine, nordihydroguaiaretic acid (NDGA), lycopene, sulfur-containing compounds from Allium and cruciferous vegetables (sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS), allyl mercaptan (AM)), antibiotics (mithramycin A, apicidin), pharmacological agents (celecoxib, DFMO, 5-aza-2'-deoxycytidine and zebularine), compounds affecting sirtuin activity (resveratrol, dihydrocoumarin, cambinol), inhibitors of histone acetyl transferases (anacardic acid, garcinol, ursodeoxycholic acid), and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogues, n-3 polyunsaturated fatty acids)."
21158707_2011.ann,lycopene,epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit. E), butyrate, polyphenols (from green tea, apples, coffee, and other dietary sources), genistein and soy isoflavones, parthenolide, curcumin, ellagitannin, indol-3-carbinol (I3C) and diindolylmethane (DIM), mahanine, nordihydroguaiaretic acid (NDGA), lycopene, sulfur-containing compounds from Allium and cruciferous vegetables (sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS), allyl mercaptan (AM)), antibiotics (mithramycin A, apicidin), pharmacological agents (celecoxib, DFMO, 5-aza-2'-deoxycytidine and zebularine), compounds affecting sirtuin activity (resveratrol, dihydrocoumarin, cambinol), inhibitors of histone acetyl transferases (anacardic acid, garcinol, ursodeoxycholic acid), and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogues, n-3 polyunsaturated fatty acids)."
21158707_2011.ann,polyphenols,epigenome,7,"Chemopreventive agents with reported mechanisms targeting the epigenome include micronutrients (folate, selenium, retinoic acid, Vit. E), butyrate, polyphenols (from green tea, apples, coffee, and other dietary sources), genistein and soy isoflavones, parthenolide, curcumin, ellagitannin, indol-3-carbinol (I3C) and diindolylmethane (DIM), mahanine, nordihydroguaiaretic acid (NDGA), lycopene, sulfur-containing compounds from Allium and cruciferous vegetables (sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS), allyl mercaptan (AM)), antibiotics (mithramycin A, apicidin), pharmacological agents (celecoxib, DFMO, 5-aza-2'-deoxycytidine and zebularine), compounds affecting sirtuin activity (resveratrol, dihydrocoumarin, cambinol), inhibitors of histone acetyl transferases (anacardic acid, garcinol, ursodeoxycholic acid), and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogues, n-3 polyunsaturated fatty acids)."
15459021_2005.ann,"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",beta-catenin gene,7,"Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity  for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase."
15459021_2005.ann,dextran sodium sulfate,beta-catenin gene,7,"Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity  for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase."
18381954_2008.ann,curcumin,NF-kappaB-regulated gene,7,"CONCLUSION: Collectively, our results suggest that curcumin potentiates the antitumor effects of radiation therapy in colorectal cancer by suppressing NF-kappaB and NF-kappaB-regulated gene products, leading to inhibition of proliferation and angiogenesis."
19706164_2009.ann,celecoxib,p53,7,CONCLUSION: Our findings reveal that p53 increases human glioblastoma sensitivity to celecoxib.
11076880_2000.ann,sulindac,APC mRNA,7,CONCLUSIONS: Both sulindac and etodolac reduced the occurrence of ACF and induced an increase in APC mRNA in rat colon mucosa.
11076880_2000.ann,etodolac,APC mRNA,7,CONCLUSIONS: Both sulindac and etodolac reduced the occurrence of ACF and induced an increase in APC mRNA in rat colon mucosa.
19427195_2009.ann,FTS,Ras,7,CONCLUSIONS: FTS inhibits Ras activation and prevents preneoplastic liver nodule development by inducing apoptosis in transformed hepatocytes through activation of the Fas/Fas ligand system.
22486562_2012.ann,ROS,KLF6(Full)  expression,7,CONCLUSIONS: The novel effect of ROS on modulating KLF6(Full)  expression and its splice variants could play a relevant role in liver injury and in TNFalpha regulation.
22700541_2012.ann,arsenic,HO-1,7,"Consistently, expression of an oxidative-stress-inducible gene heme oxygenase-1 (HO-1) was upregulated in the livers of the arsenic group."
22700541_2012.ann,arsenic,heme oxygenase-1 (HO-1),7,"Consistently, expression of an oxidative-stress-inducible gene heme oxygenase-1 (HO-1) was upregulated in the livers of the arsenic group."
22700541_2012.ann,arsenic,heme oxygenase-1,7,"Consistently, expression of an oxidative-stress-inducible gene heme oxygenase-1 (HO-1) was upregulated in the livers of the arsenic group."
28230855_2017.ann,simvastatin,Skp2,7,"Consistently, we found that simvastatin also increased p21 and p27 expression in  tumor sections by reducing Skp2 expression and inducing AMPK activation and STAT3 suppression in the same tumor tissues."
17704804_2008.ann,5-FU,IEX-1,7,"Conversely, IEX-1 overexpression in Colo320mut cells caused an increase of basal  and TNFalpha- or 5-FU-induced apoptosis, an effect not further triggered by G17 treatment."
20540746_2010.ann,MBO-asGCS,MDR-1,7,"Conversely, MBO-asGCS treatments decreased globo series GSLs (Gb3, Gb4), cSrc kinase and nuclear beta-catenin, and suppressed MDR-1 expression in dose-dependent pattern."
15882924_2006.ann,traditional Chinese herb medicine,p53,7,Correction of malignant behavior of tumor cells by traditional Chinese herb medicine through a restoration of p53.
27323401_2016.ann,Cr(VI),PDCD4,7,Cr(VI) caused  a significant increase of miR-21 expression associated with an inhibition of PDCD4 expression.
26300002_2016.ann,AOM,MybER,7,CRC-associated symptoms of patients including intestinal bleeding and anaemia were faithfully mimicked in AOM-treated MybER transgenic mice and implicated hypoxia and vessel leakage identifying an additional pathogenic role for Myb.
26528816_2015.ann,beta-catenin,Myc,7,"Ctnnb1 hemizygous dose markedly inhibited increases in beta-catenin levels in the cytoplasm and nucleus following Apc inactivation in colon epithelium, with attenuated expression of key beta-catenin/TCF-regulated target genes, including those encoding the EphB2/B3 receptors, the stem cell marker Lgr5, and Myc, leading to maintenance of crypt compartmentalization and restriction of stem and proliferating cells to the crypt base."
20824699_2011.ann,Curcumin,c-myc,7,"Curcumin suppressed the expression of proteins related to cell survival (bcl-2 and bcl-xL), proliferation (cyclin D1 and c-myc), tumor invasion (MMP-9 and ICAM-1) and angiogenesis (VEGF), and microvessel density."
20824699_2011.ann,Curcumin,ICAM-1,7,"Curcumin suppressed the expression of proteins related to cell survival (bcl-2 and bcl-xL), proliferation (cyclin D1 and c-myc), tumor invasion (MMP-9 and ICAM-1) and angiogenesis (VEGF), and microvessel density."
20824699_2011.ann,Curcumin,bcl-2,7,"Curcumin suppressed the expression of proteins related to cell survival (bcl-2 and bcl-xL), proliferation (cyclin D1 and c-myc), tumor invasion (MMP-9 and ICAM-1) and angiogenesis (VEGF), and microvessel density."
12727805_2003.ann,oxazepam,Gadd45beta,7,"Cyp2b20,  growth arrest- and damage-inducible gene beta (Gadd45beta), tumor necrosis factor alpha-induced protein 2 and insulin-like growth factor binding protein 1 (Igfbp5) genes and proteins were upregulated by oxazepam, and Cyp2b20, Cyclin D1, proliferating cell nuclear antigen, Igfbp5, Gadd45beta and cell death-inducing DNA fragmentation factor alpha subunit-like effector A exhibited higher expression after Wy-14,643 treatment."
12727805_2003.ann,oxazepam,growth arrest- and damage-inducible gene beta,7,"Cyp2b20,  growth arrest- and damage-inducible gene beta (Gadd45beta), tumor necrosis factor alpha-induced protein 2 and insulin-like growth factor binding protein 1 (Igfbp5) genes and proteins were upregulated by oxazepam, and Cyp2b20, Cyclin D1, proliferating cell nuclear antigen, Igfbp5, Gadd45beta and cell death-inducing DNA fragmentation factor alpha subunit-like effector A exhibited higher expression after Wy-14,643 treatment."
12727805_2003.ann,oxazepam,growth arrest- and damage-inducible gene beta (Gadd45beta),7,"Cyp2b20,  growth arrest- and damage-inducible gene beta (Gadd45beta), tumor necrosis factor alpha-induced protein 2 and insulin-like growth factor binding protein 1 (Igfbp5) genes and proteins were upregulated by oxazepam, and Cyp2b20, Cyclin D1, proliferating cell nuclear antigen, Igfbp5, Gadd45beta and cell death-inducing DNA fragmentation factor alpha subunit-like effector A exhibited higher expression after Wy-14,643 treatment."
11532874_2001.ann,DCA,c-myc gene,7,"DCA, TCA and to a lesser extent chloroform decreased the methylation and  increased the mRNA expression of the c-myc gene."
11532874_2001.ann,TCA,c-myc gene,7,"DCA, TCA and to a lesser extent chloroform decreased the methylation and  increased the mRNA expression of the c-myc gene."
11532874_2001.ann,chloroform,c-myc gene,7,"DCA, TCA and to a lesser extent chloroform decreased the methylation and  increased the mRNA expression of the c-myc gene."
19461054_2009.ann,NAC,phospho-H2AX,7,"DHMEQ-treated cells exhibited DNA damage, as evaluated by accumulation in nuclear foci of phospho-H2AX, which was completely reversed by NAC. Moreover, DHMEQ induced the expression of genes involved in the endoplasmic reticulum stress response (GRP78, CHOP, TRB3) and promoted the splicing of XBP1 mRNA in a dose-dependent fashion in both cell lines, which was reversed in the presence of NAC."
20061362_2010.ann,pterostilbene,beta-catenin,7,"Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats."
20061362_2010.ann,pterostilbene,p65,7,"Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats."
26528816_2015.ann,beta-catenin,Myc,7,"Differential expression of selected beta-catenin/TCF-regulated genes, such as Myc, likely underlies context-dependent effects of Ctnnb1 gene dosage in tumorigenesis."
19147571_2009.ann,oxaliplatin,Notch,7,"Down-regulation of Notch signaling also prevented the induction of prosurvival pathways, most notably phosphoinositide kinase-3/Akt, after oxaliplatin."
20540746_2010.ann,Doxorubicin,MDR1,7,"Doxorubicin treatment induced GCS and MDR1 expression in tumors, but MBO-asGCS treatment eliminated ""in-vivo"" growth of drug-resistant tumor (NCI/ADR-RES)."
18722373_2008.ann,antisense oligodeoxy nucleotides,c-Myc,7,Effect of antisense oligodeoxy nucleotides against c-Myc and E2F1 was studied in human HCC  cell lines.
11532874_2001.ann,dichloroacetic acid,c-myc gene,7,Effect of chloroform on dichloroacetic acid and trichloroacetic acid-induced hypomethylation and expression of the c-myc gene and on their promotion of liver  and kidney tumors in mice.
11532874_2001.ann,trichloroacetic acid,c-myc gene,7,Effect of chloroform on dichloroacetic acid and trichloroacetic acid-induced hypomethylation and expression of the c-myc gene and on their promotion of liver  and kidney tumors in mice.
19706164_2009.ann,celecoxib,p53,7,Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy.
18524889_2008.ann,Erlotinib,epidermal growth factor receptor,7,Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell  lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK.
18524889_2008.ann,Erlotinib,epidermal growth factor receptorL858R,7,Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell  lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK.
18524889_2008.ann,Erlotinib,L858R,7,Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell  lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK.
12800193_2003.ann,butyrate,beta-catenin target genes,7,Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirin.
12800193_2003.ann,aspirin,beta-catenin target genes,7,Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirin.
21543203_2012.ann,Flavokawain B,Bcl-2,7,"Flavokawain B also down-regulate Bcl-2 with concomitant increase in Bax level, which resulted in release of cytochrome c."
25435367_2015.ann,vandetanib,RET,7,"For therapy of advanced MTC, the Food and Drug Administration recently approved vandetanib and cabozantinib, the tyrosine kinase inhibitors targeting RET, vascular endothelial growth factor receptor, epidermal growth factor receptor and/or c-MET."
25435367_2015.ann,cabozantinib,RET,7,"For therapy of advanced MTC, the Food and Drug Administration recently approved vandetanib and cabozantinib, the tyrosine kinase inhibitors targeting RET, vascular endothelial growth factor receptor, epidermal growth factor receptor and/or c-MET."
15538739_2004.ann,5-FU,"TS-, TP-, and DPD-gene",7,"Formalin-fixed, paraffin wax-embedded pre-operative biopsies (n = 14) and surgical resection specimens (n = 40) from patients with rectal carcinoma (clinical UICC stage II/III) receiving neo-adjuvant 5-FU-based chemoradiotherapy were studied for TS-, TP-, and DPD-gene expression by quantitative TaqMan real-time PCR after laser microdissection."
20372080_2010.ann,mithramycin,FoxM1,7,FoxM1 expression and activity in cancer cells can be targeted using PPARgamma agonists or the anti-neoplastic antibiotic mithramycin.
19427195_2009.ann,DEN,Ras,7,"FTS abrogates DEN-induced Ras membrane activity, increases Tunel positive cells in transformed, GSTp-expressing hepatocytes, up-regulates caspase 3 and 8 activity, induces Fas,  Fas ligand and JNK phosphorylation that occurs independently of TNFalpha and Trail."
24036141_2013.ann,TFSC,NF-kappaB responsive genes,7,Further studies revealed that TFSC induced HCC cell apoptosis and inhibited expressional levels of NF-kappaB responsive genes in transplanted tumor tissues.
27458137_2016.ann,calcitriol,miR-627,7,"Furthermore, calcitriol (the active form of vitamin D) suppressed CYP3A4 expression by activating miR-627."
19435869_2009.ann,caspase-9,Bcl-2,7,"Furthermore, PSI treatment increased levels of Bax, cytochrome c, activated caspase-3, active  caspase-9, and cleaved poly(ADP-ribose) polymerase and decreased both Bcl-2 expression levels and extracellular signal-regulated kinase-1/2 activity."
19435869_2009.ann,caspase-3,Bcl-2,7,"Furthermore, PSI treatment increased levels of Bax, cytochrome c, activated caspase-3, active  caspase-9, and cleaved poly(ADP-ribose) polymerase and decreased both Bcl-2 expression levels and extracellular signal-regulated kinase-1/2 activity."
18339878_2008.ann,caspase-3,Bcl-2,7,"Furthermore, the cancer cells showed increased levels of activated caspase-3 and  increased Bax to Bcl-2 and Bax to Bcl-xL ratios, suggesting that the cells were undergoing apoptosis."
27323401_2016.ann,Cr(VI),PDCD4,7,"Furthermore, the Cr(VI) induced inhibition of PDCD4 suppressed downstream E-cadherin protein expression, but promoted beta-catenin/TCF-dependent transcription of uPAR and c-Myc."
27323401_2016.ann,Cr(VI),c-Myc,7,"Furthermore, the Cr(VI) induced inhibition of PDCD4 suppressed downstream E-cadherin protein expression, but promoted beta-catenin/TCF-dependent transcription of uPAR and c-Myc."
19147571_2009.ann,gamma-Secretase inhibitors,Notch-1,7,gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.
19147571_2009.ann,oxaliplatin,Notch-1,7,gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.
17638894_2007.ann,Gefitinib,ErbB-3,7,Gefitinib treatment diminished phosphorylation of the ErbB-3 > EGFR > HER2/neu and signal transducers and activators of transcriptions in a dose-dependent fashion.
17638894_2007.ann,Gefitinib,HER2/neu,7,Gefitinib treatment diminished phosphorylation of the ErbB-3 > EGFR > HER2/neu and signal transducers and activators of transcriptions in a dose-dependent fashion.
18852136_2008.ann,t-PTER,bcl-2,7,"Gene expression analysis of a Bcl-2 family of genes and antioxidant enzymes revealed that t-PTER + QUER treatment preferentially promotes, in HT-29 cells growing in vivo, (a) superoxide dismutase 2 overexpression ( approximately 5.7-fold, via specificity protein 1-dependent transcription regulation) and (b) down-regulation of bcl-2 expression ( approximately 3.3-fold, via inhibition of nuclear factor-kappaB activation)."
18852136_2008.ann,superoxide dismutase 2,bcl-2,7,"Gene expression analysis of a Bcl-2 family of genes and antioxidant enzymes revealed that t-PTER + QUER treatment preferentially promotes, in HT-29 cells growing in vivo, (a) superoxide dismutase 2 overexpression ( approximately 5.7-fold, via specificity protein 1-dependent transcription regulation) and (b) down-regulation of bcl-2 expression ( approximately 3.3-fold, via inhibition of nuclear factor-kappaB activation)."
22008536_2011.ann,CF,GADD45g (GADD45 gamma),7,"Genes encoding DNA damage-inducible 45 (GADD45) family proteins, in particular GADD45g (GADD45 gamma) were down-regulated by treatment with either PB or CF for 4 and 13 weeks."
19221000_2009.ann,5Aza-C,BTG3,7,"Genistein and 5Aza-C treatment significantly decreased promoter methylation, reactivating BTG3 expression."
18164116_2008.ann,BNF,'AhR gene battery,7,"Global gene expression analysis and subsequent quantitative real-time reverse transcription-polymerase chain reaction revealed that BNF induced not only the 'AhR gene battery'Cyp1a1, Cyp1a2, Cyp1b1, Nqo1, Aldh3a1 and Ugt1a6 but also the transcription factor NF-E2-related factor 2 (Nrf2)-regulated genes such as Gstm1, Gpx2, Akr7a3 and Yc2 (and also Nqo1), presumably due to the adaptive response against BNF-triggered oxidative stress responses."
18164116_2008.ann,BNF,transcription factor NF-E2-related factor 2 (Nrf2)-regulated genes,7,"Global gene expression analysis and subsequent quantitative real-time reverse transcription-polymerase chain reaction revealed that BNF induced not only the 'AhR gene battery'Cyp1a1, Cyp1a2, Cyp1b1, Nqo1, Aldh3a1 and Ugt1a6 but also the transcription factor NF-E2-related factor 2 (Nrf2)-regulated genes such as Gstm1, Gpx2, Akr7a3 and Yc2 (and also Nqo1), presumably due to the adaptive response against BNF-triggered oxidative stress responses."
20540746_2010.ann,Glucosylceramide synthase,MDR1,7,Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
20943371_2011.ann,Grifolin,p53,7,"Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells."
20540746_2010.ann,GSLs,MDR1,7,"GSLs, in particular globo series GSLs mediate gene expression of MDR1 through cSrc and beta-catenin signaling pathway."
20540746_2010.ann,GSLs,cSrc,7,"GSLs, in particular globo series GSLs mediate gene expression of MDR1 through cSrc and beta-catenin signaling pathway."
7585603_1995.ann,clofibrate,GST-P gene,7,"GST-P gene expression linked to a reporter gene was specifically suppressed by cotransfection with a PPAR alpha expression plasmid in the presence of the peroxisome proliferator, clofibrate."
23939942_2014.ann,H(2)O(2),Gadd45b,7,H(2)O(2) also stimulated expression of Gadd45b in cultured cells.
11532874_2001.ann,chloroform,c-myc gene,7,"Hence, chloroform prevented the hypomethylation and increased mRNA expression of the c-myc gene and the promotion of liver tumors by DCA, while enhancing DCA-promotion of kidney tumors."
20372080_2010.ann,mithramycin,FoxM1,7,"Here we show that Sp1 binds to the FoxM1 promoter region and positively regulates FoxM1 transcription, while mithramycin, a chemotherapy drug that specifically binds GC rich sequences in the DNA and inhibits activities of Sp1, inhibits expression of FoxM1."
20372080_2010.ann,mithramycin,Sp1,7,"Here we show that Sp1 binds to the FoxM1 promoter region and positively regulates FoxM1 transcription, while mithramycin, a chemotherapy drug that specifically binds GC rich sequences in the DNA and inhibits activities of Sp1, inhibits expression of FoxM1."
18417481_2008.ann,N-ethyl-N-nitrosourea,Msh6,7,"Here, we describe the functional characterization of a novel rat mutant model in which the MMR gene Msh6 has been  genetically inactivated by N-ethyl-N-nitrosourea-driven target-selected mutagenesis."
18524889_2008.ann,erlotinib,EGFR,7,"Here, we investigated the effect of erlotinib  on apoptotic signal pathways in H3255 cells with the EGFR(L858R) mutation."
18524889_2008.ann,erlotinib,EGFR(L858R),7,"Here, we investigated the effect of erlotinib  on apoptotic signal pathways in H3255 cells with the EGFR(L858R) mutation."
18524889_2008.ann,erlotinib,L858R,7,"Here, we investigated the effect of erlotinib  on apoptotic signal pathways in H3255 cells with the EGFR(L858R) mutation."
12902981_2003.ann,NaB,MUC2 gene,7,"Here, we report that NaB specifically represses the expression of the  MUC2 gene, a differentiation marker of the secretory goblet cell lineage, in forskolin- and 12-O-tetradecanoylphorbol 13-acetate-induced HT29 cells, and Cl.16E cells, a clonal derivative of HT29 cells that spontaneously differentiates into goblet cells."
21205878_2011.ann,beta-catenin,Hes1,7,Hes1 induction was mediated by beta-catenin and resulted from both the induction of the Notch ligand/receptor and Notch-independent control of the Hes1 promoter by beta-catenin.
27323401_2016.ann,ROS,PDCD4,7,Hexavalent chromium induces malignant transformation of human lung bronchial epithelial cells via ROS-dependent activation of miR-21-PDCD4 signaling.
19384949_2009.ann,Histone deacetylase inhibitors,thymidylate synthase gene,7,Histone deacetylase inhibitors suppress thymidylate synthase gene expression and  synergize with the fluoropyrimidines in colon cancer cells.
20442315_2010.ann,HO-3867,p53,7,"HO-3867 induced G(2)-M cell cycle arrest in A2780 cells by modulating cell cycle regulatory molecules p53, p21, p27, cyclin-dependent kinase 2, and cyclin,  and promoted apoptosis by caspase-8 and caspase-3 activation."
25721086_2015.ann,EGCG,BTG2,7,"However, pretreatments with selective mitogen-activated protein kinase (MAPK) inhibitors, SB203580 (p38 inhibitor) and PD0325901 (ERK1/2 inhibitor), significantly suppressed the activation of EGCG on BTG2 expression."
19934284_2009.ann,methyltransferase inhibitor,aberrantly silenced SFRP2 gene,7,"Importantly, cotreatment with low doses of oligoamines and a DNA methyltransferase inhibitor highly induces the reexpression of the aberrantly silenced SFRP2 gene and results in significant inhibition of the growth of established tumors in a human colon tumor model in vivo."
19934284_2009.ann,oligoamines,aberrantly silenced SFRP2 gene,7,"Importantly, cotreatment with low doses of oligoamines and a DNA methyltransferase inhibitor highly induces the reexpression of the aberrantly silenced SFRP2 gene and results in significant inhibition of the growth of established tumors in a human colon tumor model in vivo."
22579649_2012.ann,ACR,FXRE promoter,7,"In addition, a reporter assay indicated that the FXRE promoter activity was significantly increased by treatment with ACR plus GW4064."
27486174_2016.ann,PIM kinases,MYC,7,"In addition, PIM kinases activate MYC signaling and mRNA translation in prostate cancer and cooperate with MYC to accelerate tumorigenesis."
17715378_2007.ann,isochaihulactone,NAG-1,7,"In addition, treatment of nude mice with isochaihulactone increased the in vivo NAG-1 expression as examined by immunohistochemistry from tumor biopsy."
22832932_2012.ann,ursolic acid,p53,7,"In addition, ursolic acid suppressed EGF receptor (EGFR) and induced p53 and p21 expression."
26342199_2015.ann,anti-androgen hydroxyflutamide,c-fos,7,"In AR-positive bladder cancer cell lines, dihydrotestosterone treatment increased ELK1 expression (mRNA, protein) and its nuclear translocation, ELK1 transcriptional activity, and c-fos  expression, which was restored by an anti-androgen hydroxyflutamide."
15538739_2004.ann,5-FU,TS gene,7,"In conclusion, this study shows that TS gene expression in a pretreatment biopsy predicts the response of local rectal cancer  to neo-adjuvant 5-FU-based chemoradiotherapy in a high percentage."
12717389_2003.ann,troglitazone,Skp2,7,"In conclusion, troglitazone attenuated Skp2 expression, thereby promoting p27(Kip1) accumulation in human hepatoma cells."
24819614_2014.ann,U0126,CYP3A genes,7,"In conclusion, we found that U0126 is an atypical PXR ligand that via direct (binding and activation of PXR) and indirect (SHP dowregulation) mechanisms selectively restores CYP3A genes in HepG2 cells."
18790750_2008.ann,PGG,p53,7,"In LNCaP cells, caspase-mediated apoptosis induction by PGG was associated with and mediated in major part by activation of p53 as established through small interfering RNA knockdown and dominant-negative mutant approaches."
18790750_2008.ann,caspase,p53,7,"In LNCaP cells, caspase-mediated apoptosis induction by PGG was associated with and mediated in major part by activation of p53 as established through small interfering RNA knockdown and dominant-negative mutant approaches."
26528816_2015.ann,beta-catenin,Myc,7,"In mouse ovarian endometrioid adenocarcinomas (OEAs) arising  from Apc- and Pten-inactivation, while Ctnnb1 hemizygous dose affected beta-catenin levels and some beta-catenin/TCF target genes, Myc induction was retained and OEAs arose in a fashion akin to that seen with intact Ctnnb1 gene dose."
17417771_2007.ann,SAHA,tumor suppressor genes,7,"In summary,  SAHA inhibited the growth of human pancreatic cancer cells by inducing apoptosis, differentiation and cell cycle arrest, as well as increase in the expression of several tumor suppressor genes."
17999742_2007.ann,imatinib,CD34,7,"In summary, the small molecule inhibitor imatinib attenuates stromal cell proliferation in PDGF-C-induced HCC, which coincides with decreased expression of both CD34 and PDGFRalpha, and activated Akt."
27607580_2016.ann,JQ1,c-Myc,7,"In the H1373 xenograft model, treatment with JQ1 significantly reduced tumor growth and downregulated the expression of c-Myc."
15754328_2005.ann,2-chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU),p53,7,"In the present study, we report that in vitro treatment of primary hepatoma, HepG2 (wild-type p53), PLC/PRF/5 (p53-mutant), and Hep3B (p53-deleted) cells with 2-chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) resulted in upregulation of  p53, p21(Cip1/Waf1), phosphorylated cdc-2 at Tyr15 in wild-type p53 cells and phosphorylation of cdc-2 at Tyr15 in p53-mutant or p53-deleted hepatoma cells."
15754328_2005.ann,2-chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU),p21,7,"In the present study, we report that in vitro treatment of primary hepatoma, HepG2 (wild-type p53), PLC/PRF/5 (p53-mutant), and Hep3B (p53-deleted) cells with 2-chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) resulted in upregulation of  p53, p21(Cip1/Waf1), phosphorylated cdc-2 at Tyr15 in wild-type p53 cells and phosphorylation of cdc-2 at Tyr15 in p53-mutant or p53-deleted hepatoma cells."
15754328_2005.ann,2-chloroethyl-3-sarcosinamide-1-nitrosourea,p53,7,"In the present study, we report that in vitro treatment of primary hepatoma, HepG2 (wild-type p53), PLC/PRF/5 (p53-mutant), and Hep3B (p53-deleted) cells with 2-chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) resulted in upregulation of  p53, p21(Cip1/Waf1), phosphorylated cdc-2 at Tyr15 in wild-type p53 cells and phosphorylation of cdc-2 at Tyr15 in p53-mutant or p53-deleted hepatoma cells."
15754328_2005.ann,SarCNU,p53,7,"In the present study, we report that in vitro treatment of primary hepatoma, HepG2 (wild-type p53), PLC/PRF/5 (p53-mutant), and Hep3B (p53-deleted) cells with 2-chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) resulted in upregulation of  p53, p21(Cip1/Waf1), phosphorylated cdc-2 at Tyr15 in wild-type p53 cells and phosphorylation of cdc-2 at Tyr15 in p53-mutant or p53-deleted hepatoma cells."
15754328_2005.ann,2-chloroethyl-3-sarcosinamide-1-nitrosourea,p21,7,"In the present study, we report that in vitro treatment of primary hepatoma, HepG2 (wild-type p53), PLC/PRF/5 (p53-mutant), and Hep3B (p53-deleted) cells with 2-chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) resulted in upregulation of  p53, p21(Cip1/Waf1), phosphorylated cdc-2 at Tyr15 in wild-type p53 cells and phosphorylation of cdc-2 at Tyr15 in p53-mutant or p53-deleted hepatoma cells."
15754328_2005.ann,SarCNU,p21,7,"In the present study, we report that in vitro treatment of primary hepatoma, HepG2 (wild-type p53), PLC/PRF/5 (p53-mutant), and Hep3B (p53-deleted) cells with 2-chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) resulted in upregulation of  p53, p21(Cip1/Waf1), phosphorylated cdc-2 at Tyr15 in wild-type p53 cells and phosphorylation of cdc-2 at Tyr15 in p53-mutant or p53-deleted hepatoma cells."
19384949_2009.ann,LBH589,TS gene,7,"In this study, we demonstrate that the histone deacetylase inhibitors (HDACi) vorinostat and LBH589 significantly downregulate TS gene expression in a panel of colon cancer cell lines."
19384949_2009.ann,histone deacetylase inhibitors,TS gene,7,"In this study, we demonstrate that the histone deacetylase inhibitors (HDACi) vorinostat and LBH589 significantly downregulate TS gene expression in a panel of colon cancer cell lines."
19384949_2009.ann,HDACi,TS gene,7,"In this study, we demonstrate that the histone deacetylase inhibitors (HDACi) vorinostat and LBH589 significantly downregulate TS gene expression in a panel of colon cancer cell lines."
11753661_2001.ann,DEN,Ha-ras,7,"In tumors from mice treated with DEN alone, the prevalence of Ha-ras mutations was approximately 30% (6/20), while no beta-catenin mutations (0/13) were detectable in tumors of this treatment group."
17999742_2007.ann,imatinib,CD34,7,In vivo treatment with imatinib also blocks the expression of CD34 in PDGF-C Tg mice.
22486562_2012.ann,H(2) O(2),KLF6(Full),7,"Incubation with pro-oxidants such as arachidonic acid (AA), beta-naphtoflavone, and H(2) O(2) further enhanced KLF6(Full) and its splice variants."
20372080_2010.ann,TZDs,FoxM1,7,Inhibition of FoxM1 expression by TZDs provides a new mechanism for TZD mediated negative regulation of cancer cell growth.
19706164_2009.ann,celecoxib,p53,7,Inhibition of functional p53 in glioblastoma cells significantly reduced the anti-proliferative effect of celecoxib.
17715378_2007.ann,isochaihulactone,NAG-1,7,"Inhibition of isochaihulactone-induced NAG-1 expression by EGR-1 small interfering RNA blocked isochaihulactone-induced apoptosis in A549 cells, suggesting that induction of EGR-1 expression decreases survival of A549 cells."
17715378_2007.ann,isochaihulactone,EGR-1,7,"Inhibition of isochaihulactone-induced NAG-1 expression by EGR-1 small interfering RNA blocked isochaihulactone-induced apoptosis in A549 cells, suggesting that induction of EGR-1 expression decreases survival of A549 cells."
17699782_2007.ann,NaBT,PTEN,7,Inhibition of JNK by chemical or genetic methods attenuated NaBT-induced PTEN expression.
23774401_2013.ann,DEN,Pol III gene,7,"Interestingly, DEN-induced Pol III gene transcription and H3S10ph in tumor cells of liver are significantly higher than in non-tumor cells."
19237607_2009.ann,glycogen synthase kinase-3beta,NDRG2,7,Intracellular beta-catenin levels were slightly reduced in the NDRG2-transfected SW620 cells and this regulation of beta-catenin stability and TCF/LEF activity were mediated  through the modulation of glycogen synthase kinase-3beta activity by NDRG2 function.
19778454_2009.ann,anti-Wnt-1 antibody,c-Myc,7,"Intratumoral injection of anti-Wnt-1 antibody suppressed in vivo tumor growth in  a Huh7 xenograft model, which was also associated with apoptosis and reduced c-Myc, cyclin D1, and survivin expressions."
19778454_2009.ann,anti-Wnt-1 antibody,cyclin D1,7,"Intratumoral injection of anti-Wnt-1 antibody suppressed in vivo tumor growth in  a Huh7 xenograft model, which was also associated with apoptosis and reduced c-Myc, cyclin D1, and survivin expressions."
19778454_2009.ann,anti-Wnt-1 antibody,survivin,7,"Intratumoral injection of anti-Wnt-1 antibody suppressed in vivo tumor growth in  a Huh7 xenograft model, which was also associated with apoptosis and reduced c-Myc, cyclin D1, and survivin expressions."
17638894_2007.ann,gefitinib,HER2/neu,7,"IR-5 bears a novel point mutation in the HER2/neu that corresponds to a L726I in the ATP-binding pocket and correlates with a log decrease in sensitivity to gefitinib, increased heterodimerization with EGFR and HER3, and impaired down-regulation."
17715378_2007.ann,Isochaihulactone,EGR-1,7,Isochaihulactone increased EGR-1 and then NAG-1 mRNA and protein expression.
17715378_2007.ann,Isochaihulactone,NAG-1 mRNA,7,Isochaihulactone increased EGR-1 and then NAG-1 mRNA and protein expression.
17715378_2007.ann,Isochaihulactone,NAG-1,7,Isochaihulactone treatment increased the  luciferase activity of NAG-1 in A549 cells transfected with the NAG-1 promoter construct.
17715378_2007.ann,Isochaihulactone,EGR-1,7,"Isochaihulactone-induced increases in EGR-1 and NAG-1 expression were reduced by the mitogen-activated protein kinase kinase 1/2 inhibitor 2'-amino-3'-methoxyflavone (PD98059), and this effect was not blocked by the phosphatidylinositol 3-kinase/protein kinase B pathway inhibitor 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY294002)."
17715378_2007.ann,Isochaihulactone,NAG-1,7,"Isochaihulactone-induced increases in EGR-1 and NAG-1 expression were reduced by the mitogen-activated protein kinase kinase 1/2 inhibitor 2'-amino-3'-methoxyflavone (PD98059), and this effect was not blocked by the phosphatidylinositol 3-kinase/protein kinase B pathway inhibitor 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY294002)."
17715378_2007.ann,Isochaihulactone,gene-1 (EGR-1),7,Isochaihulactone-inducible genes included the early growth response gene-1 (EGR-1) and nonsteroidal anti-inflammatory drug-activated gene (NAG-1).
17715378_2007.ann,Isochaihulactone,nonsteroidal anti-inflammatory drug-activated gene (NAG-1),7,Isochaihulactone-inducible genes included the early growth response gene-1 (EGR-1) and nonsteroidal anti-inflammatory drug-activated gene (NAG-1).
17715378_2007.ann,Isochaihulactone,gene-1,7,Isochaihulactone-inducible genes included the early growth response gene-1 (EGR-1) and nonsteroidal anti-inflammatory drug-activated gene (NAG-1).
17715378_2007.ann,Isochaihulactone,EGR-1,7,Isochaihulactone-inducible genes included the early growth response gene-1 (EGR-1) and nonsteroidal anti-inflammatory drug-activated gene (NAG-1).
17715378_2007.ann,Isochaihulactone,nonsteroidal anti-inflammatory drug-activated gene,7,Isochaihulactone-inducible genes included the early growth response gene-1 (EGR-1) and nonsteroidal anti-inflammatory drug-activated gene (NAG-1).
17715378_2007.ann,Isochaihulactone,NAG-1,7,Isochaihulactone-inducible genes included the early growth response gene-1 (EGR-1) and nonsteroidal anti-inflammatory drug-activated gene (NAG-1).
18521906_2008.ann,caspase-3,Bcl-2,7,"It augmented caspase-3 activity and downregulated the expression of Bcl-2, Bcl-xL, cIAP1 and cFLIP."
19074836_2008.ann,dibenzazepine,Notch,7,KLF4 is therefore a potential mediator for the antitumor effect of Notch inhibitors such as dibenzazepine.
18506893_2008.ann,proteasomal,p53,7,"Ku70-/- HCCs showed high proliferative activity with increased cyclin D1 and proliferating cell nuclear antigen expression, Aurora A kinase activity, enhanced ataxia telangiectasia mutated kinase and ubiquitination, and loss of p53 via proteasomal degradation, features  which closely resemble those of human HCC."
27864128_2017.ann,PGE2,YAP,7,Levels of PGE2 correlated with those of YAP levels in human sporadic colorectal tumors and colitis-associated tumors.
21278145_2011.ann,diethylnitrosamine,Cyp26a1,7,"LRAT deficiency decreased diethylnitrosamine-induced injury and tumour load and increased the expression of the retinoic acid responsive genes Cyp26a1, RARb and p21, suggesting that the lower tumour load of LRAT-deficient mice was a result of increased retinoid signalling and subsequent p21-mediated inhibition of proliferation."
21278145_2011.ann,diethylnitrosamine,RARb,7,"LRAT deficiency decreased diethylnitrosamine-induced injury and tumour load and increased the expression of the retinoic acid responsive genes Cyp26a1, RARb and p21, suggesting that the lower tumour load of LRAT-deficient mice was a result of increased retinoid signalling and subsequent p21-mediated inhibition of proliferation."
21278145_2011.ann,diethylnitrosamine,p21,7,"LRAT deficiency decreased diethylnitrosamine-induced injury and tumour load and increased the expression of the retinoic acid responsive genes Cyp26a1, RARb and p21, suggesting that the lower tumour load of LRAT-deficient mice was a result of increased retinoid signalling and subsequent p21-mediated inhibition of proliferation."
20540746_2010.ann,MBO-asGCS,MDR1,7,MBO-asGCS suppressed the expression of MDR1 with GCS and sensitized NCI/ADR-RES tumor to doxorubicin.
27612418_2016.ann,Mebendazole,MYC,7,"Mebendazole as a single agent decreased COX2 expression, blood vessel formation, VEGFR2 phosphorylation, and worked synergistically with sulindac to reduce overexpression of MYC, BCL2, and various pro-inflammatory cytokines."
27612418_2016.ann,Mebendazole,BCL2,7,"Mebendazole as a single agent decreased COX2 expression, blood vessel formation, VEGFR2 phosphorylation, and worked synergistically with sulindac to reduce overexpression of MYC, BCL2, and various pro-inflammatory cytokines."
27612418_2016.ann,sulindac,MYC,7,"Mebendazole as a single agent decreased COX2 expression, blood vessel formation, VEGFR2 phosphorylation, and worked synergistically with sulindac to reduce overexpression of MYC, BCL2, and various pro-inflammatory cytokines."
27612418_2016.ann,sulindac,BCL2,7,"Mebendazole as a single agent decreased COX2 expression, blood vessel formation, VEGFR2 phosphorylation, and worked synergistically with sulindac to reduce overexpression of MYC, BCL2, and various pro-inflammatory cytokines."
27612418_2016.ann,sulindac,MYC,7,"Mebendazole as a single agent decreased COX2 expression, blood vessel formation, VEGFR2 phosphorylation, and worked synergistically with sulindac to reduce overexpression of MYC, BCL2, and various pro-inflammatory cytokines."
25600769_2015.ann,EPLE,Wnt target genes,7,"Mechanistically, we demonstrated EPLE exerted its function through suppressing Wnt signaling pathway, as evidenced by EPLE-mediated downregulation of Wnt target genes such as c-Myc, Axin2 and Survivin."
19709125_2009.ann,Meloxicam,Bax,7,"Meloxicam therapy inhibited cell proliferation, induced cell apoptosis, reduced expression of proliferating cell nuclear antigen, increased activation of caspase-3, and upregulated Bax. Meloxicam also slightly inhibited tumor angiogenesis with no effect on the expression of vascular endothelial growth factor or basic fibroblast growth factor."
22486562_2012.ann,ROS,KLF6(Full),7,METHODS AND RESULTS: Endogenous ROS production in  CYP2E1-expressing HepG2 cells induced mRNA and protein expression of KLF6(Full) and its splice variants compared to control cells.
20194350_2010.ann,NaTC,Shp,7,"Mice receiving NaTC manifested increased intestinal expression of the FXR-regulated genes, Shp, FGF15 and IBABP, and a concomitant decrease in cyclin D1 message."
20194350_2010.ann,NaTC,FGF15,7,"Mice receiving NaTC manifested increased intestinal expression of the FXR-regulated genes, Shp, FGF15 and IBABP, and a concomitant decrease in cyclin D1 message."
20194350_2010.ann,NaTC,IBABP,7,"Mice receiving NaTC manifested increased intestinal expression of the FXR-regulated genes, Shp, FGF15 and IBABP, and a concomitant decrease in cyclin D1 message."
15073043_2004.ann,arsenic,aberrant gene,7,"Microarray analysis of liver samples showed arsenic induced aberrant gene  expression including steroid-related genes, cytokines, apoptosis-related genes and cell cycle-related genes."
24112473_2013.ann,MK-801,TXNIP,7,"MK-801 dephosphorylated Thr24 in FOXO1 and induced its nuclear translocation, thus increasing transcription of TXNIP, a tumor suppressor gene."
23993973_2013.ann,MLN8237,NF-kappaB target genes,7,"MLN8237, an investigational small-molecule selective inhibitor of AURKA, reduced nuclear staining of nuclear factor-kappaB (NF-kappaB) p65 in human gastric cancer samples and mouse epithelial cells, suppressed NF-kappaB reporter activity, and reduced expression of NF-kappaB target genes that regulate inflammation and cell survival."
19861436_2009.ann,dasatinib,c-Src,7,"Modulation of dasatinib (c-Src inhibitor) cytotoxicity by STAT3 knockdown was measured by MTT, cell cycle, and apoptosis assays."
27157616_2016.ann,ATRA,Klf4,7,"More importantly, ATRA downregulated the expression of the CSC markers CD44 and ALDH as well as stemness genes such as Klf4 and Sox2 and induced differentiation of tumorspheres."
27157616_2016.ann,ATRA,Sox2,7,"More importantly, ATRA downregulated the expression of the CSC markers CD44 and ALDH as well as stemness genes such as Klf4 and Sox2 and induced differentiation of tumorspheres."
18644992_2008.ann,sulindac,p21(cip/waf1),7,"Moreover, although sulindac-mediated induction of p21(cip/waf1) was 113%  in wild-type HT-29, this induction was alleviated in the Csk shRNA transfectants  (65% induction; P < 0.01)."
18381954_2008.ann,curcumin,NF-kappaB-regulated gene,7,"Moreover, curcumin suppressed NF-kappaB activity and the expression of NF-kappaB-regulated gene products (cyclin D1, c-myc, Bcl-2, Bcl-xL, cellular inhibitor of apoptosis protein-1, cyclooxygenase-2, matrix metalloproteinase-9, and vascular endothelial growth factor), many of which were induced by radiation  therapy and mediate radioresistance."
18381954_2008.ann,cyclooxygenase-2,Bcl-2,7,"Moreover, curcumin suppressed NF-kappaB activity and the expression of NF-kappaB-regulated gene products (cyclin D1, c-myc, Bcl-2, Bcl-xL, cellular inhibitor of apoptosis protein-1, cyclooxygenase-2, matrix metalloproteinase-9, and vascular endothelial growth factor), many of which were induced by radiation  therapy and mediate radioresistance."
18381954_2008.ann,cyclooxygenase-2,c-myc,7,"Moreover, curcumin suppressed NF-kappaB activity and the expression of NF-kappaB-regulated gene products (cyclin D1, c-myc, Bcl-2, Bcl-xL, cellular inhibitor of apoptosis protein-1, cyclooxygenase-2, matrix metalloproteinase-9, and vascular endothelial growth factor), many of which were induced by radiation  therapy and mediate radioresistance."
20972371_2010.ann,DENA,GSHPx,7,"Moreover, DENA decreased gene expression of GSHPx, GST and CAT and caused severe histopathological lesions in liver tissue."
20972371_2010.ann,DENA,GST,7,"Moreover, DENA decreased gene expression of GSHPx, GST and CAT and caused severe histopathological lesions in liver tissue."
20972371_2010.ann,DENA,CAT,7,"Moreover, DENA decreased gene expression of GSHPx, GST and CAT and caused severe histopathological lesions in liver tissue."
20112425_2010.ann,GC7,EIF5A,7,"Moreover, inhibition of EIF5A  by small interfering RNA (siRNA) or deoxyhypusine synthase (DHPS) inhibitor GC7,  which inhibits EIF5A2 maturation, could effectively decrease cell motility."
18790758_2008.ann,MCC-555,MUC2 promoters,7,"Moreover, MCC-555 increased transcriptional activity of human and mouse MUC2 promoters."
17704804_2008.ann,5-FU,IEX-1,7,"Moreover, tumor necrosis factor alpha (TNFalpha)- or 5-FU-induced apoptosis that  is greatly enhanced by G17 treatment in Colo320wt cells was prevented if IEX-1 expression was repressed."
20372080_2010.ann,thiazolidinediones,FoxM1,7,Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.
20372080_2010.ann,mithramycin,FoxM1,7,Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.
19384947_2009.ann,PD98059,NAG-1,7,"Nevertheless, the extent of NAG-1 induction could not be altered by the ERK inhibitor PD98059."
28529629_2017.ann,Niclosamide,c-Myc,7,"Niclosamide caused a dose- and time-dependent reduction of beta-catenin and the key components [e.g., DVLs, phospho-GSK3beta (S9), c-Myc and Cyclin D1] in the canonical Wnt/beta-catenin pathway."
20727180_2010.ann,Nicotine,p53,7,Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent.
20372080_2010.ann,TZD,FoxM1,7,"No PPARgamma/retinoid X receptor (RXR) consensus DNA binding sites were detected in the FoxM1 promoter extending to -10  kb upstream, and knockdown of PPARgamma had no impact on TZD mediated downregulation of FoxM1 expression."
14566053_2003.ann,NO-ASA,downstream target gene,7,"NO-ASA reduced the expression of cyclin D1, a downstream target gene that plays an important role in colon carcinogenesis."
19934284_2009.ann,oligoamine analogues,epigenetically silenced genes,7,Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes.
11895860_2002.ann,ARE (anti-oxidant response element),GSTP1-1,7,Nrf2 transactivates a wide variety of ARE (anti-oxidant response element)-mediated enzymes including GSTP1-1.
17638894_2007.ann,gefitinib,HER2,7,"Oral administration of gefitinib was able to prevent the outgrowth of Bam1a tumor cells from palpable lesions, shrink established tumors, eliminate HER2 and HER3 phosphorylation, and decrease MAPK and Akt signaling in vivo."
17638894_2007.ann,gefitinib,HER3,7,"Oral administration of gefitinib was able to prevent the outgrowth of Bam1a tumor cells from palpable lesions, shrink established tumors, eliminate HER2 and HER3 phosphorylation, and decrease MAPK and Akt signaling in vivo."
12810952_2003.ann,Ornithine decarboxylase,c-myc,7,"Ornithine decarboxylase (ODC), the first enzyme in polyamine synthesis, is  a transcriptional target of c-myc and a modifier of APC-dependent tumorigenesis."
24886421_2014.ann,survivin,miR-520b,7,Our data revealed that  HBx survivin-dependently down-regulated miR-520b through interacting with Sp1 in  the cells.
20372080_2010.ann,TZD,Sp1,7,Our data suggest that TZD mediated suppression of Sp1 is responsible for downregulation of FoxM1 gene expression.
20372080_2010.ann,TZD,FoxM1,7,Our data suggest that TZD mediated suppression of Sp1 is responsible for downregulation of FoxM1 gene expression.
18790750_2008.ann,PGG,p53,7,Our data support PGG as a multitargeting agent for  chemoprevention and therapy of prostate cancer by activating the p53 tumor suppressor pathway and by inhibiting STAT3 oncogenic signaling.
17715378_2007.ann,isochaihulactone,NAG-1,7,Our findings suggest that NAG-1 expression is up-regulated by  isochaihulactone through an ERK-dependent pathway involving the activation of EGR-1.
19322027_2009.ann,soy peptide,p53,7,"Our results have further demonstrated that soy peptide (1) dramatically inhibits the expression of HSP90, thereby suppressing signaling pathway leading to NF-gammaB activation; (2) induces expression of p21, p53, and caspase-3 proteins; and (3) inhibits expression of VEGF."
19322027_2009.ann,soy peptide,p53,7,"Our results have further demonstrated that soy peptide (1) dramatically inhibits the expression of HSP90, thereby suppressing signaling pathway leading to NF-gammaB activation; (2) induces expression of p21, p53, and caspase-3 proteins; and (3) inhibits expression of VEGF."
25721086_2015.ann,EGCG,BTG2,7,Our results indicate that EGCG attenuates cell proliferation of OSCC cells by upregulating BTG2 expression via p38 and ERK pathways.
20689586_2010.ann,Protandim,p53,7,Our results showed that Protandim suppressed the mitochondrial translocation of p53 and mitochondrial outer membrane proteins such as Bax.
22807119_2012.ann,c-Jun N-terminal kinase 1,miR-122,7,Overexpression of c-Jun N-terminal kinase 1 (JNK1) resulted in miR-122 down-regulation with the induction of PTP1B.
17699782_2007.ann,NaBT,PTEN,7,"Overexpression of the NF-kappaB superrepressor increased PTEN expression and JNK activity, whereas overexpression of the p65 NF-kappaB subunit  reduced both basal and NaBT-mediated JNK activation and PTEN expression."
18490896_2008.ann,SOD2 promoter,luciferase reporter gene,7,"p66 overexpression also prevented the activation of a luciferase reporter gene controlled by the SOD2 promoter, indicating that p66 repression of MnSOD operates at a transcriptional level."
18790750_2008.ann,"Penta-1,2,3,4,6-O-galloyl-beta-D-glucose",p53,7,"Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in  vivo."
20809980_2010.ann,Penta-O-galloyl-beta-D-glucose,P53,7,"Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth."
18794809_2008.ann,proline,p53,7,"POX is markedly elevated during p53-induced apoptosis and generates proline-dependent reactive oxygen species (ROS), specifically superoxide radicals, to induce apoptosis through both mitochondrial  and death receptor pathways."
19447859_2009.ann,pterostilbene,MMP-9 gene,7,"Presented data reveal that pterostilbene is a novel, effective, anti-metastatic agent that functions by downregulating MMP-9 gene expression."
18413810_2008.ann,VES,NAG-1,7,"Pretreatment with p38 kinase inhibitor blocked the VES-induced increase in NAG-1 protein and mRNA levels, whereas an inhibition of protein kinase C, Akt, c-Jun NH(2)-terminal kinase, or MEK activity had no effect on VES-induced NAG-1 levels."
19671764_2009.ann,cleaved poly[ADP-ribose] polymerase,Bcl-2,7,"Protein analysis of treated tumor biopsies revealed elevated amounts of cell cycle regulators such as p21 and proapoptosis factors, such as caspase 3 and 7 and cleaved poly[ADP-ribose] polymerase, coupled with decreased levels of antiapoptotic factors such as Bcl-2 and Bcl-X(L)."
19671764_2009.ann,cleaved poly[ADP-ribose] polymerase,Bcl-X,7,"Protein analysis of treated tumor biopsies revealed elevated amounts of cell cycle regulators such as p21 and proapoptosis factors, such as caspase 3 and 7 and cleaved poly[ADP-ribose] polymerase, coupled with decreased levels of antiapoptotic factors such as Bcl-2 and Bcl-X(L)."
17699716_2007.ann,Rapamycin,HER2,7,Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a  transgenic mouse model of HER2-positive breast cancer.
19826045_2009.ann,celecoxib,p21(WAF1/CIP),7,"Rats that were fed the high-dose CP-31398 or a combination of low-dose CP-31398 and celecoxib showed considerable enhancement of p53 and p21(WAF1/CIP) expression, apoptosis, and reduced tumor cell proliferation in colonic tumors."
19826045_2009.ann,celecoxib,p21(WAF1/CIP),7,"Rats that were fed the high-dose CP-31398 or a combination of low-dose CP-31398 and celecoxib showed considerable enhancement of p53 and p21(WAF1/CIP) expression, apoptosis, and reduced tumor cell proliferation in colonic tumors."
19826045_2009.ann,celecoxib,p53,7,"Rats that were fed the high-dose CP-31398 or a combination of low-dose CP-31398 and celecoxib showed considerable enhancement of p53 and p21(WAF1/CIP) expression, apoptosis, and reduced tumor cell proliferation in colonic tumors."
19706164_2009.ann,celecoxib,p53,7,"Regardless of p53 status, celecoxib caused no significant difference in apoptosis level of U87MG, U87MG-PFT, U87MG-E6 and U373MG cells."
17699782_2007.ann,c-Jun NH2-terminal kinase,PTEN,7,Regulation of PTEN expression in intestinal epithelial cells by c-Jun NH2-terminal kinase activation and nuclear factor-kappaB inhibition.
17699782_2007.ann,nuclear factor-kappaB,PTEN,7,Regulation of PTEN expression in intestinal epithelial cells by c-Jun NH2-terminal kinase activation and nuclear factor-kappaB inhibition.
21203749_2011.ann,indole-3-carbinol,CYP1A,7,Relationship between CYP1A induction by indole-3-carbinol or flutamide and liver  tumor-promoting potential in rats.
21203749_2011.ann,flutamide,CYP1A,7,Relationship between CYP1A induction by indole-3-carbinol or flutamide and liver  tumor-promoting potential in rats.
23112173_2012.ann,"1,25D",c-MYC,7,"Remarkably,  F-box protein FBW7, an E3-ubiquitin ligase, controlled stability of both arms of  the c-MYC/MXD1 push-pull network, and FBW7 ablation attenuated 1,25D regulation of c-MYC and MXD1 turnover."
12902981_2003.ann,butyrate,MUC2 gene,7,"Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation."
19861436_2009.ann,dasatinib,c-Src,7,"RESULTS: Depletion of c-Src by small interfering RNA or sustained inhibition by dasatinib increased pSTAT3, which could be blocked by inhibition of JAK."
20540746_2010.ann,mixed-backbone oligonucleotide (MBO-asGCS),GCS,7,"RESULTS: MDR1 and GCS were coincidently overexpressed in drug-resistant breast, ovary, cervical and colon cancer cells; silencing GCS using a novel mixed-backbone oligonucleotide (MBO-asGCS) sensitized these four drug-resistant cell lines to doxorubicin."
20540746_2010.ann,mixed-backbone oligonucleotide,GCS,7,"RESULTS: MDR1 and GCS were coincidently overexpressed in drug-resistant breast, ovary, cervical and colon cancer cells; silencing GCS using a novel mixed-backbone oligonucleotide (MBO-asGCS) sensitized these four drug-resistant cell lines to doxorubicin."
20540746_2010.ann,MBO-asGCS,GCS,7,"RESULTS: MDR1 and GCS were coincidently overexpressed in drug-resistant breast, ovary, cervical and colon cancer cells; silencing GCS using a novel mixed-backbone oligonucleotide (MBO-asGCS) sensitized these four drug-resistant cell lines to doxorubicin."
21980390_2011.ann,Resveratrol,p21/CIP1,7,"Resveratrol induced cell cycle arrest by up-regulating the expression of p21/CIP1, p27/KIP1 and inhibiting the expression  of cyclin D1."
21980390_2011.ann,Resveratrol,p27/KIP1,7,"Resveratrol induced cell cycle arrest by up-regulating the expression of p21/CIP1, p27/KIP1 and inhibiting the expression  of cyclin D1."
25280562_2014.ann,Resveratrol,Kras,7,Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression.
17219422_2007.ann,beta-catenin,c-myc,7,"Retinol treatment decreased the transcription of a TOPFlash reporter construct and mRNA levels of the endogenous beta-catenin target genes, cyclin D1 and c-myc."
17219422_2007.ann,Retinol,cyclin D1,7,"Retinol treatment decreased the transcription of a TOPFlash reporter construct and mRNA levels of the endogenous beta-catenin target genes, cyclin D1 and c-myc."
17219422_2007.ann,Retinol,c-myc,7,"Retinol treatment decreased the transcription of a TOPFlash reporter construct and mRNA levels of the endogenous beta-catenin target genes, cyclin D1 and c-myc."
23774401_2013.ann,DEN,Pol III genes,7,Role of phosphorylated histone H3 serine 10 in DEN-induced deregulation of Pol III genes and cell proliferation and transformation.
20442318_2010.ann,RWPs,p16(INK4A),7,"RWPs reduced expression of VEGF, matrix metalloproteinase (MMP)-2, MMP-9, and cyclooxygenase-2 and increased expression of tumor suppressor genes p16(INK4A), p53, and p73 in tumor cells."
20442318_2010.ann,RWPs,p16,7,"RWPs reduced expression of VEGF, matrix metalloproteinase (MMP)-2, MMP-9, and cyclooxygenase-2 and increased expression of tumor suppressor genes p16(INK4A), p53, and p73 in tumor cells."
20442318_2010.ann,RWPs,INK4A,7,"RWPs reduced expression of VEGF, matrix metalloproteinase (MMP)-2, MMP-9, and cyclooxygenase-2 and increased expression of tumor suppressor genes p16(INK4A), p53, and p73 in tumor cells."
20442318_2010.ann,RWPs,p53,7,"RWPs reduced expression of VEGF, matrix metalloproteinase (MMP)-2, MMP-9, and cyclooxygenase-2 and increased expression of tumor suppressor genes p16(INK4A), p53, and p73 in tumor cells."
20442318_2010.ann,RWPs,p73,7,"RWPs reduced expression of VEGF, matrix metalloproteinase (MMP)-2, MMP-9, and cyclooxygenase-2 and increased expression of tumor suppressor genes p16(INK4A), p53, and p73 in tumor cells."
17417771_2007.ann,SAHA,cyclin B1,7,SAHA decreased cyclin B1 expression; this cyclin normally promotes progression through G2 of the cell cycle.
23807222_2013.ann,Salinomycin,Skp2,7,Salinomycin induced degradation of Skp2 and thus accumulated p27Kip1.
23807222_2013.ann,Salinomycin,Skp2,7,Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2.
22105228_2012.ann,Selenium,c-fos,7,Selenium treatment during tumor promotion increased hepatic GPx4 expression and reduced the expression of VEGF and of the AP-1 component c-fos as well as nodule growth.
20460401_2010.ann,Sesamin,Bcl-2,7,"Sesamin  also potentiated tumor necrosis factor-alpha-induced apoptosis and this correlated with the suppression of gene products linked to cell survival (e.g., Bcl-2 and survivin), proliferation (e.g., cyclin D1), inflammation (e.g., cyclooxygenase-2), invasion (e.g., matrix metalloproteinase-9, intercellular adhesion molecule 1), and angiogenesis (e.g., vascular endothelial growth factor)."
19182440_2009.ann,SGE,Cyp1a1,7,"SGE inhibited the induction of gamma-glutamyltranspeptidase-positive hepatocytes, lipid peroxidation, and gene expression of Cyp1a1, all of which were caused by DC."
23939942_2014.ann,Signal transducer and activator of transcription 3,Gadd45b gene,7,Signal transducer and activator of transcription 3 (STAT3) was found to be a repressor of the Gadd45b gene through binding to upstream regulatory elements.
20460542_2010.ann,ISO-1,CXCR4,7,"Silencing of CXCR4 and impairing the MIF-CXCR4 signaling pathways by ISO-1, pAb FL-115, AMD-3100, monoclonal antibody 12G5, and BIM-46187 abolished this aggressive phenotype."
20460542_2010.ann,AMD-3100,CXCR4,7,"Silencing of CXCR4 and impairing the MIF-CXCR4 signaling pathways by ISO-1, pAb FL-115, AMD-3100, monoclonal antibody 12G5, and BIM-46187 abolished this aggressive phenotype."
17916909_2007.ann,Silibinin,Bcl-2,7,"Silibinin strongly increased phospho-extracellular signal-regulated kinase 1/2 (ERK1/2), Cip1/p21 and Kip1/p27 (cyclin-dependent kinase inhibitors) levels but moderately decreased Bcl-2 and survivin levels."
17916909_2007.ann,survivin,Bcl-2,7,"Silibinin strongly increased phospho-extracellular signal-regulated kinase 1/2 (ERK1/2), Cip1/p21 and Kip1/p27 (cyclin-dependent kinase inhibitors) levels but moderately decreased Bcl-2 and survivin levels."
26544897_2015.ann,5-FU,p53,7,"Since the fate of chemotherapy-insensitive tumor cells is rarely described, we performed a comparative analysis of 5-FU toxicity in p53-deficient cells and conclude that p53 acts as a facilitator rather than a gatekeeper of cell death."
17533171_2007.ann,Tsc-22 oligonucleotides,Tsc-22,7,"SiRNA treatment of BNL-CL.2 cells with Tsc-22 oligonucleotides but not nonspecific oligonucleotides decreased RNA and protein expression of Tsc-22 by 80-90%, while expression of Gadd45b gene, but not Lzts2, was increased over time after an initial decrease."
17533171_2007.ann,Tsc-22 oligonucleotides,Gadd45b,7,"SiRNA treatment of BNL-CL.2 cells with Tsc-22 oligonucleotides but not nonspecific oligonucleotides decreased RNA and protein expression of Tsc-22 by 80-90%, while expression of Gadd45b gene, but not Lzts2, was increased over time after an initial decrease."
21325634_2011.ann,curcumin,c-Myc,7,"Sixth, curcumin inhibited expression of cell survival proteins such as B-cell lymphoma-2, B-cell leukemia protein xL, X-linked inhibitor of apoptosis protein,  c-FLIP, cellular inhibitor of apoptosis protein (cIAP)-1, cIAP-2 and survivin and proteins linked to cell proliferation, such as cyclin D1 and c-Myc."
18458674_2008.ann,5-Aza-2'deoxycytidine,SPARC promoter,7,SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
15592521_2005.ann,Taxol,p53,7,"Strikingly, CYR61 overexpression impaired the accumulation of wild-type p53 following Taxol exposure, while inhibition of alphavbeta3 or ERK1/ERK2 MAPK signalings completely restored Taxol-induced upregulation of p53."
19147571_2009.ann,sulfonamide GSI,Notch-1,7,Subsequent inhibition of Notch-1 signaling with a sulfonamide GSI (GSI34) prevented the induction of NICD  by chemotherapy and blunted Hes-1 activation.
19147571_2009.ann,sulfonamide GSI (GSI34),Notch-1,7,Subsequent inhibition of Notch-1 signaling with a sulfonamide GSI (GSI34) prevented the induction of NICD  by chemotherapy and blunted Hes-1 activation.
19147571_2009.ann,GSI34,Notch-1,7,Subsequent inhibition of Notch-1 signaling with a sulfonamide GSI (GSI34) prevented the induction of NICD  by chemotherapy and blunted Hes-1 activation.
26212545_2015.ann,Sugiol,STAT3 target genes,7,"Sugiol induced cell cycle arrest and decreased the expression levels of STAT3 target genes, such as cyclin D1, cyclin A, and survivin."
11076880_2000.ann,Sulindac,APC mRNA,7,"Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane."
11076880_2000.ann,etodolac,APC mRNA,7,"Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane."
23038002_2012.ann,extracellular signal-regulated kinase,DGAT2 gene,7,"TAM increased the extracellular signal-regulated kinase (ERK) phosphorylation, which is related to  the proliferation and regeneration of liver and to decreased DGAT2 gene expression."
25721086_2015.ann,EGCG,BTG2,7,The (3)H-thymidine incorporation and Western-blot assays revealed cell proliferation was attenuated by EGCG via upregulation of BTG2 expression causing cell cycle G1 phase arrest in OSCC cells.
20530712_2010.ann,PF-03084014,Hes-1,7,The ability  of PF-03084014 to inhibit gamma-secretase activity was shown by the reduction of  endogenous NICD levels and by the downregulation of Notch target genes Hes-1 and  cMyc in the T-cell acute lymphoblastic leukemia (T-ALL) cell line HPB-ALL.
20530712_2010.ann,PF-03084014,cMyc,7,The ability  of PF-03084014 to inhibit gamma-secretase activity was shown by the reduction of  endogenous NICD levels and by the downregulation of Notch target genes Hes-1 and  cMyc in the T-cell acute lymphoblastic leukemia (T-ALL) cell line HPB-ALL.
25550771_2014.ann,PDTC,PTEN,7,The activity of PTEN was restored when treated with NF-kappaB inhibitor PDTC.
22486562_2012.ann,alcohol,KLF6(Full) expression,7,"The aim of this study is  to investigate the contribution of 2 sources of ROS, cytochrome P450 2E1 (CYP2E1), NAD(P)H quinone oxidoreductase (NQO1), and alcohol on the modulation of KLF6(Full) expression, splicing to KLF6_V1 and KLF6_V2, and the effect on TNFalpha, a downstream target."
22486562_2012.ann,alcohol,TNFalpha,7,"The aim of this study is  to investigate the contribution of 2 sources of ROS, cytochrome P450 2E1 (CYP2E1), NAD(P)H quinone oxidoreductase (NQO1), and alcohol on the modulation of KLF6(Full) expression, splicing to KLF6_V1 and KLF6_V2, and the effect on TNFalpha, a downstream target."
15538739_2004.ann,5-FU,"TS-, TP-, and DPD-gene",7,"The aim of this study was to determine the correlation between TS-, TP-, and DPD-gene expression and the response to 5-FU-based long-term pre-operative chemoradiotherapy assessed by histopathological tumour regression."
26935956_2016.ann,PTC-209,v-myc avian myelocytomatosis viral oncogene homolog (MYC),7,The anti-MM activity of PTC-209 was accompanied by a significant decrease of cyclin D1 (CCND1) and v-myc avian myelocytomatosis viral oncogene homolog (MYC) expression as well as upregulation  of cyclin-dependent kinase inhibitor 1A (CDKN1A) and cyclin-dependent kinase inhibitor 1B (CDKN1B).
26935956_2016.ann,PTC-209,v-myc avian myelocytomatosis viral oncogene homolog,7,The anti-MM activity of PTC-209 was accompanied by a significant decrease of cyclin D1 (CCND1) and v-myc avian myelocytomatosis viral oncogene homolog (MYC) expression as well as upregulation  of cyclin-dependent kinase inhibitor 1A (CDKN1A) and cyclin-dependent kinase inhibitor 1B (CDKN1B).
26935956_2016.ann,PTC-209,MYC,7,The anti-MM activity of PTC-209 was accompanied by a significant decrease of cyclin D1 (CCND1) and v-myc avian myelocytomatosis viral oncogene homolog (MYC) expression as well as upregulation  of cyclin-dependent kinase inhibitor 1A (CDKN1A) and cyclin-dependent kinase inhibitor 1B (CDKN1B).
26940565_2016.ann,SRJ09,p21,7,The antitumor activity of SRJ09 is suggested mediated via the induction of p21 expression and suppression of CDK-4 expression  without affecting cyclin D1 to trigger G1 arrest leading to apoptosis.
18202802_2008.ann,PTX-2,anti-apoptotic Bcl-2,7,"The apoptosis induced by PTX-2 in Hep3B cells was associated with the down-regulation of anti-apoptotic Bcl-2 members (Bcl-2 and Bcl-xL) and IAP family proteins, the up-regulation of pro-apoptotic Bax protein and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor 1/receptor 2 (DR4/DR5) and mitochondrial dysfunction."
17704804_2008.ann,gastrin,IEX-1,7,The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.
17876044_2007.ann,doxorubicin,p130 RB tumor suppressor gene,7,"The AZD6244-doxorubicin combined protocol not only promoted apoptosis but also induced a synergistic effect not seen in single-agent-treated tumors, including increased expression of the p130 RB tumor suppressor gene."
17876044_2007.ann,AZD6244,p130 RB tumor suppressor gene,7,"The AZD6244-doxorubicin combined protocol not only promoted apoptosis but also induced a synergistic effect not seen in single-agent-treated tumors, including increased expression of the p130 RB tumor suppressor gene."
20977730_2010.ann,sodium butyrate,SOX9,7,The downregulation of IRS1 and SOX9 were also induced by sodium butyrate.
21464044_2011.ann,lapatinib,HER2,7,The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer models.
11532874_2001.ann,DCA,c-myc gene,7,The effect of chloroform on DCA and TCA-induced hypomethylation and expression of the c-myc gene and on their promotion of liver and kidney tumors was determined.
11532874_2001.ann,TCA,c-myc gene,7,The effect of chloroform on DCA and TCA-induced hypomethylation and expression of the c-myc gene and on their promotion of liver and kidney tumors was determined.
21317929_2011.ann,beta-catenin,HEF1,7,"The expression of HEF1 was upregulated by Wnt-3a, beta-catenin, and Dvl2 in a dose-dependent manner, and was suppressed following beta-catenin downregulation by shRNA."
17533171_2007.ann,carcinogenicity,Tsc-22,7,The expression of Tsc-22 was also repressed in B6C3F1 mouse liver tumors that were induced by several chemicals from 2-year carcinogenicity studies as well as in spontaneous liver tumors.
18413810_2008.ann,VES,NAG-1,7,"The inhibition of NAG-1 expression by small interfering RNA significantly blocked VES-induced poly(ADP-ribose) polymerase cleavage, suggesting that NAG-1 may play an important role in VES-induced apoptosis."
18566231_2008.ann,cyclooxygenase-2,c-myc,7,"The inhibition of NF-kappaB activation thereby led to down-regulation of gene products involved in  inflammation (cyclooxygenase-2), proliferation (cyclin D1 and c-myc), invasion (matrix metalloproteinase-9), angiogenesis (vascular endothelial growth factor),  and cell survival (cIAP1, cIAP2, X-linked inhibitor apoptosis protein, Bcl-2, and Bcl-xL)."
18566231_2008.ann,matrix metalloproteinase-9,c-myc,7,"The inhibition of NF-kappaB activation thereby led to down-regulation of gene products involved in  inflammation (cyclooxygenase-2), proliferation (cyclin D1 and c-myc), invasion (matrix metalloproteinase-9), angiogenesis (vascular endothelial growth factor),  and cell survival (cIAP1, cIAP2, X-linked inhibitor apoptosis protein, Bcl-2, and Bcl-xL)."
12060674_2002.ann,diallyl sulfide,CYP2E1,7,"The knockout animals have increased lipid peroxidation and enhanced sensitivity to CCl4-induced liver damage, which was largely due to increased CYP2E1 expression because diallyl sulfide, an inhibitor of CYP2E1, prevented CCl4-induced liver injury."
25721086_2015.ann,EGCG,BTG2,7,The objectives of this study were to examine the effect of EGCG-induced BTG2 expression and the potential signal pathways involved.
19826045_2009.ann,azoxymethane,p53,7,The present study explores the effects of p53-modulating agent CP-31398 alone and combined with celecoxib on azoxymethane-induced aberrant crypt foci (ACF) and colon adenocarcinomas in F344 rats.
19427195_2009.ann,farnesylthiosalicyclic acid (FTS),Ras,7,The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats.
19427195_2009.ann,farnesylthiosalicyclic acid,Ras,7,The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats.
19427195_2009.ann,FTS,Ras,7,The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats.
11839677_2002.ann,"S-trans,trans-farnesylthiosalicylic acid",Ras,7,"The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human  tumor cells without causing resistance."
19074836_2008.ann,dibenzazepine,Notch,7,The rate of proliferation of  HT29 human colon cancer cells was reduced when treated with the gamma-secretase inhibitor dibenzazepine to inhibit Notch signaling or small interfering RNA directed against Notch.
14688030_2004.ann,o-nitrotoluene,tumor suppressor genes,7,The recently completed o-nitrotoluene study provided the first cecal tumor response and an opportunity to evaluate the  morphology and molecular profile of oncogenes and tumor suppressor genes that are relevant to humans.
14688030_2004.ann,o-nitrotoluene,oncogenes,7,The recently completed o-nitrotoluene study provided the first cecal tumor response and an opportunity to evaluate the  morphology and molecular profile of oncogenes and tumor suppressor genes that are relevant to humans.
19706164_2009.ann,celecoxib,p53,7,The role of p53 mutation in the anti-tumour responses of the selective COX-2 inhibitor celecoxib in human glioblastoma cells is unknown.
20093774_2010.ann,NNK,tumor suppressor gene,7,The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation  and tumor suppressor gene hypermethylation in mice and lung cancer patients.
17699782_2007.ann,tumor suppressor protein phosphatase,PTEN,7,The tumor suppressor protein phosphatase and tensin homologue deleted on chromosome ten (PTEN) plays an important role in intestinal cell proliferation and differentiation and tumor suppression by antagonizing phosphatidylinositol 3-kinase.
14563831_2004.ann,omega-3 PUFAs,lipogenic gene,7,"Therefore, we investigated whether lipogenic gene expression in tumor cells is differently regulated by omega-6 and omega-3 PUFAs."
15705887_2005.ann,S-adenosylhomocysteine,RFC1 mRNA,7,These animals had reduced (P < 0.05) colonic RFC1 mRNA and exhibited a 2-fold reduction in the plasma S-adenosylmethionine/S-adenosylhomocysteine.
25280562_2014.ann,resveratrol,Kras,7,These data indicate that resveratrol can prevent the formation  and growth of colorectal tumors by downregulating Kras expression.
15347726_2004.ann,131I,NIS gene,7,These results demonstrated that SK-Hep1-NIS could be selectively killed by the induced 131I and 188Re-perrhenate accumulation through NIS gene expression.
15347726_2004.ann,188Re-perrhenate,NIS gene,7,These results demonstrated that SK-Hep1-NIS could be selectively killed by the induced 131I and 188Re-perrhenate accumulation through NIS gene expression.
20682659_2010.ann,dasatinib,Src,7,These results establish a mechanistic rationale for Src inhibition with dasatinib as a therapeutic target in the treatment of pancreatic cancer and identify potential biomarkers of resistance to Src inhibition.
17428255_2007.ann,DEN,TSLC cascade,7,These results suggest that alterations to the TSLC cascade might have a role in hepatocarcinogenesis using DEN in rats.
19182440_2009.ann,SGE,Cyp1a1,7,"These results suggest that SGE suppresses the induction of Cyp1a1, leading to inhibition of ROS generation and consequently inhibited hepatocarcinogenesis, probably due to suppression of Ahr activity."
19182440_2009.ann,SGE,Ahr,7,"These results suggest that SGE suppresses the induction of Cyp1a1, leading to inhibition of ROS generation and consequently inhibited hepatocarcinogenesis, probably due to suppression of Ahr activity."
22700541_2012.ann,arsenic,Ha-ras,7,"These results suggested that gestational arsenic exposure induces tumor-augmenting changes, including oxidative stress and L1 activation, in a late-onset manner, which would particularly promote tumorigenic  expansion of cells with a C61A Ha-ras mutation."
14691202_2004.ann,arsenic,aberrant gene,7,This toxicogenomic analysis revealed several aberrant gene expression changes associated with transplacental arsenic carcinogenesis.
23112173_2012.ann,"1,25D",c-MYC,7,"Thus, 1,25D and the VDR regulate the c-MYC/MXD1 network to suppress c-MYC function, providing a molecular basis for cancer preventive actions of vitamin D."
26544897_2015.ann,5-FU,p53,7,"Thus, the final death outcome of 5-FU-treated p53-/- cells is demonstrated to be caspase-dependent, but due to a slow pace, accumulation of mitochondrial reactive oxygen species contributes to necrotic characteristics."
17172411_2006.ann,5-fluorouracil,TS,7,Thymidylate synthase (TS) overexpression is a key determinant of 5-fluorouracil (5-FU) resistance in human cancer cells.
17172411_2006.ann,5-fluorouracil (5-FU),TS,7,Thymidylate synthase (TS) overexpression is a key determinant of 5-fluorouracil (5-FU) resistance in human cancer cells.
17172411_2006.ann,5-FU,TS,7,Thymidylate synthase (TS) overexpression is a key determinant of 5-fluorouracil (5-FU) resistance in human cancer cells.
17172411_2006.ann,5-FU,Thymidylate synthase (TS),7,Thymidylate synthase (TS) overexpression is a key determinant of 5-fluorouracil (5-FU) resistance in human cancer cells.
17172411_2006.ann,5-fluorouracil (5-FU),Thymidylate synthase (TS),7,Thymidylate synthase (TS) overexpression is a key determinant of 5-fluorouracil (5-FU) resistance in human cancer cells.
17172411_2006.ann,5-fluorouracil,Thymidylate synthase (TS),7,Thymidylate synthase (TS) overexpression is a key determinant of 5-fluorouracil (5-FU) resistance in human cancer cells.
17172411_2006.ann,5-fluorouracil,Thymidylate synthase,7,Thymidylate synthase (TS) overexpression is a key determinant of 5-fluorouracil (5-FU) resistance in human cancer cells.
17172411_2006.ann,5-fluorouracil (5-FU),Thymidylate synthase,7,Thymidylate synthase (TS) overexpression is a key determinant of 5-fluorouracil (5-FU) resistance in human cancer cells.
17172411_2006.ann,5-FU,Thymidylate synthase,7,Thymidylate synthase (TS) overexpression is a key determinant of 5-fluorouracil (5-FU) resistance in human cancer cells.
17404573_2007.ann,beta-catenin,Bcl-2,7,"To examine the possible direct transcriptional regulation of rat Bcl-2 by  beta-catenin/Tcf, we cloned and characterized the corresponding promoter region and found 70.1% similarity with its human counterpart, BCL2."
20454513_2010.ann,silibinin,APC gene,7,"Together, these findings suggest that silibinin inhibits the growth of SW480 tumors carrying the mutant APC gene by down-regulating CDK8 and beta-catenin signaling and, therefore, could be an effective agent against CRC."
19237607_2009.ann,TOPflash luciferase,NDRG2,7,"TOPflash luciferase reporter assay showed that the transcriptional activity of T-cell factor (TCF)/lymphoid enhancer factor (LEF) was reduced by NDRG2 introduction, but not by the introduction of mutant NDRG2 generated by deletion or site-directed mutagenesis."
26187448_2015.ann,Toxaphene,Cyp2b10,7,"Toxaphene induced a significant increase in expression of constitutive androstane receptor  (CAR) target genes (Cyp2b10, Cyp3a11) at 32 and 320 ppm toxaphene."
26187448_2015.ann,Toxaphene,Cyp3a11,7,"Toxaphene induced a significant increase in expression of constitutive androstane receptor  (CAR) target genes (Cyp2b10, Cyp3a11) at 32 and 320 ppm toxaphene."
24104199_2014.ann,APAP,DAX-1,7,Treatment of HepG2 cells with APAP significantly reduced the expression of DAX-1 in a concentration-dependent manner.
17591676_2007.ann,DHEA,cytochrome P450 (P450) genes,7,"Treatment of rats with DHEA influences expression of cytochrome P450 (P450) genes, including peroxisome proliferator-activated receptor alpha (PPAR alpha)- and pregnane X receptor (PXR)-mediated induction of CYP4As and CYP3A23, and suppression of CYP2C11."
17591676_2007.ann,DHEA,cytochrome P450 genes,7,"Treatment of rats with DHEA influences expression of cytochrome P450 (P450) genes, including peroxisome proliferator-activated receptor alpha (PPAR alpha)- and pregnane X receptor (PXR)-mediated induction of CYP4As and CYP3A23, and suppression of CYP2C11."
17591676_2007.ann,DHEA,P450 genes,7,"Treatment of rats with DHEA influences expression of cytochrome P450 (P450) genes, including peroxisome proliferator-activated receptor alpha (PPAR alpha)- and pregnane X receptor (PXR)-mediated induction of CYP4As and CYP3A23, and suppression of CYP2C11."
17591676_2007.ann,DHEA,peroxisome proliferator-activated receptor alpha,7,"Treatment of rats with DHEA influences expression of cytochrome P450 (P450) genes, including peroxisome proliferator-activated receptor alpha (PPAR alpha)- and pregnane X receptor (PXR)-mediated induction of CYP4As and CYP3A23, and suppression of CYP2C11."
17591676_2007.ann,DHEA,peroxisome proliferator-activated receptor alpha (PPAR alpha)-,7,"Treatment of rats with DHEA influences expression of cytochrome P450 (P450) genes, including peroxisome proliferator-activated receptor alpha (PPAR alpha)- and pregnane X receptor (PXR)-mediated induction of CYP4As and CYP3A23, and suppression of CYP2C11."
17591676_2007.ann,DHEA,PPAR alpha,7,"Treatment of rats with DHEA influences expression of cytochrome P450 (P450) genes, including peroxisome proliferator-activated receptor alpha (PPAR alpha)- and pregnane X receptor (PXR)-mediated induction of CYP4As and CYP3A23, and suppression of CYP2C11."
17591676_2007.ann,DHEA,pregnane X receptor (PXR)-,7,"Treatment of rats with DHEA influences expression of cytochrome P450 (P450) genes, including peroxisome proliferator-activated receptor alpha (PPAR alpha)- and pregnane X receptor (PXR)-mediated induction of CYP4As and CYP3A23, and suppression of CYP2C11."
17591676_2007.ann,DHEA,pregnane X receptor,7,"Treatment of rats with DHEA influences expression of cytochrome P450 (P450) genes, including peroxisome proliferator-activated receptor alpha (PPAR alpha)- and pregnane X receptor (PXR)-mediated induction of CYP4As and CYP3A23, and suppression of CYP2C11."
17591676_2007.ann,DHEA,PXR,7,"Treatment of rats with DHEA influences expression of cytochrome P450 (P450) genes, including peroxisome proliferator-activated receptor alpha (PPAR alpha)- and pregnane X receptor (PXR)-mediated induction of CYP4As and CYP3A23, and suppression of CYP2C11."
17533171_2007.ann,oxazepam,Tsc-22,7,Treatment of these cells with oxazepam for 48 h also resulted in decreased Tsc-22 and increased Gadd45b expression.
17533171_2007.ann,oxazepam,Gadd45b,7,Treatment of these cells with oxazepam for 48 h also resulted in decreased Tsc-22 and increased Gadd45b expression.
24356455_2013.ann,5-AzaC,miR-9-3,7,"Treatment with 5-AzaC concomitantly upregulated expression of miR-9-3 and miR-193a, and downregulated their respective target genes NF-kappaB and Mcl-1."
24356455_2013.ann,5-AzaC,miR-193a,7,"Treatment with 5-AzaC concomitantly upregulated expression of miR-9-3 and miR-193a, and downregulated their respective target genes NF-kappaB and Mcl-1."
12717389_2003.ann,Troglitazone,Skp2,7,Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
14618613_2004.ann,Troglitazone,Skp2,7,Troglitazone potently inhibited proteasome activity and decreased Skp2 protein levels.
17172411_2006.ann,5-FU,TS,7,"TS is also acutely up-regulated with 5-FU treatment, and, thus, novel strategies targeting TS down-regulation seem to  be promising in terms of modulating 5-FU resistance."
25721086_2015.ann,epigallocatechin-3-gallate,B-cell translocation gene 2,7,Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
12839936_2003.ann,Ursodeoxycholic acid,Ras,7,"Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer."
17704804_2008.ann,omeprazole,IEX-1,7,"Using a xenograft tumor model in severe combined immune deficiency mice, we could show that experimental systemic hypergastrinemia induced by the administration of omeprazole led to enhanced apoptosis as well as to a marked increase of IEX-1 expression in Colo320wt tumors, but not in Colo320mut tumors."
26544897_2015.ann,caspase,p53,7,"Using several experimental approaches, we further conclude that RNA-rather than DNA-related stress follows by caspase activation irrespectively of p53 status."
18194346_2008.ann,phosphatidylinositol 3-kinase,COX-2 gene,7,UV exposure results in ligand-independent activation of the epidermal growth factor receptor and subsequent activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways leading to transcriptional activation of the COX-2 gene.
27458137_2016.ann,Irinotecan,miR-627,7,Vitamin D Enhances the Efficacy of Irinotecan through miR-627-Mediated Inhibition of Intratumoral Drug Metabolism.
23112173_2012.ann,Vitamin D,c-MYC,7,"Vitamin D signaling can suppress expression of genes regulated by c-MYC, a transcription factor that controls epidermal differentiation and cell proliferation and whose activity is frequently elevated in cancer."
18413810_2008.ann,Vitamin E succinate,NAG-1,7,Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism.
18413810_2008.ann,p38 kinase,NAG-1,7,Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism.
21543203_2012.ann,flavokawain B,p53,7,"We also  observed that flavokawain B caused the G2/M phase arrest that was mediated through reductions in the levels of cyclin A, cyclin B1, Cdc2 and Cdc25C and increases in p21/WAF1, Wee1 and p53 levels."
26918606_2016.ann,FOXM1,eEF2K gene,7,We also demonstrated that FOXM1 (1B and 1C isoforms) directly binds to and transcriptionally regulates eEF2K gene expression by chromatin immunoprecipitation (ChIP) and luciferase gene reporter assays.
27735939_2016.ann,pectolinarigenin,Bcl-2,7,"We also found pectolinarigenin significantly suppressed osteosarcoma cell proliferation, induced apoptosis and reduced the level of STAT3 downstream proteins cyclin D1, Survivin, B-cell lymphoma 2 (Bcl-2), B-cell lymphoma extra-large (Bcl-xl) and myeloid cell leukemia 1 (Mcl-1)."
17638894_2007.ann,gefitinib,HER2,7,"We characterized the effects of gefitinib on EGFR, HER2, and ErbB-3 phosphorylation by Western blot and determined the effects on downstream signaling through growth, survival, and stress pathways and the effect on proliferation, cell cycle, and apoptosis."
17638894_2007.ann,gefitinib,ErbB-3,7,"We characterized the effects of gefitinib on EGFR, HER2, and ErbB-3 phosphorylation by Western blot and determined the effects on downstream signaling through growth, survival, and stress pathways and the effect on proliferation, cell cycle, and apoptosis."
12800193_2003.ann,beta-catenin,follistatin,7,"We found 7 differentially expressed genes, cyclin D1, cyclin E, c-myc, Fosl1, c-fos, Cd44 and follistatin, which are known targets of the beta-catenin and/or the ras  pathway."
12800193_2003.ann,beta-catenin,Cd44,7,"We found 7 differentially expressed genes, cyclin D1, cyclin E, c-myc, Fosl1, c-fos, Cd44 and follistatin, which are known targets of the beta-catenin and/or the ras  pathway."
12800193_2003.ann,beta-catenin,c-fos,7,"We found 7 differentially expressed genes, cyclin D1, cyclin E, c-myc, Fosl1, c-fos, Cd44 and follistatin, which are known targets of the beta-catenin and/or the ras  pathway."
12800193_2003.ann,beta-catenin,Fosl1,7,"We found 7 differentially expressed genes, cyclin D1, cyclin E, c-myc, Fosl1, c-fos, Cd44 and follistatin, which are known targets of the beta-catenin and/or the ras  pathway."
12800193_2003.ann,beta-catenin,c-myc,7,"We found 7 differentially expressed genes, cyclin D1, cyclin E, c-myc, Fosl1, c-fos, Cd44 and follistatin, which are known targets of the beta-catenin and/or the ras  pathway."
12800193_2003.ann,beta-catenin,cyclin E,7,"We found 7 differentially expressed genes, cyclin D1, cyclin E, c-myc, Fosl1, c-fos, Cd44 and follistatin, which are known targets of the beta-catenin and/or the ras  pathway."
12800193_2003.ann,beta-catenin,cyclin D1,7,"We found 7 differentially expressed genes, cyclin D1, cyclin E, c-myc, Fosl1, c-fos, Cd44 and follistatin, which are known targets of the beta-catenin and/or the ras  pathway."
17533171_2007.ann,carcinogenic,Tsc-22,7,"We found Tsc-22 downregulation in livers from B6C3F1 mice following treatment for 2 weeks  with carcinogenic doses of the antianxiety drug oxazepam (2500 ppm) or the peroxisome proliferator Wyeth-14,643 (500 ppm) but not with two other carcinogens such as o-nitrotoluene or methyleugenol or three noncarcinogens including p-nitrotoluene, eugenol, or acetaminophen."
17533171_2007.ann,antianxiety drug oxazepam,Tsc-22,7,"We found Tsc-22 downregulation in livers from B6C3F1 mice following treatment for 2 weeks  with carcinogenic doses of the antianxiety drug oxazepam (2500 ppm) or the peroxisome proliferator Wyeth-14,643 (500 ppm) but not with two other carcinogens such as o-nitrotoluene or methyleugenol or three noncarcinogens including p-nitrotoluene, eugenol, or acetaminophen."
17533171_2007.ann,"Wyeth-14,643",Tsc-22,7,"We found Tsc-22 downregulation in livers from B6C3F1 mice following treatment for 2 weeks  with carcinogenic doses of the antianxiety drug oxazepam (2500 ppm) or the peroxisome proliferator Wyeth-14,643 (500 ppm) but not with two other carcinogens such as o-nitrotoluene or methyleugenol or three noncarcinogens including p-nitrotoluene, eugenol, or acetaminophen."
10774822_2000.ann,TCE,c-jun,7,We have previously reported  that TCE decreased methylation of the c-jun and c-myc genes and increased the level of their mRNAs.
10774822_2000.ann,TCE,c-myc,7,We have previously reported  that TCE decreased methylation of the c-jun and c-myc genes and increased the level of their mRNAs.
19934284_2009.ann,oligoamine analogues,aberrantly silenced genes,7,We hypothesized that a novel class of oligoamine analogues would effectively inhibit LSD1 and thus cause the reexpression of aberrantly silenced genes.
27458137_2016.ann,vitamin D,miR-627,7,We investigated the function of vitamin D-regulated miR-627 in intratumoral CYP3A4 suppression and its role in enhancing the efficacy of chemotherapy.
19706164_2009.ann,celecoxib,p53,7,"We investigated whether the anti-glioblastoma responses of celecoxib were p53-dependent, and whether celecoxib induced DNA damage leading to p53-dependent G1 cell cycle arrest, followed by autophagy or apoptosis."
18790750_2008.ann,caspase,p53,7,"We observed the induction of G(1)- and S-phase arrests and caspase-mediated apoptosis in the  androgen-dependent human LNCaP cells, which express wild-type p53, and in the androgen-independent, p53-mutant DU145 cells."
18790750_2008.ann,androgen,p53,7,"We observed the induction of G(1)- and S-phase arrests and caspase-mediated apoptosis in the  androgen-dependent human LNCaP cells, which express wild-type p53, and in the androgen-independent, p53-mutant DU145 cells."
19384949_2009.ann,HDACi,TS gene,7,We provide evidence that HDACi treatment  leads to a potent transcriptional repression of the TS gene.
18644992_2008.ann,NSAID,tumor suppressor gene,7,We show herein that induction of the tumor suppressor gene COOH-terminal Src kinase (Csk) by NSAID is important for their antiproliferative and hence chemopreventive effects.
12810952_2003.ann,aspirin,ODC A-allele,7,We show that individuals homozygous for the minor ODC A-allele who reported using aspirin are approximately 0.10 times as likely to have an adenoma recurrence as non-aspirin users homozygous for the major G-allele.
11839677_2002.ann,FTS,Ras,7,"We showed previously that S-trans,trans-farnesylthiosalicylic acid (FTS) disrupts Ras membrane anchorage and that this disturbance contributes to inhibition of cell transformation and tumor growth."
11839677_2002.ann,"S-trans,trans-farnesylthiosalicylic acid",Ras,7,"We showed previously that S-trans,trans-farnesylthiosalicylic acid (FTS) disrupts Ras membrane anchorage and that this disturbance contributes to inhibition of cell transformation and tumor growth."
11839677_2002.ann,"S-trans,trans-farnesylthiosalicylic acid (FTS)",Ras,7,"We showed previously that S-trans,trans-farnesylthiosalicylic acid (FTS) disrupts Ras membrane anchorage and that this disturbance contributes to inhibition of cell transformation and tumor growth."
15882924_2006.ann,YGK,E6/E7 oncogenes,7,"YGK significantly repressed E6/E7 oncogenes at the transcriptional level, with subsequent reactivation of p53 and p21 expression (P<0.01)."
15882924_2006.ann,YGK,p53,7,"YGK significantly repressed E6/E7 oncogenes at the transcriptional level, with subsequent reactivation of p53 and p21 expression (P<0.01)."
15882924_2006.ann,YGK,p21,7,"YGK significantly repressed E6/E7 oncogenes at the transcriptional level, with subsequent reactivation of p53 and p21 expression (P<0.01)."
17451858_2007.ann,arsenic,stress response genes,8, Other expression alterations observed in the arsenic-treated male mouse newborn liver included the overexpression of cdk-inhibitors and stress response genes including increased expression of metallothionein-1 and decreased expression of betaine-homocysteine methyltransferase and thioether S-methyltransferase.
18403868_2008.ann,DEHP,Ppar alpha,8,"A recent study revealed that  long-term exposure to relatively low-dose DEHP (0.05%) caused liver tumors including hepatocellular carcinomas, hepatocellular adenomas, and chologiocellular carcinomas at a higher incidence in Ppar alpha-null mice (25.8%) than in wild-type mice (10.0%)."
17715378_2007.ann,protein kinase,nonsteroidal anti-inflammatory drug-activated gene-1,8,Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells.
25895606_2015.ann,erlotinib,p53,8,"Additionally, co-treatment with RV and  erlotinib repressed the expressions of anti-apoptosis proteins, such as survivin  and Mcl-1, whereas promoted p53 and PUMA expression and caspase 3 activity."
12189186_2002.ann,chemopreventive agents,p27,8,"Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by  short-term treatment with chemopreventive agents."
12189186_2002.ann,chemopreventive agents,p16,8,"Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by  short-term treatment with chemopreventive agents."
12189186_2002.ann,chemopreventive agents,c-myc,8,"Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by  short-term treatment with chemopreventive agents."
19642983_2009.ann,betaine,p16,8,Assessment of the effect of betaine on p16 and c-myc DNA methylation and mRNA expression in a chemical induced rat liver cancer model.
19642983_2009.ann,betaine,c-myc,8,Assessment of the effect of betaine on p16 and c-myc DNA methylation and mRNA expression in a chemical induced rat liver cancer model.
18205319_2008.ann,BaA,cytochrome P450 1B1,8,Both BaA and MeBaAs had similar effects on the expression of cytochrome P450 1B1  or aldo-keto reductase 1C9 in rat liver epithelial WB-F344 cells.
18205319_2008.ann,BaA,aldo-keto reductase 1C9,8,Both BaA and MeBaAs had similar effects on the expression of cytochrome P450 1B1  or aldo-keto reductase 1C9 in rat liver epithelial WB-F344 cells.
20360939_2010.ann,DEN,p53,8,"CAPE plus DEN diminished the expression of cytochrome involved in DEN bioactivation such as CYP2B1 as well as  the expression of regulators of oxidative stress such as glutathione reductase, GST-kappa and GST-theta, and cell cycle regulators such as p53. Using CAPE as a tool, we uncovered new approaches for studying the altered expression of reactive genes and identifying proteins that will help to propose well-sustained and concrete hypothesis of DEN mechanism of hepatocarcinogenesis initiation."
9214390_1997.ann,TAg,K-rasVal12,8,Coexpression of K-rasVal12 and TAgWt produces dysplasia.
24113161_2013.ann,protein kinase A,MMP2,8,"Consistent with these findings, treatment with a protein kinase A (PKA) inhibitor decreased MMP2  and MMP9 expression levels in ADCY3-overexpressing cells."
24113161_2013.ann,protein kinase A,MMP9,8,"Consistent with these findings, treatment with a protein kinase A (PKA) inhibitor decreased MMP2  and MMP9 expression levels in ADCY3-overexpressing cells."
18381954_2008.ann,Curcumin,nuclear factor-kappaB-regulated gene,8,Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
20360939_2010.ann,DEN,p53,8,"DEN treatment increased the expression of genes associated with oxidative  stress such as glutathione reductase, genes involved in cell cycle regulation including p53, and modified cytochrome P450."
20360939_2010.ann,DEN,cytochrome P450,8,"DEN treatment increased the expression of genes associated with oxidative  stress such as glutathione reductase, genes involved in cell cycle regulation including p53, and modified cytochrome P450."
20360939_2010.ann,DEN,665 genes,8,"DEN treatment modified the expression of 665 genes, and CAPE plus DEN induced changes in 1371 genes."
20360939_2010.ann,CAPE,1371 genes,8,"DEN treatment modified the expression of 665 genes, and CAPE plus DEN induced changes in 1371 genes."
20360939_2010.ann,DEN,1371 genes,8,"DEN treatment modified the expression of 665 genes, and CAPE plus DEN induced changes in 1371 genes."
18403868_2008.ann,DEHP,Ppar alpha,8,Different mechanisms of DEHP-induced hepatocellular adenoma tumorigenesis in wild-type and Ppar alpha-null mice.
19711427_2009.ann,nuclear factor kappa B,miR-155 gene,8,DNA binding activity of nuclear factor kappa B (NF-kappaB) that transactivates miR-155 gene was significantly (P = 0.002) elevated in the liver nuclear extract of mice fed CDAA diet.
11181456_2001.ann,"2-amino-1-methyl-6-phenylimidazo (4,5-b)pyridine(PhIP)",Apc gene,8,"Early detection of 2-amino-1-methyl-6-phenylimidazo (4,5-b)pyridine(PhIP)-induced mutations within the Apc gene of rat colon."
11181456_2001.ann,"2-amino-1-methyl-6-phenylimidazo (4,5-b)pyridine",Apc gene,8,"Early detection of 2-amino-1-methyl-6-phenylimidazo (4,5-b)pyridine(PhIP)-induced mutations within the Apc gene of rat colon."
11181456_2001.ann,PhIP,Apc gene,8,"Early detection of 2-amino-1-methyl-6-phenylimidazo (4,5-b)pyridine(PhIP)-induced mutations within the Apc gene of rat colon."
11285198_2001.ann,PhIP,XPA,8,"Finally, PhIP appeared to be carcinogenic for XPA(-/-) mice at subtoxic doses."
18059344_2008.ann,NSAID,NF-kappaB target gene,8,"Finally, we demonstrate that NSAID-mediated nucleolar translocation of RelA is associated with downregulation  of NF-kappaB-driven transcription and of the NF-kappaB target gene, ICAM-1."
27512943_2016.ann,isoproterenol,Nanog,8,"Furthermore, the stress-associated hormone, isoproterenol, could increase the expression levels of ""stem""-related proteins, such as CD44, Nanog, and Rex-1, and induce chemoresistance in gastric cancer cells."
12839936_2003.ann,UDCA,Ras,8,"Furthermore, UDCA inhibited Cox-2 induction by Ras-dependent and -independent mechanisms."
9927046_1999.ann,sulindac,Apc,8,Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte  migration and response to sulindac.
25047426_2014.ann,Hesperidin,PTEN,8,Hesperidin treatment caused significant up-regulation of tumour suppressor phosphatase and tensin homologue (PTEN) with a reduction in the expression of AOM mediated p-PI3K and p-Akt.
9029167_1997.ann,N-nitrosomorpholine,p53 gene,8,Highly metastatic hepatocellular carcinomas induced in male F344 rats treated with N-nitrosomorpholine in combination with other hepatocarcinogens show a high  incidence of p53 gene mutations along with altered mRNA expression of tumor-related genes.
8968066_1996.ann,glyceryl trinitrate,p53,8,Histogenesis and the role of p53 and K-ras mutations in hepatocarcinogenesis by glyceryl trinitrate (nitroglycerin) in male F344 rats.
8968066_1996.ann,nitroglycerin,K-ras,8,Histogenesis and the role of p53 and K-ras mutations in hepatocarcinogenesis by glyceryl trinitrate (nitroglycerin) in male F344 rats.
8968066_1996.ann,nitroglycerin,p53,8,Histogenesis and the role of p53 and K-ras mutations in hepatocarcinogenesis by glyceryl trinitrate (nitroglycerin) in male F344 rats.
8968066_1996.ann,glyceryl trinitrate,K-ras,8,Histogenesis and the role of p53 and K-ras mutations in hepatocarcinogenesis by glyceryl trinitrate (nitroglycerin) in male F344 rats.
24912819_2014.ann,IBN-65,Bcl-2,8,"In addition, IBN-65 induced apoptosis by down-regulating Survivin, Bcl-2 and up-regulating Bax, leading to sequential activation of Caspase-3, Caspase-9 and the cleavage of poly(ADP-ribose) polymerase (PARP)."
23151022_2012.ann,metformin,Bcl-2,8,"In addition, metformin induced apoptosis in OSCC cells, significantly down-regulating the anti-apoptotic proteins Bcl-2 and Bcl-xL and up-regulating the pro-apoptotic protein Bax."
20061362_2010.ann,pterostilbene,c-MYC,8,"In HT-29 cells, pterostilbene reduced the protein levels of beta-catenin, cyclin D1 and c-MYC, altered the cellular localization of beta-catenin and inhibited the phosphorylation of p65."
20061362_2010.ann,pterostilbene,p65,8,"In HT-29 cells, pterostilbene reduced the protein levels of beta-catenin, cyclin D1 and c-MYC, altered the cellular localization of beta-catenin and inhibited the phosphorylation of p65. Our data with pterostilbene in suppressing colon tumorigenesis, cell proliferation as well as key inflammatory markers in vivo and in vitro suggest the potential use of pterostilbene for colon cancer prevention."
12839936_2003.ann,UDCA,Ras,8,"In summary, we have shown for the first time that UDCA suppressed the development of tumors with Ras  mutations and blocked activation of WT Ras."
12839936_2003.ann,AOM,Ras,8,"In the AOM alone group, Cox-2 was up-regulated >50-fold in tumors with normal Ras activity and further enhanced in  tumors with mutant or signaling-activated Ras."
12839936_2003.ann,UDCA,Ras,8,"In this study, we examined the role of Ras in Cox-2 inhibition by UDCA."
18202802_2008.ann,pectenotoxin-2,NAG-1,8,"Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells."
18202802_2008.ann,pectenotoxin-2,Bcl-2,8,"Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells."
17397030_2007.ann,5Aza-dC,SPARC,8,Induction of SPARC was demonstrated after treatment with the demethylating agent 5Aza-dC in 5 of the 7 cell lines.
17638894_2007.ann,gefitinib,HER3,8,"IR-5 bears a novel point mutation in the HER2/neu that corresponds to a L726I in the ATP-binding pocket and correlates with a log decrease in sensitivity to gefitinib, increased heterodimerization with EGFR and HER3, and impaired down-regulation."
11139434_2000.ann,Levamisole,bcl-2,8,"Levamisole increased in ECs  integrin-dependent matrix adhesion, inhibited proliferation (-70%), reduced expression of survival factors such as clusterin (-30%), endothelin-1 (-43%), bcl-2 (-34%), endothelial NO-synthase (-32%) and pRb (Retinoblastoma protein: -89%), and increased that of growth arrest/death signals such as p21 (+73%) and bak (+50%)."
10220499_1999.ann,PD98059,mucin gene MUC2,8,"Long-term pharmacological MAP kinase inhibition with the MEK inhibitor PD98059 induced expression of the terminal differentiation markers ITF, sucrase-isomaltase, and the mucin gene MUC2."
26956619_2016.ann,diaminothiazoles,p53,8,METHODS: In this study we have used p53 mutated and knock out colon cancer cells and xenograft tumours to study the role of p53 in apoptosis mediated by diaminothiazoles.
19726678_2009.ann,sorafenib,MicroRNA-122,8,MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.
21743489_2012.ann,cisplatin,NAC1,8,"Moreover, inhibition of autophagy and sensitization to cisplatin by NAC1 knockdown or inactivation were accompanied by induction of apoptosis."
11285198_2001.ann,PhIP,lacZ reporter gene,8,"Mutation  analysis in XPA(-/-) mice carrying a lacZ reporter gene, indicated that the observed toxicity of PhIP might be caused by genotoxic effects in the small intestine."
11285198_2001.ann,PhIP,XPA,8,"Mutation  analysis in XPA(-/-) mice carrying a lacZ reporter gene, indicated that the observed toxicity of PhIP might be caused by genotoxic effects in the small intestine."
7955063_1994.ann,trichloroethylene,H-ras,8,Mutations at codons 13 and 117 plus a second exon insert contributed 4% to the total H-ras frequencies for trichloroethylene and tetrachloroethylene.
7955063_1994.ann,tetrachloroethylene,H-ras,8,Mutations at codons 13 and 117 plus a second exon insert contributed 4% to the total H-ras frequencies for trichloroethylene and tetrachloroethylene.
25056574_2014.ann,Nestin,c-Myc,8,"Nestin silencing also upregulated Axin, glycogen synthase kinase-3 beta (GSK-3beta), adenomatous polyposis coli (APC), and peroxisome proliferator-activated receptor alpha (PPARa), and downregulated beta-catenin, c-Myc, cyclin D and MMP-7 expression in CSC."
23385063_2013.ann,AcEGCG,p53,8,"Notably, AcEGCG not only inhibited the expression of p53, p21, c-Myc, cyclin B, p-CDK1 and Cdc25A but also restored the activation of extracellular signal-regulated kinase 1/2 (ERK1/2), which decreased DMBA/TPA-induced increases in tumor proliferation and mitotic index."
23385063_2013.ann,AcEGCG,c-Myc,8,"Notably, AcEGCG not only inhibited the expression of p53, p21, c-Myc, cyclin B, p-CDK1 and Cdc25A but also restored the activation of extracellular signal-regulated kinase 1/2 (ERK1/2), which decreased DMBA/TPA-induced increases in tumor proliferation and mitotic index."
23676439_2014.ann,ubiquitin ligase,Notch1,8,"OBJECTIVE: FBXW7 encodes the substrate recognition component of a ubiquitin ligase that degrades targets such as Notch1, c-Jun, c-Myc and cyclin E."
23676439_2014.ann,ubiquitin ligase,c-Myc,8,"OBJECTIVE: FBXW7 encodes the substrate recognition component of a ubiquitin ligase that degrades targets such as Notch1, c-Jun, c-Myc and cyclin E."
12060674_2002.ann,methionine adenosyltransferase,MAT1A,8,"Of the two genes that encode methionine adenosyltransferase(MAT1Aand MAT2A), MAT1A is mainly expressed in adult liver whereas MAT2A is expressed in all extrahepatic tissues."
18205319_2008.ann,10-MeBaA,p53,8,"Only 10-MeBaA induced apoptosis and accumulation of phosphorylated p53, which could be associated with  the induction of oxidative stress, similar to DMBA."
17018589_2006.ann,5FU,TS alleles,8,"Our model predicts that the 5FU sensitivity of a tumor is modified by aneuploidy  producing copy number changes of TS alleles by one or more of the following: LOH, amplification, and, as presented here, copy number changes due to polysomy."
22761897_2012.ann,DEN,beta-catenin gene,8,Our studies also demonstrate that the utilized DEN/PB protocol in the WT C57BL/6 mice did not select for beta-catenin gene mutations during hepatocarcinogenesis.
22761897_2012.ann,PB,beta-catenin gene,8,Our studies also demonstrate that the utilized DEN/PB protocol in the WT C57BL/6 mice did not select for beta-catenin gene mutations during hepatocarcinogenesis.
21464044_2011.ann,Panobinostat,HER2,8,"Panobinostat treatment induced downregulation of EGFR, HER2, and HER3 mRNA and protein through transcriptional and posttranslational mechanisms."
11181456_2001.ann,PhIP,APC,8,PhIP in the diet for >43 weeks present colon tumors with specific -1G mutations within 5'-GGGA-3' sequences of the APC: gene.
11839677_2002.ann,farnesylcysteine carboxymethyl ester,Ras,8,"Ras transformation requires Ras membrane anchorage, which is promoted by a farnesylcysteine carboxymethyl ester and by additional sequences specific to each Ras isoform."
9214390_1997.ann,TAg,p53,8,Reentry is dependent upon the ability of TAg to bind pRB and is associated with a p53-independent apoptosis.
26673619_2016.ann,Cyclin-dependent Kinase 2,miR-372,8,RT-PCR and Western blot assays detected the expression of known targets of miR-372 in other malignant tumors and found Cyclin A1 and Cyclin-dependent Kinase 2 (CDK2) was downregulated by miR-372.
17417771_2007.ann,SAHA,p21(WAF1) promoter,8,"SAHA mediated acetylation of histone H3 globally, as well as, associated with the p21(WAF1) promoter, as measured by chromatin immunoprecipitation."
23144237_2013.ann,lapatinib,HER2,8,"Saracatinib enhanced the effects of lapatinib, an EGFR/HER2 dual inhibitor, in SNU216 and NCI-N87 cells."
11181456_2001.ann,carcinogens,Short G-rich repetitive sequences,8,Short G-rich repetitive sequences have been previously identified as hot-spots for frameshift mutagenesis induced by a large variety of carcinogens belonging to several families of widespread environmental pollutants.
18403868_2008.ann,DEHP,Gadd45a,8,"Taken together, DEHP may  induce hepatocellular adenomas, in part, via suppression of G2/M arrest regulated by Gadd45a and caspase 3-dependent apoptosis in Ppar alpha-null mice, but these genes may not be involved in tumorigenesis in the wild-type mice."
20689586_2010.ann,Protandim,p53,8,The chemopreventive effects of Protandim: modulation of p53 mitochondrial translocation and apoptosis during skin carcinogenesis.
11375891_2001.ann,NSAID,cyclooxygenase (COX) gene,8,"The classically recognized target for NSAID action are the two isoforms of the cyclooxygenase (COX) gene, which is responsible for prostaglandin production."
17018589_2006.ann,5FU,TS,8,The data suggest that TS copy number in a patient's tumor may be a dominating variable affecting 5FU responsiveness.
9214390_1997.ann,TAg,K-rasVal12,8,The dysplastic epithelium of K-rasVal12 x TAgWt mice does not develop neoplasms.
15705887_2005.ann,azoxymethane,folate transporter gene,8,The effect of folate transporter gene ablation on colon carcinogenesis was evaluated 8 and 38 weeks post-azoxymethane injection in wild-type and heterozygous mice.
7955063_1994.ann,tetrachloroethylene,H-ras codon 61,8,The H-ras codon 61 mutation frequency  for tetrachloroethylene-induced tumors was significantly lower (24%) than that of combined controls and also that of the two other chemicals.
9214390_1997.ann,TAg,K-rasVal12,8,The K-rasVal12-augmented apoptosis is unrelated to this dysplasia; enhanced apoptosis is also observed in  cycling nondysplastic enterocytes that produce K-rasVal12 and a TAg with a COOH-terminal truncation.
7955063_1994.ann,dichloroacetic acid,H-ras codon 61,8,The mutation spectra of H-ras codon 61 mutations showed a significant decrease in AAA and increase in CTA mutations for dichloroacetic acid- and trichloroethylene-induced  tumors when compared to combined controls.
7955063_1994.ann,trichloroethylene,H-ras codon 61,8,The mutation spectra of H-ras codon 61 mutations showed a significant decrease in AAA and increase in CTA mutations for dichloroacetic acid- and trichloroethylene-induced  tumors when compared to combined controls.
11285198_2001.ann,PhIP,XPA,8,"The results show that PhIP is extremely toxic to XPA(-/-) mice, even at doses 10-fold lower than tolerated by wild-type C57BL/6 mice."
7955063_1994.ann,tetrachloroethylene,K-ras,8,There was also a higher incidence of K-ras activation (13%) in tetrachloroethylene-induced tumors  than in the other chemically induced or control tumors.
15705887_2005.ann,S-adenosylmethionine,RFC1 mRNA,8,These animals had reduced (P < 0.05) colonic RFC1 mRNA and exhibited a 2-fold reduction in the plasma S-adenosylmethionine/S-adenosylhomocysteine.
7955063_1994.ann,dichloroacetic acid,codon 61 of H-ras,8,"These findings suggest that exposure to dichloroacetic acid, trichloroethylene and tetrachloroethylene provides a selective growth advantage to spontaneously occurring mutations in codon 61 of H-ras and, at the same time,  is responsible for a small number of unique molecular lesions suggestive of either a random genotoxic mode of action or a non-specific result of secondary DNA damage."
7955063_1994.ann,trichloroethylene,codon 61 of H-ras,8,"These findings suggest that exposure to dichloroacetic acid, trichloroethylene and tetrachloroethylene provides a selective growth advantage to spontaneously occurring mutations in codon 61 of H-ras and, at the same time,  is responsible for a small number of unique molecular lesions suggestive of either a random genotoxic mode of action or a non-specific result of secondary DNA damage."
7955063_1994.ann,tetrachloroethylene,codon 61 of H-ras,8,"These findings suggest that exposure to dichloroacetic acid, trichloroethylene and tetrachloroethylene provides a selective growth advantage to spontaneously occurring mutations in codon 61 of H-ras and, at the same time,  is responsible for a small number of unique molecular lesions suggestive of either a random genotoxic mode of action or a non-specific result of secondary DNA damage."
8200073_1994.ann,oxazepam,ras,8,"These results, together with those from the National Toxicology Program study showing no evidence of cytotoxicity or genotoxicity by oxazepam, suggest that oxazepam preferentially promotes cells that have activating lesions other than ras."
17018589_2006.ann,5-fluorouracil,TS,8,Thymidylate synthase (TS) is an important target for 5-fluorouracil (5FU)-based therapy.
17018589_2006.ann,5-fluorouracil (5FU),TS,8,Thymidylate synthase (TS) is an important target for 5-fluorouracil (5FU)-based therapy.
17018589_2006.ann,5FU,TS,8,Thymidylate synthase (TS) is an important target for 5-fluorouracil (5FU)-based therapy.
17018589_2006.ann,5FU,Thymidylate synthase (TS),8,Thymidylate synthase (TS) is an important target for 5-fluorouracil (5FU)-based therapy.
17018589_2006.ann,5-fluorouracil (5FU),Thymidylate synthase (TS),8,Thymidylate synthase (TS) is an important target for 5-fluorouracil (5FU)-based therapy.
17018589_2006.ann,5-fluorouracil,Thymidylate synthase (TS),8,Thymidylate synthase (TS) is an important target for 5-fluorouracil (5FU)-based therapy.
17018589_2006.ann,5-fluorouracil,Thymidylate synthase,8,Thymidylate synthase (TS) is an important target for 5-fluorouracil (5FU)-based therapy.
17018589_2006.ann,5-fluorouracil (5FU),Thymidylate synthase,8,Thymidylate synthase (TS) is an important target for 5-fluorouracil (5FU)-based therapy.
17018589_2006.ann,5FU,Thymidylate synthase,8,Thymidylate synthase (TS) is an important target for 5-fluorouracil (5FU)-based therapy.
8603461_1995.ann,DHEA,Ki-ras,8,"Tumors isolated from trout treated with DHEA alone contained mutations in Ki-ras, primarily codon 12[1] G-->A transitions, providing the first suggestive evidence that DHEA could  be a genotoxic carcinogen."
12839936_2003.ann,UDCA,Ras,8,UDCA significantly inhibited Cox-2 protein and mRNA levels in tumors with normal Ras activity.
17018589_2006.ann,5FU,TS gene,8,"Using genetic engineering, we deleted the short tandem repeat (two repeats) allele and retained the long (three repeats) allele to produce artificial LOH at the TS gene; the TS(+/-) line had a reduced TS protein expression and was hypersensitive to 5FU and 5-fluoro-2'-deoxyuridine in vitro as compared with syngeneic control lines."
17018589_2006.ann,5-fluoro-2'-deoxyuridine,TS gene,8,"Using genetic engineering, we deleted the short tandem repeat (two repeats) allele and retained the long (three repeats) allele to produce artificial LOH at the TS gene; the TS(+/-) line had a reduced TS protein expression and was hypersensitive to 5FU and 5-fluoro-2'-deoxyuridine in vitro as compared with syngeneic control lines."
9037065_1997.ann,matrilysin,Min,8,We analyzed matrilysin expression in benign intestinal tumors from mice heterozygous for the ApcMin allele (Min/+) and found that the mRNA was induced in the majority (88%) of these adenomas.
22700541_2012.ann,arsenic,Ha-ras,8,We explored tumor-promoting changes by gestational arsenic exposure with a focus on Ha-ras mutation and gene  expression changes.
21038412_2010.ann,glycogen synthase kinase-3 beta,miR-122,8,We further demonstrated that miR-122 suppressed insulin-like growth factor 1 receptor (IGF-1R) translation and sustained glycogen synthase kinase-3 beta (GSK-3beta) activity.
17823441_2007.ann,calcium,TRPM7 gene,9," OBJECTIVE: We aimed to test whether the association of colorectal polyps with intake of calcium, magnesium, or both and Thr1482Ile polymorphism in the TRPM7 gene is modified by the Ca:Mg intake."
17823441_2007.ann,magnesium,TRPM7 gene,9," OBJECTIVE: We aimed to test whether the association of colorectal polyps with intake of calcium, magnesium, or both and Thr1482Ile polymorphism in the TRPM7 gene is modified by the Ca:Mg intake."
27607580_2016.ann,drug combinations,BET-dependent genes,9,"Altogether, these results show that the identification of BET-dependent genes provides guidance for the choice of drug combinations in cancer treatment."
20454513_2010.ann,silibinin,c-Myc,9,"Analyses of xenografts showed that similar to cell culture findings, silibinin decreases proliferation and expression of beta-catenin, cyclin D1, c-Myc, and CDK8 but induces apoptosis in vivo."
18676755_2008.ann,5-fluorouracil,K-Ras,9,"Because combinations of anti-EGFR with 5-fluorouracil (5-FU)-based chemotherapy are promising treatments, we analyzed the effect of K-Ras mutations in patients having received exclusive 5-FU therapy."
18676755_2008.ann,5-FU,K-Ras,9,"Because combinations of anti-EGFR with 5-fluorouracil (5-FU)-based chemotherapy are promising treatments, we analyzed the effect of K-Ras mutations in patients having received exclusive 5-FU therapy."
23686482_2013.ann,MICA,MICA promoter,9,"Both Tyr(705) phosphorylation and binding of STAT3 on MICA promoter are reduced by GSK3 inhibitors; in addition, overexpression of a constitutively active form of STAT3  significantly inhibits MICA upregulation."
27207656_2016.ann,PhIP,Apc and Ctnnb1 genes,9,"By sequencing Apc and Ctnnb1 genes, we found that most PhIP-induced small intestinal tumors in obese mice carried only a single heterozygous mutation in Apc By bisulfite-sequencing of CpG islands of Apc, we found DNA hypermethylation in a CpG cluster located in its transcription  initiation site, which most likely caused the inactivation of the wild-type Apc allele."
28392392_2017.ann,circadian cycle genes - primarily transcription factors,Arntl,9,"Changes in circadian cycle genes - primarily transcription factors - showed strong concentration-related response at higher concentrations (Arntl, Npas2, and Clock were down-regulated; Cry2, Wee1, Bhlhe40, Per3, Nr1d1, Nr1d2 and Dbp) were up-regulated with similar directionality in both tissues."
28392392_2017.ann,circadian cycle genes - primarily transcription factors,Npas2,9,"Changes in circadian cycle genes - primarily transcription factors - showed strong concentration-related response at higher concentrations (Arntl, Npas2, and Clock were down-regulated; Cry2, Wee1, Bhlhe40, Per3, Nr1d1, Nr1d2 and Dbp) were up-regulated with similar directionality in both tissues."
28392392_2017.ann,circadian cycle genes - primarily transcription factors,Clock,9,"Changes in circadian cycle genes - primarily transcription factors - showed strong concentration-related response at higher concentrations (Arntl, Npas2, and Clock were down-regulated; Cry2, Wee1, Bhlhe40, Per3, Nr1d1, Nr1d2 and Dbp) were up-regulated with similar directionality in both tissues."
28392392_2017.ann,circadian cycle genes - primarily transcription factors,Bhlhe40,9,"Changes in circadian cycle genes - primarily transcription factors - showed strong concentration-related response at higher concentrations (Arntl, Npas2, and Clock were down-regulated; Cry2, Wee1, Bhlhe40, Per3, Nr1d1, Nr1d2 and Dbp) were up-regulated with similar directionality in both tissues."
28392392_2017.ann,circadian cycle genes - primarily transcription factors,Per3,9,"Changes in circadian cycle genes - primarily transcription factors - showed strong concentration-related response at higher concentrations (Arntl, Npas2, and Clock were down-regulated; Cry2, Wee1, Bhlhe40, Per3, Nr1d1, Nr1d2 and Dbp) were up-regulated with similar directionality in both tissues."
28392392_2017.ann,circadian cycle genes - primarily transcription factors,Nr1d1,9,"Changes in circadian cycle genes - primarily transcription factors - showed strong concentration-related response at higher concentrations (Arntl, Npas2, and Clock were down-regulated; Cry2, Wee1, Bhlhe40, Per3, Nr1d1, Nr1d2 and Dbp) were up-regulated with similar directionality in both tissues."
28392392_2017.ann,circadian cycle genes - primarily transcription factors,Nr1d2,9,"Changes in circadian cycle genes - primarily transcription factors - showed strong concentration-related response at higher concentrations (Arntl, Npas2, and Clock were down-regulated; Cry2, Wee1, Bhlhe40, Per3, Nr1d1, Nr1d2 and Dbp) were up-regulated with similar directionality in both tissues."
28392392_2017.ann,circadian cycle genes - primarily transcription factors,Dbp,9,"Changes in circadian cycle genes - primarily transcription factors - showed strong concentration-related response at higher concentrations (Arntl, Npas2, and Clock were down-regulated; Cry2, Wee1, Bhlhe40, Per3, Nr1d1, Nr1d2 and Dbp) were up-regulated with similar directionality in both tissues."
23824743_2013.ann,flavonoid isorhamnetin,oncogenic Src,9,Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is  mediated by oncogenic Src and beta-catenin.
27207670_2016.ann,ASA,IL-6,9,"Collectively, our results suggest that a potential novel epigenetic mechanism underlies the chemopreventive effects of ASA, and this mechanism attenuates CAC in AOM/DSS-induced CF-1 mice via the inhibition of HDACs and the modification of  H3K27ac marks that suppress iNOS, TNF-alpha and IL-6."
28230855_2017.ann,simvastatin,p21,9,"Consistently, we found that simvastatin also increased p21 and p27 expression in  tumor sections by reducing Skp2 expression and inducing AMPK activation and STAT3 suppression in the same tumor tissues."
28230855_2017.ann,simvastatin,p27,9,"Consistently, we found that simvastatin also increased p21 and p27 expression in  tumor sections by reducing Skp2 expression and inducing AMPK activation and STAT3 suppression in the same tumor tissues."
24037716_2014.ann,CpG island methylation,ALX4,9,"CpG island methylation and expression of ALX4 were evaluated by methylation-specific polymerase chain reaction (PCR), bisulfite genomic sequencing, reverse-transcription PCR and Western blotting."
24037716_2014.ann,CpG island hypermethylation,ALX4,9,Demethylation experiments further confirmed that loss of ALX4 expression  was regulated by CpG island hypermethylation.
30423403_2019.ann,DEN,NF-kappaB,9,"DEN-induced rats exhibited increased gene expression of NF-kappaB, COX-2, CYP2E1, VEGF, Bcl-2, PI3K/AKT/mTOR and significantly decreased the gene expression of p53, Bax, caspase-9 and caspase-3."
30423403_2019.ann,DEN,COX-2,9,"DEN-induced rats exhibited increased gene expression of NF-kappaB, COX-2, CYP2E1, VEGF, Bcl-2, PI3K/AKT/mTOR and significantly decreased the gene expression of p53, Bax, caspase-9 and caspase-3."
30423403_2019.ann,DEN,CYP2E1,9,"DEN-induced rats exhibited increased gene expression of NF-kappaB, COX-2, CYP2E1, VEGF, Bcl-2, PI3K/AKT/mTOR and significantly decreased the gene expression of p53, Bax, caspase-9 and caspase-3."
30423403_2019.ann,DEN,VEGF,9,"DEN-induced rats exhibited increased gene expression of NF-kappaB, COX-2, CYP2E1, VEGF, Bcl-2, PI3K/AKT/mTOR and significantly decreased the gene expression of p53, Bax, caspase-9 and caspase-3."
30423403_2019.ann,DEN,Bcl-2,9,"DEN-induced rats exhibited increased gene expression of NF-kappaB, COX-2, CYP2E1, VEGF, Bcl-2, PI3K/AKT/mTOR and significantly decreased the gene expression of p53, Bax, caspase-9 and caspase-3."
30423403_2019.ann,DEN,PI3K,9,"DEN-induced rats exhibited increased gene expression of NF-kappaB, COX-2, CYP2E1, VEGF, Bcl-2, PI3K/AKT/mTOR and significantly decreased the gene expression of p53, Bax, caspase-9 and caspase-3."
30423403_2019.ann,DEN,AKT,9,"DEN-induced rats exhibited increased gene expression of NF-kappaB, COX-2, CYP2E1, VEGF, Bcl-2, PI3K/AKT/mTOR and significantly decreased the gene expression of p53, Bax, caspase-9 and caspase-3."
30423403_2019.ann,DEN,mTOR,9,"DEN-induced rats exhibited increased gene expression of NF-kappaB, COX-2, CYP2E1, VEGF, Bcl-2, PI3K/AKT/mTOR and significantly decreased the gene expression of p53, Bax, caspase-9 and caspase-3."
26956619_2016.ann,diaminothiazoles,p53,9,"Dependence of diaminothiazoles, compounds that have gained importance recently due to their anticancer and anti angiogenic activities, were tested in cancer models with varying p53 or Ras/Raf mutational status."
11181456_2001.ann,"2-amino-1-methyl-6-phenylimidazo (4,5-b)pyridine",Apc gene,9,"Early detection of 2-amino-1-methyl-6-phenylimidazo (4,5-b)pyridine(PhIP)-induced mutations within the Apc gene of rat colon."
28214826_2017.ann,Emodin,Sp1,9,"Emodin also inhibited growth of lung xenograft tumors and Sp1, and increased IGFBP1 and PPARgamma protein expressions In vivo."
19221000_2009.ann,5Aza-C,methyl-CpG-binding domain 2,9,"Enzymatic assays showed genistein and 5Aza-C decreased DNA Methyltransferase, methyl-CpG-binding domain 2 activity and increased HAT activity."
19221000_2009.ann,DNA Methyltransferase,methyl-CpG-binding domain 2,9,"Enzymatic assays showed genistein and 5Aza-C decreased DNA Methyltransferase, methyl-CpG-binding domain 2 activity and increased HAT activity."
19221000_2009.ann,genistein,methyl-CpG-binding domain 2,9,"Enzymatic assays showed genistein and 5Aza-C decreased DNA Methyltransferase, methyl-CpG-binding domain 2 activity and increased HAT activity."
26956619_2016.ann,diaminothiazole,p53,9,ERK mediated upregulation of death receptor 5 overcomes the lack of p53 functionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells.
23032719_2013.ann,Evodiamine,STAT3-mediated genes,9,"Evodiamine also suppressed STAT3 DNA binding activity and down-regulated the expression of STAT3-mediated genes leading to the suppression of proliferation, induction of cell apoptosis and cell cycle arrest."
27624867_2017.ann,alternol,p38,9,"Exposure to alternol resulted in excessive reactive oxygen species (ROS) generation and Jun amino-terminal kinases (JNK), extracellular signal-regulated kinases (ERK1/2) and p38 activation."
27624867_2017.ann,reactive oxygen species (ROS),p38,9,"Exposure to alternol resulted in excessive reactive oxygen species (ROS) generation and Jun amino-terminal kinases (JNK), extracellular signal-regulated kinases (ERK1/2) and p38 activation."
27624867_2017.ann,reactive oxygen species,p38,9,"Exposure to alternol resulted in excessive reactive oxygen species (ROS) generation and Jun amino-terminal kinases (JNK), extracellular signal-regulated kinases (ERK1/2) and p38 activation."
27624867_2017.ann,ROS,p38,9,"Exposure to alternol resulted in excessive reactive oxygen species (ROS) generation and Jun amino-terminal kinases (JNK), extracellular signal-regulated kinases (ERK1/2) and p38 activation."
27831561_2016.ann,AOM,p53,9,"Finally, RNAseq analysis indicated that p53 signaling in Lgr5+ stem cells from mice exposed to AOM was uniquely upregulated only following n-3 PUFA+curcumin cotreatment."
27831561_2016.ann,n-3 PUFA,p53,9,"Finally, RNAseq analysis indicated that p53 signaling in Lgr5+ stem cells from mice exposed to AOM was uniquely upregulated only following n-3 PUFA+curcumin cotreatment."
27831561_2016.ann,curcumin,p53,9,"Finally, RNAseq analysis indicated that p53 signaling in Lgr5+ stem cells from mice exposed to AOM was uniquely upregulated only following n-3 PUFA+curcumin cotreatment."
24607276_2014.ann,FL3,gene knockdown,9,"Forced inhibition of p38 MAPK activity by the specific pharmacological inhibitor SB203580 or by p38 MAPK gene knockdown using small-interfering RNA (siRNA) counteracted the effects of FL3, demonstrating that its chemopreventive action is related to growth inhibition and a p38-dependent caspase-3-dependent induction of apoptosis in Oct4-expressing CSCs."
27706811_2017.ann,TA,oncogene,9,"From  the list of differentially expressed genes prioritized by transcriptome profiling, Mmp7, S100a9, Nppb and Aldh1a3 were defined as key oncogene candidates downregulated in colon tumors after TA treatment."
23620411_2013.ann,Japonicone A,NF-kappaB target genes,9,"Furthermore, exposure of cells to Japonicone A caused inactivation of the TNF-alpha-TAK1-IKK-NF-kappaB axis and inhibition of TNF-alpha-stimulated NF-kappaB activity and nuclear translocation,  followed by downregulation of NF-kappaB target genes involved in cell apoptosis (Bcl-2, Bcl-xL, XIAP, TRAF2) and in the cell cycle and growth (cyclin D, c-Myc)."
23620411_2013.ann,Japonicone A,c-Myc,9,"Furthermore, exposure of cells to Japonicone A caused inactivation of the TNF-alpha-TAK1-IKK-NF-kappaB axis and inhibition of TNF-alpha-stimulated NF-kappaB activity and nuclear translocation,  followed by downregulation of NF-kappaB target genes involved in cell apoptosis (Bcl-2, Bcl-xL, XIAP, TRAF2) and in the cell cycle and growth (cyclin D, c-Myc)."
25047426_2014.ann,hesperidin,c-myc,9,"Furthermore, hesperidin administration restored glycogen synthase kinase-3 beta (GSK-3beta) activity which in turn prevented the accumulation of oncoproteins beta-catenin, c-jun and c-myc."
23668310_2013.ann,TQ,c-myc,9,"Furthermore, upon TQ treatment, beta-catenin was retained at the membrane and c-myc decreased in the nucleus, which was associated with a reduced cell proliferation in the villi."
23934188_2014.ann,doxorubicin,miR-137,9,"Here, we report the inversely related expression of miR-137 and CAR in parental and doxorubicin-resistant neuroblastoma cells, wherein miR-137 is downregulated in resistant cells."
22120709_2012.ann,IGF ligand,Pten,9,"However, it remains unknown whether neoplasia associated with Pten loss is dependent on upstream IGF ligand supply in vivo."
15713900_2005.ann,sulindac,mda-7,9,"However, the combined effects of mda-7 and sulindac have not previously  been tested."
23934188_2014.ann,doxorubicin,miR-137,9,Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.
23668310_2013.ann,TQ,c-myc,9,"Immunohistochemistry for beta-catenin, c-myc, Ki-67 and TUNEL-staining was performed to investigate TQ's effect on major colorectal cancer pathways."
27144434_2016.ann,5-FU,p53,9,"In addition, ERK5 inhibition increased the response of HCT116 p53+/+ cells to 5-FU, but failed to sensitize HCT116 p53-/- cells to the cytotoxic effects of this chemotherapeutic agent, suggesting a p53-dependent  axis mediating 5-FU sensitization."
26716648_2016.ann,SHH inhibitors,IL-6,9,"In the intestinal epithelial cells IEC-6 and colon cancer cells HCT-116, IL-6 expression and its signaling were assessed with SHH inhibitors and levels of other inflammatory mediators, proliferation, apoptosis, tumorsphere formation, and tumorigenesis were also measured."
26716648_2016.ann,SHH inhibitors,IEC-6,9,"In the intestinal epithelial cells IEC-6 and colon cancer cells HCT-116, IL-6 expression and its signaling were assessed with SHH inhibitors and levels of other inflammatory mediators, proliferation, apoptosis, tumorsphere formation, and tumorigenesis were also measured."
26716648_2016.ann,SHH inhibitors,IL-6,9,"In the mouse model, SHH inhibitors significantly reduced tumor incidence and multiplicity, decreased the expression of IL-6, TNF-alpha, COX-2, STAT3, and NF-kappaB, and significantly induced apoptosis."
28230855_2017.ann,simvastatin,p21,9,"In this study, we demonstrated simvastatin-induced G0/G1 arrest by inducing p21 and p27 accumulation in HepG2 and Hep3B cells."
28230855_2017.ann,simvastatin,p27,9,"In this study, we demonstrated simvastatin-induced G0/G1 arrest by inducing p21 and p27 accumulation in HepG2 and Hep3B cells."
20971808_2010.ann,"1-(2-hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione",CEBPD,9,"In this study, we identified a novel CEBPD activator, 1-(2-hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione (HMDB)."
20971808_2010.ann,HMDB,CEBPD,9,"In this study, we identified a novel CEBPD activator, 1-(2-hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione (HMDB)."
20971808_2010.ann,"1-(2-hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione (HMDB)",CEBPD,9,"In this study, we identified a novel CEBPD activator, 1-(2-hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione (HMDB)."
23668310_2013.ann,TQ,c-myc,9,"In vitro, TQ activated GSK-3beta, which induced membranous localization of beta-catenin and reduced nuclear c-myc expression."
27006469_2016.ann,Iso-3,p21,9,"Iso-3 induced growth arrest of cancer cells in G0/G1 concomitant with increased p21 and p27 expression and reduced cyclin E1, PCNA and c-myc levels."
27006469_2016.ann,Iso-3,p27,9,"Iso-3 induced growth arrest of cancer cells in G0/G1 concomitant with increased p21 and p27 expression and reduced cyclin E1, PCNA and c-myc levels."
23824743_2013.ann,Isorhamnetin,c-Src,9,"Isorhamnetin inhibited AOM/DSS-induced oncogenic c-Src activation and beta-catenin nuclear translocation, while promoting the expression of C-terminal Src kinase (CSK), a negative regulator of Src family of tyrosine kinases."
18676755_2008.ann,fluoropyrimidine,K-Ras,9,K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
18413814_2008.ann,ligands,K-ras,9,K-ras mutations were assessed by PCR and mRNA for egfr ligands by quantitative real-time PCR.
17920061_2007.ann,progastrin,GAST gene,9,"METHODS: Stable or transient RNA silencing of the GAST gene was induced in human tumor cells and in mice carrying  a heterozygous Apc mutation (APCDelta14), which overexpress progastrin but not amidated or glycine-extended gastrin."
17920061_2007.ann,glycine,GAST gene,9,"METHODS: Stable or transient RNA silencing of the GAST gene was induced in human tumor cells and in mice carrying  a heterozygous Apc mutation (APCDelta14), which overexpress progastrin but not amidated or glycine-extended gastrin."
17920061_2007.ann,gastrin,GAST gene,9,"METHODS: Stable or transient RNA silencing of the GAST gene was induced in human tumor cells and in mice carrying  a heterozygous Apc mutation (APCDelta14), which overexpress progastrin but not amidated or glycine-extended gastrin."
28230855_2017.ann,Mevalonate,Skp2,9,"Mevalonate decreased simvastatin-induced AMPK activation and rescued phospho-STAT3 and Skp2 expression in HCC cells, which resulted in the prevention  of G0/G1 arrest through inhibition of p21 and p27 accumulation."
28230855_2017.ann,Mevalonate,p21,9,"Mevalonate decreased simvastatin-induced AMPK activation and rescued phospho-STAT3 and Skp2 expression in HCC cells, which resulted in the prevention  of G0/G1 arrest through inhibition of p21 and p27 accumulation."
28230855_2017.ann,Mevalonate,p27,9,"Mevalonate decreased simvastatin-induced AMPK activation and rescued phospho-STAT3 and Skp2 expression in HCC cells, which resulted in the prevention  of G0/G1 arrest through inhibition of p21 and p27 accumulation."
23934188_2014.ann,doxorubicin,miR-137,9,"miR-137 overexpression resulted in downregulation of CAR protein and mRNA (via mRNA degradation); it sensitized doxorubicin-resistant cells to doxorubicin (as shown  by reduced proliferation, increased apoptosis and increased G2-phase cell cycle arrest) and reduced the in vivo growth rate of neuroblastoma xenografts."
23934188_2014.ann,doxorubicin,miR-137,9,miR-137 regulates the constitutive androstane receptor and modulates doxorubicin  sensitivity in parental and doxorubicin-resistant neuroblastoma cells.
23032719_2013.ann,evodiamine,SHP-1 gene,9,"Moreover, inhibition of SHP-1 gene by small interference RNA abolished the ability of evodiamine to inhibit IL-6-induced STAT3 (Tyr(705)) activation."
23032719_2013.ann,evodiamine,interference RNA,9,"Moreover, inhibition of SHP-1 gene by small interference RNA abolished the ability of evodiamine to inhibit IL-6-induced STAT3 (Tyr(705)) activation."
27501171_2016.ann,vimentin,EMT-associated genes,9,"Moreover, miR-221 reduction resulted in alteration of EMT-associated genes such as E-cadherin and vimentin as well as significantly slower xenograft tumor growth in nude mice."
28214826_2017.ann,emodin,IGFBP1 gene,9,"Moreover, silencing of IGFBP1 gene blunted emodin-induced inhibition of cell growth and cell cycle arrest."
27831561_2016.ann,polyphenols,Wnt- and NF-kappaB- (nuclear factor-kappa light-chain  enhancer,9,Natural lipophilic polyphenols and long-chain polyunsaturated fatty acids (PUFAs) generally suppress Wnt- and NF-kappaB- (nuclear factor-kappa light-chain  enhancer of activated B-cell) related pathways.
27831561_2016.ann,polyunsaturated fatty acids (PUFAs),Wnt- and NF-kappaB- (nuclear factor-kappa light-chain  enhancer,9,Natural lipophilic polyphenols and long-chain polyunsaturated fatty acids (PUFAs) generally suppress Wnt- and NF-kappaB- (nuclear factor-kappa light-chain  enhancer of activated B-cell) related pathways.
27831561_2016.ann,polyunsaturated fatty acids,Wnt- and NF-kappaB- (nuclear factor-kappa light-chain  enhancer,9,Natural lipophilic polyphenols and long-chain polyunsaturated fatty acids (PUFAs) generally suppress Wnt- and NF-kappaB- (nuclear factor-kappa light-chain  enhancer of activated B-cell) related pathways.
27831561_2016.ann,PUFAs,Wnt- and NF-kappaB- (nuclear factor-kappa light-chain  enhancer,9,Natural lipophilic polyphenols and long-chain polyunsaturated fatty acids (PUFAs) generally suppress Wnt- and NF-kappaB- (nuclear factor-kappa light-chain  enhancer of activated B-cell) related pathways.
27486174_2016.ann,CX-5461,TP53,9,"Oral administration of 50 mg/kg CX-5461 induced TP53 expression and activity and reduced proliferation (MKI67) and invasion (loss of ductal actin) in Hi-MYC tumors, but not in PTEN-null (low MYC) tumors."
27486174_2016.ann,MKI67,TP53,9,"Oral administration of 50 mg/kg CX-5461 induced TP53 expression and activity and reduced proliferation (MKI67) and invasion (loss of ductal actin) in Hi-MYC tumors, but not in PTEN-null (low MYC) tumors."
20454513_2010.ann,silibinin,beta-catenin target genes,9,"Other studies, therefore, were performed only  in SW480 cells where silibinin significantly decreased beta-catenin-dependent T-cell factor-4 (TCF-4) transcriptional activity and protein expression of beta-catenin target genes such as c-Myc and cyclin D1."
20454513_2010.ann,silibinin,c-Myc,9,"Other studies, therefore, were performed only  in SW480 cells where silibinin significantly decreased beta-catenin-dependent T-cell factor-4 (TCF-4) transcriptional activity and protein expression of beta-catenin target genes such as c-Myc and cyclin D1."
23824743_2013.ann,isorhamnetin,oncogenic Src,9,"Our observations suggest the chemoprotective effects of isorhamnetin in colon cancer are linked to its anti-inflammatory activities and its inhibition of oncogenic Src activity and consequential loss of nuclear beta-catenin, activities that are dependent on CSK  expression."
18701434_2008.ann,ADN,WIF1 gene,9,Our results showed that ADN time dependently stimulated WIF1 gene and protein expressions in MDA-MB-231 cells.
24268029_2013.ann,telomerase,PinX1,9,"Overexpression of PinX1 resulted in G1/S phase arrest and cell growth/proliferation inhibition, while silencing PinX1 led to acceleration of G1/S transition, and cell growth/proliferation promotion by inhibiting/enhancing telomerase activity and via the p16/cyclin D1 pathway."
24268029_2013.ann,telomerase,PinX1,9,"Overexpression of PinX1 resulted in G1/S phase arrest and cell growth/proliferation inhibition, while silencing PinX1 led to acceleration of G1/S transition, and cell growth/proliferation promotion by inhibiting/enhancing telomerase activity and via the p16/cyclin D1 pathway."
19652364_2009.ann,progastrin,gastrin gene,9,"Overexpression of progastrin, a nonamidated and incompletely processed product of the gastrin gene, has been shown to induce colonic hyperproliferation and promote colorectal cancer in mice, but the mechanism of pathogenesis has not been defined."
24268029_2013.ann,telomerase,PinX1,9,PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.
27578530_2016.ann,DRD2  inhibitor,DRD2,9,"RNA interference knockdown of DRD2 in pancreatic tumor cells reduced growth of xenograft tumors in mice, and administration of the DRD2  inhibitor haloperidol to mice with orthotopic xenograft tumors reduced final tumor size and metastasis."
23824743_2013.ann,isorhamnetin,oncogenic Src,9,"Similarly, in HT-29 colon cancer cells, isorhamnetin inhibited oncogenic Src activity and beta-catenin nuclear translocation by inducing expression of csk, as verified by RNA interference knockdown of csk."
28230855_2017.ann,Simvastatin,Skp2,9,"Simvastatin decreased Skp2 expression at the transcriptional level, which resulted in p27 accumulation  by preventing proteasomal degradation, an effect mediated by signal transducer and activator of transcription 3 (STAT3) inhibition."
28230855_2017.ann,Simvastatin,p27,9,"Simvastatin decreased Skp2 expression at the transcriptional level, which resulted in p27 accumulation  by preventing proteasomal degradation, an effect mediated by signal transducer and activator of transcription 3 (STAT3) inhibition."
27729552_2016.ann,transcription factor,p38,9,"Specifically, coregulation of the kinases p38 and ERK, the translation regulator 4EBP1, and the transcription factor CREB in proliferating normal colon cells was lost in CRC."
15713900_2005.ann,Sulindac,mda-7,9,Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in  human lung cancer.
26716648_2016.ann,SHH inhibitors,IL-6,9,"Taken together, our data suggest that administration of SHH inhibitors could be an effective strategy to prevent colitis-induced colorectal carcinogenesis, mainly by targeting IL-6 signaling, ablating CSCs, and suppressing oncogenic inflammation, achieving chemoquiescence ultimately."
28230855_2017.ann,simvastatin,p21,9,"Taken together, these findings are demonstrative of the existence of a novel pathway in which simvastatin induces G0/G1 arrest by upregulating p21 and p27 by activating AMPK and inhibiting the STAT3-Skp2 axis, respectively."
28230855_2017.ann,simvastatin,p27,9,"Taken together, these findings are demonstrative of the existence of a novel pathway in which simvastatin induces G0/G1 arrest by upregulating p21 and p27 by activating AMPK and inhibiting the STAT3-Skp2 axis, respectively."
28126350_2017.ann,P anaerobius,gene expression profiling,9,"The colon epithelial cell line NCM460 and colon cancer cell lines HT-29 and Caco-2 were exposed to P anaerobius or control bacteria; cells were analyzed by immunoblot, proliferation, and bacterial attachment analyses and compared in gene expression profiling studies."
23766363_2013.ann,limonoid,c-Myc,9,"The limonoid-treated xenografts exhibited significant downregulation in the expression of proteins involved in tumor cell survival (Bcl-2, Bcl-xL, c-IAP-1, survivin, and Mcl-1), proliferation (c-Myc and cyclin D1), invasion (MMP-9, ICAM-1), metastasis (CXCR4), and angiogenesis (VEGF)."
23934188_2014.ann,doxorubicin,miR-137,9,"These findings  demonstrate that miR-137 is a crucial regulator of cancer response to doxorubicin treatment, and they identify miR-137 as a highly promising target to reduce CAR-driven doxorubicin resistance."
28214826_2017.ann,emodin,IGFBP1 gene,9,"Thus, the signaling cascades, positive feedback loop and cooperative interplay between transcription factors-induced the expression of IGFBP1 gene contribute to the overall responses of emodin."
21743489_2012.ann,3-methyladenosine,beclin 1,9,"To confirm  that the sensitizing effect of NAC1 inhibition on the cytotoxicity of cisplatin was attributed to suppression of autophagy, we assessed the effects of the autophagy inhibitors 3-methyladenosine and chloroquine, and small interfering RNAs (siRNAs) targeting beclin 1 or Atg5 on the cytotoxicity of cisplatin."
21743489_2012.ann,3-methyladenosine,Atg5,9,"To confirm  that the sensitizing effect of NAC1 inhibition on the cytotoxicity of cisplatin was attributed to suppression of autophagy, we assessed the effects of the autophagy inhibitors 3-methyladenosine and chloroquine, and small interfering RNAs (siRNAs) targeting beclin 1 or Atg5 on the cytotoxicity of cisplatin."
21743489_2012.ann,cisplatin,Atg5,9,"To confirm  that the sensitizing effect of NAC1 inhibition on the cytotoxicity of cisplatin was attributed to suppression of autophagy, we assessed the effects of the autophagy inhibitors 3-methyladenosine and chloroquine, and small interfering RNAs (siRNAs) targeting beclin 1 or Atg5 on the cytotoxicity of cisplatin."
21743489_2012.ann,cisplatin,beclin 1,9,"To confirm  that the sensitizing effect of NAC1 inhibition on the cytotoxicity of cisplatin was attributed to suppression of autophagy, we assessed the effects of the autophagy inhibitors 3-methyladenosine and chloroquine, and small interfering RNAs (siRNAs) targeting beclin 1 or Atg5 on the cytotoxicity of cisplatin."
23934188_2014.ann,doxorubicin,miR-137,9,"We observed similar results in cellular models of hepatocellular and colon cancers,  indicating that the doxorubicin-sensitizing effect of miR-137 is not tumor type-specific."
